{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-08-23 23:06:54", "record_count": 1211, "schema_variant": "rights-safe-core-v1", "text_redistribution": "Source-derived abstracts, descriptions, keywords, and unrestricted payload text are not redistributed." }, "papers": [ { "id": 4197, "title": "Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.", "authors": "Husein A, Traylor M, Vest MF, Wood BJ, Brogan M, Thomas A, McNeil S, Bhuiyan MAN, Hendricks P, Kelly JR, Gribben A, Al-Qahtani MM, Keys K, Edinoff AN, Patterson JC, Murnane KS", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1177/28314425251381806", "pubmed_id": "42539773", "openalex_id": "https://openalex.org/W7117566828", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539773/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:27:44", "bibtex": null, "source_record_id": "PMID:42539773", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42539773/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42539773", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539773/", "doi": "10.1177/28314425251381806", "pmid": "42539773", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1990, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.", "authors": "Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1177/28314425251404460", "pubmed_id": "42539893", "openalex_id": "https://openalex.org/W7116873484", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:27:44", "bibtex": null, "source_record_id": "PMID:42539893", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42539893", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42539893/", "doi": "10.1177/28314425251404460", "pmid": "42539893", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 51, "title": "Balancing safety and access in Oregon’s psilocybin services", "authors": "Cheung Katherine, Propes Caleigh, Yaden David B.", "journal": "International Journal of Drug Policy", "publication_date": "2026-09-01", "publication_year": 2026, "doi": "10.1016/j.drugpo.2026.105384", "pubmed_id": "42288041", "openalex_id": "https://openalex.org/W7164654902", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105384", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42288041", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2026.105384", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42288041", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105384", "doi": "10.1016/j.drugpo.2026.105384", "pmid": "42288041", "publication_date": "2026-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5875, "title": "JAMA study examines Oregon's psilocybin services model", "authors": "Canady Valerie A.", "journal": "Mental Health Weekly", "publication_date": "2026-08-24", "publication_year": 2026, "doi": "10.1002/mhw.34984", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203871494", "source_url": "https://doi.org/10.1002/mhw.34984", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-22 01:20:15", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34984", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/mhw.34984", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1002/mhw.34984", "source_url": "https://doi.org/10.1002/mhw.34984", "doi": "10.1002/mhw.34984", "pmid": "", "publication_date": "2026-08-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5876, "title": "Complex Fatal Self-Harm Under Psilocybin Intoxication: Suicidal Manner of Death or Not?", "authors": "Labonté Caleb, Walker Alfredo E.", "journal": "Academic Forensic Pathology", "publication_date": "2026-08-21", "publication_year": 2026, "doi": "10.1177/19253621261468084", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203928864", "source_url": "https://doi.org/10.1177/19253621261468084", "substance_tags": "psilocybin,psilocin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-22 01:20:15", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.1177/19253621261468084", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/19253621261468084", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1177/19253621261468084", "source_url": "https://doi.org/10.1177/19253621261468084", "doi": "10.1177/19253621261468084", "pmid": "", "publication_date": "2026-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5877, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review", "authors": "Clark Rachel N", "journal": "Lynchburg Journal of Medical Science", "publication_date": "2026-08-20", "publication_year": 2026, "doi": "10.63932/3067-7106.1087", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.63932/3067-7106.1087", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-22 01:20:15", "last_checked": "2026-08-23 01:20:15", "bibtex": null, "source_record_id": "DOI:10.63932/3067-7106.1087", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.63932/3067-7106.1087", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.63932/3067-7106.1087", "source_url": "https://doi.org/10.63932/3067-7106.1087", "doi": "10.63932/3067-7106.1087", "pmid": "", "publication_date": "2026-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5872, "title": "Psilocybin in the Treatment of Methamphetamine Use Disorder", "authors": "Peter Hendricks", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07774702", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-08-20 01:29:20", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07774702", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07774702", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07774702", "source_url": "https://clinicaltrials.gov/study/NCT07774702", "doi": "", "pmid": "", "publication_date": "2026-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5870, "title": "Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation service", "authors": "Harrison, H. V.; Gaillard, M.; Cook, R. R.; Sarparast, A.; Levander, X. A.", "journal": "medRxiv", "publication_date": "2026-08-19", "publication_year": 2026, "doi": "10.64898/2026.08.17.26360633", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.08.17.26360633", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-08-20 01:20:38", "last_checked": "2026-08-23 01:20:34", "bibtex": null, "source_record_id": "DOI:10.64898/2026.08.17.26360633", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.08.17.26360633", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.08.17.26360633", "source_url": "https://doi.org/10.64898/2026.08.17.26360633", "doi": "10.64898/2026.08.17.26360633", "pmid": "", "publication_date": "2026-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5868, "title": "The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing", "authors": "Page Jeni, Moore Alexandra, Hawkins Bridget E., Lyons Elizabeth J., Lorenzo Elizabeth", "journal": "Frontiers in Psychiatry", "publication_date": "2026-08-19", "publication_year": 2026, "doi": "10.3389/fpsyt.2026.1866881", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2026.1866881", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Microdosing,Wellbeing,Creativity,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-20 01:20:15", "last_checked": "2026-08-23 01:20:15", "bibtex": null, "source_record_id": "DOI:10.3389/fpsyt.2026.1866881", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2026.1866881", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3389/fpsyt.2026.1866881", "source_url": "https://doi.org/10.3389/fpsyt.2026.1866881", "doi": "10.3389/fpsyt.2026.1866881", "pmid": "", "publication_date": "2026-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5867, "title": "Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services", "authors": "Korthuis P. Todd, Cook Ryan R., Gregoire Devin, Stauffer Christopher S., Luoma Jason B., Pertl Kellie, Des Jarlais Don, McCarty Dennis, Levander Ximena A., Hoffman Kim A., Wilson-Poe Adrianne R.", "journal": "JAMA Network Open", "publication_date": "2026-08-19", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.30608", "pubmed_id": "42616497", "openalex_id": "https://openalex.org/W7203781486", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.30608", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Observational Study,Veterans,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-20 01:20:15", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "PMID:42616497", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.30608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42616497", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.30608", "doi": "10.1001/jamanetworkopen.2026.30608", "pmid": "42616497", "publication_date": "2026-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5719, "title": "Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants", "authors": "Mason, N. L.; Haijen-Bongers, E. C.; Kuypers, K. P. C.; Frick, A.; Toennes, S. W.; Mallaroni, P.; Ramaekers, J. G.", "journal": "bioRxiv", "publication_date": "2026-08-19", "publication_year": 2026, "doi": "10.64898/2026.07.08.737179", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.07.08.737179", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-14 01:27:23", "last_checked": "2026-08-21 01:26:27", "bibtex": null, "source_record_id": "DOI:10.64898/2026.07.08.737179", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.07.08.737179", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.07.08.737179", "source_url": "https://doi.org/10.64898/2026.07.08.737179", "doi": "10.64898/2026.07.08.737179", "pmid": "", "publication_date": "2026-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5869, "title": "The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies", "authors": "Michael J. Broman, Jhuma N. Acharya, Kaltum Ahmed, Stacey B. Armstrong, Alan K. Davis", "journal": "Current Addiction Reports", "publication_date": "2026-08-18", "publication_year": 2026, "doi": "10.1007/s40429-026-00774-8", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203711549", "source_url": "https://doi.org/10.1007/s40429-026-00774-8", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-20 01:20:19", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.1007/s40429-026-00774-8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40429-026-00774-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40429-026-00774-8", "source_url": "https://doi.org/10.1007/s40429-026-00774-8", "doi": "10.1007/s40429-026-00774-8", "pmid": "", "publication_date": "2026-08-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3490, "title": "A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07570654", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07570654", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "source_url": "https://clinicaltrials.gov/study/NCT07570654", "doi": "", "pmid": "", "publication_date": "2026-08-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5866, "title": "Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care", "authors": "Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements", "journal": null, "publication_date": "2026-08-17", "publication_year": 2026, "doi": "10.5281/zenodo.21983116", "pubmed_id": null, "openalex_id": "https://openalex.org/W7203633773", "source_url": "https://doi.org/10.5281/zenodo.21983116", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-19 01:20:25", "last_checked": "2026-08-23 01:20:19", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21983116", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21983116", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21983116", "source_url": "https://doi.org/10.5281/zenodo.21983116", "doi": "10.5281/zenodo.21983116", "pmid": "", "publication_date": "2026-08-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5865, "title": "Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.", "authors": "Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B.", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-08-17", "publication_year": 2026, "doi": "10.1177/02698811261473436", "pubmed_id": "42609034", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811261473436", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-19 01:20:04", "last_checked": "2026-08-23 01:20:15", "bibtex": null, "source_record_id": "PMID:42609034", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811261473436", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42609034", "source_url": "https://doi.org/10.1177/02698811261473436", "doi": "10.1177/02698811261473436", "pmid": "42609034", "publication_date": "2026-08-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5742, "title": "An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life", "authors": "Charles Raison", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07719088", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Mechanism of Action,Biomarkers,Aging,Epigenetics,Cellular Senescence,Longevity,Oxidative Stress,Wellbeing,Clinical Trial,Observational Study,Animal Study,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-23 01:25:56", "last_checked": "2026-08-23 01:23:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07719088", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07719088", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07719088", "source_url": "https://clinicaltrials.gov/study/NCT07719088", "doi": "", "pmid": "", "publication_date": "2026-08-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5864, "title": "Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.", "authors": "Kelly C, Cooley BJ, Zeng L, Hurzeler T, Manning V, McNally GP, Watt J, Haber PS, Morley KC.", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2026-08-14", "publication_year": 2026, "doi": "10.1016/j.neubiorev.2026.106911", "pubmed_id": "42600962", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106911", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Systematic Review,Review Article,Animal Study,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-16 01:20:05", "last_checked": "2026-08-21 01:20:41", "bibtex": null, "source_record_id": "PMID:42600962", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2026.106911", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42600962", "source_url": "https://doi.org/10.1016/j.neubiorev.2026.106911", "doi": "10.1016/j.neubiorev.2026.106911", "pmid": "42600962", "publication_date": "2026-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3626, "title": "The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults", "authors": "Region Skane", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07169747", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-21 01:27:47", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07169747", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "source_url": "https://clinicaltrials.gov/study/NCT07169747", "doi": "", "pmid": "", "publication_date": "2026-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3602, "title": "Safety for Home Administration of Microdose Psilocybin Use", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06450210", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-21 01:27:46", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06450210", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06450210", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06450210", "source_url": "https://clinicaltrials.gov/study/NCT06450210", "doi": "", "pmid": "", "publication_date": "2026-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3472, "title": "A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans", "authors": "VA Office of Research and Development", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07226232", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-21 01:27:46", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07226232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "source_url": "https://clinicaltrials.gov/study/NCT07226232", "doi": "", "pmid": "", "publication_date": "2026-08-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5862, "title": "Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.", "authors": "Meshkat S, Leung M, Meshkat S, Lin Q, Wijendran D, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Monson CM, Vermetten E, Jetly R, Lou W, Zeifman RJ, Bhat V.", "journal": "CNS drugs", "publication_date": "2026-08-13", "publication_year": 2026, "doi": "10.1007/s40263-026-01325-5", "pubmed_id": "42593636", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-026-01325-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Microdosing,Personality Change,Creativity,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-15 01:20:04", "last_checked": "2026-08-20 01:20:16", "bibtex": null, "source_record_id": "PMID:42593636", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-026-01325-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42593636", "source_url": "https://doi.org/10.1007/s40263-026-01325-5", "doi": "10.1007/s40263-026-01325-5", "pmid": "42593636", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3562, "title": "Processing Intergenerational Trauma With Psilocybin-Assisted Therapy", "authors": "Rachel Yehuda", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06899165", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Biomarkers,Wellbeing,Resilience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06899165", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "source_url": "https://clinicaltrials.gov/study/NCT06899165", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3485, "title": "PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)", "authors": "Nathan Brashares Sackett", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06853912", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06853912", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "source_url": "https://clinicaltrials.gov/study/NCT06853912", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3440, "title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial", "authors": "Brigham and Women's Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296094", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-20 01:29:20", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296094", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "source_url": "https://clinicaltrials.gov/study/NCT07296094", "doi": "", "pmid": "", "publication_date": "2026-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5861, "title": "Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework", "authors": "Anthony L. Back, Robert Bosnak", "journal": "Frontiers in Psychiatry", "publication_date": "2026-08-12", "publication_year": 2026, "doi": "10.3389/fpsyt.2026.1895181", "pubmed_id": null, "openalex_id": "https://openalex.org/W7202255093", "source_url": "https://doi.org/10.3389/fpsyt.2026.1895181", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Creativity,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-14 01:20:19", "last_checked": "2026-08-19 01:20:25", "bibtex": null, "source_record_id": "DOI:10.3389/fpsyt.2026.1895181", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2026.1895181", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/fpsyt.2026.1895181", "source_url": "https://doi.org/10.3389/fpsyt.2026.1895181", "doi": "10.3389/fpsyt.2026.1895181", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5859, "title": "Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and Colorado", "authors": "Thompson, S.; Effinger, D.; Novick, A.; Bates, S.; Conley, A.; Tobin-Cambell, C.; Epperson, N.; Skievaski, N.", "journal": "medRxiv", "publication_date": "2026-08-12", "publication_year": 2026, "doi": "10.64898/2026.08.11.26360133", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.08.11.26360133", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Wellbeing,Mystical Experience,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-08-13 01:20:49", "last_checked": "2026-08-19 01:20:41", "bibtex": null, "source_record_id": "DOI:10.64898/2026.08.11.26360133", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.08.11.26360133", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.08.11.26360133", "source_url": "https://doi.org/10.64898/2026.08.11.26360133", "doi": "10.64898/2026.08.11.26360133", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5856, "title": "Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)", "authors": "Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria", "journal": "Journal of Clinical Medicine", "publication_date": "2026-08-12", "publication_year": 2026, "doi": "10.3390/jcm15166228", "pubmed_id": null, "openalex_id": "https://openalex.org/W7202254245", "source_url": "https://doi.org/10.3390/jcm15166228", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-13 01:20:21", "last_checked": "2026-08-19 01:20:25", "bibtex": null, "source_record_id": "DOI:10.3390/jcm15166228", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/jcm15166228", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3390/jcm15166228", "source_url": "https://doi.org/10.3390/jcm15166228", "doi": "10.3390/jcm15166228", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3684, "title": "TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06200155", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06200155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "source_url": "https://clinicaltrials.gov/study/NCT06200155", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3674, "title": "TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06801041", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06801041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "source_url": "https://clinicaltrials.gov/study/NCT06801041", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3581, "title": "Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality", "authors": "The University of Texas Health Science Center, Houston", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06706232", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06706232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "source_url": "https://clinicaltrials.gov/study/NCT06706232", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3574, "title": "Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids", "authors": "Roswell Park Cancer Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06827054", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Spirituality,Clinical Trial,Cancer Patients,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06827054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "source_url": "https://clinicaltrials.gov/study/NCT06827054", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3426, "title": "A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder", "authors": "Claudio N Soares", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06969170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-19 01:24:01", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06969170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "source_url": "https://clinicaltrials.gov/study/NCT06969170", "doi": "", "pmid": "", "publication_date": "2026-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5847, "title": "An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.", "authors": "Kothiwala FM, Murphy RJ, Alshakhouri M, Douglass HM, Evans WJ, Paterson T, Muthukumaraswamy S, Sumner RL.", "journal": "Pharmacology", "publication_date": "2026-08-10", "publication_year": 2026, "doi": "10.1159/pha/aejag002", "pubmed_id": "42574302", "openalex_id": "https://openalex.org/W7202192981", "source_url": "https://doi.org/10.1159/pha/aejag002", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Healthy Volunteers,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-11 01:20:06", "last_checked": "2026-08-17 01:20:29", "bibtex": null, "source_record_id": "PMID:42574302", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1159/pha/aejag002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42574302", "source_url": "https://doi.org/10.1159/pha/aejag002", "doi": "10.1159/pha/aejag002", "pmid": "42574302", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3532, "title": "A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05711940", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05711940", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "source_url": "https://clinicaltrials.gov/study/NCT05711940", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3531, "title": "Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury", "authors": "James J. Peters Veterans Affairs Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07251491", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Wellbeing,Veterans,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07251491", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "source_url": "https://clinicaltrials.gov/study/NCT07251491", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3521, "title": "A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05624268", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05624268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "source_url": "https://clinicaltrials.gov/study/NCT05624268", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3495, "title": "A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07516405", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-17 01:21:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07516405", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "source_url": "https://clinicaltrials.gov/study/NCT07516405", "doi": "", "pmid": "", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3262, "title": "'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.", "authors": "Ham R, Gardner J, Carter A, Liknaitzky P.", "journal": "Psychology and psychotherapy", "publication_date": "2026-08-10", "publication_year": 2026, "doi": "10.1111/papt.70098", "pubmed_id": "42572818", "openalex_id": null, "source_url": "https://doi.org/10.1111/papt.70098", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-17 01:20:29", "bibtex": null, "source_record_id": "PMID:42572818", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/papt.70098", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42572818", "source_url": "https://doi.org/10.1111/papt.70098", "doi": "10.1111/papt.70098", "pmid": "42572818", "publication_date": "2026-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5784, "title": "Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.", "authors": "Dean JG, Hurwitz E, Furnish T, Castellanos J, McKinty A, Farrell B, Barrows D, Peck SK, Trim J, Samadhi E, Renwick G, Mudge R, Vieten C, Cuccurazzu B, Coleman P, Lin A, Geyer MA, Zeidan F, Halberstadt AL.", "journal": "The journal of pain", "publication_date": "2026-08-07", "publication_year": 2026, "doi": "10.1016/j.jpain.2026.106404", "pubmed_id": "42567236", "openalex_id": "https://openalex.org/W7201834409", "source_url": "https://doi.org/10.1016/j.jpain.2026.106404", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-08 01:20:18", "last_checked": "2026-08-14 01:20:15", "bibtex": null, "source_record_id": "PMID:42567236", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpain.2026.106404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42567236", "source_url": "https://doi.org/10.1016/j.jpain.2026.106404", "doi": "10.1016/j.jpain.2026.106404", "pmid": "42567236", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5781, "title": "Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.", "authors": "Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA.", "journal": "CNS drugs", "publication_date": "2026-08-07", "publication_year": 2026, "doi": "10.1007/s40263-026-01326-4", "pubmed_id": "42566154", "openalex_id": "https://openalex.org/W7201866252", "source_url": "https://doi.org/10.1007/s40263-026-01326-4", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Consciousness,Clinical Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-08 01:20:06", "last_checked": "2026-08-14 01:20:19", "bibtex": null, "source_record_id": "PMID:42566154", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-026-01326-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42566154", "source_url": "https://doi.org/10.1007/s40263-026-01326-4", "doi": "10.1007/s40263-026-01326-4", "pmid": "42566154", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5746, "title": "Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease", "authors": "National Institute on Aging (NIA)", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07721467", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Mitochondrial Function,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Older Adults,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-24 01:25:24", "last_checked": "2026-08-14 01:24:53", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07721467", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07721467", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07721467", "source_url": "https://clinicaltrials.gov/study/NCT07721467", "doi": "", "pmid": "", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3561, "title": "The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06455293", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Microdosing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-14 01:24:53", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06455293", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06455293", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06455293", "source_url": "https://clinicaltrials.gov/study/NCT06455293", "doi": "", "pmid": "", "publication_date": "2026-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5782, "title": "Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.", "authors": "Giovenzana M, Nicosia N, Spinosa S, Musazzi L, Mingardi J.", "journal": "Pharmacological research", "publication_date": "2026-08-06", "publication_year": 2026, "doi": "10.1016/j.phrs.2026.108366", "pubmed_id": "42562081", "openalex_id": "https://openalex.org/W7196936402", "source_url": "https://doi.org/10.1016/j.phrs.2026.108366", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Receptor Pharmacology,Emotional Processing,Observational Study,Animal Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-08 01:20:07", "last_checked": "2026-08-13 01:20:27", "bibtex": null, "source_record_id": "PMID:42562081", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.phrs.2026.108366", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42562081", "source_url": "https://doi.org/10.1016/j.phrs.2026.108366", "doi": "10.1016/j.phrs.2026.108366", "pmid": "42562081", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3704, "title": "Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder", "authors": "Trent Emerick", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07406828", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07406828", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "source_url": "https://clinicaltrials.gov/study/NCT07406828", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3582, "title": "Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731621", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "source_url": "https://clinicaltrials.gov/study/NCT06731621", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3507, "title": "An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy", "authors": "University of Southern California", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06233344", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Spirituality,Clinical Trial,Observational Study,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-13 01:25:57", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06233344", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "source_url": "https://clinicaltrials.gov/study/NCT06233344", "doi": "", "pmid": "", "publication_date": "2026-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3437, "title": "Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06001749", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-12 01:27:30", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06001749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "source_url": "https://clinicaltrials.gov/study/NCT06001749", "doi": "", "pmid": "", "publication_date": "2026-08-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 240, "title": "Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review.", "authors": "Thomas JE, Dellarole A, Caballero J", "journal": "American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists", "publication_date": "2026-08-05", "publication_year": 2026, "doi": "10.1093/ajhp/zxag062", "pubmed_id": "41784123", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41784123/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Randomized Controlled Trial,Systematic Review,Review Article,Veterans,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-12 01:20:06", "bibtex": null, "source_record_id": "PMID:41784123", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41784123/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41784123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41784123/", "doi": "10.1093/ajhp/zxag062", "pmid": "41784123", "publication_date": "2026-08-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5846, "title": "Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07745569", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Brain Imaging,Aging,Emotional Processing,Observational Study,Safety,Transcriptomics", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-08-09 10:12:43", "last_checked": "2026-08-11 01:26:59", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07745569", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07745569", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07745569", "source_url": "https://clinicaltrials.gov/study/NCT07745569", "doi": "", "pmid": "", "publication_date": "2026-08-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5776, "title": "Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.", "authors": "Kuypers KPC, Mason NL, Carlier A, Totomanova I, Haijen-Bongers ECHM.", "journal": "Molecular psychiatry", "publication_date": "2026-08-04", "publication_year": 2026, "doi": "10.1038/s41380-026-03801-2", "pubmed_id": "42552418", "openalex_id": "https://openalex.org/W7172382485", "source_url": "https://doi.org/10.1038/s41380-026-03801-2", "substance_tags": "psilocin", "topic_tags": "Depression,Anxiety,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Longevity,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-06 01:20:05", "last_checked": "2026-08-11 01:20:23", "bibtex": null, "source_record_id": "PMID:42552418", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-026-03801-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42552418", "source_url": "https://doi.org/10.1038/s41380-026-03801-2", "doi": "10.1038/s41380-026-03801-2", "pmid": "42552418", "publication_date": "2026-08-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5773, "title": "Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.", "authors": "Schaefer DA, Agrawal M, Mazzola E, Leff MK, Leeks C, Kematick BS, Beaussant Y.", "journal": "Journal of pain and symptom management", "publication_date": "2026-08-03", "publication_year": 2026, "doi": "10.1016/j.jpainsymman.2026.07.030", "pubmed_id": "42546985", "openalex_id": "https://openalex.org/W7172261546", "source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-08-04 01:20:19", "last_checked": "2026-08-10 01:20:17", "bibtex": null, "source_record_id": "PMID:42546985", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42546985", "source_url": "https://doi.org/10.1016/j.jpainsymman.2026.07.030", "doi": "10.1016/j.jpainsymman.2026.07.030", "pmid": "42546985", "publication_date": "2026-08-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3565, "title": "Psilocybin as a Treatment for Chronic Pain in Smokers", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07118332", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-10 01:26:25", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07118332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "source_url": "https://clinicaltrials.gov/study/NCT07118332", "doi": "", "pmid": "", "publication_date": "2026-08-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3455, "title": "Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study", "authors": "Oregon Health and Science University", "journal": "ClinicalTrials.gov", "publication_date": "2026-08-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06988319", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-10 01:26:25", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06988319", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06988319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06988319", "source_url": "https://clinicaltrials.gov/study/NCT06988319", "doi": "", "pmid": "", "publication_date": "2026-08-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5752, "title": "Evaluating psilocybin for the management of depression: a literature review", "authors": "Sinclair Rachel", "journal": "British Journal of Mental Health Nursing", "publication_date": "2026-08-02", "publication_year": 2026, "doi": "10.12968/bjmh.2025.0020", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171361377", "source_url": "https://doi.org/10.12968/bjmh.2025.0020", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Microdosing,Wellbeing,Review Article,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-29 01:20:18", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.12968/bjmh.2025.0020", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.12968/bjmh.2025.0020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.12968/bjmh.2025.0020", "source_url": "https://doi.org/10.12968/bjmh.2025.0020", "doi": "10.12968/bjmh.2025.0020", "pmid": "", "publication_date": "2026-08-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5762, "title": "Cardiovascular safety of psilocybin in psychiatric practice: a narrative review", "authors": "Szarpak Lukasz, Pruc Michal, Swieczkowski Damian, Rybczynski Bernard, Pieta Aleksandra, Cubała Wiesław Jerzy", "journal": "European Journal of Clinical Pharmacology", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1007/s00228-026-04151-2", "pubmed_id": "42538465", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00228-026-04151-2", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-01 01:20:18", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42538465", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1007/s00228-026-04151-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42538465", "source_url": "https://doi.org/10.1007/s00228-026-04151-2", "doi": "10.1007/s00228-026-04151-2", "pmid": "42538465", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 66, "title": "Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.", "authors": "Boehnke KF, Pouyan N, Aday JS", "journal": "Drugs", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1007/s40265-026-02339-5", "pubmed_id": "42243569", "openalex_id": "https://openalex.org/W7163536837", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42243569/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Animal Study,Healthcare Workers,Safety,Drug Interactions,Contraindications,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42243569", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42243569/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42243569", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42243569/", "doi": "10.1007/s40265-026-02339-5", "pmid": "42243569", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 49, "title": "Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.", "authors": "Guimarães AL, Beserra FR, Cruz L, Bienemmann B, Freind JMK, Guinle V, Rodrigues RS, Regalado JA, Mograbi DC", "journal": "Clinical therapeutics", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.clinthera.2026.05.012", "pubmed_id": "42288429", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42288429/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42288429", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42288429/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42288429", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42288429/", "doi": "10.1016/j.clinthera.2026.05.012", "pmid": "42288429", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2, "title": "Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.", "authors": "Berg CJ, LoParco CR, Rossheim ME, McCready DM, Langan L, Platt E, Romm KF, Johnson M, Speer MB, Burris S, Cavazos-Rehg PA", "journal": "Drug and alcohol dependence", "publication_date": "2026-08-01", "publication_year": 2026, "doi": "10.1016/j.drugalcdep.2026.113218", "pubmed_id": "42224931", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42224931/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42224931", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42224931/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42224931", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42224931/", "doi": "10.1016/j.drugalcdep.2026.113218", "pmid": "42224931", "publication_date": "2026-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5767, "title": "The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and Setting", "authors": "Eric P. Rubenstein", "journal": "International Journal For Multidisciplinary Research", "publication_date": "2026-07-31", "publication_year": 2026, "doi": "10.36948/ijfmr.2026.v08i04.84804", "pubmed_id": null, "openalex_id": "https://openalex.org/W7172008736", "source_url": "https://doi.org/10.36948/ijfmr.2026.v08i04.84804", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-02 01:20:21", "last_checked": "2026-08-09 08:24:59", "bibtex": null, "source_record_id": "DOI:10.36948/ijfmr.2026.v08i04.84804", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36948/ijfmr.2026.v08i04.84804", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36948/ijfmr.2026.v08i04.84804", "source_url": "https://doi.org/10.36948/ijfmr.2026.v08i04.84804", "doi": "10.36948/ijfmr.2026.v08i04.84804", "pmid": "", "publication_date": "2026-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3576, "title": "A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-31", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07336238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07336238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "source_url": "https://clinicaltrials.gov/study/NCT07336238", "doi": "", "pmid": "", "publication_date": "2026-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5770, "title": "Retreat from racism: A psychedelic group experience for racial stress and trauma", "authors": "Sergio R Pérez Rosal, Sonya Faber, M. Myriah MacIntyre, Monnica Williams", "journal": "Psychedelics", "publication_date": "2026-07-30", "publication_year": 2026, "doi": "10.1016/j.psyche.2026.100031", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171783611", "source_url": "https://doi.org/10.1016/j.psyche.2026.100031", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Mechanism of Action,Wellbeing,Spirituality,Psychological Flexibility,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-03 01:20:22", "last_checked": "2026-08-09 08:24:59", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2026.100031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2026.100031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2026.100031", "source_url": "https://doi.org/10.1016/j.psyche.2026.100031", "doi": "10.1016/j.psyche.2026.100031", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5764, "title": "Childhood trauma and psychological outcomes following psychedelic use: a scoping review", "authors": "Lorraine Li, Paige Seath, Nadav Liam Modlin, James Rucker", "journal": "npj Mental Health Research", "publication_date": "2026-07-30", "publication_year": 2026, "doi": "10.1038/s44184-026-00233-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171830787", "source_url": "https://doi.org/10.1038/s44184-026-00233-2", "substance_tags": "psilocybin", "topic_tags": "Resilience,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-01 01:20:23", "last_checked": "2026-08-09 08:24:59", "bibtex": null, "source_record_id": "DOI:10.1038/s44184-026-00233-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s44184-026-00233-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1038/s44184-026-00233-2", "source_url": "https://doi.org/10.1038/s44184-026-00233-2", "doi": "10.1038/s44184-026-00233-2", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5760, "title": "Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress Disorder", "authors": "Tel-Aviv Sourasky Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07737054", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-31 01:27:07", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07737054", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07737054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07737054", "source_url": "https://clinicaltrials.gov/study/NCT07737054", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5759, "title": "Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial", "authors": "Armstrong Stacey B., Levin Adam W., Sepeda Nathan D., Shaub Hillary, Hunter Taweh, Douglas Angela, Lancelotta Rafaelle, Davis Alan K.", "journal": "Communications Medicine", "publication_date": "2026-07-30", "publication_year": 2026, "doi": "10.1038/s43856-026-01767-4", "pubmed_id": "42533157", "openalex_id": "https://openalex.org/W7171854693", "source_url": "https://doi.org/10.1038/s43856-026-01767-4", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-31 01:20:20", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42533157", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s43856-026-01767-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42533157", "source_url": "https://doi.org/10.1038/s43856-026-01767-4", "doi": "10.1038/s43856-026-01767-4", "pmid": "42533157", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3591, "title": "Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06518720", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06518720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "source_url": "https://clinicaltrials.gov/study/NCT06518720", "doi": "", "pmid": "", "publication_date": "2026-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3654, "title": "An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD", "authors": "Scottsdale Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07275970", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07275970", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "source_url": "https://clinicaltrials.gov/study/NCT07275970", "doi": "", "pmid": "", "publication_date": "2026-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3542, "title": "Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05866471", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05866471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "source_url": "https://clinicaltrials.gov/study/NCT05866471", "doi": "", "pmid": "", "publication_date": "2026-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3529, "title": "Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06299319", "substance_tags": "psilocybin", "topic_tags": "Addiction,OCD,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Case Report,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06299319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "source_url": "https://clinicaltrials.gov/study/NCT06299319", "doi": "", "pmid": "", "publication_date": "2026-07-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5788, "title": "Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review", "authors": "Nicholas Vucak, Raimondo Bruno, Julio Quealy, James G. Casimaty, Susan L. Rossell, D Castle, Nicola Acevedo", "journal": "Psychedelics", "publication_date": "2026-07-26", "publication_year": 2026, "doi": "10.1016/j.psyche.2026.100030", "pubmed_id": null, "openalex_id": "https://openalex.org/W7171322300", "source_url": "https://doi.org/10.1016/j.psyche.2026.100030", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Randomized Controlled Trial,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:00", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.1016/j.psyche.2026.100030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psyche.2026.100030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psyche.2026.100030", "source_url": "https://doi.org/10.1016/j.psyche.2026.100030", "doi": "10.1016/j.psyche.2026.100030", "pmid": "", "publication_date": "2026-07-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3590, "title": "Psilocybin and Affective Function in Chronic Lower Back Pain Depression", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06355414", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Observational Study,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06355414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "source_url": "https://clinicaltrials.gov/study/NCT06355414", "doi": "", "pmid": "", "publication_date": "2026-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5744, "title": "Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response Model", "authors": "Tyler WJ, Sellers E, McDonnell MB.", "journal": "bioRxiv", "publication_date": "2026-07-23", "publication_year": 2026, "doi": "10.64898/2026.07.19.739440", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.07.19.739440", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,Mechanism of Action,Receptor Pharmacology,Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-24 01:20:23", "last_checked": "2026-08-09 08:14:49", "bibtex": null, "source_record_id": "DOI:10.64898/2026.07.19.739440", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.07.19.739440", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.07.19.739440", "source_url": "https://doi.org/10.64898/2026.07.19.739440", "doi": "10.64898/2026.07.19.739440", "pmid": "", "publication_date": "2026-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3710, "title": "A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.", "authors": "Francisco A Moreno", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07347405", "substance_tags": "psilocybin", "topic_tags": "OCD,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07347405", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07347405", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07347405", "source_url": "https://clinicaltrials.gov/study/NCT07347405", "doi": "", "pmid": "", "publication_date": "2026-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3615, "title": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06308653", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06308653", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "source_url": "https://clinicaltrials.gov/study/NCT06308653", "doi": "", "pmid": "", "publication_date": "2026-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5740, "title": "Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations", "authors": "Cervera-Sanchez Miguel Benjamin, San-Juan Daniel, Díaz-Peregrino Roberto, Camacho-Castillo Evelin Zulema, Bringas-Ortiz Sthefany Anahi, Padilla-Cabezutd Christian", "journal": "British Journal of Clinical Pharmacology", "publication_date": "2026-07-21", "publication_year": 2026, "doi": "10.1002/bcp.70690", "pubmed_id": "42482371", "openalex_id": null, "source_url": "https://doi.org/10.1002/bcp.70690", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-23 01:20:05", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42482371", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/bcp.70690", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42482371", "source_url": "https://doi.org/10.1002/bcp.70690", "doi": "10.1002/bcp.70690", "pmid": "42482371", "publication_date": "2026-07-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3522, "title": "Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06814522", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Biomarkers,Wellbeing,Emotional Processing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06814522", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "source_url": "https://clinicaltrials.gov/study/NCT06814522", "doi": "", "pmid": "", "publication_date": "2026-07-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5845, "title": "The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07610369", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-08-09 10:12:43", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07610369", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "source_url": "https://clinicaltrials.gov/study/NCT07610369", "doi": "", "pmid": "", "publication_date": "2026-07-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5737, "title": "Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis", "authors": "Tsang Vivian WL, Kryskow Pamela, Watler Crosbie, Allard Pearl, Dames Shannon", "journal": "Frontiers in Public Health", "publication_date": "2026-07-20", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1767215", "pubmed_id": "42548601", "openalex_id": "https://openalex.org/W7169758970", "source_url": "https://doi.org/10.3389/fpubh.2026.1767215", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Resilience,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-21 01:20:20", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42548601", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1767215", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42548601", "source_url": "https://doi.org/10.3389/fpubh.2026.1767215", "doi": "10.3389/fpubh.2026.1767215", "pmid": "42548601", "publication_date": "2026-07-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5736, "title": "A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults", "authors": "Levy-Cooperman N, Sellers E, Glue P, Szeto I, Brown D, Jarecki-Smith J, Tyler WJ, McDonnell MB.", "journal": "medRxiv", "publication_date": "2026-07-19", "publication_year": 2026, "doi": "10.64898/2026.07.16.26358273", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.07.16.26358273", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-20 01:20:48", "last_checked": "2026-08-09 08:14:49", "bibtex": null, "source_record_id": "DOI:10.64898/2026.07.16.26358273", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.07.16.26358273", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.07.16.26358273", "source_url": "https://doi.org/10.64898/2026.07.16.26358273", "doi": "10.64898/2026.07.16.26358273", "pmid": "", "publication_date": "2026-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5734, "title": "Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression", "authors": "Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra Blicharz, Wojciech Kozdraś, Lidia Kozaczko, Gabriela Szewczyk, Elżbieta Bukowczan, Alicja Zając, Damian Broda, Alicja Benecka", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-07-17", "publication_year": 2026, "doi": "10.5281/zenodo.21406174", "pubmed_id": null, "openalex_id": "https://openalex.org/W7169604178", "source_url": "https://doi.org/10.5281/zenodo.21406174", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-19 01:20:13", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.21406174", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.21406174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.21406174", "source_url": "https://doi.org/10.5281/zenodo.21406174", "doi": "10.5281/zenodo.21406174", "pmid": "", "publication_date": "2026-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5731, "title": "A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin", "authors": "Diamond Therapeutics Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07710027", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Review Article,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-18 01:24:24", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07710027", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07710027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07710027", "source_url": "https://clinicaltrials.gov/study/NCT07710027", "doi": "", "pmid": "", "publication_date": "2026-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5735, "title": "Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder", "authors": "Jakub Bajer, Aleksandra Włodarczyk, Hubert Kulawinek, Julia Obersztyn, Krzysztof Kasparek, Marta Czech, Grzegorz Kasparek, Adrianna Szczecińska, Wiktoria Glanert, Aleksandra Mliczek, Piotr Mrozek", "journal": "Journal of Education Health and Sport", "publication_date": "2026-07-16", "publication_year": 2026, "doi": "10.12775/jehs.2026.94.73071", "pubmed_id": null, "openalex_id": "https://openalex.org/W7169523177", "source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-19 01:20:13", "last_checked": "2026-08-09 08:25:00", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.94.73071", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2026.94.73071", "source_url": "https://doi.org/10.12775/jehs.2026.94.73071", "doi": "10.12775/jehs.2026.94.73071", "pmid": "", "publication_date": "2026-07-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5723, "title": "The ANCHOR Framework for Psychedelic Accompaniment", "authors": "Ron Shore", "journal": "PsyArXiv", "publication_date": "2026-07-15", "publication_year": 2026, "doi": "10.31234/osf.io/6jdaw_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6jdaw_v1", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Psychological Flexibility,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-16 01:20:10", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/6jdaw_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6jdaw_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/6jdaw_v1", "source_url": "https://osf.io/preprints/psyarxiv/6jdaw_v1", "doi": "10.31234/osf.io/6jdaw_v1", "pmid": "", "publication_date": "2026-07-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5721, "title": "Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.", "authors": "Zarrabi AJ, Mletzko T, Grant G, Peacock C, Palitsky R, McPherson T, Shub I, Eisenacher S, Maples-Keller JL, Kaplan D, Rothbaum BO, Rab F, Dalal N, Curseen KA, Raison C, Dunlop BW", "journal": "medRxiv: the preprint server for health sciences", "publication_date": "2026-07-14", "publication_year": 2026, "doi": "10.64898/2026.07.11.26357570", "pubmed_id": "42528601", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42528601/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Chronic Pain,Spirituality,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-15 01:20:32", "last_checked": "2026-08-09 08:27:45", "bibtex": null, "source_record_id": "PMID:42528601", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42528601/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42528601", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42528601/", "doi": "10.64898/2026.07.11.26357570", "pmid": "42528601", "publication_date": "2026-07-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5787, "title": "MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments", "authors": "Brinzei OV.", "journal": "ScienceOpen Preprints", "publication_date": "2026-07-12", "publication_year": 2026, "doi": "10.14293/pr2199.004090.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.14293/pr2199.004090.v1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-08-09 08:14:50", "last_checked": "2026-08-09 08:14:50", "bibtex": null, "source_record_id": "DOI:10.14293/pr2199.004090.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.14293/pr2199.004090.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.14293/pr2199.004090.v1", "source_url": "https://doi.org/10.14293/pr2199.004090.v1", "doi": "10.14293/pr2199.004090.v1", "pmid": "", "publication_date": "2026-07-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3502, "title": "PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial", "authors": "Bruyère Health Research Institute.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07063862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Aging,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07063862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "source_url": "https://clinicaltrials.gov/study/NCT07063862", "doi": "", "pmid": "", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3467, "title": "PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial", "authors": "Ottawa Hospital Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04754061", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04754061", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "source_url": "https://clinicaltrials.gov/study/NCT04754061", "doi": "", "pmid": "", "publication_date": "2026-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5680, "title": "Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.", "authors": "Gagnon F, Philibert A, Carignan B, Labonté E, Dufresne Y", "journal": "The International journal on drug policy", "publication_date": "2026-07-09", "publication_year": 2026, "doi": "10.1016/j.drugpo.2026.105427", "pubmed_id": "42424668", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42424668/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-10 01:20:03", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42424668", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42424668/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42424668", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42424668/", "doi": "10.1016/j.drugpo.2026.105427", "pmid": "42424668", "publication_date": "2026-07-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3610, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06341426", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06341426", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "source_url": "https://clinicaltrials.gov/study/NCT06341426", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5676, "title": "Psilocybin therapy for adult females with anorexia nervosa: pilot study", "authors": "Douglass Hannah M., Spriggs Meg J., Godfrey Kate, Danby Jennifer L., de Magalhaes Frederico J. C., Macdonald Lauren, Alderton Kirsty L., Archer Stephanie, Ahmad Kirran, Martell Jonny, Frias Jennifer T., Sawicka Gabriela, Read Tim, Blemings Allan, Lafrance Adele, Nicholls Dasha, Erritzoe David, Park Rebecca J., Nutt David J., Carhart-Harris Robin L.", "journal": "The British Journal of Psychiatry", "publication_date": "2026-07-08", "publication_year": 2026, "doi": "10.1192/bjp.2026.10687", "pubmed_id": "42414058", "openalex_id": "https://openalex.org/W7167587921", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-08 01:20:22", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42414058", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1192/bjp.2026.10687", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42414058", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "doi": "10.1192/bjp.2026.10687", "pmid": "42414058", "publication_date": "2026-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5685, "title": "Synthesis and Biological Evaluation of 4-Bromo-dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.", "authors": "Bray E, Glatfelter GC, Maitland AD, Gonzalez NR, Walther D, Yacoub J, Baumann MH, von Salm JL", "journal": "ACS omega", "publication_date": "2026-07-07", "publication_year": 2026, "doi": "10.1021/acsomega.6c02996", "pubmed_id": "42428867", "openalex_id": "https://openalex.org/W7165624128", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42428867/", "substance_tags": "psilocin", "topic_tags": "Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-11 01:20:04", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42428867", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42428867/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42428867", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42428867/", "doi": "10.1021/acsomega.6c02996", "pmid": "42428867", "publication_date": "2026-07-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3652, "title": "Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04161066", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04161066", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "source_url": "https://clinicaltrials.gov/study/NCT04161066", "doi": "", "pmid": "", "publication_date": "2026-07-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5672, "title": "Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development", "authors": "Enriquez-Geppert Stefanie, Bevers Lisa, Rosander Arvid, Fodran Peter, Polito Vince", "journal": "Biomolecules", "publication_date": "2026-07-03", "publication_year": 2026, "doi": "10.3390/biom16070983", "pubmed_id": "42509777", "openalex_id": "https://openalex.org/W7167239267", "source_url": "https://doi.org/10.3390/biom16070983", "substance_tags": "psilocybin", "topic_tags": "Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-05 01:20:15", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42509777", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/biom16070983", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42509777", "source_url": "https://doi.org/10.3390/biom16070983", "doi": "10.3390/biom16070983", "pmid": "42509777", "publication_date": "2026-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3982, "title": "Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?", "authors": "Matthew A. Boehm, Oriana Mayorga", "journal": "Journal of Science Policy & Governance", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.38126/jspg280103", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167073096", "source_url": "https://doi.org/10.38126/jspg280103", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:30", "last_checked": "2026-08-09 08:25:03", "bibtex": null, "source_record_id": "DOI:10.38126/jspg280103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.38126/jspg280103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.38126/jspg280103", "source_url": "https://doi.org/10.38126/jspg280103", "doi": "10.38126/jspg280103", "pmid": "", "publication_date": "2026-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3976, "title": "Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions", "authors": "Koning Elena, Richard Jérémie, Keshen Aaron", "journal": "International Journal of Eating Disorders", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.1002/eat.70164", "pubmed_id": "42393007", "openalex_id": "https://openalex.org/W7167014213", "source_url": "https://doi.org/10.1002/eat.70164", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 01:20:05", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42393007", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/eat.70164", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42393007", "source_url": "https://doi.org/10.1002/eat.70164", "doi": "10.1002/eat.70164", "pmid": "42393007", "publication_date": "2026-07-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5720, "title": "Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study", "authors": "Meyer Thomas D, Vale Lauren N, Ibrahim Maya, Olmos Carolina, Quevedo João, Soares Jair C", "journal": "BMJ Open", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1136/bmjopen-2026-118471", "pubmed_id": "42442821", "openalex_id": "https://openalex.org/W7168165083", "source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-15 01:20:04", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42442821", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42442821", "source_url": "https://doi.org/10.1136/bmjopen-2026-118471", "doi": "10.1136/bmjopen-2026-118471", "pmid": "42442821", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3662, "title": "Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07638553", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07638553", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "source_url": "https://clinicaltrials.gov/study/NCT07638553", "doi": "", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3547, "title": "A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06902974", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06902974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "source_url": "https://clinicaltrials.gov/study/NCT06902974", "doi": "", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1975, "title": "Raman Activity Investigation and Utilization of Psilocybin", "authors": "Sun Mingyu, Zhao Xiaoyu, Kong Fandi, Wang Jinsong, Lu Yunchang, Tong Liang", "journal": "Journal of Raman Spectroscopy", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1002/jrs.70133", "pubmed_id": null, "openalex_id": "https://openalex.org/W7139132619", "source_url": "https://doi.org/10.1002/jrs.70133", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.1002/jrs.70133", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1002/jrs.70133", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1002/jrs.70133", "source_url": "https://doi.org/10.1002/jrs.70133", "doi": "10.1002/jrs.70133", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1923, "title": "Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence", "authors": "Sabani Astrit, Khatak Adnan", "journal": "Annals of Medicine & Surgery", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1097/ms9.0000000000005244", "pubmed_id": "42433813", "openalex_id": "https://openalex.org/W7165127045", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42433813", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1097/ms9.0000000000005244", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42433813", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "doi": "10.1097/ms9.0000000000005244", "pmid": "42433813", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 107, "title": "Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders", "authors": "Plourde Louis, Chang Sue-Ling, Nguyen Olivia, Garel Nicolas, Farzin Houman, Stephan Jean-François, Fallu Jean-Sébastien, Dorval Michel", "journal": "Palliative Medicine", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1177/02692163261446141", "pubmed_id": "42154482", "openalex_id": "https://openalex.org/W7161714083", "source_url": "https://doi.org/10.1177/02692163261446141", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42154482", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/02692163261446141", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42154482", "source_url": "https://doi.org/10.1177/02692163261446141", "doi": "10.1177/02692163261446141", "pmid": "42154482", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 30, "title": "The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.", "authors": "Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1177/02698811261456191", "pubmed_id": "42345450", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42345450", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42345450", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "doi": "10.1177/02698811261456191", "pmid": "42345450", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 25, "title": "Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.", "authors": "Özaydın Y, Canlan Özaydın B", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1177/02698811261456196", "pubmed_id": "42365488", "openalex_id": "https://openalex.org/W7166465028", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42365488/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Microdosing,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42365488", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42365488/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42365488", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42365488/", "doi": "10.1177/02698811261456196", "pmid": "42365488", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 11, "title": "Recreational drug poisonings reported to six European poison centres from 2021 to 2024.", "authors": "Hondebrink L, Faber K, Kader A, Jagpal PS, Arif T, Hermanns-Clausen M", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1080/15563650.2026.2628073", "pubmed_id": "41778415", "openalex_id": "https://openalex.org/W7133986324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41778415/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:41778415", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41778415/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41778415", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41778415/", "doi": "10.1080/15563650.2026.2628073", "pmid": "41778415", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 9, "title": "Psychedelics as a potential treatment for borderline personality disorder: A narrative review.", "authors": "Artna E, Sandhu G, Chisamore N, Lipsitz O, Kaczmarek ES, Johnson DE, Rosenblat JD, Sediqzadah S", "journal": "Psychiatry research", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1016/j.psychres.2026.117152", "pubmed_id": "41955843", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955843/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Personality Change,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:41955843", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41955843/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41955843", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955843/", "doi": "10.1016/j.psychres.2026.117152", "pmid": "41955843", "publication_date": "2026-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 303, "title": "Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”", "authors": "Sjöström David, Schau Rybäck Olea, Claesdotter Knutsson Emma, Kajonius Petri, Jensen Sondén Oskar, Carlbring Per, Björkstrand Johannes, Movahed Rad Pouya", "journal": "PLOS One", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1371/journal.pone.0352246", "pubmed_id": "42378255", "openalex_id": "https://openalex.org/W7166779507", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Brain Imaging,Aging,Wellbeing,Personality Change,Clinical Trial,Randomized Controlled Trial,Review Article,Adolescents,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:03", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42378255", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0352246", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42378255", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "doi": "10.1371/journal.pone.0352246", "pmid": "42378255", "publication_date": "2026-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 22, "title": "Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.", "authors": "Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT", "journal": "Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1007/s40211-026-00584-4", "pubmed_id": "42377806", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Aging,Epigenetics,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42377806", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42377806", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42377806/", "doi": "10.1007/s40211-026-00584-4", "pmid": "42377806", "publication_date": "2026-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3979, "title": "Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development", "authors": "Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito", "journal": "University of Groningen research database (University of Groningen / Centre for Information Technology)", "publication_date": "2026-06-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7167168218", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:27", "last_checked": "2026-08-09 08:25:04", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "doi": "", "pmid": "", "publication_date": "2026-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3621, "title": "Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial", "authors": "Unity Health Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06386003", "substance_tags": "psilocybin", "topic_tags": "PTSD,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06386003", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06386003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06386003", "source_url": "https://clinicaltrials.gov/study/NCT06386003", "doi": "", "pmid": "", "publication_date": "2026-06-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3595, "title": "Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06884514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Wellbeing,Personality Change,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06884514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "source_url": "https://clinicaltrials.gov/study/NCT06884514", "doi": "", "pmid": "", "publication_date": "2026-06-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5790, "title": "PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW", "authors": "Łoś Aleksandra, Szkodziński Kacper, Jakubczyk Inga, Maternia Jagoda, Majowicz-Czaszyńska Karolina, Pempuś Wiktoria, Król Nikola, Tomaszek Barbara, Blok Aleksandra, Wiater Dominik, Płodzień Gabriela", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-06-24", "publication_year": 2026, "doi": "10.31435/ijitss.2(50).2026.5755", "pubmed_id": null, "openalex_id": "https://openalex.org/W7168266726", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5755", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-08-09 08:25:05", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5755", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31435/ijitss.2(50).2026.5755", "source_url": "https://doi.org/10.31435/ijitss.2(50).2026.5755", "doi": "10.31435/ijitss.2(50).2026.5755", "pmid": "", "publication_date": "2026-06-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3987, "title": "Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.", "authors": "Claudino Dos Santos JC, Bolan SJ, Lodetti G, Viana GL, Rico EP, Gonçalves CL", "journal": "Journal of psychiatric research", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1016/j.jpsychires.2026.06.035", "pubmed_id": "42385294", "openalex_id": "https://openalex.org/W7165638399", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42385294/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42385294", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42385294/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42385294", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42385294/", "doi": "10.1016/j.jpsychires.2026.06.035", "pmid": "42385294", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3705, "title": "Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07449351", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Longevity,Microdosing,Wellbeing,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07449351", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "source_url": "https://clinicaltrials.gov/study/NCT07449351", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3650, "title": "Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07048743", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07048743", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "source_url": "https://clinicaltrials.gov/study/NCT07048743", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 33, "title": "Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.", "authors": "van den Busken WJ, Dines AM, Eyer F, Heyerdahl F, Hovda KE, Liechti ME, Miró Ò, Vallersnes OM, Wood DM, Yates C, Dargan PI, (on behalf of the Euro-DEN Plus Research Group), Gresnigt FMJ, Euro-DEN Plus Research Group", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2026-06-23", "publication_year": 2026, "doi": "10.1080/15563650.2026.2669671", "pubmed_id": "42334445", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42334445/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Mechanism of Action,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42334445", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42334445/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42334445", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42334445/", "doi": "10.1080/15563650.2026.2669671", "pmid": "42334445", "publication_date": "2026-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3471, "title": "Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06407635", "substance_tags": "psilocybin", "topic_tags": "PTSD,Receptor Pharmacology,Consciousness,Wellbeing,Mystical Experience,Randomized Controlled Trial,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06407635", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06407635", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06407635", "source_url": "https://clinicaltrials.gov/study/NCT06407635", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3460, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06416085", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06416085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "source_url": "https://clinicaltrials.gov/study/NCT06416085", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3988, "title": "Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1", "authors": "Racca Camille, Cordier Cécilie", "journal": "protocols.io", "publication_date": "2026-06-21", "publication_year": 2026, "doi": "10.17504/protocols.io.j8nlk7ey6g5r/v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165566978", "source_url": "https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "protocol", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-08-09 09:00:16", "bibtex": null, "source_record_id": "DOI:10.17504/protocols.io.j8nlk7ey6g5r/v1", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.17504/protocols.io.j8nlk7ey6g5r/v1", "source_url": "https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1", "doi": "10.17504/protocols.io.j8nlk7ey6g5r/v1", "pmid": "", "publication_date": "2026-06-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 35, "title": "Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.", "authors": "Low ZXB", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2026-06-20", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111717", "pubmed_id": "42034276", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42034276/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42034276", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42034276/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42034276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42034276/", "doi": "10.1016/j.pnpbp.2026.111717", "pmid": "42034276", "publication_date": "2026-06-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 38, "title": "Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.", "authors": "Berg CJ, McCready DM, LoParco CR, Schubel LC, Romm KF, Thakkar S, Williams J, Cavazos-Rehg PA, Yang YT", "journal": "Journal of psychoactive drugs", "publication_date": "2026-06-19", "publication_year": 2026, "doi": "10.1080/02791072.2026.2685527", "pubmed_id": "42318842", "openalex_id": "https://openalex.org/W7165130491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42318842/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:47", "bibtex": null, "source_record_id": "PMID:42318842", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42318842/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42318842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42318842/", "doi": "10.1080/02791072.2026.2685527", "pmid": "42318842", "publication_date": "2026-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 39, "title": "DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish", "authors": "Dong Mengxuan, Zhang Yi, Cao Manzhu, Shi Tong, Li Liqin, Zong Xingxing, Wang Chen", "journal": "Molecules", "publication_date": "2026-06-18", "publication_year": 2026, "doi": "10.3390/molecules31122143", "pubmed_id": "42357539", "openalex_id": "https://openalex.org/W7165199227", "source_url": "https://doi.org/10.3390/molecules31122143", "substance_tags": "psilocybin,psilocin", "topic_tags": "Brain Imaging,Aging,Safety,Toxicity", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:42357539", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/molecules31122143", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42357539", "source_url": "https://doi.org/10.3390/molecules31122143", "doi": "10.3390/molecules31122143", "pmid": "42357539", "publication_date": "2026-06-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3993, "title": "“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse", "authors": "Wanke Michał, Matuszewski Paweł, Siuda Piotr", "journal": "OSF Preprints", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.31235/osf.io/tk4bv_v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165030356", "source_url": "https://doi.org/10.31235/osf.io/tk4bv_v1", "substance_tags": "psilocybin", "topic_tags": "Aging,Safety", "study_type": "Qualitative Study", "source_name": "Crossref", "publication_status": "preprint", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 09:00:16", "bibtex": null, "source_record_id": "DOI:10.31235/osf.io/tk4bv_v1", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31235/osf.io/tk4bv_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31235/osf.io/tk4bv_v1", "source_url": "https://doi.org/10.31235/osf.io/tk4bv_v1", "doi": "10.31235/osf.io/tk4bv_v1", "pmid": "", "publication_date": "2026-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3990, "title": "Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use", "authors": "Eric P. Rubenstein", "journal": "Journal of Advances in Developmental Research", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.71097/ijaidr.v17.i1.1997", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166450540", "source_url": "https://doi.org/10.71097/ijaidr.v17.i1.1997", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Emotional Processing,Creativity,Spirituality,Psychological Flexibility,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "DOI:10.71097/ijaidr.v17.i1.1997", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.71097/ijaidr.v17.i1.1997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.71097/ijaidr.v17.i1.1997", "source_url": "https://doi.org/10.71097/ijaidr.v17.i1.1997", "doi": "10.71097/ijaidr.v17.i1.1997", "pmid": "", "publication_date": "2026-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1924, "title": "Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico", "authors": "Leeman Lawrence, Armstrong Maya, Menashi Dara, Nayo-Washington Hanifa, Marseille Elliot, Herrera Janus, Romero Crystal, Page-Reeves Janet", "journal": "Frontiers in Public Health", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1845943", "pubmed_id": "42395285", "openalex_id": "https://openalex.org/W7165032301", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "substance_tags": "psilocybin", "topic_tags": "PTSD,Aging,Clinical Trial,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "PMID:42395285", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42395285", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "doi": "10.3389/fpubh.2026.1845943", "pmid": "42395285", "publication_date": "2026-06-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1927, "title": "Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA", "authors": "SAIMSARA", "journal": "SAIMSARA Journal", "publication_date": "2026-06-15", "publication_year": 2026, "doi": "10.62487/saimsara7a54f680", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164845889", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.62487/saimsara7a54f680", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.62487/saimsara7a54f680", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.62487/saimsara7a54f680", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "doi": "10.62487/saimsara7a54f680", "pmid": "", "publication_date": "2026-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1926, "title": "Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis", "authors": "Labra-Lorenzana Angel, Lima-Sánchez Dania Nimbe, Delaflor-Wagner Christian Alejandro, Martínez-Hernández Diana, Ramos-Jiménez Christian, Toledo-Lozano Christian Gabriel", "journal": "Psychiatry International", "publication_date": "2026-06-15", "publication_year": 2026, "doi": "10.3390/psychiatryint7030137", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164820747", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-08-09 08:28:46", "bibtex": null, "source_record_id": "DOI:10.3390/psychiatryint7030137", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/psychiatryint7030137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3390/psychiatryint7030137", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "doi": "10.3390/psychiatryint7030137", "pmid": "", "publication_date": "2026-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3996, "title": "Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review", "authors": "Edward P. Hackett, Aditi Chaudhri -, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H. Dworkin", "journal": "CNS Drugs", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.1007/s40263-026-01305-9", "pubmed_id": "42295696", "openalex_id": "https://openalex.org/W7164826955", "source_url": "https://doi.org/10.1007/s40263-026-01305-9", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mystical Experience,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "PMID:42295696", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40263-026-01305-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42295696", "source_url": "https://doi.org/10.1007/s40263-026-01305-9", "doi": "10.1007/s40263-026-01305-9", "pmid": "42295696", "publication_date": "2026-06-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3999, "title": "Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments", "authors": "Zuzana Postránecká, Matyáš Lucký, Viktor Mravčík, Tomáš Páleníček", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-06-12", "publication_year": 2026, "doi": "10.1556/2054.2026.00514", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165879237", "source_url": "https://doi.org/10.1556/2054.2026.00514", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:06", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00514", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00514", "source_url": "https://doi.org/10.1556/2054.2026.00514", "doi": "10.1556/2054.2026.00514", "pmid": "", "publication_date": "2026-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3238, "title": "Altered States, Enhanced Potential: Psychedelics and Physical Performance", "authors": "Zane Qarni, Jeremie Richard", "journal": "PsyArXiv", "publication_date": "2026-06-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/txgq2_v2", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Consciousness,Microdosing,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/txgq2_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/txgq2_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/txgq2_v2", "source_url": "https://osf.io/preprints/psyarxiv/txgq2_v2", "doi": "", "pmid": "", "publication_date": "2026-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 52, "title": "Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.", "authors": "Zhang T, Lin C, Wang X", "journal": "ACS pharmacology & translational science", "publication_date": "2026-06-12", "publication_year": 2026, "doi": "10.1021/acsptsci.6c00146", "pubmed_id": "42312173", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42312173/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42312173", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42312173/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42312173", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42312173/", "doi": "10.1021/acsptsci.6c00146", "pmid": "42312173", "publication_date": "2026-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 57, "title": "Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.", "authors": "Gillet M, Doudeau N, Vilain F, Sadat K, Morvan Y, Frajerman A", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2026-06-09", "publication_year": 2026, "doi": "10.1177/07067437261457220", "pubmed_id": "42262154", "openalex_id": "https://openalex.org/W7164034416", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42262154/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:48", "bibtex": null, "source_record_id": "PMID:42262154", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42262154/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42262154", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42262154/", "doi": "10.1177/07067437261457220", "pmid": "42262154", "publication_date": "2026-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3452, "title": "A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease", "authors": "Jennifer Mitchell", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07386730", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Aging,Wellbeing,Animal Study,Healthy Volunteers,Older Adults,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07386730", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07386730", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07386730", "source_url": "https://clinicaltrials.gov/study/NCT07386730", "doi": "", "pmid": "", "publication_date": "2026-06-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 60, "title": "Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity", "authors": "Ahmadian-Moghadam Samaneh, Roshan-Milani Shiva, Saboory Ehsan", "journal": "Translational Psychiatry", "publication_date": "2026-06-05", "publication_year": 2026, "doi": "10.1038/s41398-026-04151-x", "pubmed_id": "42248832", "openalex_id": "https://openalex.org/W7163694045", "source_url": "https://doi.org/10.1038/s41398-026-04151-x", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Safety", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42248832", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1038/s41398-026-04151-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42248832", "source_url": "https://doi.org/10.1038/s41398-026-04151-x", "doi": "10.1038/s41398-026-04151-x", "pmid": "42248832", "publication_date": "2026-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3367, "title": "Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults", "authors": "Carter D, Reardon I, Swain J, Vando L.", "journal": "Research Square", "publication_date": "2026-06-02", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9839240/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "doi": "10.21203/rs.3.rs-9839240/v1", "pmid": "", "publication_date": "2026-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3095, "title": "Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey", "authors": "Li EJ, Mosharraf B, Ali H, Noyes M, Doshi P, Wallace C, Petranker R, Adili A, Khan M, Busse JW, MacKillop J, Madden K.", "journal": "medRxiv", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.64898/2026.05.29.26354422", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.05.29.26354422", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:58", "bibtex": null, "source_record_id": "DOI:10.64898/2026.05.29.26354422", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.05.29.26354422", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.05.29.26354422", "source_url": "https://doi.org/10.64898/2026.05.29.26354422", "doi": "10.64898/2026.05.29.26354422", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 88, "title": "Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin.", "authors": "Stanger MK, Soffer HO, Bryan AD, Skrzynski CJ", "journal": "Cannabis and cannabinoid research", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1089/can.2024.0059", "pubmed_id": "38885938", "openalex_id": "https://openalex.org/W4399722371", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38885938/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:38885938", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38885938/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38885938", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38885938/", "doi": "10.1089/can.2024.0059", "pmid": "38885938", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 86, "title": "Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.", "authors": "He Z, Wang Y, Chen J, Cheng J, Feng Y, Niu S, Yan J", "journal": "European archives of psychiatry and clinical neuroscience", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1007/s00406-025-02165-y", "pubmed_id": "41677823", "openalex_id": "https://openalex.org/W7128718542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41677823/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:41677823", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41677823/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41677823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41677823/", "doi": "10.1007/s00406-025-02165-y", "pmid": "41677823", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 84, "title": "Lifetime psychedelic use and opioid use disorder severity in a National Survey: the roles of psychedelic type and mental health.", "authors": "Ehmann S, Hager NM, Regier PS, Jones G, Allen JJB", "journal": "Addictive behaviors", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1016/j.addbeh.2026.108652", "pubmed_id": "41723946", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41723946/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:41723946", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41723946/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41723946", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41723946/", "doi": "10.1016/j.addbeh.2026.108652", "pmid": "41723946", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 83, "title": "Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations", "authors": "Yonezawa Kengo, Hirata Mayuko, Takano Hiroaki, Kusudo Keisuke, Tomiyama Sota, Harada Lisa, Suzuki Kouta, Nutt David J., Uchida Hiroyuki, Tani Hideaki", "journal": "Psychiatry and Clinical Neurosciences", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1111/pcn.70042", "pubmed_id": "41749057", "openalex_id": "https://openalex.org/W7131868995", "source_url": "https://doi.org/10.1111/pcn.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Brain Imaging,Aging,Spirituality,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41749057", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1111/pcn.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41749057", "source_url": "https://doi.org/10.1111/pcn.70042", "doi": "10.1111/pcn.70042", "pmid": "41749057", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 82, "title": "Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.", "authors": "Sabé M, Grof P, Sackett NB, Tai S, Kryskow P, Bershad A, Turkington D, Buonarroti M, De Pieri M, Baniotopoulos P, Eskinazi M, Böge K, Leucht S, Seragnoli F, Furtado L, Brakha TA, Curtis L, Kirschner M, Kaiser S, Penzenstadler L, Zullino D, Højlund M, Gallo J, Solmi M, Sapienza J, Bosia M, La Torre J", "journal": "Schizophrenia research", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.1016/j.schres.2026.03.003", "pubmed_id": "41830808", "openalex_id": "https://openalex.org/W7135185290", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41830808/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:41830808", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41830808/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41830808", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41830808/", "doi": "10.1016/j.schres.2026.03.003", "pmid": "41830808", "publication_date": "2026-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 90, "title": "Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.", "authors": "Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M", "journal": "Molecular psychiatry", "publication_date": "2026-05-29", "publication_year": 2026, "doi": "10.1038/s41380-026-03657-6", "pubmed_id": "42215638", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42215638/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42215638", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42215638/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42215638", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42215638/", "doi": "10.1038/s41380-026-03657-6", "pmid": "42215638", "publication_date": "2026-05-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 97, "title": "Psilocybin-induced neurocardiogenic syncope: a case report", "authors": "Atiq Mazen A., Weisman Eli, Guerra Rodrigo B., Martinez Luis Luna, Yaden David B., Barrett Frederick S., Nayak Sandeep, Sayali Ceyda", "journal": "Psychopharmacology", "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1007/s00213-026-07079-8", "pubmed_id": "42207275", "openalex_id": "https://openalex.org/W7162662445", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Consciousness,Aging,Emotional Processing,Clinical Trial,Case Report,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42207275", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1007/s00213-026-07079-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42207275", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "doi": "10.1007/s00213-026-07079-8", "pmid": "42207275", "publication_date": "2026-05-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3660, "title": "The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07332143", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07332143", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "source_url": "https://clinicaltrials.gov/study/NCT07332143", "doi": "", "pmid": "", "publication_date": "2026-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4012, "title": "Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential", "authors": "Dallas T Mason", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162235135", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4011, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach", "authors": "Rachel N Clark", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162225828", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4010, "title": "Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients", "authors": "Caleb Lemus", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162222410", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Aging,Wellbeing,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:07", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3614, "title": "Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07506395", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07506395", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "source_url": "https://clinicaltrials.gov/study/NCT07506395", "doi": "", "pmid": "", "publication_date": "2026-05-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3606, "title": "Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)", "authors": "Alan Davis", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07216404", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07216404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "source_url": "https://clinicaltrials.gov/study/NCT07216404", "doi": "", "pmid": "", "publication_date": "2026-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3035, "title": "Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.", "authors": "Jacob Cohen, Peter Parbo, Per Trads Ørskov, Dirk Wildgruber, Benjamin Kreifelts, ulrich kirk, Oke Gerke, Martin Korsbak Madsen, Mikael Palner", "journal": "PsyArXiv", "publication_date": "2026-05-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Biomarkers,Aging,Microdosing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "doi": "", "pmid": "", "publication_date": "2026-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 110, "title": "Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care", "authors": "Geller Jamarie A., Pacilio Rachel, Downey Amanda E., Ragnhildstveit Anya, Raymond-Flesch Marissa, Knatz-Peck Stephanie, Gukasyan Natalie", "journal": "Current Psychiatry Reports", "publication_date": "2026-05-14", "publication_year": 2026, "doi": "10.1007/s11920-026-01679-z", "pubmed_id": "42128951", "openalex_id": "https://openalex.org/W7161007383", "source_url": "https://doi.org/10.1007/s11920-026-01679-z", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Review Article,Adolescents,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42128951", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1007/s11920-026-01679-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42128951", "source_url": "https://doi.org/10.1007/s11920-026-01679-z", "doi": "10.1007/s11920-026-01679-z", "pmid": "42128951", "publication_date": "2026-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 113, "title": "Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation", "authors": "Vaart Andrew van der, LaPratt Jeffrey, Swartz Kimberly, Shoultz Audrey, Lauterbach Margo, Suppes Trisha, Sackeim Harold A., Aaronson Scott T.", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2026-05-13", "publication_year": 2026, "doi": "10.4088/jcp.26m16338", "pubmed_id": "42138588", "openalex_id": "https://openalex.org/W7160906477", "source_url": "https://doi.org/10.4088/jcp.26m16338", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42138588", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.4088/jcp.26m16338", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42138588", "source_url": "https://doi.org/10.4088/jcp.26m16338", "doi": "10.4088/jcp.26m16338", "pmid": "42138588", "publication_date": "2026-05-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 112, "title": "Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization", "authors": "Yu Feliciano, Tafur Joe, Moreno Francisco, Dahmer Stephen", "journal": "Frontiers in Psychiatry", "publication_date": "2026-05-13", "publication_year": 2026, "doi": "10.3389/fpsyt.2026.1777387", "pubmed_id": "42233004", "openalex_id": "https://openalex.org/W7161045271", "source_url": "https://doi.org/10.3389/fpsyt.2026.1777387", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42233004", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2026.1777387", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42233004", "source_url": "https://doi.org/10.3389/fpsyt.2026.1777387", "doi": "10.3389/fpsyt.2026.1777387", "pmid": "42233004", "publication_date": "2026-05-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3593, "title": "Psilocybin for Treatment of Obsessive Compulsive Disorder", "authors": "Francisco A Moreno", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06992999", "substance_tags": "psilocybin", "topic_tags": "OCD,Brain Imaging,Consciousness,Aging,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06992999", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06992999", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06992999", "source_url": "https://clinicaltrials.gov/study/NCT06992999", "doi": "", "pmid": "", "publication_date": "2026-05-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3527, "title": "Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05322954", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05322954", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05322954", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05322954", "source_url": "https://clinicaltrials.gov/study/NCT05322954", "doi": "", "pmid": "", "publication_date": "2026-05-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3022, "title": "Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review", "authors": "Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ.", "journal": "Research Square", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9283280/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:50", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "doi": "10.21203/rs.3.rs-9283280/v1", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4019, "title": "From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice", "authors": "Jessie Kim, Liam Lochhead, Cory R. Weissman", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-05-10", "publication_year": 2026, "doi": "10.1002/prp2.70262", "pubmed_id": "42108552", "openalex_id": "https://openalex.org/W7160830727", "source_url": "https://doi.org/10.1002/prp2.70262", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:08", "bibtex": null, "source_record_id": "PMID:42108552", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42108552", "source_url": "https://doi.org/10.1002/prp2.70262", "doi": "10.1002/prp2.70262", "pmid": "42108552", "publication_date": "2026-05-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3570, "title": "The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.", "authors": "University Medical Center Groningen", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06782724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Biomarkers,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06782724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "source_url": "https://clinicaltrials.gov/study/NCT06782724", "doi": "", "pmid": "", "publication_date": "2026-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 116, "title": "Exploring new avenues: Psychedelic-assisted therapy for young people.", "authors": "Vamvakopoulou IA, Nicholls D, Nutt DJ, Di Simplicio M", "journal": "British journal of clinical pharmacology", "publication_date": "2026-05-08", "publication_year": 2026, "doi": "10.1002/bcp.70579", "pubmed_id": "42101062", "openalex_id": "https://openalex.org/W7160597817", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42101062/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Review Article,Observational Study,Adolescents,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42101062", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42101062/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42101062", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42101062/", "doi": "10.1002/bcp.70579", "pmid": "42101062", "publication_date": "2026-05-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3496, "title": "Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05710237", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05710237", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "source_url": "https://clinicaltrials.gov/study/NCT05710237", "doi": "", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1947, "title": "Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review", "authors": "Zachar Kinga, Sito Maksymilian, Jurkowski Filip, Wójcik Łukasz, Gawron Natalia, Bojanowski Hubert Tomasz, Dobracka Aleksandra, Marczak Zuzanna, Jarowicz Monika, Czmyr Jędrzej", "journal": "Journal of Education, Health and Sport", "publication_date": "2026-05-07", "publication_year": 2026, "doi": "10.12775/jehs.2026.91.70672", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160694792", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "doi": "10.12775/jehs.2026.91.70672", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 127, "title": "Psilocybin in the Treatment of Cocaine Use Disorder", "authors": "Hendricks Peter S., Lappan Sara N., Shelton Richard C., Lahti Adrienne C., Cropsey Karen L., Johnson Matthew W., Bradley Melissa, Simonsson Otto, Davis Lori L., Grossman Daniel H., Ortiz Cynthia E.", "journal": "JAMA Network Open", "publication_date": "2026-05-07", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.11029", "pubmed_id": "42096204", "openalex_id": "https://openalex.org/W7160534089", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42096204", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42096204", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "doi": "10.1001/jamanetworkopen.2026.11029", "pmid": "42096204", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 117, "title": "The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus", "authors": "Forsyth Dayna, Faraone Nicoletta, Lamarre Simon G., Currie Suzanne", "journal": "Frontiers in Behavioral Neuroscience", "publication_date": "2026-05-07", "publication_year": 2026, "doi": "10.3389/fnbeh.2026.1767175", "pubmed_id": "42182826", "openalex_id": "https://openalex.org/W7160487085", "source_url": "https://doi.org/10.3389/fnbeh.2026.1767175", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Safety,Drug Interactions", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "PMID:42182826", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fnbeh.2026.1767175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42182826", "source_url": "https://doi.org/10.3389/fnbeh.2026.1767175", "doi": "10.3389/fnbeh.2026.1767175", "pmid": "42182826", "publication_date": "2026-05-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4020, "title": "Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’", "authors": "Bart A. Ellenbroek, Gernot Riedel", "journal": "Behavioural Pharmacology", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.1097/fbp.0000000000000878", "pubmed_id": "42100839", "openalex_id": "https://openalex.org/W7160630756", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:25:08", "bibtex": null, "source_record_id": "PMID:42100839", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000878", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42100839", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "doi": "10.1097/fbp.0000000000000878", "pmid": "42100839", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3620, "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05947383", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05947383", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "source_url": "https://clinicaltrials.gov/study/NCT05947383", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3536, "title": "A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder", "authors": "Stanford University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07479550", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07479550", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "source_url": "https://clinicaltrials.gov/study/NCT07479550", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3559, "title": "A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07565909", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07565909", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "source_url": "https://clinicaltrials.gov/study/NCT07565909", "doi": "", "pmid": "", "publication_date": "2026-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3600, "title": "Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial", "authors": "Lakshmi N Yatham", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06943573", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06943573", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "source_url": "https://clinicaltrials.gov/study/NCT06943573", "doi": "", "pmid": "", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1952, "title": "6. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-Efficacy", "authors": "Pagni Broc, Ross Stephen, Kim Yuna, Bogenschutz Michael", "journal": "Biological Psychiatry", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.03.240", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155643158", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.240", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:47", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2026.03.240", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1016/j.biopsych.2026.03.240", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.240", "doi": "10.1016/j.biopsych.2026.03.240", "pmid": "", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 144, "title": "The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences.", "authors": "Diehl VJ, Calder AE, Hasler G", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251397306", "pubmed_id": "41472616", "openalex_id": "https://openalex.org/W7117768931", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41472616/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Resilience,Mystical Experience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41472616", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41472616/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41472616", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41472616/", "doi": "10.1177/02698811251397306", "pmid": "41472616", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 138, "title": "Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.", "authors": "Lewis BR, Reid MJ, Novick AM, Byrne K, Niciu MJ, Fonzo GA, Meyer TD, Feifel D, El-Mallakh RS, Soares J, Suppes T, Barrett FS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811251413490", "pubmed_id": "41645048", "openalex_id": "https://openalex.org/W7128008256", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41645048", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41645048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41645048/", "doi": "10.1177/02698811251413490", "pmid": "41645048", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 134, "title": "A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder", "authors": "Moreno Francisco A., Allen Katja E., Wiegand Christopher B., Dunne Rajan, Prickett James I., Bayze Brian, Allen John J. B.", "journal": "Journal of Psychopharmacology", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811261424214", "pubmed_id": "41825921", "openalex_id": "https://openalex.org/W7135170485", "source_url": "https://doi.org/10.1177/02698811261424214", "substance_tags": "psilocybin", "topic_tags": "OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41825921", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1177/02698811261424214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41825921", "source_url": "https://doi.org/10.1177/02698811261424214", "doi": "10.1177/02698811261424214", "pmid": "41825921", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 133, "title": "Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression", "authors": "Mertens Lea J., Koslowski Michael, Betzler Felix, Brand Manuela, Evens Ricarda, Kärtner Laura, Jungaberle Andrea, Jungaberle Henrik, Majić Tomislav, Schmitz Christian N., Ströhle Andreas, Scharf Dennis, Spangemacher Moritz, Wolff Max, Assadi Zahra, Bahri Scharif, Becher Lilith, Färber Luca V., Kirchen Niklas, Kulakova Eugenia, Kunz Linda, Meijer Andy, Rohrmoser Barbara, Wellek Stefan, Berger Moritz M., Gründer Gerhard", "journal": "JAMA Psychiatry", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0132", "pubmed_id": "41848690", "openalex_id": "https://openalex.org/W7138853109", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41848690", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41848690", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "doi": "10.1001/jamapsychiatry.2026.0132", "pmid": "41848690", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 131, "title": "Psychological support in psychedelic-assisted therapy clinical trials: A systematic review.", "authors": "Brusky B, M'Bailara K, Alla F, Barrault M", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811261424204", "pubmed_id": "41859988", "openalex_id": "https://openalex.org/W7139121355", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41859988/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41859988", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41859988/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41859988", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41859988/", "doi": "10.1177/02698811261424204", "pmid": "41859988", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 130, "title": "Trip killers: Addressing a critical knowledge gap in psychedelic research.", "authors": "O'Mahony B, Harrington C, Harkin A, Lally N", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1177/02698811261431056", "pubmed_id": "41869862", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41869862", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "doi": "10.1177/02698811261431056", "pmid": "41869862", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 129, "title": "Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.", "authors": "Gillet A, Geron C, Vitello MM, Lejeune N", "journal": "CNS drugs", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1007/s40263-026-01274-z", "pubmed_id": "41876835", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41876835/", "substance_tags": "psilocin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41876835", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41876835/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41876835", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41876835/", "doi": "10.1007/s40263-026-01274-z", "pmid": "41876835", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 122, "title": "New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants.", "authors": "Silva MH", "journal": "Birth defects research", "publication_date": "2026-05-01", "publication_year": 2026, "doi": "10.1002/bdr2.70048", "pubmed_id": "42163018", "openalex_id": "https://openalex.org/W7161947696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42163018/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:49", "bibtex": null, "source_record_id": "PMID:42163018", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42163018/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42163018", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42163018/", "doi": "10.1002/bdr2.70048", "pmid": "42163018", "publication_date": "2026-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5709, "title": "Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations", "authors": "Nayak SM, Sepeda ND, Dick MN, Tiwari P, Zahid Z, Sayalı C, Weiss BM, Yaden DB, Garcia-Romeu A, Barnett BS, Barrett FS.", "journal": "medRxiv", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.64898/2026.04.28.26351625", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.64898/2026.04.28.26351625", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.04.28.26351625", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.04.28.26351625", "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "doi": "10.64898/2026.04.28.26351625", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3041, "title": "The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder", "authors": "Marini S, De Berardis D.", "journal": "Preprints.org", "publication_date": "2026-04-29", "publication_year": 2026, "doi": "10.20944/preprints202604.1998.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.1998.v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:53", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.1998.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.1998.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.1998.v1", "source_url": "https://doi.org/10.20944/preprints202604.1998.v1", "doi": "10.20944/preprints202604.1998.v1", "pmid": "", "publication_date": "2026-04-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 156, "title": "Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders.", "authors": "Barbieri A", "journal": "Trends in psychiatry and psychotherapy", "publication_date": "2026-04-25", "publication_year": 2026, "doi": "10.47626/2237-6089-2025-1273", "pubmed_id": null, "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42033767/", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Emotional Processing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "DOI:10.47626/2237-6089-2025-1273", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42033767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "DOI:10.47626/2237-6089-2025-1273", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42033767/", "doi": "10.47626/2237-6089-2025-1273", "pmid": "", "publication_date": "2026-04-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 159, "title": "Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations.", "authors": "Salinsky LM, Fox JL, Diaz KC, Timmons BC, Ferguson SM", "journal": "Research square", "publication_date": "2026-04-23", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9306429/v1", "pubmed_id": "42078898", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42078898/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:42078898", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42078898/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42078898", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42078898/", "doi": "10.21203/rs.3.rs-9306429/v1", "pmid": "42078898", "publication_date": "2026-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3658, "title": "Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder", "authors": "Portland VA Research Foundation, Inc", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04982796", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04982796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "source_url": "https://clinicaltrials.gov/study/NCT04982796", "doi": "", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3596, "title": "A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03866174", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03866174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "source_url": "https://clinicaltrials.gov/study/NCT03866174", "doi": "", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3567, "title": "Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy", "authors": "Kyle Greenway", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07373535", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07373535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "source_url": "https://clinicaltrials.gov/study/NCT07373535", "doi": "", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1968, "title": "Psilocybin as an alternative to conventional treatments: A systematic review", "authors": "Cahuasqui-Mendoza Deivid Antonio", "journal": "Gaceta Médica de Caracas", "publication_date": "2026-04-22", "publication_year": 2026, "doi": "10.47307/gmc.2026.134.s2.32", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155199454", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "doi": "10.47307/gmc.2026.134.s2.32", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2978, "title": "The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes", "authors": "Khosravi Mohsen, De Berardis Domenico, Tusconi Massimo", "journal": "Mental Wellness", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.4081/mw.2026.40", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155066504", "source_url": "https://doi.org/10.4081/mw.2026.40", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Meta-Analysis", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.4081/mw.2026.40", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.4081/mw.2026.40", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.4081/mw.2026.40", "source_url": "https://doi.org/10.4081/mw.2026.40", "doi": "10.4081/mw.2026.40", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2977, "title": "Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials", "authors": "Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari", "journal": "Open Access Indonesian Journal of Medical Reviews", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.37275/oaijmr.v6i2.883", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155091271", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "doi": "10.37275/oaijmr.v6i2.883", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3117, "title": "Psilocybin’s Kinematic Effect on Manual Dexterity", "authors": "Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O.", "journal": "Research Square", "publication_date": "2026-04-15", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9291780/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "doi": "10.21203/rs.3.rs-9291780/v1", "pmid": "", "publication_date": "2026-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3019, "title": "Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration", "authors": "Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E.", "journal": "Preprints.org", "publication_date": "2026-04-15", "publication_year": 2026, "doi": "10.20944/preprints202604.1125.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Inflammaging,Review Article,Older Adults,Treatment-Resistant Depression,Safety,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:50", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "doi": "10.20944/preprints202604.1125.v1", "pmid": "", "publication_date": "2026-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 172, "title": "A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience", "authors": "Back Anthony L., McGregor Bonnie A., Thorn Leslie L., Harvey Kalin, Blom Dianna, Callan George, Guy John, Kumar Sameet, Hershberg Rob, Layer Melissa, Levin Jackie, Myers Susanna, Perez Juliana, Salmonson Kathy, Thompson Peter, Whinney Joseph", "journal": "Frontiers in Public Health", "publication_date": "2026-04-14", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1810904", "pubmed_id": "42058096", "openalex_id": "https://openalex.org/W7154396122", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:42058096", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:42058096", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "doi": "10.3389/fpubh.2026.1810904", "pmid": "42058096", "publication_date": "2026-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1970, "title": "Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol", "authors": "Penberthy J. Kim, A. Wise Fatma, Cherup Nicholas, Penberthy J. Morgan, Mitchell Evaline, Burns Madeline, Akinlade Oluwafunmilayo, Chung David, Parmar Harshit, Singer Jonathan", "journal": "Psychoactives", "publication_date": "2026-04-13", "publication_year": 2026, "doi": "10.3390/psychoactives5020012", "pubmed_id": null, "openalex_id": "https://openalex.org/W7153973756", "source_url": "https://doi.org/10.3390/psychoactives5020012", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives5020012", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/psychoactives5020012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3390/psychoactives5020012", "source_url": "https://doi.org/10.3390/psychoactives5020012", "doi": "10.3390/psychoactives5020012", "pmid": "", "publication_date": "2026-04-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 177, "title": "Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.", "authors": "Rumph JT, Winquist A, Troeschel AN, Pulver S, Schnall AH, Ebersole J, Yeh M, Burt B, Federman SL, Klontz K, Dasenbrock C, Leahy HL, Brady S, Stuteville H, Patel K, Daniel J, Chang A", "journal": "MMWR. Morbidity and mortality weekly report", "publication_date": "2026-04-08", "publication_year": 2026, "doi": "10.15585/mmwr.mm7513a2", "pubmed_id": "41955162", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955162/", "substance_tags": "psilocin", "topic_tags": "Microdosing,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 06:54:12", "bibtex": null, "source_record_id": "PMID:41955162", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41955162/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41955162", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955162/", "doi": "10.15585/mmwr.mm7513a2", "pmid": "41955162", "publication_date": "2026-04-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3656, "title": "Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06102434", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Aging,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06102434", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06102434", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06102434", "source_url": "https://clinicaltrials.gov/study/NCT06102434", "doi": "", "pmid": "", "publication_date": "2026-04-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3651, "title": "Effects of Psilocybin in Obsessive Compulsive Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05546658", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05546658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "source_url": "https://clinicaltrials.gov/study/NCT05546658", "doi": "", "pmid": "", "publication_date": "2026-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 200, "title": "Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.", "authors": "Schindler EAD, Gottschalk CH, Pittman BP, D'Souza DC", "journal": "Headache", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1111/head.70024", "pubmed_id": "41459830", "openalex_id": "https://openalex.org/W7117472148", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41459830/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41459830", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41459830/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41459830", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41459830/", "doi": "10.1111/head.70024", "pmid": "41459830", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 196, "title": "Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin", "authors": "Žuljević Marija Franka, Mijatović Antonija, Orhanović Renata, Goasdoué Glenn, Gujinović Diana", "journal": "Journal of Clinical Epidemiology", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1016/j.jclinepi.2026.112170", "pubmed_id": "41581835", "openalex_id": "https://openalex.org/W7125471543", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "PMID:41581835", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41581835", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "doi": "10.1016/j.jclinepi.2026.112170", "pmid": "41581835", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 190, "title": "Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.", "authors": "Bhatt KV, Friedman J, Benster L, Narasimhan R, Yang K, Mishra J, Weissman CR, Ramanathan D", "journal": "Community mental health journal", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1007/s10597-026-01620-x", "pubmed_id": "41920509", "openalex_id": "https://openalex.org/W7147451430", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41920509/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41920509", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41920509/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41920509", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41920509/", "doi": "10.1007/s10597-026-01620-x", "pmid": "41920509", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 186, "title": "Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.", "authors": "Marazziti D, Gambini M, Gurrieri R, Russomanno G, Sità G, Pescini E, Digiuseppe FR, Mucci F", "journal": "Expert opinion on pharmacotherapy", "publication_date": "2026-04-01", "publication_year": 2026, "doi": "10.1080/14656566.2026.2654682", "pubmed_id": "41944071", "openalex_id": "https://openalex.org/W7151630586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:50", "bibtex": null, "source_record_id": "PMID:41944071", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41944071", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41944071/", "doi": "10.1080/14656566.2026.2654682", "pmid": "41944071", "publication_date": "2026-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4054, "title": "Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders", "authors": "Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2026-03-30", "publication_year": 2026, "doi": "10.65801/pcp.3512", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143411647", "source_url": "https://doi.org/10.65801/pcp.3512", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.65801/pcp.3512", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65801/pcp.3512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65801/pcp.3512", "source_url": "https://doi.org/10.65801/pcp.3512", "doi": "10.65801/pcp.3512", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3478, "title": "Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder", "authors": "Indiana University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07499583", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Default Mode Network,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07499583", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "source_url": "https://clinicaltrials.gov/study/NCT07499583", "doi": "", "pmid": "", "publication_date": "2026-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3696, "title": "Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression", "authors": "Federal University of Latin American Integration", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-27", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06898606", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06898606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "source_url": "https://clinicaltrials.gov/study/NCT06898606", "doi": "", "pmid": "", "publication_date": "2026-03-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4057, "title": "Classic psychedelic medicines for adolescent refractory mental health disease", "authors": "Aly Shah Aziz", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-26", "publication_year": 2026, "doi": "10.1556/2054.2026.00452", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140928407", "source_url": "https://doi.org/10.1556/2054.2026.00452", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00452", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00452", "source_url": "https://doi.org/10.1556/2054.2026.00452", "doi": "10.1556/2054.2026.00452", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3037, "title": "Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial", "authors": "Broc A Pagni, Stephen Ross, Sarah Mennenga, Snehal R Bhatt, Richard J. Zeifman, Petros Petridis, Brennan Carrithers, Lindsay Worth, Samantha Podrebarac, Lindsey Owens", "journal": "PsyArXiv", "publication_date": "2026-03-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "doi": "", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4061, "title": "“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice", "authors": "Jordan J. Negrine, Stephen Bright, Monica J. Barratt, Matthew Pennell, Anthony Barnett, James Bennett-Levy, Timothy Piatkowski", "journal": "Drugs Education Prevention and Policy", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.1080/09687637.2026.2645025", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140027232", "source_url": "https://doi.org/10.1080/09687637.2026.2645025", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.1080/09687637.2026.2645025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09687637.2026.2645025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/09687637.2026.2645025", "source_url": "https://doi.org/10.1080/09687637.2026.2645025", "doi": "10.1080/09687637.2026.2645025", "pmid": "", "publication_date": "2026-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4060, "title": "Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military Personnel", "authors": "Alexandra Hopkins, Cassandra A. Bailey, Emily Rybak, Mia M. Ricardo", "journal": "Journal of Police and Criminal Psychology", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.1007/s11896-026-09807-4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140131017", "source_url": "https://doi.org/10.1007/s11896-026-09807-4", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "DOI:10.1007/s11896-026-09807-4", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11896-026-09807-4", "source_url": "https://doi.org/10.1007/s11896-026-09807-4", "doi": "10.1007/s11896-026-09807-4", "pmid": "", "publication_date": "2026-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3657, "title": "Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-20", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07484906", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Observational Study,Veterans,Safety,Transcriptomics", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07484906", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "source_url": "https://clinicaltrials.gov/study/NCT07484906", "doi": "", "pmid": "", "publication_date": "2026-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 222, "title": "Psychedelics in functional disorders: A scoping review.", "authors": "Bhagavan C, Carter O, Bryson A, Dandash O, Kanaan R", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2026-03-20", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111642", "pubmed_id": "41679377", "openalex_id": "https://openalex.org/W7128528342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41679377/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41679377", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41679377/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41679377", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41679377/", "doi": "10.1016/j.pnpbp.2026.111642", "pmid": "41679377", "publication_date": "2026-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 220, "title": "Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.", "authors": "Anchesi I, Raffaele I, Astorino MF, Lui M, Calabrò M, Cipriano GL", "journal": "International journal of molecular sciences", "publication_date": "2026-03-20", "publication_year": 2026, "doi": "10.3390/ijms27062811", "pubmed_id": "41898671", "openalex_id": "https://openalex.org/W7138904487", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41898671/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Review Article,Animal Study,Cancer Patients,Safety,Toxicity,Drug Interactions,Genomics", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41898671", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41898671/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41898671", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41898671/", "doi": "10.3390/ijms27062811", "pmid": "41898671", "publication_date": "2026-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1974, "title": "PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS", "authors": "Komarczewska Anna, Kociński Michał, Iglewski Patryk, Pietrasz Michał, Idziński Jakub, Lubomska Anna", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-03-19", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.5034", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164003040", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Receptor Pharmacology,Wellbeing,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "doi": "10.31435/ijitss.1(49).2026.5034", "pmid": "", "publication_date": "2026-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3641, "title": "Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study", "authors": "Gustavo Vazquez", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06818994", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Aging,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:41", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06818994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "source_url": "https://clinicaltrials.gov/study/NCT06818994", "doi": "", "pmid": "", "publication_date": "2026-03-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1976, "title": "Explainable AI framework for psilocybin depression treatment optimization", "authors": "Sungheetha Akey, Rajesh Sharma R., Aroba Oluwasegun Julius, Mahapatra Sheila, Mahendhiran P. D.", "journal": "Frontiers in Computer Science", "publication_date": "2026-03-16", "publication_year": 2026, "doi": "10.3389/fcomp.2025.1652190", "pubmed_id": null, "openalex_id": "https://openalex.org/W7136253679", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "doi": "10.3389/fcomp.2025.1652190", "pmid": "", "publication_date": "2026-03-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 231, "title": "The renaissance of research on psychedelics in child and adolescent psychopharmacology.", "authors": "Crocq MA, Auby P", "journal": "Child and adolescent psychiatry and mental health", "publication_date": "2026-03-13", "publication_year": 2026, "doi": "10.1186/s13034-026-01069-6", "pubmed_id": "41826990", "openalex_id": "https://openalex.org/W7135184973", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,OCD,Eating Disorders,Neuroplasticity,Pharmacology,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41826990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41826990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41826990/", "doi": "10.1186/s13034-026-01069-6", "pmid": "41826990", "publication_date": "2026-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3517, "title": "Psilocybin-facilitated Treatment for Chronic Pain", "authors": "University of Alabama at Birmingham", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05068791", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Personality Change,Emotional Processing,Mystical Experience,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05068791", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05068791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05068791", "source_url": "https://clinicaltrials.gov/study/NCT05068791", "doi": "", "pmid": "", "publication_date": "2026-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3473, "title": "Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06442423", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06442423", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "source_url": "https://clinicaltrials.gov/study/NCT06442423", "doi": "", "pmid": "", "publication_date": "2026-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 233, "title": "Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.", "authors": "Chauhan SB, Akhtar N, Jain C, Singh I", "journal": "CNS & neurological disorders drug targets", "publication_date": "2026-03-11", "publication_year": 2026, "doi": "10.2174/0118715273434237251212095005", "pubmed_id": "41833044", "openalex_id": "https://openalex.org/W7135100807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41833044/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41833044", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41833044/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41833044", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41833044/", "doi": "10.2174/0118715273434237251212095005", "pmid": "41833044", "publication_date": "2026-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3228, "title": "Age moderates the relationship between psychedelics use and mental health in naturalistic settings", "authors": "Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.", "journal": "Research Square", "publication_date": "2026-03-10", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9022170/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "doi": "10.21203/rs.3.rs-9022170/v1", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3028, "title": "Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response", "authors": "Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP.", "journal": "bioRxiv", "publication_date": "2026-03-10", "publication_year": 2026, "doi": "10.64898/2026.03.06.710108", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.03.06.710108", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Proteomics", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:51", "bibtex": null, "source_record_id": "DOI:10.64898/2026.03.06.710108", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.03.06.710108", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.03.06.710108", "source_url": "https://doi.org/10.64898/2026.03.06.710108", "doi": "10.64898/2026.03.06.710108", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1978, "title": "Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review", "authors": "Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-09", "publication_year": 2026, "doi": "10.1556/2054.2025.00364", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414123080", "source_url": "https://doi.org/10.1556/2054.2025.00364", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:28:48", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00364", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00364", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1556/2054.2025.00364", "source_url": "https://doi.org/10.1556/2054.2025.00364", "doi": "10.1556/2054.2025.00364", "pmid": "", "publication_date": "2026-03-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3296, "title": "Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report", "authors": "Shah S, Morrin H.", "journal": "Research Square", "publication_date": "2026-03-08", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8919841/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8919841/v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Spirituality,Case Report,Healthcare Workers,Safety,Drug Interactions", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:20", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8919841/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8919841/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8919841/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8919841/v1", "doi": "10.21203/rs.3.rs-8919841/v1", "pmid": "", "publication_date": "2026-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 237, "title": "The combination of exercise and psychedelics for the treatment of major depressive disorder.", "authors": "Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R", "journal": "Discover mental health", "publication_date": "2026-03-07", "publication_year": 2026, "doi": "10.1007/s44192-026-00408-5", "pubmed_id": "41793582", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Resilience,Emotional Processing,Psychological Flexibility,Safety,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41793582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41793582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "doi": "10.1007/s44192-026-00408-5", "pmid": "41793582", "publication_date": "2026-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3497, "title": "Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial", "authors": "Ohio State University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05554094", "substance_tags": "psilocybin", "topic_tags": "PTSD,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05554094", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05554094", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05554094", "source_url": "https://clinicaltrials.gov/study/NCT05554094", "doi": "", "pmid": "", "publication_date": "2026-03-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3616, "title": "A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.", "authors": "Psyence Australia Pty Ltd", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07072728", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07072728", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "source_url": "https://clinicaltrials.gov/study/NCT07072728", "doi": "", "pmid": "", "publication_date": "2026-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 241, "title": "Mushroom-Derived Carbon Nanosheets for Efficient Photothermal De-Icing Applications.", "authors": "Prusti SP, Salian R, Das AK, Kumbhakar P", "journal": "Langmuir: the ACS journal of surfaces and colloids", "publication_date": "2026-03-03", "publication_year": 2026, "doi": "10.1021/acs.langmuir.5c05324", "pubmed_id": "41569282", "openalex_id": "https://openalex.org/W7125380576", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41569282/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41569282", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41569282/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41569282", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41569282/", "doi": "10.1021/acs.langmuir.5c05324", "pmid": "41569282", "publication_date": "2026-03-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 258, "title": "Meaning and Psychedelics in Palliative Care: A Narrative Review.", "authors": "Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA", "journal": "Journal of pain and symptom management", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.jpainsymman.2025.10.015", "pubmed_id": "41173063", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41173063", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41173063", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "doi": "10.1016/j.jpainsymman.2025.10.015", "pmid": "41173063", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 255, "title": "Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase).", "authors": "Syed OA, Nestor SM, Husain MI, Sinyor M, Alam F, Giacobbe P", "journal": "Psychiatry research", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.psychres.2025.116929", "pubmed_id": "41485400", "openalex_id": "https://openalex.org/W7117472051", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485400/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41485400", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41485400/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41485400", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485400/", "doi": "10.1016/j.psychres.2025.116929", "pmid": "41485400", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 254, "title": "Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023-2024.", "authors": "Jorgenson DM, Santos Leon E, Vakkalanka JP, Krispin S, Radke JB", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1080/15563650.2025.2599402", "pubmed_id": "41493095", "openalex_id": "https://openalex.org/W7119143402", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493095/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41493095", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41493095/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41493095", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41493095/", "doi": "10.1080/15563650.2025.2599402", "pmid": "41493095", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 252, "title": "Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.", "authors": "Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS", "journal": "CNS drugs", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1007/s40263-025-01256-7", "pubmed_id": "41546846", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41546846/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41546846", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41546846/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41546846", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41546846/", "doi": "10.1007/s40263-025-01256-7", "pmid": "41546846", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 250, "title": "Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.", "authors": "Xu T, Wong S, Le GH, Dri CE, Teopiz KM, Lu A, Lee S, Rhee TG, Yin L, Bargiota S, Ho R, McIntyre RS", "journal": "Pharmacopsychiatry", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1055/a-2794-6487", "pubmed_id": "41643722", "openalex_id": "https://openalex.org/W7128030169", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41643722/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41643722", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41643722/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41643722", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41643722/", "doi": "10.1055/a-2794-6487", "pmid": "41643722", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 249, "title": "Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.", "authors": "Shiju S, Tirumala R, Marseille E", "journal": "Exploratory research in clinical and social pharmacy", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.rcsop.2026.100709", "pubmed_id": "41674667", "openalex_id": "https://openalex.org/W7125712119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41674667/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Microdosing,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41674667", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41674667/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41674667", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41674667/", "doi": "10.1016/j.rcsop.2026.100709", "pmid": "41674667", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 247, "title": "Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.", "authors": "Shokr MM, Fawzy MN, Abdelaziz AM", "journal": "Molecular and cellular neurosciences", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1016/j.mcn.2026.104076", "pubmed_id": "41763341", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41763341/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41763341", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41763341/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41763341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41763341/", "doi": "10.1016/j.mcn.2026.104076", "pmid": "41763341", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 244, "title": "Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.", "authors": "van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2026-03-01", "publication_year": 2026, "doi": "10.1177/28314425251364182", "pubmed_id": "42130778", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42130778/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:42130778", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42130778/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42130778", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42130778/", "doi": "10.1177/28314425251364182", "pmid": "42130778", "publication_date": "2026-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4076, "title": "Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making", "authors": "C Faria, Diana Dias da Silva, João José Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7173", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166641777", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:10", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "doi": "10.26537/prpaeh.v4i3.7173", "pmid": "", "publication_date": "2026-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 261, "title": "Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.", "authors": "Beaussant Y, Sager Z, Brennan C, Kristan I, Ljuslin M, Mazzola E, Macdonald D, Murphy ME, Nigam K, Rinaldi AD, Sanders J, Schaefer KG, Sholevar R, Summer L, Waliji-Banglawala A, Yudilevich-Espinoza S, Tulsky JA", "journal": "BMJ supportive & palliative care", "publication_date": "2026-02-27", "publication_year": 2026, "doi": "10.1136/spcare-2025-005773", "pubmed_id": "41184102", "openalex_id": "https://openalex.org/W4415820910", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41184102/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Emotional Processing,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41184102", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41184102/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41184102", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41184102/", "doi": "10.1136/spcare-2025-005773", "pmid": "41184102", "publication_date": "2026-02-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4078, "title": "Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico Evidence", "authors": "Diana Silva, Andreia Machado Brito-da-Costa, Mariana Carvalho, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Sérgio F. Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-25", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7159", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166650553", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7159", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Pharmacology,In Vitro Study,Safety,Toxicity,Drug Interactions", "study_type": "In Vitro Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7159", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7159", "doi": "10.26537/prpaeh.v4i3.7159", "pmid": "", "publication_date": "2026-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3032, "title": "Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial", "authors": "Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A.", "journal": "Research Square", "publication_date": "2026-02-23", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8319478/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:52", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "doi": "10.21203/rs.3.rs-8319478/v1", "pmid": "", "publication_date": "2026-02-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3182, "title": "Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives", "authors": "Christina Chwyl, Alissa Bazinet, Adie Wilson-Poe, Kim Hoffman, Kellie Pertl, Sara McCrimmon, Philip Korthuis, Jason Luoma", "journal": "PsyArXiv", "publication_date": "2026-02-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "doi": "", "pmid": "", "publication_date": "2026-02-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3520, "title": "Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04950608", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Cancer Patients,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04950608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "source_url": "https://clinicaltrials.gov/study/NCT04950608", "doi": "", "pmid": "", "publication_date": "2026-02-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 269, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.", "authors": "Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Jaglinska M, Son T, Farb N, Petranker R", "journal": "BJPsych open", "publication_date": "2026-02-16", "publication_year": 2026, "doi": "10.1192/bjo.2025.10968", "pubmed_id": "41693474", "openalex_id": "https://openalex.org/W7129015437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41693474", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41693474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41693474/", "doi": "10.1192/bjo.2025.10968", "pmid": "41693474", "publication_date": "2026-02-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3541, "title": "A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07050368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07050368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "source_url": "https://clinicaltrials.gov/study/NCT07050368", "doi": "", "pmid": "", "publication_date": "2026-02-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3425, "title": "Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07053917", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07053917", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "source_url": "https://clinicaltrials.gov/study/NCT07053917", "doi": "", "pmid": "", "publication_date": "2026-02-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3624, "title": "Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07405606", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07405606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "source_url": "https://clinicaltrials.gov/study/NCT07405606", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3690, "title": "Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers", "authors": "Hadassah Medical Organization", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07079930", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Clinical Trial,Observational Study,Animal Study,Healthy Volunteers,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07079930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "source_url": "https://clinicaltrials.gov/study/NCT07079930", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3550, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06206265", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Aging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06206265", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "source_url": "https://clinicaltrials.gov/study/NCT06206265", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3486, "title": "Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study", "authors": "Nantes University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07391332", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07391332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "source_url": "https://clinicaltrials.gov/study/NCT07391332", "doi": "", "pmid": "", "publication_date": "2026-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3272, "title": "Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models", "authors": "Ben-Zion Z, Simon G, Lazebnik T.", "journal": "Research Square", "publication_date": "2026-02-02", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8682370/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8682370/v1", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Mystical Experience,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8682370/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8682370/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8682370/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8682370/v1", "doi": "10.21203/rs.3.rs-8682370/v1", "pmid": "", "publication_date": "2026-02-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 306, "title": "Psilocybin use in bipolar disorder: A comprehensive review.", "authors": "Do A, Cloutier L, Hébert-Tremblay L, Thauvin C", "journal": "Journal of affective disorders", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120485", "pubmed_id": "41177271", "openalex_id": "https://openalex.org/W4415742444", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41177271", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41177271", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41177271/", "doi": "10.1016/j.jad.2025.120485", "pmid": "41177271", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 295, "title": "Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.", "authors": "Olofsson M, Osika W, Goldberg SB, Hendricks PS, Petrovic P, White T, Stenfors CUD, Chaturvedi S, Simonsson O", "journal": "The International journal on drug policy", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1016/j.drugpo.2025.105105", "pubmed_id": "41389560", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41389560/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41389560", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41389560/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41389560", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41389560/", "doi": "10.1016/j.drugpo.2025.105105", "pmid": "41389560", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 294, "title": "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.", "authors": "Dutton M, Schwenn P, Mitchell J, Hoffmann P, Bailey NW, Fitzgerald PB, Lagopoulos J, Can AT", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1177/00048674251398677", "pubmed_id": "41405025", "openalex_id": "https://openalex.org/W4417431364", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41405025/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41405025", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41405025/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41405025", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41405025/", "doi": "10.1177/00048674251398677", "pmid": "41405025", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 291, "title": "Psilocybin and Bipolar Depression: Promise and Prudence.", "authors": "Marques MG, Patarroyo-Rodriguez L, Singh B", "journal": "CNS drugs", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1007/s40263-025-01255-8", "pubmed_id": "41485178", "openalex_id": "https://openalex.org/W7118127068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41485178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41485178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485178/", "doi": "10.1007/s40263-025-01255-8", "pmid": "41485178", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 288, "title": "Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy.", "authors": "Ham R, Gardner J, Carter A, Liknaitzky P", "journal": "Brain and behavior", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.1002/brb3.71262", "pubmed_id": "41699875", "openalex_id": "https://openalex.org/W7129297531", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41699875/", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41699875", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41699875/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41699875", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41699875/", "doi": "10.1002/brb3.71262", "pmid": "41699875", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 285, "title": "[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].", "authors": "Roser P", "journal": "Therapeutische Umschau. Revue therapeutique", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.23785/tu.2026.01.006", "pubmed_id": "41878754", "openalex_id": "https://openalex.org/W7140918736", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41878754/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:52", "bibtex": null, "source_record_id": "PMID:41878754", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41878754/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41878754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41878754/", "doi": "10.23785/tu.2026.01.006", "pmid": "41878754", "publication_date": "2026-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4097, "title": "Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective", "authors": "Aditi Kanwar, Nitin Jeengar, Pramod Kumar Ashaiya", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-30", "publication_year": 2026, "doi": "10.5281/zenodo.18425838", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126227261", "source_url": "https://doi.org/10.5281/zenodo.18425838", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Consciousness,Emotional Processing,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18425838", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18425838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18425838", "source_url": "https://doi.org/10.5281/zenodo.18425838", "doi": "10.5281/zenodo.18425838", "pmid": "", "publication_date": "2026-01-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1989, "title": "PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION", "authors": "Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-28", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4711", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125929049", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:11", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "doi": "10.31435/ijitss.1(49).2026.4711", "pmid": "", "publication_date": "2026-01-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4101, "title": "Psychedelics in psychiatric treatment: a literature review", "authors": "Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska", "journal": "Quality in Sport", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.12775/qs.2026.50.68013", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125801196", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.50.68013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.50.68013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.50.68013", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "doi": "10.12775/qs.2026.50.68013", "pmid": "", "publication_date": "2026-01-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4100, "title": "The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence", "authors": "Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-26", "publication_year": 2026, "doi": "10.5281/zenodo.18375715", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125699554", "source_url": "https://doi.org/10.5281/zenodo.18375715", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18375715", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18375715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18375715", "source_url": "https://doi.org/10.5281/zenodo.18375715", "doi": "10.5281/zenodo.18375715", "pmid": "", "publication_date": "2026-01-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1991, "title": "The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression", "authors": "Rishika Scott, James Smith", "journal": "Emerging Minds Journal for Student Research", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.59973/emjsr.317", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125652025", "source_url": "https://doi.org/10.59973/emjsr.317", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.59973/emjsr.317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59973/emjsr.317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59973/emjsr.317", "source_url": "https://doi.org/10.59973/emjsr.317", "doi": "10.59973/emjsr.317", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3673, "title": "A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06796062", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06796062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "source_url": "https://clinicaltrials.gov/study/NCT06796062", "doi": "", "pmid": "", "publication_date": "2026-01-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4106, "title": "Does psilocybin help with mental health conditions?", "authors": "Tripdatabase", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.5281/zenodo.18339283", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125428177", "source_url": "https://doi.org/10.5281/zenodo.18339283", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18339283", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18339283", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18339283", "source_url": "https://doi.org/10.5281/zenodo.18339283", "doi": "10.5281/zenodo.18339283", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3703, "title": "The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma", "authors": "Baylor College of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06888128", "substance_tags": "psilocybin", "topic_tags": "PTSD,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06888128", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06888128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06888128", "source_url": "https://clinicaltrials.gov/study/NCT06888128", "doi": "", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1992, "title": "THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS", "authors": "Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4582", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127606273", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "doi": "10.31435/ijitss.1(49).2026.4582", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4108, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-01-21", "publication_year": 2026, "doi": "10.48620/94398", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128014083", "source_url": "https://doi.org/10.48620/94398", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.48620/94398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/94398", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/94398", "source_url": "https://doi.org/10.48620/94398", "doi": "10.48620/94398", "pmid": "", "publication_date": "2026-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 323, "title": "[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].", "authors": "Xia K, Gao T", "journal": "Nan fang yi ke da xue xue bao = Journal of Southern Medical University", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pubmed_id": "41540686", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41540686/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41540686", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41540686/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41540686", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41540686/", "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pmid": "41540686", "publication_date": "2026-01-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1993, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon", "journal": "Psychedelic Medicine", "publication_date": "2026-01-18", "publication_year": 2026, "doi": "10.1177/28314425251413856", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124682544", "source_url": "https://doi.org/10.1177/28314425251413856", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:12", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251413856", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251413856", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251413856", "source_url": "https://doi.org/10.1177/28314425251413856", "doi": "10.1177/28314425251413856", "pmid": "", "publication_date": "2026-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3029, "title": "Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial", "authors": "Benjamin Kelmendi, Thomas Adams, Terence Ching, Rachael Grazioplene, Stephen Kichuk, Geena Fram, Prerana Patel, Jeff Eilbott, Elizabeth D’Amico, Sarah Shnayder", "journal": "PsyArXiv", "publication_date": "2026-01-15", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "doi": "", "pmid": "", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 326, "title": "Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.", "authors": "Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS", "journal": "Journal of affective disorders", "publication_date": "2026-01-15", "publication_year": 2026, "doi": "10.1016/j.jad.2025.120335", "pubmed_id": "40962065", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40962065/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:40962065", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40962065/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40962065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40962065/", "doi": "10.1016/j.jad.2025.120335", "pmid": "40962065", "publication_date": "2026-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 333, "title": "An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.", "authors": "Dallery J, Miller JL, Boissoneault J, Harvey L, Ives L, Knerr A, Blaes S, Ransom MN, Munson M, Gilligan JP, Silverman MH, Guzzo PR, Loeser B", "journal": "Journal of eating disorders", "publication_date": "2026-01-03", "publication_year": 2026, "doi": "10.1186/s40337-025-01508-3", "pubmed_id": "41485073", "openalex_id": "https://openalex.org/W7118124310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485073/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Brain Imaging,Biomarkers,Aging,Emotional Processing,Psychological Flexibility,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41485073", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41485073/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41485073", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41485073/", "doi": "10.1186/s40337-025-01508-3", "pmid": "41485073", "publication_date": "2026-01-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 337, "title": "Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress", "authors": "Sancilio Frederick D., Dariani Maghsoud, Chavda Purvi, Rajagopal Harsha Mysore, Tomlinson Lyl", "journal": "Journal of Psychoactive Drugs", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1080/02791072.2025.2607726", "pubmed_id": "41482437", "openalex_id": "https://openalex.org/W7118088356", "source_url": "https://doi.org/10.1080/02791072.2025.2607726", "substance_tags": "psilocin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:41482437", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2607726", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:41482437", "source_url": "https://doi.org/10.1080/02791072.2025.2607726", "doi": "10.1080/02791072.2025.2607726", "pmid": "41482437", "publication_date": "2026-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 336, "title": "The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis.", "authors": "Moshfeghinia R, Mostafavi S, Jazi K, Ghasemi AR, Khosravaninezhad Y, Narayanan S, Ahmadi J, Pasalar M", "journal": "BMC psychology", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1186/s40359-025-03935-y", "pubmed_id": "41484687", "openalex_id": "https://openalex.org/W7118088637", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41484687/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41484687", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41484687/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41484687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41484687/", "doi": "10.1186/s40359-025-03935-y", "pmid": "41484687", "publication_date": "2026-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 335, "title": "Reported Safety Practices of Publicly Advertised Psychedelic Retreats.", "authors": "McGuire AL, Neitzke-Spruill L, Robinson JO, Beit CS, Singh N, Mathai DS, Averill LA", "journal": "JAMA network open", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.52505", "pubmed_id": "41499117", "openalex_id": "https://openalex.org/W7118708255", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41499117/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41499117", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41499117/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41499117", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41499117/", "doi": "10.1001/jamanetworkopen.2025.52505", "pmid": "41499117", "publication_date": "2026-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 334, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM", "journal": "JAMA network open", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.54843", "pubmed_id": "41563753", "openalex_id": "https://openalex.org/W7125277592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Drug Interactions", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41563753", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41563753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41563753/", "doi": "10.1001/jamanetworkopen.2025.54843", "pmid": "41563753", "publication_date": "2026-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5794, "title": "Psychedelic Drugs", "authors": "Federico Durbano, Marco Otto Toscano", "journal": "IntechOpen", "publication_date": "2026-01-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7170998516", "source_url": "https://www.intechopen.com/books/1004886", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Consciousness,Emotional Processing,Spirituality,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:13", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://www.intechopen.com/books/1004886", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.intechopen.com/books/1004886", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.intechopen.com/books/1004886", "source_url": "https://www.intechopen.com/books/1004886", "doi": "", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4179, "title": "Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review", "authors": "Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate", "journal": "Open Science Framework", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.17605/osf.io/yu3n9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162447643", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/yu3n9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/yu3n9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/yu3n9", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "doi": "10.17605/osf.io/yu3n9", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4161, "title": "‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury", "authors": "Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah", "journal": "Internal Medicine Journal", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1111/imj.70313", "pubmed_id": "41518153", "openalex_id": "https://openalex.org/W7119893738", "source_url": "https://doi.org/10.1111/imj.70313", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "PMID:41518153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/imj.70313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41518153", "source_url": "https://doi.org/10.1111/imj.70313", "doi": "10.1111/imj.70313", "pmid": "41518153", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4158, "title": "Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial", "authors": "L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.105779", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005769", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "doi": "10.1016/j.nsa.2025.105779", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4155, "title": "An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes", "authors": "N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.nsa.2025.106821", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117964120", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "doi": "10.1016/j.nsa.2025.106821", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4152, "title": "Psilocybin Treatment for Refractory Depression: A Clinical Review", "authors": "Jensen, Hailey A", "journal": "Digital Commons - Gardner-Webb University (Gardner-Webb University)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110564344", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:13", "bibtex": null, "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "doi": "", "pmid": "", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4036, "title": "Oregon's Psilocybin Services: A Summary and Public Health Commentary.", "authors": "LoParco CR, Bone C, Galvin AM, Rossheim ME, Berg CJ", "journal": "Health behavior research", "publication_date": "2026-01-01", "publication_year": 2026, "doi": null, "pubmed_id": "42428139", "openalex_id": "https://openalex.org/W7154872659", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42428139/", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Adolescents,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-08-09 08:34:30", "bibtex": null, "source_record_id": "PMID:42428139", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42428139/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42428139", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42428139/", "doi": "", "pmid": "42428139", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 374, "title": "Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.", "authors": "Holze F, Liechti ME, Müller F", "journal": "Current topics in behavioral neurosciences", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/7854_2024_510", "pubmed_id": "39080236", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39080236/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Pharmacology,Receptor Pharmacology,Emotional Processing,Safety,Adverse Events,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39080236", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39080236/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39080236", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39080236/", "doi": "10.1007/7854_2024_510", "pmid": "39080236", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 372, "title": "Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.", "authors": "Viljoen G, Betzler F", "journal": "Current topics in behavioral neurosciences", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/7854_2024_534", "pubmed_id": "39436632", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39436632", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39436632", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "doi": "10.1007/7854_2024_534", "pmid": "39436632", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 368, "title": "Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.", "authors": "Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811241303594", "pubmed_id": "39655749", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655749/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39655749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39655749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39655749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655749/", "doi": "10.1177/02698811241303594", "pmid": "39655749", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 367, "title": "Informed Consent in Psychedelic-Assisted Therapy.", "authors": "Bradberry MM, Appelbaum PS, Gukasyan N", "journal": "Current topics in behavioral neurosciences", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/7854_2024_559", "pubmed_id": "39739178", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39739178/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:39739178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39739178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39739178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39739178/", "doi": "10.1007/7854_2024_559", "pmid": "39739178", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 365, "title": "Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.", "authors": "Prostko S, Wu A, Maddams S, Szpak V, Rosenblum N, Hilt LM, Suzuki J", "journal": "Journal of addiction medicine", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/adm.0000000000001517", "pubmed_id": "40433994", "openalex_id": "https://openalex.org/W4410826214", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40433994/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40433994", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40433994/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40433994", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40433994/", "doi": "10.1097/adm.0000000000001517", "pmid": "40433994", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 363, "title": "Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.", "authors": "Chwyl C, Wilson-Poe AR, Hoffman KA, Bazinet A, Pertl K, Luoma JB, des Jarlais D, Bielavitz S, Korthuis PT", "journal": "The International journal on drug policy", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.drugpo.2025.104938", "pubmed_id": "40803962", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40803962/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40803962", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40803962/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40803962", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40803962/", "doi": "10.1016/j.drugpo.2025.104938", "pmid": "40803962", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 361, "title": "Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.", "authors": "McGowan NM, Rucker JJ, Yehuda R, Agrawal M, Modlin NL, Simmons H, Tofil-Kaluza A, Das S, Goodwin GM", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251362390", "pubmed_id": "40883964", "openalex_id": "https://openalex.org/W4413839750", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Headache / Migraine,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:40883964", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40883964", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883964/", "doi": "10.1177/02698811251362390", "pmid": "40883964", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 360, "title": "Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.", "authors": "Hirschfeld T, Blei F, Stegemann L, van der Gouwe D, Smit-Rigter L", "journal": "Current topics in behavioral neurosciences", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/7854_2025_606", "pubmed_id": "41087826", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41087826/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41087826", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41087826/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41087826", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41087826/", "doi": "10.1007/7854_2025_606", "pmid": "41087826", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 359, "title": "Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.", "authors": "Heal DJ, Gosden J, Smith SL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251382147", "pubmed_id": "41099474", "openalex_id": "https://openalex.org/W4415246143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099474/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Safety,Abuse Liability", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41099474", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41099474/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41099474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099474/", "doi": "10.1177/02698811251382147", "pmid": "41099474", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 358, "title": "A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.", "authors": "Marek GJ, Makai-Bölöni S, Umbricht D, Christian EP, Winters J, Dvorak D, Raines S, Hughes ZA, Austin EW, Klein AK, Leong W, Krol FJ, Graaf AJV, Juachon MJ, Otto ME, Borghans LGJM, Jacobs G, Kruegel AC, Sporn J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251378512", "pubmed_id": "41099491", "openalex_id": "https://openalex.org/W4415246252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Biomarkers,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41099491", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41099491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41099491/", "doi": "10.1177/02698811251378512", "pmid": "41099491", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 357, "title": "Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use.", "authors": "Hutchison KE, Hooper JF, Karoly HC", "journal": "JAMA psychiatry", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2025.3038", "pubmed_id": "41191341", "openalex_id": "https://openalex.org/W4415929140", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41191341/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41191341", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41191341/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41191341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41191341/", "doi": "10.1001/jamapsychiatry.2025.3038", "pmid": "41191341", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 354, "title": "Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.", "authors": "Konstantinou GN, Rosenblat J, Hales S, Husain MI, Blumberger DM", "journal": "General hospital psychiatry", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1016/j.genhosppsych.2025.12.005", "pubmed_id": "41401486", "openalex_id": "https://openalex.org/W4417166023", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Default Mode Network,Aging,Clinical Trial,Review Article,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41401486", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41401486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41401486/", "doi": "10.1016/j.genhosppsych.2025.12.005", "pmid": "41401486", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 353, "title": "Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.", "authors": "Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S", "journal": "Palliative medicine", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02692163251383335", "pubmed_id": "41410211", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41410211", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41410211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410211/", "doi": "10.1177/02692163251383335", "pmid": "41410211", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 348, "title": "Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder.", "authors": "Rasheed S, Arif R, Raza AA, Samadi A", "journal": "Annals of medicine and surgery (2012)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/ms9.0000000000004349", "pubmed_id": "41497122", "openalex_id": "https://openalex.org/W4416592848", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41497122", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41497122", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497122/", "doi": "10.1097/ms9.0000000000004349", "pmid": "41497122", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 347, "title": "Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.", "authors": "Freitas da Costa B, Hartmann P, Pagnin D", "journal": "Human psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1002/hup.70032", "pubmed_id": "41502021", "openalex_id": "https://openalex.org/W7118595574", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41502021/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41502021", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41502021/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41502021", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41502021/", "doi": "10.1002/hup.70032", "pmid": "41502021", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 346, "title": "Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.", "authors": "Magar V, Robbins M, Fernández Lobo Blanco ÓML, Ali IL, Anderson B, Grob C, Henningfield JE, Kryskow P, Kuiper H, Loizaga-Velder A, Rush B, Volat M, Iron Rope S", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/02698811251387104", "pubmed_id": "41618525", "openalex_id": "https://openalex.org/W7126158169", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41618525/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41618525", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41618525/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41618525", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41618525/", "doi": "10.1177/02698811251387104", "pmid": "41618525", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 342, "title": "Classifying Psychedelic-Related Complications.", "authors": "Majić T, Gouzoulis-Mayfrank E, Evens R", "journal": "Current topics in behavioral neurosciences", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/7854_2026_614", "pubmed_id": "41749025", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41749025/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41749025", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41749025/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41749025", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41749025/", "doi": "10.1007/7854_2026_614", "pmid": "41749025", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 341, "title": "Contextualizing Violence Risk Associated With Hallucinogens.", "authors": "Durns T, Iannuzzi G", "journal": "Focus (American Psychiatric Publishing)", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1176/appi.focus.20250027", "pubmed_id": "41953889", "openalex_id": "https://openalex.org/W7124312498", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41953889/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41953889", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41953889/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41953889", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41953889/", "doi": "10.1176/appi.focus.20250027", "pmid": "41953889", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 340, "title": "New Antidepressant Development in the Treatment of Depression.", "authors": "Spiti A, Caldirola D, Perna G", "journal": "Advances in experimental medicine and biology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/978-981-95-6872-7_23", "pubmed_id": "42036580", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42036580", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42036580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036580/", "doi": "10.1007/978-981-95-6872-7_23", "pmid": "42036580", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 339, "title": "Psychedelics: Future Therapeutics in Major Depression?", "authors": "Olivier B, Olivier JDA", "journal": "Advances in experimental medicine and biology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1007/978-981-95-6872-7_25", "pubmed_id": "42036582", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:42036582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42036582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42036582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42036582/", "doi": "10.1007/978-981-95-6872-7_25", "pmid": "42036582", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 235, "title": "Psychedelic therapy and postpartum depression: priorities and prospects.", "authors": "Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/20451253251408280", "pubmed_id": "41816502", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Aging,Review Article,Safety,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41816502", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41816502", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "doi": "10.1177/20451253251408280", "pmid": "41816502", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 206, "title": "Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.", "authors": "Albert OM, Arthur A", "journal": "Therapeutic advances in drug safety", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1177/20420986261436104", "pubmed_id": "41930230", "openalex_id": "https://openalex.org/W7143884623", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41930230/", "substance_tags": "psilocybin", "topic_tags": "Meta-Analysis,Review Article,Case Report,Observational Study,Healthcare Workers,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:51", "bibtex": null, "source_record_id": "PMID:41930230", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41930230/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41930230", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41930230/", "doi": "10.1177/20420986261436104", "pmid": "41930230", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 6, "title": "Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.", "authors": "Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B", "journal": "Journal of clinical psychopharmacology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1097/jcp.0000000000002197", "pubmed_id": "42228481", "openalex_id": "https://openalex.org/W7163126953", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42228481/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-08-09 08:27:46", "bibtex": null, "source_record_id": "PMID:42228481", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42228481/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42228481", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42228481/", "doi": "10.1097/jcp.0000000000002197", "pmid": "42228481", "publication_date": "2026-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3479, "title": "A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06615908", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Headache / Migraine,Emotional Processing,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06615908", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06615908", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06615908", "source_url": "https://clinicaltrials.gov/study/NCT06615908", "doi": "", "pmid": "", "publication_date": "2025-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3464, "title": "Microdosing Psychedelics to Improve Mood", "authors": "Rotem Petranker", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05259943", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05259943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "source_url": "https://clinicaltrials.gov/study/NCT05259943", "doi": "", "pmid": "", "publication_date": "2025-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3017, "title": "Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks", "authors": "Cervera-Sanchez MB, San-Juan D, Díaz-Peregrino R, Camacho-Castillo EZ, Bringas-Ortiz SA, Padilla-Cabezutd C.", "journal": "Authorea Preprints", "publication_date": "2025-12-29", "publication_year": 2025, "doi": "10.22541/au.176701186.65064859/v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117461912", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-08-09 08:14:49", "bibtex": null, "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "doi": "10.22541/au.176701186.65064859/v1", "pmid": "", "publication_date": "2025-12-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 377, "title": "Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.", "authors": "Dominiak M, Gędek A, Modrzejewski S, Permoda-Pachuta A, Antosik AZ", "journal": "Journal of clinical medicine", "publication_date": "2025-12-29", "publication_year": 2025, "doi": "10.3390/jcm15010253", "pubmed_id": "41517502", "openalex_id": "https://openalex.org/W7117705718", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41517502/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Randomized Controlled Trial,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41517502", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41517502/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41517502", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41517502/", "doi": "10.3390/jcm15010253", "pmid": "41517502", "publication_date": "2025-12-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4189, "title": "A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder", "authors": "Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail", "journal": "Current Treatment Options in Psychiatry", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1007/s40501-025-00373-w", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117327267", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 06:34:37", "bibtex": null, "source_record_id": "DOI:10.1007/s40501-025-00373-w", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40501-025-00373-w", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "doi": "10.1007/s40501-025-00373-w", "pmid": "", "publication_date": "2025-12-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3701, "title": "The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05220410", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05220410", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "source_url": "https://clinicaltrials.gov/study/NCT05220410", "doi": "", "pmid": "", "publication_date": "2025-12-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3506, "title": "An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder", "authors": "University of Chicago", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05399498", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05399498", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "source_url": "https://clinicaltrials.gov/study/NCT05399498", "doi": "", "pmid": "", "publication_date": "2025-12-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3055, "title": "A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants", "authors": "Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA.", "journal": "medRxiv", "publication_date": "2025-12-23", "publication_year": 2025, "doi": "10.64898/2025.12.22.25342874", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Consciousness,Clinical Trial,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:54", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.22.25342874", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.22.25342874", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2025.12.22.25342874", "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "doi": "10.64898/2025.12.22.25342874", "pmid": "", "publication_date": "2025-12-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3585, "title": "Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296328", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296328", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "source_url": "https://clinicaltrials.gov/study/NCT07296328", "doi": "", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 391, "title": "Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.", "authors": "Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-12-20", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111541", "pubmed_id": "41138900", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41138900", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41138900", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41138900/", "doi": "10.1016/j.pnpbp.2025.111541", "pmid": "41138900", "publication_date": "2025-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3093, "title": "Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development", "authors": "Koning E, Gamberg S, Keshen A.", "journal": "Preprints.org", "publication_date": "2025-12-19", "publication_year": 2025, "doi": "10.20944/preprints202512.1705.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202512.1705.v1", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:57", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202512.1705.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202512.1705.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202512.1705.v1", "source_url": "https://doi.org/10.20944/preprints202512.1705.v1", "doi": "10.20944/preprints202512.1705.v1", "pmid": "", "publication_date": "2025-12-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 392, "title": "Psilocybin reporting in media (PRiMe) for the treatment of depression.", "authors": "Brar G, Burke T, Gribben AD, Harrington C, Thuery G, Kelly JR", "journal": "Irish journal of psychological medicine", "publication_date": "2025-12-18", "publication_year": 2025, "doi": "10.1017/ipm.2025.10142", "pubmed_id": "41410115", "openalex_id": "https://openalex.org/W4417453981", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41410115", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41410115", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41410115/", "doi": "10.1017/ipm.2025.10142", "pmid": "41410115", "publication_date": "2025-12-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4200, "title": "Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment", "authors": "M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya", "journal": "˜The œjournal of desk research review and analysis.", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.4038/jdrra.v3i2.87", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115587785", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "doi": "10.4038/jdrra.v3i2.87", "pmid": "", "publication_date": "2025-12-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 394, "title": "Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.", "authors": "Ledwos N, Baer J, Husain MI, Blumberger DM, Patterson R, Hollingdrake E, Cheung E, Hawco C, Zrenner C, Zrenner B, Feusner JD, Rossell SL, Castle DJ, Zai G", "journal": "BJPsych open", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.1192/bjo.2025.10895", "pubmed_id": "41392767", "openalex_id": "https://openalex.org/W4417362478", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41392767/", "substance_tags": "psilocybin", "topic_tags": "OCD,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41392767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41392767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41392767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41392767/", "doi": "10.1192/bjo.2025.10895", "pmid": "41392767", "publication_date": "2025-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3048, "title": "Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study", "authors": "Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S.", "journal": "Research Square", "publication_date": "2025-12-10", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8079137/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:53", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "doi": "10.21203/rs.3.rs-8079137/v1", "pmid": "", "publication_date": "2025-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3625, "title": "Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06798636", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06798636", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "source_url": "https://clinicaltrials.gov/study/NCT06798636", "doi": "", "pmid": "", "publication_date": "2025-12-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4210, "title": "Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges", "authors": "Taslim Uddin, Suma Akter, Kanak Yadab Ghosh", "journal": "Advanced Neurology", "publication_date": "2025-12-04", "publication_year": 2025, "doi": "10.36922/an025410095", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417099564", "source_url": "https://doi.org/10.36922/an025410095", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "DOI:10.36922/an025410095", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36922/an025410095", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36922/an025410095", "source_url": "https://doi.org/10.36922/an025410095", "doi": "10.36922/an025410095", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3692, "title": "Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study", "authors": "University of British Columbia", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05585229", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Mechanism of Action,Safety,Adverse Events,Contraindications", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05585229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05585229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05585229", "source_url": "https://clinicaltrials.gov/study/NCT05585229", "doi": "", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3513, "title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05398484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05398484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "source_url": "https://clinicaltrials.gov/study/NCT05398484", "doi": "", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4212, "title": "Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears", "authors": "Spohn, Kyle", "journal": "eYLS (Yale Law School)", "publication_date": "2025-12-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112471464", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:14", "bibtex": null, "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "doi": "", "pmid": "", "publication_date": "2025-12-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3252, "title": "Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study", "authors": "Bukovsky D, Amaev A, Song J, Torres-Carmona E, Kyte S, Ueno F, Deluca V, Bowie C, Flint A, Husain I, Graff-Guerrero A, Gerretsen P.", "journal": "Alzheimer's & dementia: the journal of the Alzheimer's Association", "publication_date": "2025-12-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12740486", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Older Adults,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:15", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12740486", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12740486", "source_url": "https://europepmc.org/article/PMC/PMC12740486", "doi": "", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3154, "title": "Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland", "authors": "Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L.", "journal": "medRxiv", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1101/2025.12.01.25341335", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:06", "bibtex": null, "source_record_id": "DOI:10.1101/2025.12.01.25341335", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.12.01.25341335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.12.01.25341335", "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "doi": "10.1101/2025.12.01.25341335", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 418, "title": "Exploring the therapeutic potential of psychedelics in treating substance use disorders.", "authors": "Li Y, Li H, Wang H, Wang X", "journal": "Molecular psychiatry", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1038/s41380-025-03168-w", "pubmed_id": "40830580", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830580/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40830580", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40830580/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40830580", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40830580/", "doi": "10.1038/s41380-025-03168-w", "pmid": "40830580", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 417, "title": "Between enhancement and risk: A critical review of psychedelic microdosing.", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC", "journal": "Current opinion in psychology", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.copsyc.2025.102129", "pubmed_id": "40834796", "openalex_id": "https://openalex.org/W4413020215", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40834796/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Microdosing,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:40834796", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40834796/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40834796", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40834796/", "doi": "10.1016/j.copsyc.2025.102129", "pmid": "40834796", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 408, "title": "Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.", "authors": "Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.euroneuro.2025.09.011", "pubmed_id": "41205366", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41205366", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41205366", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41205366/", "doi": "10.1016/j.euroneuro.2025.09.011", "pmid": "41205366", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 401, "title": "Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.", "authors": "Modlin NL, Williamson V, Goodwin GM, Malievskaia E, Atli M, Elek Z, Gaillard A, Koelpin D, Cleare A, Agrawal M, Yehuda R, Kirlic N, Rucker J", "journal": "EClinicalMedicine", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103692", "pubmed_id": "41497513", "openalex_id": "https://openalex.org/W4417031290", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41497513", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41497513", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41497513/", "doi": "10.1016/j.eclinm.2025.103692", "pmid": "41497513", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 384, "title": "Griffiths et al.'s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective.", "authors": "Lorenz J, Hawkins S, McCarthy B", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1177/28314425251406251", "pubmed_id": "41869005", "openalex_id": "https://openalex.org/W4417034603", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869005/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Mystical Experience,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41869005", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869005/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869005", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869005/", "doi": "10.1177/28314425251406251", "pmid": "41869005", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 383, "title": "Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.", "authors": "Griffiths RR, Jesse R, Richards WA, Johnson MW, Sepeda ND, Bossis AP, Ross S", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.1089/psymed.2023.0044", "pubmed_id": "41869007", "openalex_id": "https://openalex.org/W4410448036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41869007", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869007/", "doi": "10.1089/psymed.2023.0044", "pmid": "41869007", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 380, "title": "Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review.", "authors": "Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J", "journal": "Cureus", "publication_date": "2025-12-01", "publication_year": 2025, "doi": "10.7759/cureus.99942", "pubmed_id": "41583322", "openalex_id": "https://openalex.org/W7116864166", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41583322", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41583322", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41583322/", "doi": "10.7759/cureus.99942", "pmid": "41583322", "publication_date": "2025-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4230, "title": "Efficacy of psilocybin on death anxiety in terminal patients: a narrative review", "authors": "Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana", "journal": "Progress in Palliative Care", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1080/09699260.2026.2657096", "pubmed_id": null, "openalex_id": "https://openalex.org/W7152631097", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1080/09699260.2026.2657096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09699260.2026.2657096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/09699260.2026.2657096", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "doi": "10.1080/09699260.2026.2657096", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3681, "title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder", "authors": "University of Texas at Austin", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-26", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06132178", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06132178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "source_url": "https://clinicaltrials.gov/study/NCT06132178", "doi": "", "pmid": "", "publication_date": "2025-11-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3700, "title": "Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life", "authors": "Charles S. Grob, M.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05403086", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05403086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "source_url": "https://clinicaltrials.gov/study/NCT05403086", "doi": "", "pmid": "", "publication_date": "2025-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 423, "title": "Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.", "authors": "Kruger DJ, Mersereau G, Sullivan A, Barron J, Herberholz M, Pouyan N, Aday JS, Boehnke KF", "journal": "Harm reduction journal", "publication_date": "2025-11-25", "publication_year": 2025, "doi": "10.1186/s12954-025-01337-2", "pubmed_id": "41291774", "openalex_id": "https://openalex.org/W4416671509", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41291774/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41291774", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41291774/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41291774", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41291774/", "doi": "10.1186/s12954-025-01337-2", "pmid": "41291774", "publication_date": "2025-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 425, "title": "Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?", "authors": "Natoli S, Cuomo A, Marchesini M, Luongo L, Lo Bianco G, Guardamagna VA, Yamaguchi S", "journal": "Medical sciences (Basel, Switzerland)", "publication_date": "2025-11-20", "publication_year": 2025, "doi": "10.3390/medsci13040277", "pubmed_id": "41283278", "openalex_id": "https://openalex.org/W4416407616", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41283278/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41283278", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41283278/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41283278", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41283278/", "doi": "10.3390/medsci13040277", "pmid": "41283278", "publication_date": "2025-11-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3548, "title": "A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07183748", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07183748", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "source_url": "https://clinicaltrials.gov/study/NCT07183748", "doi": "", "pmid": "", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3454, "title": "Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04882839", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Spirituality,Clinical Trial,Case Report,Animal Study,Cancer Patients,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04882839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "source_url": "https://clinicaltrials.gov/study/NCT04882839", "doi": "", "pmid": "", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 428, "title": "Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics.", "authors": "Agrawal R, Gillie D, Mungenast A, Chytil M, Engel S, Wu MC, Rasmussen K, Salinas E, Olson DE", "journal": "ACS chemical neuroscience", "publication_date": "2025-11-19", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00667", "pubmed_id": "41078264", "openalex_id": "https://openalex.org/W4415115279", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41078264/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41078264", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41078264/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41078264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41078264/", "doi": "10.1021/acschemneuro.5c00667", "pmid": "41078264", "publication_date": "2025-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3061, "title": "Psilocybin Experiential Therapist Training: Insights from a World-First Study", "authors": "Ioakimidis-MacDougall G, Gardner J, Liknaitzky P.", "journal": "medRxiv", "publication_date": "2025-11-17", "publication_year": 2025, "doi": "10.1101/2025.11.15.25340324", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.11.15.25340324", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2025.11.15.25340324", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.11.15.25340324", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.11.15.25340324", "source_url": "https://doi.org/10.1101/2025.11.15.25340324", "doi": "10.1101/2025.11.15.25340324", "pmid": "", "publication_date": "2025-11-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3058, "title": "Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son", "journal": "PsyArXiv", "publication_date": "2025-11-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "doi": "", "pmid": "", "publication_date": "2025-11-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 438, "title": "Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.", "authors": "Renner AC, Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2025-11-13", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00595", "pubmed_id": "41256989", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41256989/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41256989", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41256989/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41256989", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41256989/", "doi": "10.1021/acsmedchemlett.5c00595", "pmid": "41256989", "publication_date": "2025-11-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 441, "title": "Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.", "authors": "Mehtani NJ, Mian MN, Agin-Liebes G, Coker AR, Huebner C, Anderson BT, Mitchell JM", "journal": "Journal of psychoactive drugs", "publication_date": "2025-11-10", "publication_year": 2025, "doi": "10.1080/02791072.2025.2583960", "pubmed_id": "41214462", "openalex_id": "https://openalex.org/W4416137526", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41214462/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Spirituality,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41214462", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41214462/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41214462", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41214462/", "doi": "10.1080/02791072.2025.2583960", "pmid": "41214462", "publication_date": "2025-11-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 443, "title": "The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.", "authors": "Zech JM, Richard J, Jones GM", "journal": "Journal of psychoactive drugs", "publication_date": "2025-11-09", "publication_year": 2025, "doi": "10.1080/02791072.2025.2583967", "pubmed_id": "41208129", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41208129/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41208129", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41208129/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41208129", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41208129/", "doi": "10.1080/02791072.2025.2583967", "pmid": "41208129", "publication_date": "2025-11-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3489, "title": "A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05847686", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05847686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "source_url": "https://clinicaltrials.gov/study/NCT05847686", "doi": "", "pmid": "", "publication_date": "2025-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 446, "title": "Psilocybin and chronic neuropathic pain: a systematic review.", "authors": "Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T, Broachwala MY, AlFarra T, Silver C, Kreitzer G, Oreoluwa P, Weissman BB, AlFarra A, Mayrsohn BG, Orhurhu V, Emerick T, Furnish T, Castellanos JP", "journal": "Regional anesthesia and pain medicine", "publication_date": "2025-11-05", "publication_year": 2025, "doi": "10.1136/rapm-2024-105532", "pubmed_id": "39106989", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39106989/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:39106989", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39106989/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39106989", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39106989/", "doi": "10.1136/rapm-2024-105532", "pmid": "39106989", "publication_date": "2025-11-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 448, "title": "Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.", "authors": "Bhagavan C, Bryson A, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Eleftheriadis D, Oliver G, Mayne D, Roebuck G, Rucker J, Butler M, Kanaan R", "journal": "Acta neuropsychiatrica", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1017/neu.2025.10042", "pubmed_id": "41186141", "openalex_id": "https://openalex.org/W4415851344", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41186141/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Personality Change,Randomized Controlled Trial,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41186141", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41186141/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41186141", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41186141/", "doi": "10.1017/neu.2025.10042", "pmid": "41186141", "publication_date": "2025-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 449, "title": "Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.", "authors": "Marinis J, Clarke ST, Guerin AA, Guastella AJ, Bedi G", "journal": "BJPsych open", "publication_date": "2025-11-03", "publication_year": 2025, "doi": "10.1192/bjo.2025.10847", "pubmed_id": "41178084", "openalex_id": "https://openalex.org/W4415782096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41178084", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41178084", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41178084/", "doi": "10.1192/bjo.2025.10847", "pmid": "41178084", "publication_date": "2025-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1987, "title": "Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?", "authors": "Thomas Zandonai, Sofia Venturini, Ornella Corazza", "journal": "Performance Enhancement & Health", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.peh.2025.100386", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415757045", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Resilience,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.1016/j.peh.2025.100386", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.peh.2025.100386", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.peh.2025.100386", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "doi": "10.1016/j.peh.2025.100386", "pmid": "", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 463, "title": "Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "International journal of psychiatry in medicine", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1177/00912174251337572", "pubmed_id": "40279353", "openalex_id": "https://openalex.org/W4409797469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40279353/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40279353", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40279353/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40279353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40279353/", "doi": "10.1177/00912174251337572", "pmid": "40279353", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 459, "title": "Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.", "authors": "Koenig HG", "journal": "International journal of psychiatry in medicine", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1177/00912174251369880", "pubmed_id": "40833259", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40833259/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40833259", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40833259", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40833259/", "doi": "10.1177/00912174251369880", "pmid": "40833259", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 458, "title": "The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.", "authors": "Rahmani S, Crupi R, Riley AL, Davidson T", "journal": "Pharmacology, biochemistry, and behavior", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.pbb.2025.174087", "pubmed_id": "40849009", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40849009", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40849009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "doi": "10.1016/j.pbb.2025.174087", "pmid": "40849009", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 456, "title": "Emerging mechanisms of psilocybin-induced neuroplasticity.", "authors": "Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A", "journal": "Trends in pharmacological sciences", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.tips.2025.08.012", "pubmed_id": "40957728", "openalex_id": "https://openalex.org/W4414267802", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40957728/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:40957728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40957728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40957728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40957728/", "doi": "10.1016/j.tips.2025.08.012", "pmid": "40957728", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 453, "title": "Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.", "authors": "Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS", "journal": "EClinicalMedicine", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103517", "pubmed_id": "41048658", "openalex_id": "https://openalex.org/W4414476150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41048658/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41048658", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41048658/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41048658", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41048658/", "doi": "10.1016/j.eclinm.2025.103517", "pmid": "41048658", "publication_date": "2025-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4256, "title": "Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications", "authors": "André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich", "journal": "Caderno Pedagógico", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.54033/cadpedv22n12-345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415830103", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.54033/cadpedv22n12-345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54033/cadpedv22n12-345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54033/cadpedv22n12-345", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "doi": "10.54033/cadpedv22n12-345", "pmid": "", "publication_date": "2025-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3597, "title": "A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?", "authors": "Anna Rose Childress, Ph.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06786325", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Consciousness,Biomarkers,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06786325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "source_url": "https://clinicaltrials.gov/study/NCT06786325", "doi": "", "pmid": "", "publication_date": "2025-10-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 467, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.", "authors": "Richardson C, Chan C, Macgregor E, Hare C, Hannon B, Black S, Schneider E, Buchman D, Wang S, Rac V, Abrahamyan L, Huszti E, Nissim R, Li M, Zimmermann C, Hapke E, Rosenbaum D, Hales S", "journal": "Pilot and feasibility studies", "publication_date": "2025-10-28", "publication_year": 2025, "doi": "10.1186/s40814-025-01706-5", "pubmed_id": "41152967", "openalex_id": "https://openalex.org/W4415616586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41152967", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41152967", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41152967/", "doi": "10.1186/s40814-025-01706-5", "pmid": "41152967", "publication_date": "2025-10-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3640, "title": "A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-14", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06644170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06644170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "source_url": "https://clinicaltrials.gov/study/NCT06644170", "doi": "", "pmid": "", "publication_date": "2025-10-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4272, "title": "Psychedelics in Practice: Science, Safety, and the Future of Healing", "authors": "Renee Ireland", "journal": "˜The œproceedings of sliit international conference on advancements in science and humanities", "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.54389/epsd8792", "pubmed_id": null, "openalex_id": "https://openalex.org/W7119484008", "source_url": "https://doi.org/10.54389/epsd8792", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Treatment-Resistant Depression,Safety,Toxicity,Contraindications", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.54389/epsd8792", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54389/epsd8792", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54389/epsd8792", "source_url": "https://doi.org/10.54389/epsd8792", "doi": "10.54389/epsd8792", "pmid": "", "publication_date": "2025-10-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3668, "title": "A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine", "authors": "Kevin Murnane", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06899594", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Review Article,Safety", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06899594", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06899594", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06899594", "source_url": "https://clinicaltrials.gov/study/NCT06899594", "doi": "", "pmid": "", "publication_date": "2025-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3575, "title": "Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)", "authors": "Centre Hospitalier St Anne", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07210112", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07210112", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "source_url": "https://clinicaltrials.gov/study/NCT07210112", "doi": "", "pmid": "", "publication_date": "2025-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4488, "title": "Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD", "authors": "Mackenzie Hancock, Nicole Getz, Shambhu Prasad Adhikari", "journal": "Open Science Framework", "publication_date": "2025-10-06", "publication_year": 2025, "doi": "10.17605/osf.io/ar2s4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106330185", "source_url": "https://osf.io/ar2s4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/ar2s4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://osf.io/ar2s4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/ar2s4", "source_url": "https://osf.io/ar2s4", "doi": "10.17605/osf.io/ar2s4", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4275, "title": "Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders", "authors": "M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali", "journal": "Journal of Pharma Insights and Research.", "publication_date": "2025-10-05", "publication_year": 2025, "doi": "10.69613/thv1dn30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416779935", "source_url": "https://doi.org/10.69613/thv1dn30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:16", "bibtex": null, "source_record_id": "DOI:10.69613/thv1dn30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.69613/thv1dn30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.69613/thv1dn30", "source_url": "https://doi.org/10.69613/thv1dn30", "doi": "10.69613/thv1dn30", "pmid": "", "publication_date": "2025-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 480, "title": "Harm reduction practises for users of psychedelic drugs: a scoping review.", "authors": "Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P", "journal": "Harm reduction journal", "publication_date": "2025-10-03", "publication_year": 2025, "doi": "10.1186/s12954-025-01264-2", "pubmed_id": "41044617", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41044617/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41044617", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41044617/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41044617", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41044617/", "doi": "10.1186/s12954-025-01264-2", "pmid": "41044617", "publication_date": "2025-10-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5795, "title": "Psilocybin as a Treatment for Depression", "authors": "Arif Ersegün Kahraman", "journal": "University of Debrecen Electronic Archive", "publication_date": "2025-10-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7198794859", "source_url": "https://hdl.handle.net/2437/398317", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:16", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://hdl.handle.net/2437/398317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/2437/398317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://hdl.handle.net/2437/398317", "source_url": "https://hdl.handle.net/2437/398317", "doi": "", "pmid": "", "publication_date": "2025-10-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3677, "title": "Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment", "authors": "University Hospital, Geneva", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-02", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164287", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164287", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "source_url": "https://clinicaltrials.gov/study/NCT07164287", "doi": "", "pmid": "", "publication_date": "2025-10-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3552, "title": "Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06989957", "substance_tags": "psilocybin", "topic_tags": "PTSD,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06989957", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06989957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06989957", "source_url": "https://clinicaltrials.gov/study/NCT06989957", "doi": "", "pmid": "", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 500, "title": "Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.", "authors": "Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD", "journal": "Psychopharmacology", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1007/s00213-025-06788-w", "pubmed_id": "40266291", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40266291/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40266291", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40266291/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40266291", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40266291/", "doi": "10.1007/s00213-025-06788-w", "pmid": "40266291", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 491, "title": "Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.", "authors": "Rajwani K, Jacobs E, Bruce L, Hokanson J, Almonte MT, Feroz F, Waldman E, Cheung K, Levy N, Savulescu J, Singh I, Yaden DB, Earp BD", "journal": "The Lancet. Child & adolescent health", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1016/s2352-4642(25)00208-1", "pubmed_id": "40908054", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40908054/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Review Article,Adolescents,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40908054", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40908054/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40908054", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40908054/", "doi": "10.1016/s2352-4642(25)00208-1", "pmid": "40908054", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 490, "title": "US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022.", "authors": "Montoy JCC, Wang RC, Coker AR, Smollin CG, Anderson BT", "journal": "Journal of the American College of Emergency Physicians open", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1016/j.acepjo.2025.100231", "pubmed_id": "40927687", "openalex_id": "https://openalex.org/W4413851486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40927687/", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40927687", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40927687/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40927687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40927687/", "doi": "10.1016/j.acepjo.2025.100231", "pmid": "40927687", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 489, "title": "Concomitant use of antidepressants and classic psychedelics: A scoping review.", "authors": "Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1177/02698811251368360", "pubmed_id": "40937732", "openalex_id": "https://openalex.org/W4414152565", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40937732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40937732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40937732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40937732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40937732/", "doi": "10.1177/02698811251368360", "pmid": "40937732", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 488, "title": "Serotonin 5-HT Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.", "authors": "Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD", "journal": "ACS chemical neuroscience", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647", "pubmed_id": "40944639", "openalex_id": "https://openalex.org/W4414162276", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40944639/", "substance_tags": "psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40944639", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40944639/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40944639", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40944639/", "doi": "10.1021/acschemneuro.5c00647", "pmid": "40944639", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 487, "title": "Dynamic myocardial injury and variable hallucination latency in poisoning: a molecularly confirmed case series from China.", "authors": "He Z, Tang R, Feng M, Li X, Zhang C, Li J", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2025-10-01", "publication_year": 2025, "doi": "10.1080/15563650.2025.2552438", "pubmed_id": "40948398", "openalex_id": "https://openalex.org/W4414167818", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40948398/", "substance_tags": "psilocybin", "topic_tags": "Biomarkers,Aging,Case Report,Safety,Toxicity", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40948398", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40948398/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40948398", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40948398/", "doi": "10.1080/15563650.2025.2552438", "pmid": "40948398", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 485, "title": "[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?].", "authors": "Sabé M, Seragnoli F, Penzenstadler L, Thorens G", "journal": "La Revue du praticien", "publication_date": "2025-10-01", "publication_year": 2025, "doi": null, "pubmed_id": "41575100", "openalex_id": "https://openalex.org/W7125566383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:41575100", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41575100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100/", "doi": "", "pmid": "41575100", "publication_date": "2025-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4278, "title": "B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024", "authors": "Stephanie Marco", "journal": "Clinical Chemistry", "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1093/clinchem/hvaf086.689", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414740466", "source_url": "https://doi.org/10.1093/clinchem/hvaf086.689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/clinchem/hvaf086.689", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/clinchem/hvaf086.689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/clinchem/hvaf086.689", "source_url": "https://doi.org/10.1093/clinchem/hvaf086.689", "doi": "10.1093/clinchem/hvaf086.689", "pmid": "", "publication_date": "2025-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 505, "title": "Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.", "authors": "Hatzipantelis CJ, Liu M, Love A, Leventhal SJ, Maera H, Viswanathan S, Avetisyan E, Belinsky L, Rangel MM, Jain NJ, Kelly M, Copeland C, Khatib YA, Fiehn O, Olson DE, Stolzenberg DS", "journal": "Nature communications", "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1038/s41467-025-64371-5", "pubmed_id": "41027992", "openalex_id": "https://openalex.org/W4414669838", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41027992/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41027992", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41027992/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41027992", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41027992/", "doi": "10.1038/s41467-025-64371-5", "pmid": "41027992", "publication_date": "2025-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 508, "title": "Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.", "authors": "Caporuscio C, Poppe C, Gieselmann A, Repantis D", "journal": "Psychological medicine", "publication_date": "2025-09-29", "publication_year": 2025, "doi": "10.1017/s0033291725101761", "pubmed_id": "41017267", "openalex_id": "https://openalex.org/W4414616693", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41017267/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41017267", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41017267/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41017267", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41017267/", "doi": "10.1017/s0033291725101761", "pmid": "41017267", "publication_date": "2025-09-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4289, "title": "Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review", "authors": "Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti", "journal": "Clinical Neuropsychopharmacology and Addiction", "publication_date": "2025-09-24", "publication_year": 2025, "doi": "10.53941/cna.2025.100006", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414523550", "source_url": "https://doi.org/10.53941/cna.2025.100006", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Biomarkers,Aging,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.53941/cna.2025.100006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53941/cna.2025.100006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53941/cna.2025.100006", "source_url": "https://doi.org/10.53941/cna.2025.100006", "doi": "10.53941/cna.2025.100006", "pmid": "", "publication_date": "2025-09-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3588, "title": "Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism", "authors": "Healing Advocacy Fund", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07189988", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07189988", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "source_url": "https://clinicaltrials.gov/study/NCT07189988", "doi": "", "pmid": "", "publication_date": "2025-09-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4290, "title": "With great power comes great responsibility: Promise and caution in the new psychedelic renaissance", "authors": "Matthew Halma, R. Levy, Joseph Varón", "journal": "Brain Disorders", "publication_date": "2025-09-23", "publication_year": 2025, "doi": "10.1016/j.dscb.2025.100286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414440106", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "doi": "10.1016/j.dscb.2025.100286", "pmid": "", "publication_date": "2025-09-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 509, "title": "Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.", "authors": "Knock E, Siefried KJ, Bedi G, Albert S, Day RO, Ezard N, Ross M, Liknaitzky P, Brett J", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-09-20", "publication_year": 2025, "doi": "10.1111/add.70187", "pubmed_id": "40974259", "openalex_id": "https://openalex.org/W4414374510", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40974259", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40974259", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40974259/", "doi": "10.1111/add.70187", "pmid": "40974259", "publication_date": "2025-09-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 513, "title": "Reappraisal of the hype and hope offered by psilocybin treatment of depression.", "authors": "Beaglehole B, Manuel J", "journal": "The New Zealand medical journal", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.26635/6965.7138", "pubmed_id": "40966702", "openalex_id": "https://openalex.org/W4414175451", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40966702/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40966702", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40966702/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40966702", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40966702/", "doi": "10.26635/6965.7138", "pmid": "40966702", "publication_date": "2025-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 511, "title": "Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US.", "authors": "Calin A, Burlec AF, Mircea C, Macovei I, Hancianu M, Corciova A", "journal": "Journal of clinical medicine", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.3390/jcm14186613", "pubmed_id": "41010814", "openalex_id": "https://openalex.org/W4414341779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41010814/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41010814", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41010814/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41010814", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41010814/", "doi": "10.3390/jcm14186613", "pmid": "41010814", "publication_date": "2025-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4294, "title": "Trauma under psychedelics: how psychoactive substances impact trauma processing", "authors": "Ophir Netzer, Noa Magal, Yonatan Stern, Tzuk Polinsky, Raz Gross, Roee Admon, Roy Salomon", "journal": "World Psychiatry", "publication_date": "2025-09-15", "publication_year": 2025, "doi": "10.1002/wps.21363", "pubmed_id": "40948086", "openalex_id": "https://openalex.org/W4414167960", "source_url": "https://doi.org/10.1002/wps.21363", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,End-of-Life Distress,Receptor Pharmacology,Observational Study,Safety,Drug Interactions", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "PMID:40948086", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.21363", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40948086", "source_url": "https://doi.org/10.1002/wps.21363", "doi": "10.1002/wps.21363", "pmid": "40948086", "publication_date": "2025-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3435, "title": "The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.", "authors": "Maastricht University", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06368492", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06368492", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06368492", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06368492", "source_url": "https://clinicaltrials.gov/study/NCT06368492", "doi": "", "pmid": "", "publication_date": "2025-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5626, "title": "Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism", "authors": "Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910)", "journal": "Figshare", "publication_date": "2025-09-13", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111383702", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-08-09 08:25:59", "bibtex": null, "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "doi": "10.1021/acschemneuro.5c00647.s001", "pmid": "", "publication_date": "2025-09-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 517, "title": "Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy.", "authors": "Bélanger A, Chang SL, Stephan JF, Moureaux F, Tapp D, Foxman R, Gagnon P, Hébert J, Farzin H, Dorval M", "journal": "Healthcare (Basel, Switzerland)", "publication_date": "2025-09-12", "publication_year": 2025, "doi": "10.3390/healthcare13182290", "pubmed_id": "41008422", "openalex_id": "https://openalex.org/W4414258408", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41008422/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41008422", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41008422/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41008422", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41008422/", "doi": "10.3390/healthcare13182290", "pmid": "41008422", "publication_date": "2025-09-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4296, "title": "The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting", "authors": "Tereza Dleštíková", "journal": "Psychoactives", "publication_date": "2025-09-11", "publication_year": 2025, "doi": "10.3390/psychoactives4030034", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414123257", "source_url": "https://doi.org/10.3390/psychoactives4030034", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030034", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030034", "source_url": "https://doi.org/10.3390/psychoactives4030034", "doi": "10.3390/psychoactives4030034", "pmid": "", "publication_date": "2025-09-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 519, "title": "Therapeutic Divergence in 5-HTA Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2025-09-11", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00475", "pubmed_id": "40959252", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40959252/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40959252", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40959252/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40959252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40959252/", "doi": "10.1021/acsmedchemlett.5c00475", "pmid": "40959252", "publication_date": "2025-09-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3699, "title": "Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-10", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164755", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Treatment-Resistant Depression,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "source_url": "https://clinicaltrials.gov/study/NCT07164755", "doi": "", "pmid": "", "publication_date": "2025-09-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4297, "title": "Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder", "authors": "Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-09-04", "publication_year": 2025, "doi": "10.1556/2054.2025.00461", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413975912", "source_url": "https://doi.org/10.1556/2054.2025.00461", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00461", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00461", "source_url": "https://doi.org/10.1556/2054.2025.00461", "doi": "10.1556/2054.2025.00461", "pmid": "", "publication_date": "2025-09-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3775, "title": "Blunted psychedelic drug effects in older adults", "authors": "Aday JS, Carhart-Harris R, Boehnke KF.", "journal": "PsyArXiv", "publication_date": "2025-09-04", "publication_year": 2025, "doi": "10.31234/osf.io/yz4cd_v2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/yz4cd_v2", "substance_tags": "psilocybin", "topic_tags": "Aging,Longevity,Older Adults,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-08-09 08:15:14", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/yz4cd_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/yz4cd_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/yz4cd_v2", "source_url": "https://doi.org/10.31234/osf.io/yz4cd_v2", "doi": "10.31234/osf.io/yz4cd_v2", "pmid": "", "publication_date": "2025-09-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3239, "title": "Blunted psychedelic drug effects in older adults", "authors": "Jacob S. Aday, Robin Carhart-Harris, Kevin F. Boehnke", "journal": "PsyArXiv", "publication_date": "2025-09-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "substance_tags": "psilocybin", "topic_tags": "Aging,Longevity,Older Adults,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "source_url": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "doi": "", "pmid": "", "publication_date": "2025-09-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 525, "title": "Sample composition and HIV prevention indicator differences using physical vs virtual venue recruitment of men who have sex with men in San Francisco.", "authors": "Chiu I, Tate M, Trujillo D, Suprasert B, Marr A, Arayasirikul S, Wilson EC, Raymond HF, McFarland W", "journal": "American journal of epidemiology", "publication_date": "2025-09-03", "publication_year": 2025, "doi": "10.1093/aje/kwae443", "pubmed_id": "39673252", "openalex_id": "https://openalex.org/W4405398417", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39673252/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:39673252", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39673252/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39673252", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39673252/", "doi": "10.1093/aje/kwae443", "pmid": "39673252", "publication_date": "2025-09-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 524, "title": "Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.", "authors": "Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM", "journal": "Acta neuropsychiatrica", "publication_date": "2025-09-03", "publication_year": 2025, "doi": "10.1017/neu.2025.10039", "pubmed_id": "40899152", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40899152/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40899152", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40899152/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40899152", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40899152/", "doi": "10.1017/neu.2025.10039", "pmid": "40899152", "publication_date": "2025-09-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4300, "title": "Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?", "authors": "Gregor Hasler", "journal": "Psychedelics.", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.61373/pp025k.0032", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413911705", "source_url": "https://doi.org/10.61373/pp025k.0032", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Biomarkers,Safety,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0032", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0032", "source_url": "https://doi.org/10.61373/pp025k.0032", "doi": "10.61373/pp025k.0032", "pmid": "", "publication_date": "2025-09-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4298, "title": "Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care", "authors": "Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher", "journal": "Psychoactives", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.3390/psychoactives4030031", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413908189", "source_url": "https://doi.org/10.3390/psychoactives4030031", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Wellbeing,Resilience,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030031", "source_url": "https://doi.org/10.3390/psychoactives4030031", "doi": "10.3390/psychoactives4030031", "pmid": "", "publication_date": "2025-09-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4305, "title": "Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report", "authors": "M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler", "journal": "Psychoactives", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.3390/psychoactives4030030", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413893315", "source_url": "https://doi.org/10.3390/psychoactives4030030", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Case Report,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030030", "source_url": "https://doi.org/10.3390/psychoactives4030030", "doi": "10.3390/psychoactives4030030", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 541, "title": "Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.", "authors": "Blanton AM, Parikh P, Zhou S, Mohamed M, Ufret-Vincenty RL, Mancini R", "journal": "American journal of ophthalmology case reports", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1016/j.ajoc.2025.102359", "pubmed_id": "40535325", "openalex_id": "https://openalex.org/W4410946123", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40535325/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Case Report,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40535325", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40535325/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40535325", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40535325/", "doi": "10.1016/j.ajoc.2025.102359", "pmid": "40535325", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 537, "title": "Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics.", "authors": "Swieczkowski D, Kwaśny A, Ciurkowska P, Pruc M, Szarpak L, Cubała WJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1177/02698811251353250", "pubmed_id": "40643096", "openalex_id": "https://openalex.org/W4412197020", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40643096/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Clinical Trial,Review Article,Healthy Volunteers,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40643096", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40643096/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40643096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40643096/", "doi": "10.1177/02698811251353250", "pmid": "40643096", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 536, "title": "A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.", "authors": "Glenn DL, Choi SH, Zimmerman RS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1177/02698811251353251", "pubmed_id": "40643107", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40643107/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Consciousness,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40643107", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40643107/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40643107", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40643107/", "doi": "10.1177/02698811251353251", "pmid": "40643107", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 535, "title": "Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.", "authors": "Nadeem Z, Parker S, McGovern H, Sebben B, Oestreich LK", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1177/00048674251346679", "pubmed_id": "40660894", "openalex_id": "https://openalex.org/W4412418522", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40660894/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40660894", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40660894/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40660894", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40660894/", "doi": "10.1177/00048674251346679", "pmid": "40660894", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 512, "title": "Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL", "journal": "PLoS medicine", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519", "pubmed_id": "40972137", "openalex_id": "https://openalex.org/W4414366251", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40972137/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40972137", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40972137/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40972137", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40972137/", "doi": "10.1371/journal.pmed.1004519", "pmid": "40972137", "publication_date": "2025-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4303, "title": "A lexicon for psychedelic research and treatment", "authors": "David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill", "journal": "Drug Science Policy and Law", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20503245251380511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414407628", "source_url": "https://doi.org/10.1177/20503245251380511", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251380511", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251380511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251380511", "source_url": "https://doi.org/10.1177/20503245251380511", "doi": "10.1177/20503245251380511", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 556, "title": "Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.", "authors": "Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-08-30", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111448", "pubmed_id": "40669813", "openalex_id": "https://openalex.org/W4412433881", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40669813/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Review Article,Animal Study,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40669813", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40669813/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40669813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40669813/", "doi": "10.1016/j.pnpbp.2025.111448", "pmid": "40669813", "publication_date": "2025-08-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 557, "title": "Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.", "authors": "Avanceña ALV, Vuong L, Kahn JG, Marseille E", "journal": "Translational psychiatry", "publication_date": "2025-08-29", "publication_year": 2025, "doi": "10.1038/s41398-025-03556-4", "pubmed_id": "40883271", "openalex_id": "https://openalex.org/W4413817374", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883271/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40883271", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40883271/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40883271", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40883271/", "doi": "10.1038/s41398-025-03556-4", "pmid": "40883271", "publication_date": "2025-08-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4312, "title": "Psychedelic minimalism: the case against music in psychedelic therapy settings", "authors": "Samir A Nader", "journal": "Frontiers in Psychiatry", "publication_date": "2025-08-26", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1652568", "pubmed_id": "40933801", "openalex_id": "https://openalex.org/W4413614435", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:17", "bibtex": null, "source_record_id": "PMID:40933801", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40933801", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "doi": "10.3389/fpsyt.2025.1652568", "pmid": "40933801", "publication_date": "2025-08-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4314, "title": "“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy", "authors": "Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant", "journal": "Psychedelic Medicine", "publication_date": "2025-08-25", "publication_year": 2025, "doi": "10.1177/28314425251370303", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414955208", "source_url": "https://doi.org/10.1177/28314425251370303", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251370303", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251370303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251370303", "source_url": "https://doi.org/10.1177/28314425251370303", "doi": "10.1177/28314425251370303", "pmid": "", "publication_date": "2025-08-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 561, "title": "Psychedelics and the Serotonin Hypothesis of Eating Disorders.", "authors": "Bilenker D, Avena NM", "journal": "Brain sciences", "publication_date": "2025-08-21", "publication_year": 2025, "doi": "10.3390/brainsci15080893", "pubmed_id": "40867224", "openalex_id": "https://openalex.org/W4413411862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40867224/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40867224", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40867224/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40867224", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40867224/", "doi": "10.3390/brainsci15080893", "pmid": "40867224", "publication_date": "2025-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3557, "title": "Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-20", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06650800", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06650800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "source_url": "https://clinicaltrials.gov/study/NCT06650800", "doi": "", "pmid": "", "publication_date": "2025-08-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3466, "title": "A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05733546", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05733546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "source_url": "https://clinicaltrials.gov/study/NCT05733546", "doi": "", "pmid": "", "publication_date": "2025-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3307, "title": "Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis", "authors": "Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE.", "journal": "Research Square", "publication_date": "2025-08-19", "publication_year": 2025, "doi": "10.21203/rs.3.rs-6941009/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-6941009/v1", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:15:22", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-6941009/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-6941009/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-6941009/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-6941009/v1", "doi": "10.21203/rs.3.rs-6941009/v1", "pmid": "", "publication_date": "2025-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3070, "title": "Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource", "authors": "Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD.", "journal": "medRxiv", "publication_date": "2025-08-16", "publication_year": 2025, "doi": "10.1101/2025.08.13.25333530", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2025.08.13.25333530", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.08.13.25333530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.08.13.25333530", "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "doi": "10.1101/2025.08.13.25333530", "pmid": "", "publication_date": "2025-08-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 565, "title": "Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.", "authors": "Repple J, Bayas M, Möser C, Kobayashi NF, Reif A", "journal": "Biological psychiatry", "publication_date": "2025-08-15", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.903", "pubmed_id": "40064389", "openalex_id": "https://openalex.org/W4408254485", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40064389", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40064389", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40064389/", "doi": "10.1016/j.biopsych.2025.02.903", "pmid": "40064389", "publication_date": "2025-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 567, "title": "Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.", "authors": "Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A", "journal": "Medical science monitor: international medical journal of experimental and clinical research", "publication_date": "2025-08-09", "publication_year": 2025, "doi": "10.12659/msm.948302", "pubmed_id": "40781763", "openalex_id": "https://openalex.org/W4411816478", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40781763", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40781763", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40781763/", "doi": "10.12659/msm.948302", "pmid": "40781763", "publication_date": "2025-08-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 566, "title": "Psychedelics and Headache Disorders: an Update.", "authors": "Im JJH, Sandoe CH", "journal": "Current neurology and neuroscience reports", "publication_date": "2025-08-09", "publication_year": 2025, "doi": "10.1007/s11910-025-01446-2", "pubmed_id": "40782223", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40782223/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Review Article,Case Report,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40782223", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40782223/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40782223", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40782223/", "doi": "10.1007/s11910-025-01446-2", "pmid": "40782223", "publication_date": "2025-08-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4322, "title": "670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?", "authors": "Guy M. Goodwin", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284175", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:18", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "doi": "10.1093/ijnp/pyaf052.159", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3265, "title": "631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS", "authors": "G Martinotti, C Cavallotto, G D'Andrea, A D'Attilio, G Mammarella, F Zoratto, M Pettorruso", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2025-08-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359594", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:16", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "source_url": "https://europepmc.org/article/PMC/PMC12359594", "doi": "", "pmid": "", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 588, "title": "Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.", "authors": "Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Psychiatry research", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116559", "pubmed_id": "40440859", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40440859", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40440859", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40440859/", "doi": "10.1016/j.psychres.2025.116559", "pmid": "40440859", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 585, "title": "Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.", "authors": "Vinarcsik L, Smoller C, Grossberg G", "journal": "Drugs & aging", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1007/s40266-025-01221-5", "pubmed_id": "40553322", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40553322/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Review Article,Older Adults,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40553322", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40553322/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40553322", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40553322/", "doi": "10.1007/s40266-025-01221-5", "pmid": "40553322", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 583, "title": "Australia's psychedelic experiment: reflections from a psychiatrist clinical researcher.", "authors": "Bayes A", "journal": "Australasian psychiatry: bulletin of Royal Australian and New Zealand College of Psychiatrists", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1177/10398562251347890", "pubmed_id": "40574457", "openalex_id": "https://openalex.org/W4411736916", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40574457", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40574457", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40574457/", "doi": "10.1177/10398562251347890", "pmid": "40574457", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 582, "title": "Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.", "authors": "Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M", "journal": "Asian journal of psychiatry", "publication_date": "2025-08-01", "publication_year": 2025, "doi": "10.1016/j.ajp.2025.104604", "pubmed_id": "40614615", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40614615/", "substance_tags": "psilocybin", "topic_tags": "Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40614615", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40614615/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40614615", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40614615/", "doi": "10.1016/j.ajp.2025.104604", "pmid": "40614615", "publication_date": "2025-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4339, "title": "204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER", "authors": "Bernard Lerer, Peretz Golding, Michal Brownstien, Adam Kozikowski, Tzuri Lifschytz", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.019", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413285218", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.019", "substance_tags": "psilocybin", "topic_tags": "OCD,Receptor Pharmacology,Animal Study,In Vitro Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.019", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.019", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.019", "doi": "10.1093/ijnp/pyaf052.019", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4335, "title": "577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES", "authors": "Hiroe Tani", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284846", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "doi": "10.1093/ijnp/pyaf052.377", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 597, "title": "Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.", "authors": "Cheung K, Brodie M, Chang SL, Deschamps P, Fallu JS, Farzin H, Hébert J, Stephan JF, Dorval M, Joly Y, P3A Study Group", "journal": "The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1017/jme.2025.10109", "pubmed_id": "40739983", "openalex_id": "https://openalex.org/W4412810429", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40739983", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40739983", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40739983/", "doi": "10.1017/jme.2025.10109", "pmid": "40739983", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 595, "title": "Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.", "authors": "Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L", "journal": "Folia medica Cracoviensia", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.24425/fmc.2025.156119", "pubmed_id": "41329968", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41329968/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Toxicity,Inflammation", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:41329968", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41329968/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41329968", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41329968/", "doi": "10.24425/fmc.2025.156119", "pmid": "41329968", "publication_date": "2025-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 598, "title": "Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.", "authors": "Modlin NL, Jessica L MK, Sarang M, Siebenaler L, Maggio C, Pick S, Williamson V, Cleare A, Rucker J", "journal": "Psychiatry and clinical psychopharmacology", "publication_date": "2025-07-30", "publication_year": 2025, "doi": "10.5152/pcp.2025.24934", "pubmed_id": "40864832", "openalex_id": "https://openalex.org/W4413381444", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40864832/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40864832", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40864832/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40864832", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40864832/", "doi": "10.5152/pcp.2025.24934", "pmid": "40864832", "publication_date": "2025-07-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 599, "title": "Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.", "authors": "Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A", "journal": "Eating and weight disorders: EWD", "publication_date": "2025-07-29", "publication_year": 2025, "doi": "10.1007/s40519-025-01771-y", "pubmed_id": "40730892", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40730892/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40730892", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40730892/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40730892", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40730892/", "doi": "10.1007/s40519-025-01771-y", "pmid": "40730892", "publication_date": "2025-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 602, "title": "Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.", "authors": "Luquiens A, Belahda D, Graux C, Igounenc N, Serrand C, Rochefort P, Mura T, Sergent F", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-07-24", "publication_year": 2025, "doi": "10.1111/add.70152", "pubmed_id": "40702912", "openalex_id": "https://openalex.org/W4412642858", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40702912", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40702912", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40702912/", "doi": "10.1111/add.70152", "pmid": "40702912", "publication_date": "2025-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 601, "title": "Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey.", "authors": "Rodan SC, Meez N, Lloyd-Hurwitz S, Bedoya-Pérez MA, Suraev A, Sommer N, Greenstien K, Maguire S, McGregor IS", "journal": "Journal of eating disorders", "publication_date": "2025-07-24", "publication_year": 2025, "doi": "10.1186/s40337-025-01328-5", "pubmed_id": "40708053", "openalex_id": "https://openalex.org/W4412645629", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40708053/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Eating Disorders,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40708053", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40708053/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40708053", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40708053/", "doi": "10.1186/s40337-025-01328-5", "pmid": "40708053", "publication_date": "2025-07-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3633, "title": "The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05506982", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05506982", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "source_url": "https://clinicaltrials.gov/study/NCT05506982", "doi": "", "pmid": "", "publication_date": "2025-07-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 604, "title": "\"I've learned that I'm open-minded to this possibility\": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.", "authors": "Cioe PA, Stang GS, Azam D, Dugal S", "journal": "Addiction science & clinical practice", "publication_date": "2025-07-21", "publication_year": 2025, "doi": "10.1186/s13722-025-00563-0", "pubmed_id": "40691651", "openalex_id": "https://openalex.org/W4412510542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40691651/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety,Adverse Events", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40691651", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40691651/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40691651", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40691651/", "doi": "10.1186/s13722-025-00563-0", "pmid": "40691651", "publication_date": "2025-07-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4344, "title": "Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns", "authors": "Ashutosh Bhave", "journal": "Journal of Public Policy & Marketing", "publication_date": "2025-07-16", "publication_year": 2025, "doi": "10.1177/07439156251360774", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412479365", "source_url": "https://doi.org/10.1177/07439156251360774", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.1177/07439156251360774", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/07439156251360774", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/07439156251360774", "source_url": "https://doi.org/10.1177/07439156251360774", "doi": "10.1177/07439156251360774", "pmid": "", "publication_date": "2025-07-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4347, "title": "The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin", "authors": "Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899)", "journal": "Figshare", "publication_date": "2025-07-08", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00324.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111003529", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "doi": "10.1021/acsptsci.5c00324.s001", "pmid": "", "publication_date": "2025-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3072, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "Balazs Szigeti", "journal": "PsyArXiv", "publication_date": "2025-07-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "doi": "", "pmid": "", "publication_date": "2025-07-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4348, "title": "Explore the effect of psilocybin on depression and anxiety", "authors": "Yutong Song", "journal": "Arts Culture and Language", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.61173/rcg8me57", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412054280", "source_url": "https://doi.org/10.61173/rcg8me57", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Headache / Migraine,Wellbeing,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.61173/rcg8me57", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61173/rcg8me57", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61173/rcg8me57", "source_url": "https://doi.org/10.61173/rcg8me57", "doi": "10.61173/rcg8me57", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3745, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "Szigeti B.", "journal": "PsyArXiv", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.31234/osf.io/97cqx_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "doi": "10.31234/osf.io/97cqx_v1", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 615, "title": "Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.", "authors": "Ahmed KE, Abu Nasrieh D, Banihani HA, Obaidat MF, Mazzawi T, Al-Tarawneh AK, Bani Mustafa R, Al Kayed Z", "journal": "Journal of psychoactive drugs", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.1080/02791072.2025.2526403", "pubmed_id": "40619866", "openalex_id": "https://openalex.org/W4412097474", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619866/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40619866", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40619866/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40619866", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619866/", "doi": "10.1080/02791072.2025.2526403", "pmid": "40619866", "publication_date": "2025-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4350, "title": "Beyond prohibition: A public health analysis of naturalistic psychedelic use", "authors": "Mark Haden, Sarah A. Paschall, Birgitta Woods", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-07-03", "publication_year": 2025, "doi": "10.1556/2054.2025.00450", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411976075", "source_url": "https://doi.org/10.1556/2054.2025.00450", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Aging,Wellbeing,Emotional Processing,Spirituality,Psychological Flexibility,Review Article,Older Adults,Adolescents,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00450", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00450", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00450", "source_url": "https://doi.org/10.1556/2054.2025.00450", "doi": "10.1556/2054.2025.00450", "pmid": "", "publication_date": "2025-07-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4352, "title": "Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report", "authors": "David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison", "journal": "Psychoactives", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.3390/psychoactives4030022", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411885403", "source_url": "https://doi.org/10.3390/psychoactives4030022", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Receptor Pharmacology,Aging,Case Report,Healthcare Workers,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030022", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030022", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030022", "source_url": "https://doi.org/10.3390/psychoactives4030022", "doi": "10.3390/psychoactives4030022", "pmid": "", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 640, "title": "Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.", "authors": "Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS", "journal": "Psychopharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1007/s00213-024-06599-5", "pubmed_id": "38743110", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:38743110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38743110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "doi": "10.1007/s00213-024-06599-5", "pmid": "38743110", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 637, "title": "Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise.", "authors": "Croarkin PE, Sutherland I, Ho MF", "journal": "Journal of the American Academy of Child and Adolescent Psychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.jaac.2024.12.003", "pubmed_id": "39709009", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39709009/", "substance_tags": "psilocybin", "topic_tags": "Adolescents,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:39709009", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39709009/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39709009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39709009/", "doi": "10.1016/j.jaac.2024.12.003", "pmid": "39709009", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 635, "title": "Exploring serotonergic psychedelics as a treatment for personality disorders.", "authors": "Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ", "journal": "Neuropharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.neuropharm.2025.110413", "pubmed_id": "40081794", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40081794/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Personality Change,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40081794", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40081794/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40081794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40081794/", "doi": "10.1016/j.neuropharm.2025.110413", "pmid": "40081794", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 634, "title": "Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.", "authors": "Bradley ER, Sakai K, Fernandes-Osterhold G, Szigeti B, Ludwig C, Ostrem JL, Tanner CM, Bock MA, Llerena K, Finley PR, O'Donovan A, Zuzuarregui JRP, Busby Z, McKernan A, Penn AD, Wang ACC, Rosen RC, Woolley JD", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1038/s41386-025-02097-0", "pubmed_id": "40205013", "openalex_id": "https://openalex.org/W4409286565", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40205013/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40205013", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40205013/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40205013", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40205013/", "doi": "10.1038/s41386-025-02097-0", "pmid": "40205013", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 633, "title": "Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Pharmacopsychiatry", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1055/a-2529-7029", "pubmed_id": "40245934", "openalex_id": "https://openalex.org/W4409534321", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40245934", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40245934", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245934/", "doi": "10.1055/a-2529-7029", "pmid": "40245934", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 630, "title": "The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.", "authors": "Syed OA, Petranker R, Tsang B", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106204", "pubmed_id": "40348309", "openalex_id": "https://openalex.org/W4410237490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40348309/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Wellbeing,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40348309", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40348309/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40348309", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40348309/", "doi": "10.1016/j.neubiorev.2025.106204", "pmid": "40348309", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 623, "title": "Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.", "authors": "Calnan M, Blest-Hopley G, Busch C, Adams M, Ruffell SGD, Piper T, Roseman L, Kettner H, Carhart-Harris R", "journal": "Brain and behavior", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.1002/brb3.70660", "pubmed_id": "40619953", "openalex_id": "https://openalex.org/W4412096805", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619953/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Veterans,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40619953", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40619953/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40619953", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40619953/", "doi": "10.1002/brb3.70660", "pmid": "40619953", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 616, "title": "Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances.", "authors": "Christen SE, Bekka E, Schmid Y, Benowitz NL, Liakoni E", "journal": "Swiss medical weekly", "publication_date": "2025-07-01", "publication_year": 2025, "doi": "10.57187/s.4346", "pubmed_id": "40811135", "openalex_id": "https://openalex.org/W4412107589", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40811135/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Consciousness,Emotional Processing,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40811135", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40811135/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40811135", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40811135/", "doi": "10.57187/s.4346", "pmid": "40811135", "publication_date": "2025-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 644, "title": "Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.", "authors": "Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE", "journal": "Current oncology (Toronto, Ont.)", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.3390/curroncol32070380", "pubmed_id": "40710191", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40710191/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40710191", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40710191/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40710191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40710191/", "doi": "10.3390/curroncol32070380", "pmid": "40710191", "publication_date": "2025-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4358, "title": "Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease", "authors": "Nayiri Barton", "journal": "Global Journal of Medical Research", "publication_date": "2025-06-28", "publication_year": 2025, "doi": "10.34257/gjmravol25is1pg1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412955867", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-08-09 08:25:19", "bibtex": null, "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "doi": "10.34257/gjmravol25is1pg1", "pmid": "", "publication_date": "2025-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 650, "title": "Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study.", "authors": "Koolen M, Wirsching A, Krediet E, van Elk M", "journal": "Journal of psychoactive drugs", "publication_date": "2025-06-23", "publication_year": 2025, "doi": "10.1080/02791072.2025.2508156", "pubmed_id": "40551401", "openalex_id": "https://openalex.org/W4411571625", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40551401/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Observational Study,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40551401", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40551401/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40551401", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40551401/", "doi": "10.1080/02791072.2025.2508156", "pmid": "40551401", "publication_date": "2025-06-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3096, "title": "The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review", "authors": "Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S.", "journal": "Preprints.org", "publication_date": "2025-06-19", "publication_year": 2025, "doi": "10.20944/preprints202506.1536.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202506.1536.v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Randomized Controlled Trial,Review Article,Case Report,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:58", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202506.1536.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202506.1536.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202506.1536.v1", "source_url": "https://doi.org/10.20944/preprints202506.1536.v1", "doi": "10.20944/preprints202506.1536.v1", "pmid": "", "publication_date": "2025-06-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 652, "title": "Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.", "authors": "Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A", "journal": "ACS chemical neuroscience", "publication_date": "2025-06-18", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00152", "pubmed_id": "40474592", "openalex_id": "https://openalex.org/W4411103150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40474592", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40474592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40474592/", "doi": "10.1021/acschemneuro.5c00152", "pmid": "40474592", "publication_date": "2025-06-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 654, "title": "Long-term benefits of single-dose psilocybin in depressed patients with cancer.", "authors": "Agrawal M, Roddy K, Jenkins B, Leeks C, Emanuel E", "journal": "Cancer", "publication_date": "2025-06-15", "publication_year": 2025, "doi": "10.1002/cncr.35889", "pubmed_id": "40518804", "openalex_id": "https://openalex.org/W4411327114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40518804", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40518804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40518804/", "doi": "10.1002/cncr.35889", "pmid": "40518804", "publication_date": "2025-06-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 656, "title": "Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.", "authors": "Erkizia-Santamaría I, Horrillo I, Martínez-Álvarez N, Pérez-Martínez D, Rivero G, Erdozain AM, Meana JJ, Ortega JE", "journal": "Translational psychiatry", "publication_date": "2025-06-14", "publication_year": 2025, "doi": "10.1038/s41398-025-03421-4", "pubmed_id": "40517150", "openalex_id": "https://openalex.org/W4411302754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40517150", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40517150", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40517150/", "doi": "10.1038/s41398-025-03421-4", "pmid": "40517150", "publication_date": "2025-06-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3482, "title": "The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05312151", "substance_tags": "psilocybin", "topic_tags": "PTSD,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05312151", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05312151", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05312151", "source_url": "https://clinicaltrials.gov/study/NCT05312151", "doi": "", "pmid": "", "publication_date": "2025-06-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3611, "title": "A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-12", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06643637", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06643637", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "source_url": "https://clinicaltrials.gov/study/NCT06643637", "doi": "", "pmid": "", "publication_date": "2025-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3746, "title": "Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder", "authors": "Agin-Liebes G, Petridis P, Zeifman R, Link M, Cordova MJ, Bogenschutz M.", "journal": "PsyArXiv", "publication_date": "2025-06-10", "publication_year": 2025, "doi": "10.31234/osf.io/f27jm_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/f27jm_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/f27jm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/f27jm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/f27jm_v1", "source_url": "https://doi.org/10.31234/osf.io/f27jm_v1", "doi": "10.31234/osf.io/f27jm_v1", "pmid": "", "publication_date": "2025-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3617, "title": "Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy Adults", "authors": "University of California, San Francisco", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-10", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05317689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05317689", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05317689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05317689", "source_url": "https://clinicaltrials.gov/study/NCT05317689", "doi": "", "pmid": "", "publication_date": "2025-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3074, "title": "Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder", "authors": "Gabrielle Agin-Liebes, Petros Petridis, Richard Zeifman, Max Link, Matthew J Cordova, Michael Bogenschutz", "journal": "PsyArXiv", "publication_date": "2025-06-10", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/f27jm_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/f27jm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/f27jm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/f27jm_v1", "source_url": "https://osf.io/preprints/psyarxiv/f27jm_v1", "doi": "", "pmid": "", "publication_date": "2025-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3672, "title": "Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study", "authors": "Matthew Hicks", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06372197", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06372197", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "source_url": "https://clinicaltrials.gov/study/NCT06372197", "doi": "", "pmid": "", "publication_date": "2025-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3480, "title": "Optimizing Microdosing and Meditation", "authors": "National University of Natural Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06560658", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Microdosing,Wellbeing,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06560658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "source_url": "https://clinicaltrials.gov/study/NCT06560658", "doi": "", "pmid": "", "publication_date": "2025-06-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 682, "title": "Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.", "authors": "Glynos NG, Baker A, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P", "journal": "British journal of pain", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1177/20494637251319497", "pubmed_id": "39944237", "openalex_id": "https://openalex.org/W4407380636", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39944237/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:39944237", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39944237/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39944237", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39944237/", "doi": "10.1177/20494637251319497", "pmid": "39944237", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 680, "title": "The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.", "authors": "Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA", "journal": "Psychiatry research", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116446", "pubmed_id": "40147088", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40147088/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40147088", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40147088/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40147088", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40147088/", "doi": "10.1016/j.psychres.2025.116446", "pmid": "40147088", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 677, "title": "Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.", "authors": "Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106163", "pubmed_id": "40245969", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245969/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Aging,Microdosing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40245969", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40245969/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40245969", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40245969/", "doi": "10.1016/j.neubiorev.2025.106163", "pmid": "40245969", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 676, "title": "Innovation and inequity in psychedelic research at the Mayo Clinic.", "authors": "Klim C, VanDreese B, Meyerhoefer T, Breitinger S", "journal": "History of psychiatry", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1177/0957154x251318489", "pubmed_id": "40293719", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40293719/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40293719", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40293719/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40293719", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40293719/", "doi": "10.1177/0957154x251318489", "pmid": "40293719", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 674, "title": "The pharmacological treatment of anxiety in people with eating disorders: A systematic review.", "authors": "Morris R, Keeler J, Treasure J, Himmerich H", "journal": "Pharmacological research", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1016/j.phrs.2025.107782", "pubmed_id": "40378942", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40378942/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Eating Disorders,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40378942", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40378942/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40378942", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40378942/", "doi": "10.1016/j.phrs.2025.107782", "pmid": "40378942", "publication_date": "2025-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 690, "title": "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.", "authors": "Peck SK, Brewerton TD, Fisher H, Trim J, Shao S, Modlin NL, Kim J, Finn DM, Kaye WH", "journal": "Journal of eating disorders", "publication_date": "2025-05-26", "publication_year": 2025, "doi": "10.1186/s40337-025-01274-2", "pubmed_id": "40420197", "openalex_id": "https://openalex.org/W4410748059", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40420197/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Eating Disorders,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40420197", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40420197/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40420197", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40420197/", "doi": "10.1186/s40337-025-01274-2", "pmid": "40420197", "publication_date": "2025-05-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3762, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C.", "journal": "PsyArXiv", "publication_date": "2025-05-16", "publication_year": 2025, "doi": "10.31234/osf.io/6hjkm_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:08", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "doi": "10.31234/osf.io/6hjkm_v1", "pmid": "", "publication_date": "2025-05-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3183, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "Lukas A. Basedow, Lynn Lottes, Irina Falkenberg, Christoph Vogelbacher, Cüneyt Yildiz", "journal": "PsyArXiv", "publication_date": "2025-05-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "doi": "", "pmid": "", "publication_date": "2025-05-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5798, "title": "Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review", "authors": "Ritika Jagdeep Shah, Ashish Sarangi", "journal": "Alcoholism Treatment Quarterly", "publication_date": "2025-05-02", "publication_year": 2025, "doi": "10.1080/07347324.2025.2500345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4410043539", "source_url": "https://doi.org/10.1080/07347324.2025.2500345", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:20", "last_checked": "2026-08-09 08:25:20", "bibtex": null, "source_record_id": "DOI:10.1080/07347324.2025.2500345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/07347324.2025.2500345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/07347324.2025.2500345", "source_url": "https://doi.org/10.1080/07347324.2025.2500345", "doi": "10.1080/07347324.2025.2500345", "pmid": "", "publication_date": "2025-05-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 724, "title": "Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.", "authors": "Menon V, Ramamurthy P, Venu S, Andrade C", "journal": "Acta psychiatrica Scandinavica", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1111/acps.13778", "pubmed_id": "39627679", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627679/", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39627679", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39627679/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39627679", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39627679/", "doi": "10.1111/acps.13778", "pmid": "39627679", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 723, "title": "ALSUntangled #77: Psilocybin.", "authors": "Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R", "journal": "Amyotrophic lateral sclerosis & frontotemporal degeneration", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1080/21678421.2024.2441274", "pubmed_id": "39709547", "openalex_id": "https://openalex.org/W4405678445", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39709547/", "substance_tags": "psilocybin", "topic_tags": "Neurogenesis,Mechanism of Action,Review Article,Case Report,Safety,Adverse Events,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39709547", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39709547/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39709547", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39709547/", "doi": "10.1080/21678421.2024.2441274", "pmid": "39709547", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 720, "title": "Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.", "authors": "Dave M, Shore R, Cupido T, Haley C, Clinkard D", "journal": "European journal of anaesthesiology", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1097/eja.0000000000002138", "pubmed_id": "39967455", "openalex_id": "https://openalex.org/W4407753529", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39967455/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Receptor Pharmacology,Aging,Review Article,Safety,Adverse Events,Contraindications", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39967455", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39967455/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39967455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39967455/", "doi": "10.1097/eja.0000000000002138", "pmid": "39967455", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 715, "title": "IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.", "authors": "Koseli E, Buzzi B, Honaker T, Rakholia Y, Lewis M, Gaines-Smith M, Jaster AM, Gonzalez-Maeso J, Damaj MI", "journal": "Pharmacological research", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1016/j.phrs.2025.107699", "pubmed_id": "40107634", "openalex_id": "https://openalex.org/W4408540649", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40107634/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Receptor Pharmacology,Animal Study,Safety,Inflammation", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40107634", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40107634/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40107634", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40107634/", "doi": "10.1016/j.phrs.2025.107699", "pmid": "40107634", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 708, "title": "Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.", "authors": "Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1038/s41386-025-02091-6", "pubmed_id": "40258990", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40258990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40258990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40258990/", "doi": "10.1038/s41386-025-02091-6", "pmid": "40258990", "publication_date": "2025-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4381, "title": "Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study", "authors": "Kim Hoffman, Todd P. Korthuis, Kellie Pertl, David Morgan", "journal": "International Journal of Multiple Research Approaches", "publication_date": "2025-04-30", "publication_year": 2025, "doi": "10.29034/ijmra.v17n1a1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155048769", "source_url": "https://doi.org/10.29034/ijmra.v17n1a1", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.29034/ijmra.v17n1a1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29034/ijmra.v17n1a1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29034/ijmra.v17n1a1", "source_url": "https://doi.org/10.29034/ijmra.v17n1a1", "doi": "10.29034/ijmra.v17n1a1", "pmid": "", "publication_date": "2025-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 732, "title": "[Treatment with psychedelics: potential benefits in Parkinson's disease].", "authors": "Penzenstadler L, Baudois S, Lingenberg A, Catalano Chiuvé S, Tomkova E, Fleury V", "journal": "Revue medicale suisse", "publication_date": "2025-04-23", "publication_year": 2025, "doi": "10.53738/revmed.2025.21.915.47180", "pubmed_id": "40275842", "openalex_id": "https://openalex.org/W4409833807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40275842", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40275842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842/", "doi": "10.53738/revmed.2025.21.915.47180", "pmid": "40275842", "publication_date": "2025-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 734, "title": "Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.", "authors": "Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD", "journal": "Palliative & supportive care", "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.1017/s147895152500032x", "pubmed_id": "40259688", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40259688/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40259688", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40259688/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40259688", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40259688/", "doi": "10.1017/s147895152500032x", "pmid": "40259688", "publication_date": "2025-04-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3465, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia", "authors": "Kevin Boehnke", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-16", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05128162", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05128162", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "source_url": "https://clinicaltrials.gov/study/NCT05128162", "doi": "", "pmid": "", "publication_date": "2025-04-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 739, "title": "Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.", "authors": "Beesley VL, Kennedy TJ, Maccallum F, Ross M, Harvey R, Rossell SL, Sarris J, Perkins D, Neale RE, Bennett-Levy J, Johnson S, Beebe H, Roset N, Strobel J, Parker S", "journal": "BMJ open", "publication_date": "2025-04-15", "publication_year": 2025, "doi": "10.1136/bmjopen-2024-095992", "pubmed_id": "40233965", "openalex_id": "https://openalex.org/W4409449177", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Psychological Flexibility,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40233965", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40233965", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40233965/", "doi": "10.1136/bmjopen-2024-095992", "pmid": "40233965", "publication_date": "2025-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3612, "title": "The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training", "authors": "Felix Mueller", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-14", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05570708", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety,Drug Interactions", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05570708", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05570708", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05570708", "source_url": "https://clinicaltrials.gov/study/NCT05570708", "doi": "", "pmid": "", "publication_date": "2025-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3288, "title": "Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice", "authors": "Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM.", "journal": "bioRxiv", "publication_date": "2025-04-14", "publication_year": 2025, "doi": "10.1101/2025.04.08.647757", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.04.08.647757", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Microdosing,Emotional Processing,Animal Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:19", "bibtex": null, "source_record_id": "DOI:10.1101/2025.04.08.647757", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.04.08.647757", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.04.08.647757", "source_url": "https://doi.org/10.1101/2025.04.08.647757", "doi": "10.1101/2025.04.08.647757", "pmid": "", "publication_date": "2025-04-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 740, "title": "Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond.", "authors": "Hu S, Lin C, Wang H, Wang X", "journal": "ACS pharmacology & translational science", "publication_date": "2025-04-11", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00094", "pubmed_id": "40242584", "openalex_id": "https://openalex.org/W4408221975", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40242584/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Wellbeing,Emotional Processing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40242584", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40242584/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40242584", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40242584/", "doi": "10.1021/acsptsci.5c00094", "pmid": "40242584", "publication_date": "2025-04-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4396, "title": "13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study", "authors": "Danielle Bukovsky, Aron Amaev, Jianmeng Song, Edgardo Torres Carmona, S. Lauren Kyte, Fumihiko Ueno, Vincenzo De Luca, Christopher R. Bowie, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen", "journal": "Biological Psychiatry", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.250", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409280654", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.250", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Receptor Pharmacology,Aging,Older Adults,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.250", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.250", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.250", "doi": "10.1016/j.biopsych.2025.02.250", "pmid": "", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 745, "title": "The Emergence of Psilocybin in Psychiatry and Neuroscience.", "authors": "Omidian H, Omidian A", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2025-04-09", "publication_year": 2025, "doi": "10.3390/ph18040555", "pubmed_id": "40283990", "openalex_id": "https://openalex.org/W4409313347", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40283990", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40283990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40283990/", "doi": "10.3390/ph18040555", "pmid": "40283990", "publication_date": "2025-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4404, "title": "Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization", "authors": "Jennifer Jones", "journal": "Frontiers in Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1565852", "pubmed_id": "40264517", "openalex_id": "https://openalex.org/W4409274889", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Animal Study,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:21", "bibtex": null, "source_record_id": "PMID:40264517", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40264517", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "doi": "10.3389/fpsyt.2025.1565852", "pmid": "40264517", "publication_date": "2025-04-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4420, "title": "Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders", "authors": "Ioana A. Cristea, G Tomei, Jazmín Freddi, A. Bonessio", "journal": "European Psychiatry", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1192/j.eurpsy.2025.393", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414208490", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "doi": "10.1192/j.eurpsy.2025.393", "pmid": "", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4410, "title": "Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight", "authors": "A. Oliveira-Maia", "journal": "European Psychiatry", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1192/j.eurpsy.2025.64", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414181599", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.64", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2025.64", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2025.64", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2025.64", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.64", "doi": "10.1192/j.eurpsy.2025.64", "pmid": "", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2999, "title": "A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.", "authors": "Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE", "journal": "Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1097/njh.0000000000001113", "pubmed_id": "40042324", "openalex_id": "https://openalex.org/W4408245726", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40042324/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40042324", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40042324/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40042324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40042324/", "doi": "10.1097/njh.0000000000001113", "pmid": "40042324", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 761, "title": "Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.", "authors": "Sutherland I, Ho MF, Croarkin PE", "journal": "Journal of child and adolescent psychopharmacology", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1089/cap.2024.0082", "pubmed_id": "39761065", "openalex_id": "https://openalex.org/W4406088503", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39761065/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39761065", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39761065/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39761065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39761065/", "doi": "10.1089/cap.2024.0082", "pmid": "39761065", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 759, "title": "Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon.", "authors": "Correia MS, Gonzaga MJ, Temple C, Gerona RR", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1080/15563650.2025.2450240", "pubmed_id": "39977248", "openalex_id": "https://openalex.org/W4407767327", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39977248/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39977248", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39977248/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39977248", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39977248/", "doi": "10.1080/15563650.2025.2450240", "pmid": "39977248", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 757, "title": "A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.", "authors": "Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE", "journal": "Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1097/njh.0000000000001096", "pubmed_id": "39699865", "openalex_id": "https://openalex.org/W4405599715", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699865/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:39699865", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39699865/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39699865", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699865/", "doi": "10.1097/njh.0000000000001096", "pmid": "39699865", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 737, "title": "Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.", "authors": "Mimms C, Sotelo K, Khaliq AS", "journal": "Cureus", "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.7759/cureus.82532", "pubmed_id": "40385821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40385821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40385821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385821/", "doi": "10.7759/cureus.82532", "pmid": "40385821", "publication_date": "2025-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3635, "title": "Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN", "authors": "Unity Health Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731335", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "source_url": "https://clinicaltrials.gov/study/NCT06731335", "doi": "", "pmid": "", "publication_date": "2025-03-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4424, "title": "Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?", "authors": "M. Cirillo", "journal": "Journal of Humanistic Psychology", "publication_date": "2025-03-21", "publication_year": 2025, "doi": "10.1177/00221678251321040", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408724359", "source_url": "https://doi.org/10.1177/00221678251321040", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 06:34:40", "bibtex": null, "source_record_id": "DOI:10.1177/00221678251321040", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678251321040", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678251321040", "source_url": "https://doi.org/10.1177/00221678251321040", "doi": "10.1177/00221678251321040", "pmid": "", "publication_date": "2025-03-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3544, "title": "An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study", "authors": "McMaster University", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06225232", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06225232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "source_url": "https://clinicaltrials.gov/study/NCT06225232", "doi": "", "pmid": "", "publication_date": "2025-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3457, "title": "Psilocybin in Alcohol Use Disorder With Comorbid Depression", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06235411", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06235411", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "source_url": "https://clinicaltrials.gov/study/NCT06235411", "doi": "", "pmid": "", "publication_date": "2025-03-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4432, "title": "Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee", "authors": "Lauren Wilseck, Preet Chatha, Lawrence Canale, Dhvanit Raval, Jeremy Weleff", "journal": "American Journal of Psychiatry Residents Journal", "publication_date": "2025-03-06", "publication_year": 2025, "doi": "10.1176/appi.ajp-rj.2025.200301", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408204973", "source_url": "https://doi.org/10.1176/appi.ajp-rj.2025.200301", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp-rj.2025.200301", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp-rj.2025.200301", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.ajp-rj.2025.200301", "source_url": "https://doi.org/10.1176/appi.ajp-rj.2025.200301", "doi": "10.1176/appi.ajp-rj.2025.200301", "pmid": "", "publication_date": "2025-03-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4431, "title": "Risks of using psilocybin in treatment of treatment-resistant depression", "authors": "Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska", "journal": "Journal of Education Health and Sport", "publication_date": "2025-03-06", "publication_year": 2025, "doi": "10.12775/jehs.2025.79.58319", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408197223", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:22", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "doi": "10.12775/jehs.2025.79.58319", "pmid": "", "publication_date": "2025-03-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3666, "title": "Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-05", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05523401", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05523401", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "source_url": "https://clinicaltrials.gov/study/NCT05523401", "doi": "", "pmid": "", "publication_date": "2025-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 787, "title": "Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study.", "authors": "Yalovitser J, Levine J, Zweber C, Tien L, Stultz M, Mitchell H, Cote E, MacLean CD", "journal": "Journal of psychoactive drugs", "publication_date": "2025-03-05", "publication_year": 2025, "doi": "10.1080/02791072.2025.2474246", "pubmed_id": "40045530", "openalex_id": "https://openalex.org/W4408177956", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40045530/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40045530", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40045530/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40045530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40045530/", "doi": "10.1080/02791072.2025.2474246", "pmid": "40045530", "publication_date": "2025-03-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4433, "title": "Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?", "authors": "Craig, Danny R, Blalock, Eric M.", "journal": "UKnowledge (University of Kentucky)", "publication_date": "2025-03-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110662772", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Cellular Senescence,Resilience,Clinical Trial,Randomized Controlled Trial,Animal Study,Older Adults,Adolescents,Treatment-Resistant Depression,Safety,Drug Interactions,Transcriptomics,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "doi": "", "pmid": "", "publication_date": "2025-03-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 811, "title": "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.", "authors": "Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M", "journal": "Molecular psychiatry", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1038/s41380-024-02800-5", "pubmed_id": "39592825", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39592825", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39592825", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39592825/", "doi": "10.1038/s41380-024-02800-5", "pmid": "39592825", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 810, "title": "Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.", "authors": "Høgsted ES, Beliveau V, Ozenne B, Madsen MK, Svarer C, Dam VH, Johansen A, Fisher P, Knudsen GM, Frokjaer VG, Sankar A", "journal": "The British journal of psychiatry: the journal of mental science", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1192/bjp.2024.143", "pubmed_id": "39632615", "openalex_id": "https://openalex.org/W4405084592", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632615/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Personality Change,Observational Study,Healthy Volunteers,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:39632615", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39632615/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39632615", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632615/", "doi": "10.1192/bjp.2024.143", "pmid": "39632615", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 808, "title": "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E", "journal": "Journal of affective disorders", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1016/j.jad.2024.12.061", "pubmed_id": "39706482", "openalex_id": "https://openalex.org/W4405528804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39706482/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Consciousness,Emotional Processing,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:39706482", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39706482/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39706482", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39706482/", "doi": "10.1016/j.jad.2024.12.061", "pmid": "39706482", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 797, "title": "Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.", "authors": "Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB", "journal": "Cancer medicine", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1002/cam4.70586", "pubmed_id": "40052631", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40052631", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40052631", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40052631/", "doi": "10.1002/cam4.70586", "pmid": "40052631", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 795, "title": "Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.", "authors": "Modlin NL, McPhee T, Zazon N, Sarang M, Hignett R, Pick S, Cleare A, Williamson V, Rucker J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0027", "pubmed_id": "40337755", "openalex_id": "https://openalex.org/W4404743266", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337755/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40337755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40337755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40337755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337755/", "doi": "10.1089/psymed.2024.0027", "pmid": "40337755", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 794, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.", "authors": "Meshkat S, Kaczmarek E, Doyle Z, Brudner RM, Gomes FA, Blainey MG, Weiglein G, McIntyre RS, Mansur RB, Rosenblat JD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0032", "pubmed_id": "40337756", "openalex_id": "https://openalex.org/W4404460385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337756/", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:02", "bibtex": null, "source_record_id": "PMID:40337756", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40337756/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40337756", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40337756/", "doi": "10.1089/psymed.2024.0032", "pmid": "40337756", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 793, "title": "A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.", "authors": "Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.1089/psymed.2024.0019", "pubmed_id": "40351554", "openalex_id": "https://openalex.org/W4406633420", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40351554/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Wellbeing,Review Article,Safety,Adverse Events,Contraindications", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40351554", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40351554/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40351554", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40351554/", "doi": "10.1089/psymed.2024.0019", "pmid": "40351554", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 778, "title": "A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.", "authors": "Dino F", "journal": "Cureus", "publication_date": "2025-03-01", "publication_year": 2025, "doi": "10.7759/cureus.80707", "pubmed_id": "40242672", "openalex_id": "https://openalex.org/W4408529433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40242672/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions,Contraindications", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:01", "bibtex": null, "source_record_id": "PMID:40242672", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40242672/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40242672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40242672/", "doi": "10.7759/cureus.80707", "pmid": "40242672", "publication_date": "2025-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3748, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2025-02-28", "publication_year": 2025, "doi": "10.31234/osf.io/93x5h_v3", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h_v3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-08-09 08:15:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h_v3", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h_v3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h_v3", "source_url": "https://doi.org/10.31234/osf.io/93x5h_v3", "doi": "10.31234/osf.io/93x5h_v3", "pmid": "", "publication_date": "2025-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3110, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2025-02-28", "publication_year": 2025, "doi": "10.31234/osf.io/93x5h_v2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h_v2", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:15:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h_v2", "source_url": "https://doi.org/10.31234/osf.io/93x5h_v2", "doi": "10.31234/osf.io/93x5h_v2", "pmid": "", "publication_date": "2025-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3109, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Anna-Leigh Hodge, Anna Forsyth, Tehseen Noorani, Suresh Muthukumaraswamy, Anna Rolleston, Patrick McHugh", "journal": "PsyArXiv", "publication_date": "2025-02-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/93x5h_v3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/93x5h_v3", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/93x5h_v3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/93x5h_v3", "source_url": "https://osf.io/preprints/psyarxiv/93x5h_v3", "doi": "", "pmid": "", "publication_date": "2025-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3077, "title": "The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.", "authors": "Hitchins K, Reynolds J.", "journal": "PsyArXiv", "publication_date": "2025-02-25", "publication_year": 2025, "doi": "10.31234/osf.io/48yg7_v2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/48yg7_v2", "substance_tags": "psilocybin", "topic_tags": "Longevity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/48yg7_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/48yg7_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/48yg7_v2", "source_url": "https://doi.org/10.31234/osf.io/48yg7_v2", "doi": "10.31234/osf.io/48yg7_v2", "pmid": "", "publication_date": "2025-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 532, "title": "The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.", "authors": "Karla Hitchins, James Reynolds", "journal": "PsyArXiv", "publication_date": "2025-02-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/48yg7_v2", "substance_tags": "psilocybin", "topic_tags": "Longevity,Personality Change,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/48yg7_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/48yg7_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/48yg7_v2", "source_url": "https://osf.io/preprints/psyarxiv/48yg7_v2", "doi": "", "pmid": "", "publication_date": "2025-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3080, "title": "The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.", "authors": "Hitchins K, Reynolds J.", "journal": "PsyArXiv", "publication_date": "2025-02-24", "publication_year": 2025, "doi": "10.31234/osf.io/48yg7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/48yg7_v1", "substance_tags": "psilocybin", "topic_tags": "Longevity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:56", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/48yg7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/48yg7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/48yg7_v1", "source_url": "https://doi.org/10.31234/osf.io/48yg7_v1", "doi": "10.31234/osf.io/48yg7_v1", "pmid": "", "publication_date": "2025-02-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 816, "title": "Psychedelics and Suicide-Related Outcomes: A Systematic Review.", "authors": "Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V", "journal": "Journal of clinical medicine", "publication_date": "2025-02-20", "publication_year": 2025, "doi": "10.3390/jcm14051416", "pubmed_id": "40094838", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40094838/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:40094838", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40094838/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40094838", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40094838/", "doi": "10.3390/jcm14051416", "pmid": "40094838", "publication_date": "2025-02-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 820, "title": "Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology.", "authors": "Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF", "journal": "bioRxiv: the preprint server for biology", "publication_date": "2025-02-11", "publication_year": 2025, "doi": "10.1101/2025.02.03.636248", "pubmed_id": "39975204", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39975204/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39975204", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39975204/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39975204", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39975204/", "doi": "10.1101/2025.02.03.636248", "pmid": "39975204", "publication_date": "2025-02-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4441, "title": "Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle?", "authors": "Bor Luen Tang", "journal": "Psychoactives", "publication_date": "2025-02-06", "publication_year": 2025, "doi": "10.3390/psychoactives4010005", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407194293", "source_url": "https://doi.org/10.3390/psychoactives4010005", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4010005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4010005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4010005", "source_url": "https://doi.org/10.3390/psychoactives4010005", "doi": "10.3390/psychoactives4010005", "pmid": "", "publication_date": "2025-02-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4443, "title": "Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners", "authors": "Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.1556/2054.2025.00375", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407157019", "source_url": "https://doi.org/10.1556/2054.2025.00375", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Receptor Pharmacology,Personality Change,Mystical Experience,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:23", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00375", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00375", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00375", "source_url": "https://doi.org/10.1556/2054.2025.00375", "doi": "10.1556/2054.2025.00375", "pmid": "", "publication_date": "2025-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 838, "title": "Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.", "authors": "Calder AE, Hase A, Hasler G", "journal": "Molecular psychiatry", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1038/s41380-024-02830-z", "pubmed_id": "39613915", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39613915/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Biomarkers,Aging,Meta-Analysis,Systematic Review,Review Article,Animal Study,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39613915", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39613915/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39613915", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39613915/", "doi": "10.1038/s41380-024-02830-z", "pmid": "39613915", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 837, "title": "The safety of psilocybin-assisted psychotherapy: A systematic review.", "authors": "Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1177/00048674241289024", "pubmed_id": "39670342", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39670342", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39670342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39670342/", "doi": "10.1177/00048674241289024", "pmid": "39670342", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 836, "title": "Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.", "authors": "Marazziti D, Weiss F, Gurrieri R, Russomanno G, Gambini M, Magnesa A, Coccoglioniti A, Perugi G", "journal": "Expert review of neurotherapeutics", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1080/14737175.2024.2445016", "pubmed_id": "39699299", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699299/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39699299", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39699299/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39699299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699299/", "doi": "10.1080/14737175.2024.2445016", "pmid": "39699299", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 835, "title": "Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.", "authors": "Geller J, Whitney E", "journal": "Current psychiatry reports", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1007/s11920-024-01577-2", "pubmed_id": "39699759", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Aging,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39699759", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39699759", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699759/", "doi": "10.1007/s11920-024-01577-2", "pmid": "39699759", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 834, "title": "Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.", "authors": "Ferreira AE, Reis-Pina P", "journal": "Journal of psychosomatic research", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1016/j.jpsychores.2024.112020", "pubmed_id": "39705901", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39705901/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Mechanism of Action,Wellbeing,Spirituality,Mystical Experience,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39705901", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39705901/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39705901", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39705901/", "doi": "10.1016/j.jpsychores.2024.112020", "pmid": "39705901", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 833, "title": "Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ", "journal": "Psychiatry research", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1016/j.psychres.2024.116337", "pubmed_id": "39754904", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39754904", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39754904", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39754904/", "doi": "10.1016/j.psychres.2024.116337", "pmid": "39754904", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 832, "title": "The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour.", "authors": "Louie E, Towers E, Morse AR, Watt J, Bryant Z, Haber P, Morley K", "journal": "International journal of mental health nursing", "publication_date": "2025-02-01", "publication_year": 2025, "doi": "10.1111/inm.70010", "pubmed_id": "39952893", "openalex_id": "https://openalex.org/W4407570589", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39952893/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39952893", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39952893/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39952893", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39952893/", "doi": "10.1111/inm.70010", "pmid": "39952893", "publication_date": "2025-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 846, "title": "Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.", "authors": "Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-01-30", "publication_year": 2025, "doi": "10.1111/add.16762", "pubmed_id": "39887551", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39887551/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39887551", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39887551/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39887551", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39887551/", "doi": "10.1111/add.16762", "pmid": "39887551", "publication_date": "2025-01-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4461, "title": "Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?", "authors": "Louis Plourde, Sue-Ling Chang, Houman Farzin, Jean-François Stephan, Jean-Sébastien Fallu, Michel Dorval", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-01-21", "publication_year": 2025, "doi": "10.1556/2054.2024.00431", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406667242", "source_url": "https://doi.org/10.1556/2054.2024.00431", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00431", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00431", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00431", "source_url": "https://doi.org/10.1556/2054.2024.00431", "doi": "10.1556/2054.2024.00431", "pmid": "", "publication_date": "2025-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3679, "title": "A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression", "authors": "Central Institute of Mental Health, Mannheim", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-20", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04670081", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04670081", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "source_url": "https://clinicaltrials.gov/study/NCT04670081", "doi": "", "pmid": "", "publication_date": "2025-01-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 854, "title": "Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.", "authors": "Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2025-01-19", "publication_year": 2025, "doi": "10.3390/ph18010130", "pubmed_id": "39861191", "openalex_id": "https://openalex.org/W4406629036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39861191", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39861191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39861191/", "doi": "10.3390/ph18010130", "pmid": "39861191", "publication_date": "2025-01-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 857, "title": "Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.", "authors": "Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA", "journal": "Current pain and headache reports", "publication_date": "2025-01-16", "publication_year": 2025, "doi": "10.1007/s11916-024-01321-8", "pubmed_id": "39820774", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39820774/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39820774", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39820774/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39820774", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39820774/", "doi": "10.1007/s11916-024-01321-8", "pmid": "39820774", "publication_date": "2025-01-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 856, "title": "Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.", "authors": "Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-01-16", "publication_year": 2025, "doi": "10.1111/add.16767", "pubmed_id": "39821493", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39821493/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39821493", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39821493/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39821493", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39821493/", "doi": "10.1111/add.16767", "pmid": "39821493", "publication_date": "2025-01-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 859, "title": "Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.", "authors": "Ellis S, Bostian C, Feng W, Fischer E, Schwartz G, Eisen K, Lean M, Conlan E, Ostacher M, Aaronson S, Suppes T", "journal": "Journal of affective disorders", "publication_date": "2025-01-15", "publication_year": 2025, "doi": "10.1016/j.jad.2024.09.133", "pubmed_id": "39343309", "openalex_id": "https://openalex.org/W4402912774", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39343309/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Treatment-Resistant Depression,Veterans,Safety,Adverse Events,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39343309", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39343309/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39343309", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39343309/", "doi": "10.1016/j.jad.2024.09.133", "pmid": "39343309", "publication_date": "2025-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3086, "title": "Age- and estrous-dependent effects of psilocybin in rats", "authors": "Zylko A, Rakoczy R, Roberts B, Wilson M, Powell A, Page A, Heitkamp M, Fiest D, Jones J, McMurray M.", "journal": "bioRxiv", "publication_date": "2025-01-14", "publication_year": 2025, "doi": "10.1101/2025.01.10.632408", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.01.10.632408", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Animal Study,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:56", "bibtex": null, "source_record_id": "DOI:10.1101/2025.01.10.632408", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.01.10.632408", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.01.10.632408", "source_url": "https://doi.org/10.1101/2025.01.10.632408", "doi": "10.1101/2025.01.10.632408", "pmid": "", "publication_date": "2025-01-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4463, "title": "Study finds encouraging results in psilocybin treatment for TRD patients", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1002/mhw.34292", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406243180", "source_url": "https://doi.org/10.1002/mhw.34292", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34292", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34292", "source_url": "https://doi.org/10.1002/mhw.34292", "doi": "10.1002/mhw.34292", "pmid": "", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 867, "title": "The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.", "authors": "Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2024.111139", "pubmed_id": "39251080", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39251080/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety,Inflammation,Immune Function", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39251080", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39251080/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39251080", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39251080/", "doi": "10.1016/j.pnpbp.2024.111139", "pmid": "39251080", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 865, "title": "Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).", "authors": "Kopra EI, Penttinen J, Rucker JJ, Copeland CS", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2024.111177", "pubmed_id": "39437962", "openalex_id": "https://openalex.org/W4403579240", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39437962/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39437962", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39437962/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39437962", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39437962/", "doi": "10.1016/j.pnpbp.2024.111177", "pmid": "39437962", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 863, "title": "Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.", "authors": "Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2025-01-10", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111249", "pubmed_id": "39778644", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39778644", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39778644", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39778644/", "doi": "10.1016/j.pnpbp.2025.111249", "pmid": "39778644", "publication_date": "2025-01-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4464, "title": "PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS", "authors": "Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo", "journal": "Health and Society", "publication_date": "2025-01-08", "publication_year": 2025, "doi": "10.51249/hs.v5i01.2377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406161181", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:24", "bibtex": null, "source_record_id": "DOI:10.51249/hs.v5i01.2377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51249/hs.v5i01.2377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51249/hs.v5i01.2377", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "doi": "10.51249/hs.v5i01.2377", "pmid": "", "publication_date": "2025-01-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 869, "title": "Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.", "authors": "Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J", "journal": "Current pain and headache reports", "publication_date": "2025-01-07", "publication_year": 2025, "doi": "10.1007/s11916-024-01353-0", "pubmed_id": "39775134", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39775134/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39775134", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39775134/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39775134", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39775134/", "doi": "10.1007/s11916-024-01353-0", "pmid": "39775134", "publication_date": "2025-01-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4498, "title": "Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke", "authors": "Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal", "journal": "Figshare", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.6084/m9.figshare.29615217", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130712582", "source_url": "https://doi.org/10.6084/m9.figshare.29615217", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.6084/m9.figshare.29615217", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.6084/m9.figshare.29615217", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.6084/m9.figshare.29615217", "source_url": "https://doi.org/10.6084/m9.figshare.29615217", "doi": "10.6084/m9.figshare.29615217", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4484, "title": "Alternative therapy for neurological and psychiatric disorders using psilocybin", "authors": "Machado Henrique Tofoli Vieira, Seixas Geovana Mendes de, Silva Luis Gustavo Alves, Brito Mariana Duarte Garcia, Castro Giovanna Miziara", "journal": "São Paulo Medical Journal", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.5327/1516-3180.cpn.1123", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417514861", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Wellbeing,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:35:10", "bibtex": null, "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "doi": "10.5327/1516-3180.cpn.1123", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4477, "title": "Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model", "authors": "Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva", "journal": "RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.51126/revsalus.v7isup.1031", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411369954", "source_url": "https://doi.org/10.51126/revsalus.v7isup.1031", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Mitochondrial Function,In Vitro Study,Safety,Toxicity", "study_type": "In Vitro Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.51126/revsalus.v7isup.1031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51126/revsalus.v7isup.1031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51126/revsalus.v7isup.1031", "source_url": "https://doi.org/10.51126/revsalus.v7isup.1031", "doi": "10.51126/revsalus.v7isup.1031", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4465, "title": "From Safe Touch to Sexual Abuse: Walking the Tightrope of Patient Safety in Psychedelic Therapy", "authors": "Y. Tony Yang", "journal": "The American Journal of Bioethics", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/15265161.2024.2433418", "pubmed_id": "39804319", "openalex_id": "https://openalex.org/W4406325093", "source_url": "https://doi.org/10.1080/15265161.2024.2433418", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39804319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/15265161.2024.2433418", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39804319", "source_url": "https://doi.org/10.1080/15265161.2024.2433418", "doi": "10.1080/15265161.2024.2433418", "pmid": "39804319", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4198, "title": "Subjective Effects of Psychedelics Are the Plausible Mechanism of Psychedelic Moral Enhancement Rather than a Risk. Comment on Tang, B.L. Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle? Psychoactives 2025, 4, 5", "authors": "Juuso Kähönen", "journal": "Työväentutkimus Vuosikirja", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3390/psychoactives4040043", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128101855", "source_url": "https://philarchive.org/rec/KHNSEO", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4040043", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://philarchive.org/rec/KHNSEO", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4040043", "source_url": "https://philarchive.org/rec/KHNSEO", "doi": "10.3390/psychoactives4040043", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3687, "title": "Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04932434", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04932434", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "source_url": "https://clinicaltrials.gov/study/NCT04932434", "doi": "", "pmid": "", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 919, "title": "Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.", "authors": "Bahji A, Lunsky I, Gutierrez G, Vazquez G", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2023.2278586", "pubmed_id": "37968944", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37968944/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Aging,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:37968944", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37968944/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37968944", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37968944/", "doi": "10.1080/02791072.2023.2278586", "pmid": "37968944", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 915, "title": "Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.", "authors": "Humphreys K, Todd Korthuis P, Stjepanović D, Hall W", "journal": "Annual review of psychology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1146/annurev-psych-020124-023532", "pubmed_id": "39094057", "openalex_id": "https://openalex.org/W4401244642", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39094057/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39094057", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39094057/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39094057", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39094057/", "doi": "10.1146/annurev-psych-020124-023532", "pmid": "39094057", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 914, "title": "Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.", "authors": "Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D", "journal": "Clinical pharmacology and therapeutics", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1002/cpt.3459", "pubmed_id": "39345195", "openalex_id": "https://openalex.org/W4402965277", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39345195/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Review Article,Animal Study,Safety,Genomics", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39345195", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39345195/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39345195", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39345195/", "doi": "10.1002/cpt.3459", "pmid": "39345195", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 912, "title": "Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling.", "authors": "Negrine JJ, Puljević C, Ferris J, Liknaitzky P, Perlman C, Piatkowski T", "journal": "Drug and alcohol review", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1111/dar.13973", "pubmed_id": "39499579", "openalex_id": "https://openalex.org/W4404059132", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39499579/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39499579", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39499579/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39499579", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39499579/", "doi": "10.1111/dar.13973", "pmid": "39499579", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 910, "title": "Associations between psychedelic use and cannabis use disorder in a nationally representative sample.", "authors": "Zech JM, Yaden DB, Jones GM", "journal": "Drug and alcohol dependence", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.drugalcdep.2024.112502", "pubmed_id": "39586127", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39586127/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39586127", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39586127/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39586127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39586127/", "doi": "10.1016/j.drugalcdep.2024.112502", "pmid": "39586127", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 908, "title": "Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.", "authors": "Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ", "journal": "The lancet. Psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/s2215-0366(24)00333-x", "pubmed_id": "39667373", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39667373/", "substance_tags": "psilocybin", "topic_tags": "Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39667373", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39667373/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39667373", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39667373/", "doi": "10.1016/s2215-0366(24)00333-x", "pmid": "39667373", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 902, "title": "Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.", "authors": "Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Suppes T, Sackeim HA", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20231063", "pubmed_id": "39741440", "openalex_id": "https://openalex.org/W4405955624", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741440/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741440", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741440/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741440", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741440/", "doi": "10.1176/appi.ajp.20231063", "pmid": "39741440", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 900, "title": "Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.", "authors": "Pagni BA, Zeifman RJ, Mennenga SE, Carrithers BM, Goldway N, Bhatt S, O'Donnell KC, Ross S, Bogenschutz MP", "journal": "The American journal of psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1176/appi.ajp.20230887", "pubmed_id": "39741446", "openalex_id": "https://openalex.org/W4405955644", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Personality Change,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39741446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39741446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39741446/", "doi": "10.1176/appi.ajp.20230887", "pmid": "39741446", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 899, "title": "Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.", "authors": "Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM", "journal": "Clinical neuropharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/wnf.0000000000000617", "pubmed_id": "39787428", "openalex_id": "https://openalex.org/W4405922737", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Healthy Volunteers,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39787428", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39787428", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39787428/", "doi": "10.1097/wnf.0000000000000617", "pmid": "39787428", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 898, "title": "Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial.", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL", "journal": "medRxiv: the preprint server for health sciences", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1101/2024.12.31.24319806", "pubmed_id": "39802794", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:39802794", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39802794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39802794/", "doi": "10.1101/2024.12.31.24319806", "pmid": "39802794", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 893, "title": "Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.", "authors": "Nogueira M, García-Hernández S, Roberto GS, Marques LZ", "journal": "International journal of medicinal mushrooms", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1615/intjmedmushrooms.2024057053", "pubmed_id": "40096533", "openalex_id": "https://openalex.org/W4404063451", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40096533/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40096533", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40096533/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40096533", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40096533/", "doi": "10.1615/intjmedmushrooms.2024057053", "pmid": "40096533", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 886, "title": "Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.002", "pubmed_id": "40541311", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Pharmacology,Microdosing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541311", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541311", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541311/", "doi": "10.1016/bs.irn.2025.03.002", "pmid": "40541311", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 885, "title": "Serotonergic psychedelics for depression: A comprehensive overview.", "authors": "Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.04.009", "pubmed_id": "40541312", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541312", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541312", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541312/", "doi": "10.1016/bs.irn.2025.04.009", "pmid": "40541312", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 884, "title": "Psychedelics and substance use disorder treatment.", "authors": "DuPont CM, Johnson MW", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.005", "pubmed_id": "40541314", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541314/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541314", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541314/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541314", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541314/", "doi": "10.1016/bs.irn.2025.03.005", "pmid": "40541314", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 881, "title": "Clinical pharmacology.", "authors": "Vogt SB, Liechti ME", "journal": "International review of neurobiology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.02.003", "pubmed_id": "40541320", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541320/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40541320", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40541320/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40541320", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40541320/", "doi": "10.1016/bs.irn.2025.02.003", "pmid": "40541320", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 880, "title": "Emerging Risks of Amanita Muscaria: Case Reports on Increasing Consumption and Health Risks.", "authors": "Savickaitė E, Laubner-Sakalauskienė G", "journal": "Acta medica Lituanica", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.15388/amed.2025.32.1.23", "pubmed_id": "40641545", "openalex_id": "https://openalex.org/W4411132101", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40641545/", "substance_tags": "psilocybin", "topic_tags": "Case Report,Safety,Toxicity", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:40641545", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40641545/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40641545", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40641545/", "doi": "10.15388/amed.2025.32.1.23", "pmid": "40641545", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 875, "title": "\"\" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.", "authors": "D M Schuman H, Barkova S, Mina R, Deleemans JM, Nguyen T, Carlson LE", "journal": "Integrative cancer therapies", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/15347354251370982", "pubmed_id": "41013977", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41013977/", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Spirituality,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:04", "bibtex": null, "source_record_id": "PMID:41013977", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41013977/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41013977", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41013977/", "doi": "10.1177/15347354251370982", "pmid": "41013977", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 855, "title": "Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.", "authors": "Meshkat S, J Zeifman R, Stewart K, Janssen-Aguilar R, Lou W, Jetly R, Monson CM, Bhat V", "journal": "PloS one", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1371/journal.pone.0313741", "pubmed_id": "39823496", "openalex_id": "https://openalex.org/W4406512218", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39823496/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Wellbeing,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:39823496", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39823496/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39823496", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39823496/", "doi": "10.1371/journal.pone.0313741", "pmid": "39823496", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 815, "title": "A review of psychedelics trials completed in depression, informed by European regulatory perspectives.", "authors": "Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P", "journal": "Neuroscience applied", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105516", "pubmed_id": "40654583", "openalex_id": "https://openalex.org/W4407959310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:03", "bibtex": null, "source_record_id": "PMID:40654583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40654583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40654583/", "doi": "10.1016/j.nsa.2025.105516", "pmid": "40654583", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 738, "title": "Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care.", "authors": "Dorval M, Chang SL, Farzin H, Nguyen O, Stephan JF, Tapp D, Deschamps P, Joly Y, Moureaux F, Foxman R, Masse-Grenier M, Fallu JS, P3A Research Group", "journal": "Palliative medicine reports", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1089/pmr.2024.0108", "pubmed_id": "40385526", "openalex_id": "https://openalex.org/W4409528946", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385526/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:00", "bibtex": null, "source_record_id": "PMID:40385526", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40385526/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40385526", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40385526/", "doi": "10.1089/pmr.2024.0108", "pmid": "40385526", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 704, "title": "A landscape analysis of psychedelic retreat organizations advertising online.", "authors": "Neitzke-Spruill L, Beit CS, Robinson JO, Singh N, Kambala S, Ramesh R, McGuire AL", "journal": "PloS one", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1371/journal.pone.0321648", "pubmed_id": "40315211", "openalex_id": "https://openalex.org/W4410030136", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40315211/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Wellbeing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40315211", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40315211/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40315211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40315211/", "doi": "10.1371/journal.pone.0321648", "pmid": "40315211", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 703, "title": "A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.", "authors": "Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B", "journal": "PloS one", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1371/journal.pone.0318343", "pubmed_id": "40327705", "openalex_id": "https://openalex.org/W4410112263", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40327705/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40327705", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40327705/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40327705", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40327705/", "doi": "10.1371/journal.pone.0318343", "pmid": "40327705", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 667, "title": "Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence.", "authors": "Ross BM", "journal": "Frontiers in artificial intelligence", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/frai.2025.1589086", "pubmed_id": "40535200", "openalex_id": "https://openalex.org/W4411035865", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40535200/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Default Mode Network,Aging,Creativity,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:59", "bibtex": null, "source_record_id": "PMID:40535200", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40535200/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40535200", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40535200/", "doi": "10.3389/frai.2025.1589086", "pmid": "40535200", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 663, "title": "Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.", "authors": "Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251342319", "pubmed_id": "40492108", "openalex_id": "https://openalex.org/W4411126613", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40492108/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Eating Disorders,End-of-Life Distress,Mechanism of Action,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:58", "bibtex": null, "source_record_id": "PMID:40492108", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40492108/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40492108", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40492108/", "doi": "10.1177/20451253251342319", "pmid": "40492108", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 574, "title": "Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.", "authors": "Adeyinka D, Forsyth D, Currie S, Faraone N", "journal": "Frontiers in systems neuroscience", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fnsys.2025.1585367", "pubmed_id": "40894380", "openalex_id": "https://openalex.org/W4413969371", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894380/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Animal Study,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:40894380", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40894380/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40894380", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40894380/", "doi": "10.3389/fnsys.2025.1585367", "pmid": "40894380", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 554, "title": "Magic of the Mushrooms: Effects of Psilocybin Decriminalization.", "authors": "Bhave A", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2024.2376755", "pubmed_id": "38984875", "openalex_id": "https://openalex.org/W4400495765", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38984875/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:57", "bibtex": null, "source_record_id": "PMID:38984875", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38984875/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38984875", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38984875/", "doi": "10.1080/02791072.2024.2376755", "pmid": "38984875", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 534, "title": "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.", "authors": "Ludbrook G, Bryson N, Taylor B, Hocevar-Trnka J, Johnson MW, Hirman J, Morrish G, Alexander R, Pollack M", "journal": "Journal of clinical psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1097/jcp.0000000000002047", "pubmed_id": "40685873", "openalex_id": "https://openalex.org/W4412513351", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40685873/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Pharmacology,Mystical Experience,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40685873", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40685873/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40685873", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40685873/", "doi": "10.1097/jcp.0000000000002047", "pmid": "40685873", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 530, "title": "Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.", "authors": "Ross ML, Iyer R, Williams ML, Boughey M, O'Callaghan C, Hiscock R, Dwyer J", "journal": "General hospital psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.08.001", "pubmed_id": "40858059", "openalex_id": "https://openalex.org/W4413190735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40858059", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40858059", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40858059/", "doi": "10.1016/j.genhosppsych.2025.08.001", "pmid": "40858059", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 521, "title": "Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.", "authors": "Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251372449", "pubmed_id": "40933784", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933784/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40933784", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40933784/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40933784", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40933784/", "doi": "10.1177/20451253251372449", "pmid": "40933784", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 510, "title": "Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.", "authors": "Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M", "journal": "Frontiers in pharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fphar.2025.1651898", "pubmed_id": "41050417", "openalex_id": "https://openalex.org/W4414342713", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050417/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Review Article,Safety,Toxicity,Drug Interactions,Genomics,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41050417", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41050417/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41050417", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050417/", "doi": "10.3389/fphar.2025.1651898", "pmid": "41050417", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 494, "title": "Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis.", "authors": "Cheung K, Propes C, Graziosi M, Patch K, Yaden DB", "journal": "AJOB empirical bioethics", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/23294515.2025.2526339", "pubmed_id": "40668936", "openalex_id": "https://openalex.org/W4412488390", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40668936/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:40668936", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40668936/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40668936", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40668936/", "doi": "10.1080/23294515.2025.2526339", "pmid": "40668936", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 483, "title": "Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.", "authors": "Meikle S, Carter O, Liknaitzky P, Johansen L, Iyer R, Strauss N, Williams M, Castle D, Rossell SL", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/20451253251377187", "pubmed_id": "41050149", "openalex_id": "https://openalex.org/W4414745551", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:56", "bibtex": null, "source_record_id": "PMID:41050149", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41050149", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41050149/", "doi": "10.1177/20451253251377187", "pmid": "41050149", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 469, "title": "High Risk, Low Key: The New Face of Drug Use.", "authors": "Burmeister JR, Jung JK", "journal": "Substance use: research and treatment", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1177/29768357251389682", "pubmed_id": "41180078", "openalex_id": "https://openalex.org/W4415557007", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41180078/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Microdosing,Wellbeing,Adolescents,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41180078", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41180078/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41180078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41180078/", "doi": "10.1177/29768357251389682", "pmid": "41180078", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 465, "title": "Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.", "authors": "Glynos NG, Baker A, Aday JS, Pouyan N, Barron J, Herberholz M, Kruger D, Boehnke KF", "journal": "Journal of psychoactive drugs", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/02791072.2024.2405685", "pubmed_id": "39297183", "openalex_id": "https://openalex.org/W4402649875", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39297183/", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:39297183", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39297183/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39297183", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39297183/", "doi": "10.1080/02791072.2024.2405685", "pmid": "39297183", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 450, "title": "Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.", "authors": "Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders J, Ljuslin M, Guérin B, Sholevar R, Roddy K, Tulsky JA, Agrawal M", "journal": "General hospital psychiatry", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.10.010", "pubmed_id": "41109203", "openalex_id": "https://openalex.org/W4415081303", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:55", "bibtex": null, "source_record_id": "PMID:41109203", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41109203", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41109203/", "doi": "10.1016/j.genhosppsych.2025.10.010", "pmid": "41109203", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 378, "title": "Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey.", "authors": "Afsharnia S, Liang V, Lunsky Y, Orsini AP, Tint A, Lin HY", "journal": "PLOS mental health", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1371/journal.pmen.0000514", "pubmed_id": "41662127", "openalex_id": "https://openalex.org/W7117295770", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:54", "bibtex": null, "source_record_id": "PMID:41662127", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41662127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41662127/", "doi": "10.1371/journal.pmen.0000514", "pmid": "41662127", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 327, "title": "Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.", "authors": "Sobieraj J, Sleziak J, Szyszka M, Błażejewska M, Łukańko K, Soczomska P, Bodziony K, Piotrowski P", "journal": "Frontiers in public health", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.3389/fpubh.2025.1734137", "pubmed_id": "41584153", "openalex_id": "https://openalex.org/W7118439662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41584153/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:27:53", "bibtex": null, "source_record_id": "PMID:41584153", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41584153/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41584153", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41584153/", "doi": "10.3389/fpubh.2025.1734137", "pmid": "41584153", "publication_date": "2025-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4505, "title": "Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse", "authors": "Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly", "journal": "Saudi Journal of Medicine and Public Health", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.64483/20251153", "pubmed_id": null, "openalex_id": "https://openalex.org/W7104738164", "source_url": "https://doi.org/10.64483/20251153", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.64483/20251153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.64483/20251153", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64483/20251153", "source_url": "https://doi.org/10.64483/20251153", "doi": "10.64483/20251153", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 921, "title": "Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.", "authors": "Koning E, Chaves C, Kirkpatrick RH, Brietzke E", "journal": "Journal of eating disorders", "publication_date": "2024-12-27", "publication_year": 2024, "doi": "10.1186/s40337-024-01185-8", "pubmed_id": "39731144", "openalex_id": "https://openalex.org/W4405829539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39731144/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39731144", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39731144/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39731144", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39731144/", "doi": "10.1186/s40337-024-01185-8", "pmid": "39731144", "publication_date": "2024-12-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4508, "title": "Disentangling debate about therapeutic and recreational use of psychedelics", "authors": "Christina M. Andrews, Wayne Hall, Keith Humphreys, John Marsden", "journal": "Addiction", "publication_date": "2024-12-15", "publication_year": 2024, "doi": "10.1111/add.16744", "pubmed_id": "39676069", "openalex_id": "https://openalex.org/W4405412696", "source_url": "https://doi.org/10.1111/add.16744", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "PMID:39676069", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16744", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39676069", "source_url": "https://doi.org/10.1111/add.16744", "doi": "10.1111/add.16744", "pmid": "39676069", "publication_date": "2024-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4510, "title": "Chronic pain education: past, present, and future of psychedelics for the management of chronic pain", "authors": "Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick", "journal": "Pain Medicine", "publication_date": "2024-12-10", "publication_year": 2024, "doi": "10.1093/pm/pnae124", "pubmed_id": "39658247", "openalex_id": "https://openalex.org/W4405231848", "source_url": "https://doi.org/10.1093/pm/pnae124", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Microdosing,Spirituality,Review Article,Animal Study,Healthcare Workers,Safety,Adverse Events,Drug Interactions,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "PMID:39658247", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/pm/pnae124", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39658247", "source_url": "https://doi.org/10.1093/pm/pnae124", "doi": "10.1093/pm/pnae124", "pmid": "39658247", "publication_date": "2024-12-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3689, "title": "Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2024-12-04", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05481736", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05481736", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05481736", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05481736", "source_url": "https://clinicaltrials.gov/study/NCT05481736", "doi": "", "pmid": "", "publication_date": "2024-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 932, "title": "Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML", "journal": "Translational psychiatry", "publication_date": "2024-12-04", "publication_year": 2024, "doi": "10.1038/s41398-024-03187-1", "pubmed_id": "39632810", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632810/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39632810", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39632810/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39632810", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39632810/", "doi": "10.1038/s41398-024-03187-1", "pmid": "39632810", "publication_date": "2024-12-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5701, "title": "Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence", "authors": "Shabir Kanwal", "journal": "Premier Journal of Science", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.70389/pjs.100036", "pubmed_id": null, "openalex_id": "https://openalex.org/W4405531629", "source_url": "https://doi.org/10.70389/pjs.100036", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Resilience,Emotional Processing,Review Article,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.70389/pjs.100036", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.70389/pjs.100036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.70389/pjs.100036", "source_url": "https://doi.org/10.70389/pjs.100036", "doi": "10.70389/pjs.100036", "pmid": "", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4515, "title": "Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia", "authors": "Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath", "journal": "Alzheimer s & Dementia", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1002/alz.084413", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406224088", "source_url": "https://doi.org/10.1002/alz.084413", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Spirituality,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:25", "bibtex": null, "source_record_id": "DOI:10.1002/alz.084413", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/alz.084413", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/alz.084413", "source_url": "https://doi.org/10.1002/alz.084413", "doi": "10.1002/alz.084413", "pmid": "", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 952, "title": "Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.", "authors": "Jeffrey JK, Weintraub MJ, Grob CS", "journal": "Journal of the American Academy of Child and Adolescent Psychiatry", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.jaac.2024.03.021", "pubmed_id": "38734406", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38734406/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Adolescents,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:38734406", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38734406/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38734406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38734406/", "doi": "10.1016/j.jaac.2024.03.021", "pmid": "38734406", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 951, "title": "Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.", "authors": "Hinkle JT, Graziosi M, Nayak SM, Yaden DB", "journal": "JAMA psychiatry", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.2546", "pubmed_id": "39230883", "openalex_id": "https://openalex.org/W4402221705", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39230883/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39230883", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39230883/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39230883", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39230883/", "doi": "10.1001/jamapsychiatry.2024.2546", "pmid": "39230883", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 949, "title": "Exploring the regulatory framework of psychedelics in the US & Europe.", "authors": "Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S", "journal": "Asian journal of psychiatry", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104242", "pubmed_id": "39305768", "openalex_id": "https://openalex.org/W39305768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39305768/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39305768", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39305768/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39305768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39305768/", "doi": "10.1016/j.ajp.2024.104242", "pmid": "39305768", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 947, "title": "Impact of psilocybin on cognitive function: A systematic review.", "authors": "Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V", "journal": "Psychiatry and clinical neurosciences", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1111/pcn.13741", "pubmed_id": "39354706", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39354706/", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Creativity,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39354706", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39354706/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39354706", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39354706/", "doi": "10.1111/pcn.13741", "pmid": "39354706", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 942, "title": "The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.", "authors": "Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A", "journal": "CNS spectrums", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1017/s1092852924002268", "pubmed_id": "39655426", "openalex_id": "https://openalex.org/W4405207112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655426/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Personality Change,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39655426", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39655426/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39655426", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39655426/", "doi": "10.1017/s1092852924002268", "pmid": "39655426", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 941, "title": "Psilocybin and hallucinogenic mushrooms.", "authors": "Fradet M, Kelly CM, Donnelly AJ, Suppes T", "journal": "CNS spectrums", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1017/s1092852924002487", "pubmed_id": "39789676", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39789676/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39789676", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39789676/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39789676", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39789676/", "doi": "10.1017/s1092852924002487", "pmid": "39789676", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 939, "title": "Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.", "authors": "Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1080/09540261.2024.2357668", "pubmed_id": "39980217", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mystical Experience,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39980217", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39980217", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39980217/", "doi": "10.1080/09540261.2024.2357668", "pmid": "39980217", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 934, "title": "Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy.", "authors": "Back A, Myers S, Guy J, Perez J, Lazar Thorn L, McGregor B", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0069", "pubmed_id": "40051480", "openalex_id": "https://openalex.org/W4396720923", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051480/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:40051480", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051480/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051480", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051480/", "doi": "10.1089/psymed.2023.0069", "pmid": "40051480", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 933, "title": "Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.", "authors": "Piercey CJ, Gray B, Sung A, Henry D, Karoly HC", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0052", "pubmed_id": "40051484", "openalex_id": "https://openalex.org/W4400297240", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051484/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:40051484", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051484/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051484", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051484/", "doi": "10.1089/psymed.2023.0052", "pmid": "40051484", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 931, "title": "Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.", "authors": "Terao I, Kodama W", "journal": "PCN reports: psychiatry and clinical neurosciences", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1002/pcn5.70042", "pubmed_id": "39641126", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39641126/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39641126", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39641126/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39641126", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39641126/", "doi": "10.1002/pcn5.70042", "pmid": "39641126", "publication_date": "2024-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 953, "title": "A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient.", "authors": "Morris SL", "journal": "Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology", "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.9758/cpn.24.1180", "pubmed_id": "39420616", "openalex_id": "https://openalex.org/W4398182074", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39420616/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change,Review Article,Case Report,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39420616", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39420616/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39420616", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39420616/", "doi": "10.9758/cpn.24.1180", "pmid": "39420616", "publication_date": "2024-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3157, "title": "Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration", "authors": "Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B.", "journal": "bioRxiv", "publication_date": "2024-11-28", "publication_year": 2024, "doi": "10.1101/2024.11.28.625811", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.11.28.625811", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:05", "bibtex": null, "source_record_id": "DOI:10.1101/2024.11.28.625811", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.11.28.625811", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.11.28.625811", "source_url": "https://doi.org/10.1101/2024.11.28.625811", "doi": "10.1101/2024.11.28.625811", "pmid": "", "publication_date": "2024-11-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 954, "title": "Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.", "authors": "Adams DR, Allen H, Nicol GE, Cabassa LJ", "journal": "Translational behavioral medicine", "publication_date": "2024-11-25", "publication_year": 2024, "doi": "10.1093/tbm/ibae053", "pubmed_id": "39419768", "openalex_id": "https://openalex.org/W4403502370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39419768", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39419768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39419768/", "doi": "10.1093/tbm/ibae053", "pmid": "39419768", "publication_date": "2024-11-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4520, "title": "Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)", "authors": "Jaime Rojas-Hernández, Lucas F. Borkel, Domingo Jesús Quintana Hernández, Ángelo Santana del Pino, Luis Alberto Henríquez-Hernández", "journal": "Current Psychology", "publication_date": "2024-11-21", "publication_year": 2024, "doi": "10.1007/s12144-024-07017-x", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404599367", "source_url": "https://doi.org/10.1007/s12144-024-07017-x", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.1007/s12144-024-07017-x", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s12144-024-07017-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s12144-024-07017-x", "source_url": "https://doi.org/10.1007/s12144-024-07017-x", "doi": "10.1007/s12144-024-07017-x", "pmid": "", "publication_date": "2024-11-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 955, "title": "Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.", "authors": "Wood MJ, McAlpine RG, Kamboj SK", "journal": "Scientific reports", "publication_date": "2024-11-21", "publication_year": 2024, "doi": "10.1038/s41598-024-79931-w", "pubmed_id": "39572645", "openalex_id": "https://openalex.org/W4404604989", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39572645/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Emotional Processing,Observational Study,Safety,Drug Interactions", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39572645", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39572645/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39572645", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39572645/", "doi": "10.1038/s41598-024-79931-w", "pmid": "39572645", "publication_date": "2024-11-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3512, "title": "A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05035927", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05035927", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "source_url": "https://clinicaltrials.gov/study/NCT05035927", "doi": "", "pmid": "", "publication_date": "2024-11-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 958, "title": "Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.", "authors": "Wang E, Mathai DS, Gukasyan N, Nayak S, Garcia-Romeu A", "journal": "Scientific reports", "publication_date": "2024-11-14", "publication_year": 2024, "doi": "10.1038/s41598-024-78736-1", "pubmed_id": "39543323", "openalex_id": "https://openalex.org/W4404374254", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39543323/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Observational Study,Safety,Contraindications", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39543323", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39543323/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39543323", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39543323/", "doi": "10.1038/s41598-024-78736-1", "pmid": "39543323", "publication_date": "2024-11-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3128, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2024-11-07", "publication_year": 2024, "doi": "10.31234/osf.io/93x5h", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h", "source_url": "https://doi.org/10.31234/osf.io/93x5h", "doi": "10.31234/osf.io/93x5h", "pmid": "", "publication_date": "2024-11-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3127, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2024-11-07", "publication_year": 2024, "doi": "10.31234/osf.io/93x5h_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h_v1", "source_url": "https://doi.org/10.31234/osf.io/93x5h_v1", "doi": "10.31234/osf.io/93x5h_v1", "pmid": "", "publication_date": "2024-11-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4524, "title": "Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics", "authors": "Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak", "journal": "Frontiers in Psychiatry", "publication_date": "2024-11-06", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1485337", "pubmed_id": "39568756", "openalex_id": "https://openalex.org/W4404119543", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Neurogenesis,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Emotional Processing,Mystical Experience,Review Article,Observational Study,Animal Study,Healthy Volunteers,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "PMID:39568756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39568756", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "doi": "10.3389/fpsyt.2024.1485337", "pmid": "39568756", "publication_date": "2024-11-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3669, "title": "PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-06", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06258031", "substance_tags": "psilocybin", "topic_tags": "OCD,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Observational Study,Safety,Inflammation", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06258031", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06258031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06258031", "source_url": "https://clinicaltrials.gov/study/NCT06258031", "doi": "", "pmid": "", "publication_date": "2024-11-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3134, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF.", "journal": "PsyArXiv", "publication_date": "2024-11-04", "publication_year": 2024, "doi": "10.31234/osf.io/j8zb5", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/j8zb5", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/j8zb5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/j8zb5", "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "doi": "10.31234/osf.io/j8zb5", "pmid": "", "publication_date": "2024-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 776, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "Jacob S. Aday, Jenna McAfee, Deirdre A. Conroy, Avinash Hosanagar, Vijay Tarnal, Cody Weston, Katharine Scott, Dana Horowitz, Steven E. Harte, Niloufar Pouyan", "journal": "PsyArXiv", "publication_date": "2024-11-04", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "doi": "", "pmid": "", "publication_date": "2024-11-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 977, "title": "Psychoactive substances for the treatment of neuropsychiatric disorders.", "authors": "Zhen Z, Sun X, Yuan S, Zhang J", "journal": "Asian journal of psychiatry", "publication_date": "2024-11-01", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104193", "pubmed_id": "39243659", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39243659/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39243659", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39243659/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39243659", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39243659/", "doi": "10.1016/j.ajp.2024.104193", "pmid": "39243659", "publication_date": "2024-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3136, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "Luoma JB, Wilson-Poe A, Pertl K, Hoffman K, Bazinet A, Stauffer C, McCarty D, Korthuis P.", "journal": "PsyArXiv", "publication_date": "2024-10-31", "publication_year": 2024, "doi": "10.31234/osf.io/dwhcu_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "doi": "10.31234/osf.io/dwhcu_v1", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 551, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "Jason Luoma, Adie Wilson-Poe, Kellie Pertl, Kim Hoffman, Alissa Bazinet, Christopher Stauffer, Dennis McCarty, Philip Korthuis", "journal": "PsyArXiv", "publication_date": "2024-10-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "doi": "", "pmid": "", "publication_date": "2024-10-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3584, "title": "A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study", "authors": "Filament Health Corp.", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-30", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06666010", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06666010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "source_url": "https://clinicaltrials.gov/study/NCT06666010", "doi": "", "pmid": "", "publication_date": "2024-10-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4537, "title": "The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment", "authors": "Hannah Douglass", "journal": "Open MIND", "publication_date": "2024-10-10", "publication_year": 2024, "doi": "10.25560/118978", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166080670", "source_url": "https://hdl.handle.net/10044/1/118978", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Resilience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:26", "bibtex": null, "source_record_id": "DOI:10.25560/118978", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/10044/1/118978", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25560/118978", "source_url": "https://hdl.handle.net/10044/1/118978", "doi": "10.25560/118978", "pmid": "", "publication_date": "2024-10-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3469, "title": "A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06326606", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06326606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "source_url": "https://clinicaltrials.gov/study/NCT06326606", "doi": "", "pmid": "", "publication_date": "2024-10-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4542, "title": "Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis", "authors": "Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar", "journal": "Psychoactives", "publication_date": "2024-10-03", "publication_year": 2024, "doi": "10.3390/psychoactives3040029", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403113128", "source_url": "https://doi.org/10.3390/psychoactives3040029", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Pharmacology,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3040029", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3040029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3040029", "source_url": "https://doi.org/10.3390/psychoactives3040029", "doi": "10.3390/psychoactives3040029", "pmid": "", "publication_date": "2024-10-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1012, "title": "Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.", "authors": "Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Wells HG, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Jones JA, McMurray MS", "journal": "British journal of pharmacology", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1111/bph.16466", "pubmed_id": "38825326", "openalex_id": "https://openalex.org/W4399276098", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38825326/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Biomarkers,Aging,In Vitro Study,Safety", "study_type": "In Vitro Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:38825326", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38825326/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38825326", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38825326/", "doi": "10.1111/bph.16466", "pmid": "38825326", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1011, "title": "Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.", "authors": "Nadeem Z, Parker S, McGovern H, Oestreich LK", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1177/00048674241261779", "pubmed_id": "38907608", "openalex_id": "https://openalex.org/W4399918457", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38907608/", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:38907608", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38907608/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38907608", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38907608/", "doi": "10.1177/00048674241261779", "pmid": "38907608", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1008, "title": "Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.", "authors": "Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A", "journal": "CNS drugs", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1007/s40263-024-01101-3", "pubmed_id": "39033264", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39033264/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39033264", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39033264/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39033264", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39033264/", "doi": "10.1007/s40263-024-01101-3", "pmid": "39033264", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1003, "title": "The role of psilocybin in depressive disorders.", "authors": "Najib J", "journal": "Current medical research and opinion", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1080/03007995.2024.2396536", "pubmed_id": "39177339", "openalex_id": "https://openalex.org/W4401815070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39177339", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39177339", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39177339/", "doi": "10.1080/03007995.2024.2396536", "pmid": "39177339", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 997, "title": "Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.", "authors": "Erritzoe D, Barba T, Greenway KT, Murphy R, Martell J, Giribaldi B, Timmermann C, Murphy-Beiner A, Jones MB, Nutt D, Weiss B, Carhart-Harris R", "journal": "EClinicalMedicine", "publication_date": "2024-10-01", "publication_year": 2024, "doi": "10.1016/j.eclinm.2024.102799", "pubmed_id": "39764567", "openalex_id": "https://openalex.org/W4402747955", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39764567", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39764567", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39764567/", "doi": "10.1016/j.eclinm.2024.102799", "pmid": "39764567", "publication_date": "2024-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1015, "title": "Beyond the numbers: reimagining healing with psychedelics for eating disorders.", "authors": "Lafrance A, Spriggs MJ, Gukasyan N, Peck SK", "journal": "Journal of eating disorders", "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1186/s40337-024-01111-y", "pubmed_id": "39350242", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39350242/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39350242", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39350242/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39350242", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39350242/", "doi": "10.1186/s40337-024-01111-y", "pmid": "39350242", "publication_date": "2024-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3592, "title": "An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder", "authors": "University of California, San Francisco", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-25", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05065294", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05065294", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "source_url": "https://clinicaltrials.gov/study/NCT05065294", "doi": "", "pmid": "", "publication_date": "2024-09-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1018, "title": "Psychedelic research at a crossroads.", "authors": "Armstrong SB, Davis AK", "journal": "Science (New York, N.Y.)", "publication_date": "2024-09-20", "publication_year": 2024, "doi": "10.1126/science.adt1024", "pubmed_id": "39298596", "openalex_id": "https://openalex.org/W4402625697", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39298596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39298596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39298596/", "doi": "10.1126/science.adt1024", "pmid": "39298596", "publication_date": "2024-09-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3528, "title": "Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus", "authors": "University Hospital, Ghent", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06378229", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06378229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "source_url": "https://clinicaltrials.gov/study/NCT06378229", "doi": "", "pmid": "", "publication_date": "2024-09-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3122, "title": "Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distress", "authors": "Mageean S, Daniel A, Tai S.", "journal": "Research Square", "publication_date": "2024-09-18", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4862438/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4862438/v1", "substance_tags": "psilocybin", "topic_tags": "Cancer Patients,Safety,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4862438/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4862438/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4862438/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4862438/v1", "doi": "10.21203/rs.3.rs-4862438/v1", "pmid": "", "publication_date": "2024-09-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1020, "title": "Psychedelics as a potential treatment for tobacco use disorder: a systematic review.", "authors": "Spoelstra SK, Schoevers RA, Venema SD, Knegtering H", "journal": "Discover mental health", "publication_date": "2024-09-17", "publication_year": 2024, "doi": "10.1007/s44192-024-00095-0", "pubmed_id": "39289250", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39289250/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39289250", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39289250/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39289250", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39289250/", "doi": "10.1007/s44192-024-00095-0", "pmid": "39289250", "publication_date": "2024-09-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4551, "title": "Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials", "authors": "Danielle B Rodrigues", "journal": "Journal of Complementary Medicine & Alternative Healthcare", "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.19080/jcmah.2024.13.555852", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408545862", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "doi": "10.19080/jcmah.2024.13.555852", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1025, "title": "Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.", "authors": "Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C", "journal": "The Cochrane database of systematic reviews", "publication_date": "2024-09-12", "publication_year": 2024, "doi": "10.1002/14651858.cd015383.pub2", "pubmed_id": "39260823", "openalex_id": "https://openalex.org/W4402500386", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39260823/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Headache / Migraine,Emotional Processing,Spirituality,Randomized Controlled Trial,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39260823", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39260823/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39260823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39260823/", "doi": "10.1002/14651858.cd015383.pub2", "pmid": "39260823", "publication_date": "2024-09-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4558, "title": "Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine", "authors": "Albert Garcia-Romeu", "journal": "Psychedelic Medicine", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1089/psymed.2024.65789.rfs2023", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402269098", "source_url": "https://doi.org/10.1089/psymed.2024.65789.rfs2023", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Wellbeing,Spirituality,Healthy Volunteers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1089/psymed.2024.65789.rfs2023", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.65789.rfs2023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1089/psymed.2024.65789.rfs2023", "source_url": "https://doi.org/10.1089/psymed.2024.65789.rfs2023", "doi": "10.1089/psymed.2024.65789.rfs2023", "pmid": "", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1037, "title": "Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems.", "authors": "Korthuis PT, Wilson-Poe AR, Black JC, Monte A", "journal": "Addiction (Abingdon, England)", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1111/add.16589", "pubmed_id": "38881433", "openalex_id": "https://openalex.org/W4399750332", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38881433/", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38881433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38881433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38881433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38881433/", "doi": "10.1111/add.16589", "pmid": "38881433", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1036, "title": "Effects of psilocybin on uncertain punishment learning.", "authors": "Jacobs DS, Bogachuk AP, Le Moing CL, Moghaddam B", "journal": "Neurobiology of learning and memory", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1016/j.nlm.2024.107954", "pubmed_id": "38909970", "openalex_id": "https://openalex.org/W4399926705", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38909970/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38909970", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38909970/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38909970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38909970/", "doi": "10.1016/j.nlm.2024.107954", "pmid": "38909970", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1034, "title": "Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.", "authors": "Guo Q, Guo L, Wang Y, Shang S", "journal": "Psychiatry research", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116018", "pubmed_id": "38924903", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38924903/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38924903", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38924903/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38924903", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38924903/", "doi": "10.1016/j.psychres.2024.116018", "pmid": "38924903", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1030, "title": "[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].", "authors": "Jungwirth J, Bavato F, Quednow BB", "journal": "Der Nervenarzt", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1007/s00115-024-01727-0", "pubmed_id": "39196383", "openalex_id": "https://openalex.org/W4401966685", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39196383/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39196383", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39196383/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39196383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39196383/", "doi": "10.1007/s00115-024-01727-0", "pmid": "39196383", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1029, "title": "Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.", "authors": "Federico S, Geo M, Entela M, Bachmann S, Elisa R, Silvio C, Zoë D, Louise P, Gabriel T, Joël B, Daniele Z", "journal": "Clinical case reports", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1002/ccr3.9305", "pubmed_id": "39219779", "openalex_id": "https://openalex.org/W4402098372", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39219779/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Case Report,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39219779", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39219779/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39219779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39219779/", "doi": "10.1002/ccr3.9305", "pmid": "39219779", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1027, "title": "Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.", "authors": "Loizaga-Velder A, Loizaga Pazzi A", "journal": "Journal of studies on alcohol and drugs", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.15288/jsad.23-00011", "pubmed_id": "39400118", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39400118/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Consciousness,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39400118", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39400118/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39400118", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39400118/", "doi": "10.15288/jsad.23-00011", "pmid": "39400118", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1026, "title": "Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.", "authors": "Smith CL, Sackett N, Stark BC, Dinh V, Romesburg EW, Roll J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-09-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0074", "pubmed_id": "40051684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:40051684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "doi": "10.1089/psymed.2023.0074", "pmid": "40051684", "publication_date": "2024-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4560, "title": "G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?", "authors": "Amany E. Ayad", "journal": "Ask the expert - Psychedelic substances", "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1136/rapm-2024-esra.582", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402766768", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:37:59", "bibtex": null, "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "doi": "10.1136/rapm-2024-esra.582", "pmid": "", "publication_date": "2024-08-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3141, "title": "The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting", "authors": "Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T.", "journal": "medRxiv", "publication_date": "2024-08-26", "publication_year": 2024, "doi": "10.1101/2024.08.26.24311611", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,Brain Imaging,Consciousness,Emotional Processing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:04", "bibtex": null, "source_record_id": "DOI:10.1101/2024.08.26.24311611", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.08.26.24311611", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.08.26.24311611", "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "doi": "10.1101/2024.08.26.24311611", "pmid": "", "publication_date": "2024-08-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3075, "title": "­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study", "authors": "Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A.", "journal": "Research Square", "publication_date": "2024-08-23", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4947184/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "doi": "10.21203/rs.3.rs-4947184/v1", "pmid": "", "publication_date": "2024-08-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4565, "title": "Tripping on Utopia: Margaret Mead, the Cold War, and the troubled birth of psychedelic science By BenjaminBreen. New York: Grand Central Publishing, 2024. 384 pp.", "authors": "Jim Weil", "journal": "American Anthropologist", "publication_date": "2024-08-19", "publication_year": 2024, "doi": "10.1111/aman.28009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401690921", "source_url": "http://dx.doi.org/10.1111/aman.28009", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Personality Change,Mystical Experience,Observational Study,Veterans,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1111/aman.28009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1111/aman.28009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/aman.28009", "source_url": "http://dx.doi.org/10.1111/aman.28009", "doi": "10.1111/aman.28009", "pmid": "", "publication_date": "2024-08-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4567, "title": "Psychedelic use and psychological flexibility: The role of meaningful intention and decentering", "authors": "William M. Campo, Ann Marie Yali", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-08-16", "publication_year": 2024, "doi": "10.1556/2054.2024.00350", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401710092", "source_url": "https://doi.org/10.1556/2054.2024.00350", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Wellbeing,Mystical Experience,Psychological Flexibility,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:27", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00350", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00350", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00350", "source_url": "https://doi.org/10.1556/2054.2024.00350", "doi": "10.1556/2054.2024.00350", "pmid": "", "publication_date": "2024-08-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3428, "title": "A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)", "authors": "Clairvoyant Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-15", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05646303", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05646303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "source_url": "https://clinicaltrials.gov/study/NCT05646303", "doi": "", "pmid": "", "publication_date": "2024-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3609, "title": "An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433858", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "source_url": "https://clinicaltrials.gov/study/NCT04433858", "doi": "", "pmid": "", "publication_date": "2024-08-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3438, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms", "authors": "Brugmann University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-07", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06160232", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06160232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "source_url": "https://clinicaltrials.gov/study/NCT06160232", "doi": "", "pmid": "", "publication_date": "2024-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1069, "title": "The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.", "authors": "Kaminski D, Reinert JP", "journal": "The Annals of pharmacotherapy", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1177/10600280231205645", "pubmed_id": "37902038", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37902038/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:37902038", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37902038/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37902038", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37902038/", "doi": "10.1177/10600280231205645", "pmid": "37902038", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1067, "title": "Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.", "authors": "Sakai K, Bradley ER, Zamaria JA, Agin-Liebes G, Kelley DP, Fish A, Martini V, Ferris MC, Morton E, Michalak EE, O'Donovan A, Woolley JD", "journal": "Psychopharmacology", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1007/s00213-024-06585-x", "pubmed_id": "38687360", "openalex_id": "https://openalex.org/W4396518351", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38687360/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Safety,Toxicity,Drug Interactions", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38687360", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38687360/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38687360", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38687360/", "doi": "10.1007/s00213-024-06585-x", "pmid": "38687360", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1065, "title": "Psychedelic-assisted psychotherapy: where is the psychotherapy research?", "authors": "Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD", "journal": "Psychopharmacology", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1007/s00213-024-06620-x", "pubmed_id": "38782821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38782821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38782821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "doi": "10.1007/s00213-024-06620-x", "pmid": "38782821", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1064, "title": "Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.", "authors": "Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD", "journal": "Journal of psychiatric research", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.05.051", "pubmed_id": "38850581", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38850581", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38850581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38850581/", "doi": "10.1016/j.jpsychires.2024.05.051", "pmid": "38850581", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1063, "title": "Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.", "authors": "Polito V, Liknaitzky P", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1177/02698811241254831", "pubmed_id": "38877715", "openalex_id": "https://openalex.org/W4399706347", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38877715/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38877715", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38877715/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38877715", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38877715/", "doi": "10.1177/02698811241254831", "pmid": "38877715", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1062, "title": "The cyclical revival of psychedelics in psychiatric treatment.", "authors": "Appiani FJ, Caroff SN", "journal": "Current medical research and opinion", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1080/03007995.2024.2368725", "pubmed_id": "38880945", "openalex_id": "https://openalex.org/W4399756902", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38880945", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38880945", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38880945/", "doi": "10.1080/03007995.2024.2368725", "pmid": "38880945", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1061, "title": "Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.", "authors": "Korthuis PT, Hoffman K, Wilson-Poe AR, Luoma JB, Bazinet A, Pertl K, Morgan DL, Cook RR, Bielavitz S, Myers R, Wolf RC, McCarty D, Stauffer CS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1177/02698811241257839", "pubmed_id": "38888164", "openalex_id": "https://openalex.org/W4399780176", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:38888164", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38888164", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38888164/", "doi": "10.1177/02698811241257839", "pmid": "38888164", "publication_date": "2024-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4586, "title": "Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports", "authors": "Liam Engel, Sascha Thal, Stephen Bright, Mitchell Low", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-07-17", "publication_year": 2024, "doi": "10.1556/2054.2024.00377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400732567", "source_url": "https://doi.org/10.1556/2054.2024.00377", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00377", "source_url": "https://doi.org/10.1556/2054.2024.00377", "doi": "10.1556/2054.2024.00377", "pmid": "", "publication_date": "2024-07-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3638, "title": "Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study", "authors": "Anders Fink-Jensen, MD, DMSci", "journal": "ClinicalTrials.gov", "publication_date": "2024-07-12", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04718792", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04718792", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04718792", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04718792", "source_url": "https://clinicaltrials.gov/study/NCT04718792", "doi": "", "pmid": "", "publication_date": "2024-07-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3132, "title": "Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions", "authors": "Nogueira M, García-Hernández S, Roberto GS, Marques LZ.", "journal": "medRxiv", "publication_date": "2024-07-12", "publication_year": 2024, "doi": "10.1101/2024.07.11.24310147", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.07.11.24310147", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Adverse Events", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:02", "bibtex": null, "source_record_id": "DOI:10.1101/2024.07.11.24310147", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.07.11.24310147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.07.11.24310147", "source_url": "https://doi.org/10.1101/2024.07.11.24310147", "doi": "10.1101/2024.07.11.24310147", "pmid": "", "publication_date": "2024-07-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1078, "title": "[Psilocybin fungi microdose treatment in major depressive disorder: a case report].", "authors": "Zarankin M, Pellegrini MS, Zenteno F", "journal": "Vertex (Buenos Aires, Argentina)", "publication_date": "2024-07-10", "publication_year": 2024, "doi": "10.53680/vertex.v35i164.544", "pubmed_id": "39024488", "openalex_id": "https://openalex.org/W4400492401", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39024488/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Emotional Processing,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39024488", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39024488/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39024488", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39024488/", "doi": "10.53680/vertex.v35i164.544", "pmid": "39024488", "publication_date": "2024-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1079, "title": "The Black Book of Psychotropic Dosing and Monitoring.", "authors": "DeBattista C, Schatzberg AF", "journal": "Psychopharmacology bulletin", "publication_date": "2024-07-08", "publication_year": 2024, "doi": "10.64719/pb.4493", "pubmed_id": "38993656", "openalex_id": "https://openalex.org/W2983072139", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38993656", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38993656", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38993656/", "doi": "10.64719/pb.4493", "pmid": "38993656", "publication_date": "2024-07-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2993, "title": "Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study.", "authors": "Peck SK, Shao S, Gruen T, Yang K, Babakanian A, Trim J, Finn DM, Kaye WH", "journal": "Focus (American Psychiatric Publishing)", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1176/appi.focus.24022013", "pubmed_id": "38988455", "openalex_id": "https://openalex.org/W4400572892", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38988455/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38988455", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38988455/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38988455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38988455/", "doi": "10.1176/appi.focus.24022013", "pmid": "38988455", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1091, "title": "Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.", "authors": "Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X", "journal": "Psychiatry research", "publication_date": "2024-07-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115960", "pubmed_id": "38781672", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38781672/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38781672", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38781672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38781672/", "doi": "10.1016/j.psychres.2024.115960", "pmid": "38781672", "publication_date": "2024-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4601, "title": "IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?", "authors": "Nauman Ashraf", "journal": "Journal of Pakistan Psychiatric Society", "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.63050/jpps.21.02.935", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400219530", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Spirituality,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:28", "bibtex": null, "source_record_id": "DOI:10.63050/jpps.21.02.935", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.63050/jpps.21.02.935", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "doi": "10.63050/jpps.21.02.935", "pmid": "", "publication_date": "2024-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3184, "title": "Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials", "authors": "Fluyau D, Kailasam VK, Revadigar N.", "journal": "medRxiv", "publication_date": "2024-06-20", "publication_year": 2024, "doi": "10.1101/2024.06.17.24308787", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:08", "bibtex": null, "source_record_id": "DOI:10.1101/2024.06.17.24308787", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.06.17.24308787", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.06.17.24308787", "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "doi": "10.1101/2024.06.17.24308787", "pmid": "", "publication_date": "2024-06-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4605, "title": "Psychedelics’ Use as Medicine Hits Significant Roadblock", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2024-06-12", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.07.7.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399577191", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "doi": "10.1176/appi.pn.2024.07.7.54", "pmid": "", "publication_date": "2024-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3791, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK.", "journal": "PsyArXiv", "publication_date": "2024-06-10", "publication_year": 2024, "doi": "10.31234/osf.io/adnpg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/adnpg", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/adnpg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/adnpg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/adnpg", "source_url": "https://doi.org/10.31234/osf.io/adnpg", "doi": "10.31234/osf.io/adnpg", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3445, "title": "A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "University of Sydney", "journal": "ClinicalTrials.gov", "publication_date": "2024-06-10", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06444243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06444243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "source_url": "https://clinicaltrials.gov/study/NCT06444243", "doi": "", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3355, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "Dan Petrovitch, Sean M. Mitchell, Jason Van Allen, Andrew K. Littlefield", "journal": "PsyArXiv", "publication_date": "2024-06-10", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "doi": "", "pmid": "", "publication_date": "2024-06-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3341, "title": "Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA", "authors": "Calder A, Hasler G.", "journal": "PsyArXiv", "publication_date": "2024-06-07", "publication_year": 2024, "doi": "10.31234/osf.io/um2cy", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/um2cy", "substance_tags": "psilocybin", "topic_tags": "Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:26", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/um2cy", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/um2cy", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/um2cy", "source_url": "https://doi.org/10.31234/osf.io/um2cy", "doi": "10.31234/osf.io/um2cy", "pmid": "", "publication_date": "2024-06-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 956, "title": "Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA", "authors": "Abigail Calder, Gregor Hasler", "journal": "PsyArXiv", "publication_date": "2024-06-07", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/um2cy_v1", "substance_tags": "psilocybin", "topic_tags": "Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/um2cy_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/um2cy_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/um2cy_v1", "source_url": "https://osf.io/preprints/psyarxiv/um2cy_v1", "doi": "", "pmid": "", "publication_date": "2024-06-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4614, "title": "Therapeutic Implications of Psilocybin in the Wake of Decriminalization", "authors": "Nikola Lash, George Tadros, Eman Tadros", "journal": "Integrative and Complementary Therapies", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1089/ict.2024.27206.nl", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399645755", "source_url": "http://dx.doi.org/10.1089/ict.2024.27206.nl", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1089/ict.2024.27206.nl", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1089/ict.2024.27206.nl", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1089/ict.2024.27206.nl", "source_url": "http://dx.doi.org/10.1089/ict.2024.27206.nl", "doi": "10.1089/ict.2024.27206.nl", "pmid": "", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3724, "title": "Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.", "authors": "Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S", "journal": "Pharmacology & therapeutics", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1016/j.pharmthera.2024.108641", "pubmed_id": "38583670", "openalex_id": "https://openalex.org/W4394009974", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38583670/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Review Article,Animal Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38583670", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38583670/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38583670", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38583670/", "doi": "10.1016/j.pharmthera.2024.108641", "pmid": "38583670", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1124, "title": "Psilocybin in Bipolar II Study Provides Preliminary Data on Safety.", "authors": "Yaden DB, Gukasyan N, Nayak SM", "journal": "JAMA psychiatry", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2023.4680", "pubmed_id": "38055240", "openalex_id": "https://openalex.org/W4389397300", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38055240/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38055240", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38055240/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38055240", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38055240/", "doi": "10.1001/jamapsychiatry.2023.4680", "pmid": "38055240", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1123, "title": "Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.", "authors": "Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T", "journal": "JAMA psychiatry", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2023.4685", "pubmed_id": "38055270", "openalex_id": "https://openalex.org/W4389397550", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38055270/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38055270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38055270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38055270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38055270/", "doi": "10.1001/jamapsychiatry.2023.4685", "pmid": "38055270", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1120, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.", "authors": "Fried EI, Cristea IA, Naudet F", "journal": "JAMA psychiatry", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0420", "pubmed_id": "38598200", "openalex_id": "https://openalex.org/W4394676727", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598200/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38598200", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38598200/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38598200", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598200/", "doi": "10.1001/jamapsychiatry.2024.0420", "pmid": "38598200", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1119, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.", "authors": "Aaronson ST, van der Vaart A, Sackeim HA", "journal": "JAMA psychiatry", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0423", "pubmed_id": "38598225", "openalex_id": "https://openalex.org/W4394687929", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598225/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38598225", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38598225", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598225/", "doi": "10.1001/jamapsychiatry.2024.0423", "pmid": "38598225", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1114, "title": "Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.", "authors": "Chopra H, Furnish T, Verduzco-Gutierrez M, Jevotovsky DS, Castellanos J", "journal": "Clinical case reports", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1002/ccr3.8791", "pubmed_id": "38813452", "openalex_id": "https://openalex.org/W4399135187", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38813452/", "substance_tags": "psilocybin", "topic_tags": "Case Report,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38813452", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38813452/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38813452", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38813452/", "doi": "10.1002/ccr3.8791", "pmid": "38813452", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1106, "title": "A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?", "authors": "Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0051", "pubmed_id": "40051581", "openalex_id": "https://openalex.org/W4392242849", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051581/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:40051581", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051581/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051581/", "doi": "10.1089/psymed.2023.0051", "pmid": "40051581", "publication_date": "2024-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1127, "title": "Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.", "authors": "Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM", "journal": "Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology", "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.9758/cpn.23.1134", "pubmed_id": "38627070", "openalex_id": "https://openalex.org/W4389203746", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Default Mode Network,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38627070", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38627070", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38627070/", "doi": "10.9758/cpn.23.1134", "pmid": "38627070", "publication_date": "2024-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1132, "title": "Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.", "authors": "Bhagavan C, Glue P, Evans W, Reynolds L, Turner T, King C, Russell BR, Morunga E, Mills JL, Layton G, Menkes DB", "journal": "Trials", "publication_date": "2024-05-21", "publication_year": 2024, "doi": "10.1186/s13063-024-08174-x", "pubmed_id": "38773523", "openalex_id": "https://openalex.org/W4398156539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Wellbeing,Personality Change,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38773523", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38773523", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38773523/", "doi": "10.1186/s13063-024-08174-x", "pmid": "38773523", "publication_date": "2024-05-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4623, "title": "Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens", "authors": "Shunichiro Ikeda, Toshihiko Kinoshita", "journal": "Psychiatry and Clinical Neurosciences Reports", "publication_date": "2024-05-16", "publication_year": 2024, "doi": "10.1002/pcn5.196", "pubmed_id": null, "openalex_id": "https://openalex.org/W4397013596", "source_url": "https://doi.org/10.1002/pcn5.196", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1002/pcn5.196", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pcn5.196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pcn5.196", "source_url": "https://doi.org/10.1002/pcn5.196", "doi": "10.1002/pcn5.196", "pmid": "", "publication_date": "2024-05-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4624, "title": "Psilocybin as a new way for depression treatment", "authors": "Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska", "journal": "Journal of Education Health and Sport", "publication_date": "2024-05-15", "publication_year": 2024, "doi": "10.12775/jehs.2024.68.50168", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396937684", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "doi": "10.12775/jehs.2024.68.50168", "pmid": "", "publication_date": "2024-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1134, "title": "Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.", "authors": "Schindler EAD, Sewell RA, Gottschalk CH, Flynn LT, Zhu Y, Pittman BP, Cozzi NV, D'Souza DC", "journal": "Journal of the neurological sciences", "publication_date": "2024-05-15", "publication_year": 2024, "doi": "10.1016/j.jns.2024.122993", "pubmed_id": "38581739", "openalex_id": "https://openalex.org/W4393489617", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38581739/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38581739", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38581739/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38581739", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38581739/", "doi": "10.1016/j.jns.2024.122993", "pmid": "38581739", "publication_date": "2024-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3350, "title": "Psychedelics Use and the Risk of Reduced Formal Mental Health Care", "authors": "Viña S.", "journal": "Research Square", "publication_date": "2024-05-13", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4378944/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4378944/v1", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety,Drug Interactions", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:26", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4378944/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4378944/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4378944/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4378944/v1", "doi": "10.21203/rs.3.rs-4378944/v1", "pmid": "", "publication_date": "2024-05-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4628, "title": "Calls to Poison Centers Involving Psilocybin Rising in Youth", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-05-10", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.06.6.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396797833", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "doi": "10.1176/appi.pn.2024.06.6.2", "pmid": "", "publication_date": "2024-05-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4633, "title": "From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine", "authors": "Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie", "journal": "European Journal of Arts Humanities and Social Sciences", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.59324/ejahss.2024.1(3).10", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399259513", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:29", "bibtex": null, "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "doi": "10.59324/ejahss.2024.1(3).10", "pmid": "", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1154, "title": "Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.", "authors": "Holze F, Singh N, Liechti ME, D'Souza DC", "journal": "Biological psychiatry. Cognitive neuroscience and neuroimaging", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1016/j.bpsc.2024.01.007", "pubmed_id": "38301886", "openalex_id": "https://openalex.org/W4391451404", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38301886/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38301886", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38301886/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38301886", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38301886/", "doi": "10.1016/j.bpsc.2024.01.007", "pmid": "38301886", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1148, "title": "Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.", "authors": "Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1177/02698811241237870", "pubmed_id": "38520045", "openalex_id": "https://openalex.org/W4393118291", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38520045", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38520045", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38520045/", "doi": "10.1177/02698811241237870", "pmid": "38520045", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1147, "title": "Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.", "authors": "Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y", "journal": "Psychiatry research", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115886", "pubmed_id": "38574699", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38574699/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Headache / Migraine,Personality Change,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38574699", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38574699/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38574699", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38574699/", "doi": "10.1016/j.psychres.2024.115886", "pmid": "38574699", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1146, "title": "Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.", "authors": "Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A", "journal": "Psychiatry research", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115880", "pubmed_id": "38579460", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38579460/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38579460", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38579460/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38579460", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38579460/", "doi": "10.1016/j.psychres.2024.115880", "pmid": "38579460", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1142, "title": "Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "Metaxa AM, Clarke M", "journal": "BMJ (Clinical research ed.)", "publication_date": "2024-05-01", "publication_year": 2024, "doi": "10.1136/bmj-2023-078084", "pubmed_id": "38692686", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38692686", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38692686", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38692686/", "doi": "10.1136/bmj-2023-078084", "pmid": "38692686", "publication_date": "2024-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3362, "title": "Do undergraduates’ views of psychedelics relate to the context for psychedelic use?", "authors": "Petrovitch D, Van Allen J, Mitchell SM, Littlefield AK.", "journal": "PsyArXiv", "publication_date": "2024-04-24", "publication_year": 2024, "doi": "10.31234/osf.io/xnu5c", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/xnu5c", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/xnu5c", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/xnu5c", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/xnu5c", "source_url": "https://doi.org/10.31234/osf.io/xnu5c", "doi": "10.31234/osf.io/xnu5c", "pmid": "", "publication_date": "2024-04-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1162, "title": "Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.", "authors": "Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M", "journal": "Journal of eating disorders", "publication_date": "2024-04-24", "publication_year": 2024, "doi": "10.1186/s40337-024-01005-z", "pubmed_id": "38659049", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38659049/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38659049", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38659049/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38659049", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38659049/", "doi": "10.1186/s40337-024-01005-z", "pmid": "38659049", "publication_date": "2024-04-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 527, "title": "Do undergraduates’ views of psychedelics relate to the context for psychedelic use?", "authors": "Dan Petrovitch, Jason Van Allen, Sean M. Mitchell, Andrew K. Littlefield", "journal": "PsyArXiv", "publication_date": "2024-04-24", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "source_url": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "doi": "", "pmid": "", "publication_date": "2024-04-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4638, "title": "MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-04-23", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.05.5.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4395032120", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "doi": "10.1176/appi.pn.2024.05.5.1", "pmid": "", "publication_date": "2024-04-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3434, "title": "The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2024-04-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04630964", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04630964", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "source_url": "https://clinicaltrials.gov/study/NCT04630964", "doi": "", "pmid": "", "publication_date": "2024-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4639, "title": "Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression", "authors": "Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden", "journal": "Psychoactives", "publication_date": "2024-04-15", "publication_year": 2024, "doi": "10.3390/psychoactives3020014", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394855468", "source_url": "https://doi.org/10.3390/psychoactives3020014", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 06:34:43", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3020014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3020014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3020014", "source_url": "https://doi.org/10.3390/psychoactives3020014", "doi": "10.3390/psychoactives3020014", "pmid": "", "publication_date": "2024-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4644, "title": "A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions", "authors": "M. Nordin, Jón Ingi Hlynsson, Jakob Håkansson Eklund, Per Carlbring", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-04-02", "publication_year": 2024, "doi": "10.1556/2054.2024.00337", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393547236", "source_url": "https://doi.org/10.1556/2054.2024.00337", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00337", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00337", "source_url": "https://doi.org/10.1556/2054.2024.00337", "doi": "10.1556/2054.2024.00337", "pmid": "", "publication_date": "2024-04-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4658, "title": "Current situation regarding psychedelics and magic mushroom in Korea", "authors": "J. S. Seo", "journal": "European Psychiatry", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.1695", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401921810", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "doi": "10.1192/j.eurpsy.2024.1695", "pmid": "", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1183, "title": "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.", "authors": "Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders JJ, Ljuslin M, Guérin B, Thambi P, Tulsky JA, Agrawal M", "journal": "Cancer", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1002/cncr.35024", "pubmed_id": "38105653", "openalex_id": "https://openalex.org/W4389895437", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Cancer Patients,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38105653", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38105653", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105653/", "doi": "10.1002/cncr.35024", "pmid": "38105653", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1181, "title": "Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.", "authors": "Agrawal M, Richards W, Beaussant Y, Shnayder S, Ameli R, Roddy K, Stevens N, Richards B, Schor N, Honstein H, Jenkins B, Bates M, Thambi P", "journal": "Cancer", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1002/cncr.35010", "pubmed_id": "38105655", "openalex_id": "https://openalex.org/W4389900078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38105655", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38105655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38105655/", "doi": "10.1002/cncr.35010", "pmid": "38105655", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1176, "title": "Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.", "authors": "Sinha JK, Trisal A, Ghosh S, Gupta S, Singh KK, Han SS, Mahapatra M, Abomughaid MM, Abomughayedh AM, Almutary AG, Iqbal D, Bhaskar R, Mishra PC, Jha SK, Jha NK, Singh AK", "journal": "Ageing research reviews", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1016/j.arr.2024.102211", "pubmed_id": "38307424", "openalex_id": "https://openalex.org/W4391451768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38307424/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Spirituality,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38307424", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38307424/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38307424", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38307424/", "doi": "10.1016/j.arr.2024.102211", "pmid": "38307424", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1172, "title": "Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.", "authors": "Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J", "journal": "JAMA network open", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.5960", "pubmed_id": "38598236", "openalex_id": "https://openalex.org/W4394693583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38598236", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38598236", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38598236/", "doi": "10.1001/jamanetworkopen.2024.5960", "pmid": "38598236", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1170, "title": "The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.", "authors": "Wilkes R, Roberts DM, Liknaitzky P, Brett J", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1080/15563650.2024.2346612", "pubmed_id": "38753585", "openalex_id": "https://openalex.org/W4396977515", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38753585/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38753585", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38753585/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38753585", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38753585/", "doi": "10.1080/15563650.2024.2346612", "pmid": "38753585", "publication_date": "2024-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4660, "title": "MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-03-26", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393210403", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Pharmacology,Clinical Trial,Review Article,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "doi": "10.1176/appi.pn.2024.04.4.1", "pmid": "", "publication_date": "2024-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4663, "title": "Psychedelic Renaissance: Evidence and Culture", "authors": "Adrian Preda", "journal": "Psychiatric News", "publication_date": "2024-03-21", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.39", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393030764", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Emotional Processing,Spirituality,Clinical Trial,Animal Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "doi": "10.1176/appi.pn.2024.04.4.39", "pmid": "", "publication_date": "2024-03-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3697, "title": "A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer", "authors": "University of Utah", "journal": "ClinicalTrials.gov", "publication_date": "2024-03-20", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04522804", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04522804", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04522804", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04522804", "source_url": "https://clinicaltrials.gov/study/NCT04522804", "doi": "", "pmid": "", "publication_date": "2024-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1194, "title": "Ethical considerations for psychedelic-assisted therapy in military clinical settings.", "authors": "Hoener S, Wolfgang A, Nissan D, Howe E", "journal": "Journal of medical ethics", "publication_date": "2024-03-20", "publication_year": 2024, "doi": "10.1136/jme-2023-108943", "pubmed_id": "37253556", "openalex_id": "https://openalex.org/W4378782490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:37253556", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37253556", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37253556/", "doi": "10.1136/jme-2023-108943", "pmid": "37253556", "publication_date": "2024-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4664, "title": "Psychedelic drugs and the law: What’s next?", "authors": "Ben Seal", "journal": "Knowable Magazine", "publication_date": "2024-03-14", "publication_year": 2024, "doi": "10.1146/knowable-031424-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392794286", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-08-09 08:25:30", "bibtex": null, "source_record_id": "DOI:10.1146/knowable-031424-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1146/knowable-031424-2", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "doi": "10.1146/knowable-031424-2", "pmid": "", "publication_date": "2024-03-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1204, "title": "Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.", "authors": "Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A, Ali S, Bawks J, Blainey MG, Brietzke E, Cronin V, Danilewitz J, Dhawan S, Di Fonzo A, Di Fonzo M, Drzadzewski P, Dunlop W, Fiszter H, Gomes FA, Grewal S, Leon-Carlyle M, McCallum M, Mofidi N, Offman H, Riva-Cambrin J, Schmidt J, Smolkin M, Quinn JM, Zumrova A, Marlborough M, McIntyre RS", "journal": "Med (New York, N.Y.)", "publication_date": "2024-03-08", "publication_year": 2024, "doi": "10.1016/j.medj.2024.01.005", "pubmed_id": "38359838", "openalex_id": "https://openalex.org/W4391810199", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Personality Change,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38359838", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38359838", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38359838/", "doi": "10.1016/j.medj.2024.01.005", "pmid": "38359838", "publication_date": "2024-03-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1214, "title": "Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.", "authors": "Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1016/j.euroneuro.2023.12.006", "pubmed_id": "38141403", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38141403/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38141403", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38141403/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38141403", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38141403/", "doi": "10.1016/j.euroneuro.2023.12.006", "pmid": "38141403", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1212, "title": "Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.", "authors": "Rouaud A, Calder AE, Hasler G", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1177/02698811231225609", "pubmed_id": "38214279", "openalex_id": "https://openalex.org/W4390790998", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38214279/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Microdosing,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38214279", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38214279/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38214279", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38214279/", "doi": "10.1177/02698811231225609", "pmid": "38214279", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1211, "title": "Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry", "authors": "Wood Madeleine E, Brown Glenna J, Karschner Erin L, Seither Joshua Z, Brown Jordan T, Knittel Jessica L, Walterscheid Jeffrey P", "journal": "Journal of Analytical Toxicology", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1093/jat/bkae002", "pubmed_id": "38287693", "openalex_id": "https://openalex.org/W4391462932", "source_url": "https://doi.org/10.1093/jat/bkae002", "substance_tags": "psilocin", "topic_tags": "Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:49", "bibtex": null, "source_record_id": "PMID:38287693", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1093/jat/bkae002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "PMID:38287693", "source_url": "https://doi.org/10.1093/jat/bkae002", "doi": "10.1093/jat/bkae002", "pmid": "38287693", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1201, "title": "American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.", "authors": "Barnett BS, Arakelian M, Beebe D, Ontko J, Riegal C, Siu WO, Weleff J, Pope HG", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-03-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0036", "pubmed_id": "40051760", "openalex_id": "https://openalex.org/W4386824127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40051760", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051760", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051760/", "doi": "10.1089/psymed.2023.0036", "pmid": "40051760", "publication_date": "2024-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1218, "title": "Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.", "authors": "Watford T, Masood N", "journal": "Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.9758/cpn.23.1120", "pubmed_id": "38247407", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247407/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38247407", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38247407/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38247407", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38247407/", "doi": "10.9758/cpn.23.1120", "pmid": "38247407", "publication_date": "2024-02-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1221, "title": "Development of a digital intervention for psychedelic preparation (DIPP).", "authors": "McAlpine RG, Sacchet MD, Simonsson O, Khan M, Krajnovic K, Morometescu L, Kamboj SK", "journal": "Scientific reports", "publication_date": "2024-02-19", "publication_year": 2024, "doi": "10.1038/s41598-024-54642-4", "pubmed_id": "38374177", "openalex_id": "https://openalex.org/W4391926727", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38374177/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38374177", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38374177/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38374177", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38374177/", "doi": "10.1038/s41598-024-54642-4", "pmid": "38374177", "publication_date": "2024-02-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1228, "title": "The Effects of Psychedelics on Neuronal Physiology.", "authors": "Hatzipantelis CJ, Olson DE", "journal": "Annual review of physiology", "publication_date": "2024-02-12", "publication_year": 2024, "doi": "10.1146/annurev-physiol-042022-020923", "pubmed_id": "37931171", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37931171/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37931171", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37931171/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37931171", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37931171/", "doi": "10.1146/annurev-physiol-042022-020923", "pmid": "37931171", "publication_date": "2024-02-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1235, "title": "Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.", "authors": "Breeksema JJ, Niemeijer A, Krediet E, Karsten T, Kamphuis J, Vermetten E, van den Brink W, Schoevers R", "journal": "Scientific reports", "publication_date": "2024-02-05", "publication_year": 2024, "doi": "10.1038/s41598-024-53188-9", "pubmed_id": "38316896", "openalex_id": "https://openalex.org/W4391540455", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38316896", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38316896", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38316896/", "doi": "10.1038/s41598-024-53188-9", "pmid": "38316896", "publication_date": "2024-02-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1247, "title": "The development of psilocybin therapy for treatment-resistant depression: an update.", "authors": "Borissova A, Rucker JJ", "journal": "BJPsych bulletin", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1192/bjb.2023.25", "pubmed_id": "37357767", "openalex_id": "https://openalex.org/W4382010877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37357767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37357767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37357767/", "doi": "10.1192/bjb.2023.25", "pmid": "37357767", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1246, "title": "The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.", "authors": "Videira NB, Nair V, Paquet V, Calhoun D", "journal": "Journal of applied toxicology: JAT", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1002/jat.4533", "pubmed_id": "37646119", "openalex_id": "https://openalex.org/W4386272089", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:37646119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37646119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37646119/", "doi": "10.1002/jat.4533", "pmid": "37646119", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1245, "title": "The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.", "authors": "Sicignano D, Hernandez AV, Schiff B, Elmahy N, White CM", "journal": "Current medical research and opinion", "publication_date": "2024-02-01", "publication_year": 2024, "doi": "10.1080/03007995.2023.2296968", "pubmed_id": "38111216", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38111216/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38111216", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38111216/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38111216", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38111216/", "doi": "10.1080/03007995.2023.2296968", "pmid": "38111216", "publication_date": "2024-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4681, "title": "Psilocybin-assisted psychotherapy for cancer patients", "authors": "Houman Farzin", "journal": "International Journal of Whole Person Care", "publication_date": "2024-01-29", "publication_year": 2024, "doi": "10.26443/ijwpc.v11i1.390", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391329406", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Spirituality,Clinical Trial,Case Report,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "doi": "10.26443/ijwpc.v11i1.390", "pmid": "", "publication_date": "2024-01-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4685, "title": "Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists", "authors": "Payal Ghosh, Debjeet Sur", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2024-01-21", "publication_year": 2024, "doi": "10.2174/0126660822258502231120074036", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391067287", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "DOI:10.2174/0126660822258502231120074036", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0126660822258502231120074036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0126660822258502231120074036", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "doi": "10.2174/0126660822258502231120074036", "pmid": "", "publication_date": "2024-01-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1254, "title": "Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.", "authors": "Lo DF, Zia H, Rajkumar P, Thakur A, O'Donnell H", "journal": "The primary care companion for CNS disorders", "publication_date": "2024-01-16", "publication_year": 2024, "doi": "10.4088/pcc.23r03581", "pubmed_id": "38228068", "openalex_id": "https://openalex.org/W4390802651", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38228068/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Microdosing,Wellbeing,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38228068", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38228068/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38228068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38228068/", "doi": "10.4088/pcc.23r03581", "pmid": "38228068", "publication_date": "2024-01-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4687, "title": "Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma", "authors": "Kelsey Klute, Lou Lukas, Soonjo Hwang, Yeongjin Gwon, Mridula Krishnan, Jean L. Grem, Sunil R. Hingorani, Jody Koenig Kellas", "journal": "Cancer Research", "publication_date": "2024-01-15", "publication_year": 2024, "doi": "10.1158/1538-7445.panca2023-c001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390915346", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Brain Imaging,Cancer Patients,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "doi": "10.1158/1538-7445.panca2023-c001", "pmid": "", "publication_date": "2024-01-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5807, "title": "How should psychotherapy proceed when adjoined with psychedelics?", "authors": "Marc J. Weintraub, David J. Miklowitz", "journal": "World Psychiatry", "publication_date": "2024-01-12", "publication_year": 2024, "doi": "10.1002/wps.21170", "pubmed_id": "38214635", "openalex_id": "https://openalex.org/W4390795044", "source_url": "https://doi.org/10.1002/wps.21170", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Consciousness,Emotional Processing,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:31", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "PMID:38214635", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.21170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38214635", "source_url": "https://doi.org/10.1002/wps.21170", "doi": "10.1002/wps.21170", "pmid": "38214635", "publication_date": "2024-01-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3623, "title": "Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2024-01-05", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05562973", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05562973", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "source_url": "https://clinicaltrials.gov/study/NCT05562973", "doi": "", "pmid": "", "publication_date": "2024-01-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3066, "title": "Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review", "authors": "Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E.", "journal": "bioRxiv", "publication_date": "2024-01-05", "publication_year": 2024, "doi": "10.1101/2024.01.04.574146", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.01.04.574146", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:55", "bibtex": null, "source_record_id": "DOI:10.1101/2024.01.04.574146", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.01.04.574146", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.01.04.574146", "source_url": "https://doi.org/10.1101/2024.01.04.574146", "doi": "10.1101/2024.01.04.574146", "pmid": "", "publication_date": "2024-01-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3174, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial", "authors": "Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X.", "journal": "Research Square", "publication_date": "2024-01-04", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3829237/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "doi": "10.21203/rs.3.rs-3829237/v1", "pmid": "", "publication_date": "2024-01-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5809, "title": "Perceptions of Psychedelics: University Students' Attitudes and Motives for Psilocybin Use", "authors": "Shayla Frinton", "journal": "UVic's Research and Learning Repository", "publication_date": "2024-01-01", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7197325687", "source_url": "https://hdl.handle.net/1828/16134", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Microdosing,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:32", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://hdl.handle.net/1828/16134", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/1828/16134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://hdl.handle.net/1828/16134", "source_url": "https://hdl.handle.net/1828/16134", "doi": "", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5808, "title": "Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary", "authors": "Michael D. Alpert, Kelley C. O’Donnell, Casey A. Paleos, Evan Sola, Christopher S. Stauffer, Anne Catherine Wagner, Christopher R. Nicholas, Michael C. Mithoefer", "journal": "American Journal of Psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230665", "pubmed_id": "38161307", "openalex_id": "https://openalex.org/W4390485036", "source_url": "https://doi.org/10.1176/appi.ajp.20230665", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:31", "last_checked": "2026-08-09 08:25:31", "bibtex": null, "source_record_id": "PMID:38161307", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230665", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38161307", "source_url": "https://doi.org/10.1176/appi.ajp.20230665", "doi": "10.1176/appi.ajp.20230665", "pmid": "38161307", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4722, "title": "Psilocybin’s Role in Major Depressive Disorder: A Scoping Review", "authors": "Barajas, Carlos", "journal": "Digital Commons - George Fox University (George Fox University)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110533292", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Consciousness,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "doi": "", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4698, "title": "Introduction to the Special Section on Psychedelics Research and Treatment", "authors": "Dominic Sisti", "journal": "Perspectives in biology and medicine", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1353/pbm.2024.a919714", "pubmed_id": "38662067", "openalex_id": "https://openalex.org/W4391959887", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Spirituality,Mystical Experience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "PMID:38662067", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38662067", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "doi": "10.1353/pbm.2024.a919714", "pmid": "38662067", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4697, "title": "Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders", "authors": "Correa RMS", "journal": "Annals of Bioethics & Clinical Applications", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.23880/abca-16000266", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391147144", "source_url": "https://doi.org/10.23880/abca-16000266", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.23880/abca-16000266", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.23880/abca-16000266", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.23880/abca-16000266", "source_url": "https://doi.org/10.23880/abca-16000266", "doi": "10.23880/abca-16000266", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4695, "title": "Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?", "authors": "Rakesh Khanna", "journal": "Journal of Indira Gandhi Institute Of Medical Sciences", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.4103/jigims.jigims_60_23", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392948774", "source_url": "https://doi.org/10.4103/jigims.jigims_60_23", "substance_tags": "psilocybin", "topic_tags": "PTSD,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.4103/jigims.jigims_60_23", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/jigims.jigims_60_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4103/jigims.jigims_60_23", "source_url": "https://doi.org/10.4103/jigims.jigims_60_23", "doi": "10.4103/jigims.jigims_60_23", "pmid": "", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1292, "title": "Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.", "authors": "Cavarra M, Mason NL, Kuypers KPC, Bonnelle V, Smith WJ, Feilding A, Kryskow P, Ramaekers JG", "journal": "European journal of pain (London, England)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1002/ejp.2171", "pubmed_id": "37599279", "openalex_id": "https://openalex.org/W4386019370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37599279/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Microdosing,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37599279", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37599279/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37599279", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37599279/", "doi": "10.1002/ejp.2171", "pmid": "37599279", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1288, "title": "Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.", "authors": "Heresco-Levy U, Lerer B", "journal": "Molecular psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1038/s41380-023-02312-8", "pubmed_id": "37945694", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37945694/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37945694", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37945694/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37945694", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37945694/", "doi": "10.1038/s41380-023-02312-8", "pmid": "37945694", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1279, "title": "Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.", "authors": "Simonsson O, Hendricks PS, Stenfors CU, Goldberg SB, Honk L, Osika W", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/02698811231218931", "pubmed_id": "38140891", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38140891/", "substance_tags": "psilocybin", "topic_tags": "Case Report,Observational Study,Safety,Drug Interactions", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38140891", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38140891/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38140891", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38140891/", "doi": "10.1177/02698811231218931", "pmid": "38140891", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1277, "title": "Is Poorly Assisted Psilocybin Treatment an Increasing Risk?", "authors": "Schenberg EE, King F, da Fonseca JE, Roseman L", "journal": "The American journal of psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230664", "pubmed_id": "38161296", "openalex_id": "https://openalex.org/W4390484761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161296/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38161296", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38161296", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38161296/", "doi": "10.1176/appi.ajp.20230664", "pmid": "38161296", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1274, "title": "The safety of supported psilocybin use in Oregon.", "authors": "Smith WR, Sisti DA, Appelbaum PS", "journal": "Nature medicine", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1038/s41591-023-02727-4", "pubmed_id": "38238619", "openalex_id": "https://openalex.org/W4390975880", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38238619/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38238619", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38238619", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38238619/", "doi": "10.1038/s41591-023-02727-4", "pmid": "38238619", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1272, "title": "Older adults in psychedelic-assisted therapy trials: A systematic review.", "authors": "Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/02698811231215420", "pubmed_id": "38240068", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Aging,Clinical Trial,Systematic Review,Review Article,Older Adults,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38240068", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38240068", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38240068/", "doi": "10.1177/02698811231215420", "pmid": "38240068", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1271, "title": "The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.", "authors": "Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R", "journal": "Current neuropharmacology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.2174/1570159x22666231027111147", "pubmed_id": "38284341", "openalex_id": "https://openalex.org/W4390628394", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38284341/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38284341", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38284341/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38284341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38284341/", "doi": "10.2174/1570159x22666231027111147", "pmid": "38284341", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1269, "title": "[Up-to-Date on clinical and preclinical studies of psilocybin therapy].", "authors": "Ibi D", "journal": "Nihon yakurigaku zasshi. Folia pharmacologica Japonica", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1254/fpj.24007", "pubmed_id": "38945903", "openalex_id": "https://openalex.org/W4400167794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38945903/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Eating Disorders,Headache / Migraine,Receptor Pharmacology,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38945903", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38945903/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38945903", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38945903/", "doi": "10.1254/fpj.24007", "pmid": "38945903", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1268, "title": "Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).", "authors": "Olivier B, Olivier JDA", "journal": "Advances in experimental medicine and biology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1007/978-981-97-4402-2_3", "pubmed_id": "39261423", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39261423/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:39261423", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39261423/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39261423", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39261423/", "doi": "10.1007/978-981-97-4402-2_3", "pmid": "39261423", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1252, "title": "Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.", "authors": "Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.2147/ndt.s432537", "pubmed_id": "38268571", "openalex_id": "https://openalex.org/W4391053730", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38268571/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38268571", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38268571/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38268571", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38268571/", "doi": "10.2147/ndt.s432537", "pmid": "38268571", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1234, "title": "Keeping the promise: a critique of the current state of microdosing research.", "authors": "Petranker R, Anderson T, Fewster EC, Aberman Y, Hazan M, Gaffrey M, Seli P", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1217102", "pubmed_id": "38374976", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38374976/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38374976", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38374976/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38374976", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38374976/", "doi": "10.3389/fpsyt.2024.1217102", "pmid": "38374976", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1225, "title": "Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.", "authors": "Fang S, Yang X, Zhang W", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1359088", "pubmed_id": "38426002", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38426002", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38426002", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38426002/", "doi": "10.3389/fpsyt.2024.1359088", "pmid": "38426002", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1222, "title": "Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.", "authors": "Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1372373", "pubmed_id": "38435972", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38435972/", "substance_tags": "psilocybin", "topic_tags": "OCD,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38435972", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38435972/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38435972", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38435972/", "doi": "10.3389/fpsyt.2024.1372373", "pmid": "38435972", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1209, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS", "journal": "American journal of therapeutics", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001724", "pubmed_id": "38518269", "openalex_id": "https://openalex.org/W4393098899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:38518269", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38518269", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38518269/", "doi": "10.1097/mjt.0000000000001724", "pmid": "38518269", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1196, "title": "Safety pharmacology of acute psilocybin administration in healthy participants.", "authors": "Straumann I, Holze F, Becker AM, Ley L, Halter N, Liechti ME", "journal": "Neuroscience applied", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1016/j.nsa.2024.104060", "pubmed_id": "40656108", "openalex_id": "https://openalex.org/W4392888270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656108/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:10", "bibtex": null, "source_record_id": "PMID:40656108", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656108/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656108", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656108/", "doi": "10.1016/j.nsa.2024.104060", "pmid": "40656108", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1164, "title": "Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.", "authors": "Wang JR, Mendez Araque SJ, Micciche G, McMillan A, Coughlin E, Mattiola R, English D, Kaliebe K", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1301960", "pubmed_id": "38699449", "openalex_id": "https://openalex.org/W4394924908", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38699449/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Wellbeing,Observational Study,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:09", "bibtex": null, "source_record_id": "PMID:38699449", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38699449/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38699449", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38699449/", "doi": "10.3389/fpsyt.2024.1301960", "pmid": "38699449", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1110, "title": "Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.", "authors": "Szafoni S, Gręblowski P, Grabowska K, Więckiewicz G", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1406888", "pubmed_id": "38919636", "openalex_id": "https://openalex.org/W4399572299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:38919636", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38919636", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38919636/", "doi": "10.3389/fpsyt.2024.1406888", "pmid": "38919636", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1077, "title": "Psilocybin for the treatment of Alzheimer's disease.", "authors": "Zheng S, Ma R, Yang Y, Li G", "journal": "Frontiers in neuroscience", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fnins.2024.1420601", "pubmed_id": "39050672", "openalex_id": "https://openalex.org/W4400513312", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39050672/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Creativity,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39050672", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39050672/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39050672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39050672/", "doi": "10.3389/fnins.2024.1420601", "pmid": "39050672", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1076, "title": "Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.", "authors": "Do A, Michaud V, Stephan JF, Moreau M, Benoît É, Bérubé FA, Bibaud-De Serres A, Taillefer A, Vincent P", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1394962", "pubmed_id": "39086732", "openalex_id": "https://openalex.org/W4400695899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Receptor Pharmacology,Clinical Trial,Case Report,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:08", "bibtex": null, "source_record_id": "PMID:39086732", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39086732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39086732/", "doi": "10.3389/fpsyt.2024.1394962", "pmid": "39086732", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1072, "title": "Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.", "authors": "Bhagavan C, Kanaan R, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, McKernon D, Roebuck G, Rucker J, Butler M, Bryson A", "journal": "Psychiatric research and clinical practice", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1176/appi.prcp.20240047", "pubmed_id": "39669539", "openalex_id": "https://openalex.org/W4400913466", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39669539/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39669539", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39669539/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39669539", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39669539/", "doi": "10.1176/appi.prcp.20240047", "pmid": "39669539", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1054, "title": "Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.", "authors": "VanderZwaag B, Garcia-Romeu A, Garcia-Barrera MA", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1177/20451253241264812", "pubmed_id": "39132012", "openalex_id": "https://openalex.org/W4401432739", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39132012/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Aging,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39132012", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39132012/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39132012", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39132012/", "doi": "10.1177/20451253241264812", "pmid": "39132012", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1043, "title": "Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City.", "authors": "Palamar JJ, Rutherford C, Le A, Keyes KM", "journal": "Journal of psychoactive drugs", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/02791072.2023.2240322", "pubmed_id": "37605471", "openalex_id": "https://openalex.org/W4386046815", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37605471/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:37605471", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37605471/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37605471", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37605471/", "doi": "10.1080/02791072.2023.2240322", "pmid": "37605471", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1042, "title": "Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.", "authors": "Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI", "journal": "Journal of psychoactive drugs", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/02791072.2023.2251133", "pubmed_id": "37615379", "openalex_id": "https://openalex.org/W4386116467", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615379/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:37615379", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37615379/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37615379", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615379/", "doi": "10.1080/02791072.2023.2251133", "pmid": "37615379", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1017, "title": "Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.", "authors": "Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1416420", "pubmed_id": "39376971", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39376971/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:39376971", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39376971/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39376971", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39376971/", "doi": "10.3389/fpsyt.2024.1416420", "pmid": "39376971", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1014, "title": "Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia.", "authors": "Mamat R, Rashid RA, Shin SM, Ibrahim B, Wahab S, Ahmad A", "journal": "Journal of addictive diseases", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/10550887.2023.2240932", "pubmed_id": "37540000", "openalex_id": "https://openalex.org/W4385564685", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37540000/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:07", "bibtex": null, "source_record_id": "PMID:37540000", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37540000/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37540000", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37540000/", "doi": "10.1080/10550887.2023.2240932", "pmid": "37540000", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 988, "title": "Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada.", "authors": "Kim K, Yusuf A, Sud A, Persaud N, Kirubarajan A, Moller M, Lloyd T, O'Neill B", "journal": "PloS one", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1371/journal.pone.0309911", "pubmed_id": "39446753", "openalex_id": "https://openalex.org/W4403721028", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39446753/", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39446753", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39446753/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39446753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39446753/", "doi": "10.1371/journal.pone.0309911", "pmid": "39446753", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 986, "title": "A narrative exploration of psilocybin's potential in mental health.", "authors": "Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1429373", "pubmed_id": "39540010", "openalex_id": "https://openalex.org/W4403895310", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39540010/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39540010", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39540010/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39540010", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39540010/", "doi": "10.3389/fpsyt.2024.1429373", "pmid": "39540010", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 985, "title": "Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use.", "authors": "Card KG, Grewal A, Closson K, Martin G, Baracaldo L, Allison S, Kruger DJ, Walsh Z", "journal": "Journal of psychoactive drugs", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/02791072.2023.2268640", "pubmed_id": "37815125", "openalex_id": "https://openalex.org/W4387473380", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37815125/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:37815125", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37815125/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37815125", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37815125/", "doi": "10.1080/02791072.2023.2268640", "pmid": "37815125", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 974, "title": "Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.", "authors": "Rucker J, Butler M, Hambleton S, Bird C, Seynaeve M, Cheema S, Campbell-Coker K, Maggio C, Dunbar F, Lambru G, Matharu M", "journal": "Headache", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1111/head.14837", "pubmed_id": "39301810", "openalex_id": "https://openalex.org/W4402697828", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39301810/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Receptor Pharmacology,Consciousness,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39301810", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39301810/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39301810", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39301810/", "doi": "10.1111/head.14837", "pmid": "39301810", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 961, "title": "Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial.", "authors": "Lee J, Philip K, Wijeysundera DN, Clarke H, Pritlove C, Katz J, Ritvo P, Goel A, Husain MI, Ladha KS", "journal": "Canadian journal of pain = Revue canadienne de la douleur", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.1080/24740527.2024.2406285", "pubmed_id": "39529994", "openalex_id": "https://openalex.org/W4404189888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39529994/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Aging,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:06", "bibtex": null, "source_record_id": "PMID:39529994", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39529994/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39529994", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39529994/", "doi": "10.1080/24740527.2024.2406285", "pmid": "39529994", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 928, "title": "Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.", "authors": "Brett J, Knock E, Watson K, Albert S, Siefried KJ, Guss J", "journal": "Frontiers in psychiatry", "publication_date": "2024-01-01", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1490907", "pubmed_id": "39713770", "openalex_id": "https://openalex.org/W4405122998", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39713770/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Aging,Emotional Processing,Clinical Trial,Case Report,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:28:05", "bibtex": null, "source_record_id": "PMID:39713770", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39713770/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39713770", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39713770/", "doi": "10.3389/fpsyt.2024.1490907", "pmid": "39713770", "publication_date": "2024-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5702, "title": "Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge", "authors": "Verheijen Marcha C.T.", "journal": "Journal of the Netherlands Society of Toxicology", "publication_date": "2023-12-30", "publication_year": 2023, "doi": "10.61833/jnst.2024.0002", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399023496", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.61833/jnst.2024.0002", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.61833/jnst.2024.0002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.61833/jnst.2024.0002", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "doi": "10.61833/jnst.2024.0002", "pmid": "", "publication_date": "2023-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4723, "title": "Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge", "authors": "Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś", "journal": "Journal of Education Health and Sport", "publication_date": "2023-12-30", "publication_year": 2023, "doi": "10.12775/jehs.2023.50.01.005", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390439845", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Pharmacology,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "doi": "10.12775/jehs.2023.50.01.005", "pmid": "", "publication_date": "2023-12-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3751, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": "10.31234/osf.io/a8xwk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-08-09 08:15:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/a8xwk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/a8xwk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/a8xwk", "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "doi": "10.31234/osf.io/a8xwk", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3572, "title": "Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.", "authors": "Multidisciplinary Association for Psychedelic Studies", "journal": "ClinicalTrials.gov", "publication_date": "2023-12-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00979693", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Spirituality,Mystical Experience,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00979693", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "source_url": "https://clinicaltrials.gov/study/NCT00979693", "doi": "", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3133, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "PsyArXiv", "publication_date": "2023-12-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "doi": "", "pmid": "", "publication_date": "2023-12-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3549, "title": "Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2023-12-15", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02981173", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02981173", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02981173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02981173", "source_url": "https://clinicaltrials.gov/study/NCT02981173", "doi": "", "pmid": "", "publication_date": "2023-12-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5812, "title": "Psychedelics and cognitive function: A systematic review", "authors": "Caíque Gois Cardoso, Milena de Barros Viana", "journal": "Research Society and Development", "publication_date": "2023-12-13", "publication_year": 2023, "doi": "10.33448/rsd-v12i14.44436", "pubmed_id": null, "openalex_id": "https://openalex.org/W4389854594", "source_url": "http://dx.doi.org/10.33448/rsd-v12i14.44436", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Emotional Processing,Systematic Review,Review Article,Healthy Volunteers,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:32", "last_checked": "2026-08-09 08:25:32", "bibtex": null, "source_record_id": "DOI:10.33448/rsd-v12i14.44436", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.33448/rsd-v12i14.44436", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.33448/rsd-v12i14.44436", "source_url": "http://dx.doi.org/10.33448/rsd-v12i14.44436", "doi": "10.33448/rsd-v12i14.44436", "pmid": "", "publication_date": "2023-12-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4730, "title": "Studying classic psychedelics for the management of headache disorders: Considerations for Veterans.", "authors": "Schindler EAD, Sico JJ", "journal": "Journal of military, veteran and family health", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.3138/jmvfh-2023-0006", "pubmed_id": "42533876", "openalex_id": "https://openalex.org/W4389613923", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42533876/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Review Article,Veterans,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:42533876", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42533876/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42533876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42533876/", "doi": "10.3138/jmvfh-2023-0006", "pmid": "42533876", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1329, "title": "Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.", "authors": "Keyes KM, Patrick ME", "journal": "Addiction (Abingdon, England)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1111/add.16259", "pubmed_id": "37287110", "openalex_id": "https://openalex.org/W4379769663", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37287110/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37287110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37287110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37287110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37287110/", "doi": "10.1111/add.16259", "pmid": "37287110", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1326, "title": "Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use.", "authors": "Jones G, Herrmann F, Wang E", "journal": "Addictive behaviors reports", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1016/j.abrep.2023.100513", "pubmed_id": "37649653", "openalex_id": "https://openalex.org/W4385777618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37649653/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37649653", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37649653/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37649653", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37649653/", "doi": "10.1016/j.abrep.2023.100513", "pmid": "37649653", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1324, "title": "Potential use of psilocybin drugs in the treatment of depression.", "authors": "Śladowska K, Kawalec P, Brzostek T, Pilc A", "journal": "Expert opinion on emerging drugs", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1080/14728214.2023.2264180", "pubmed_id": "37817501", "openalex_id": "https://openalex.org/W4387516067", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37817501", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37817501", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817501/", "doi": "10.1080/14728214.2023.2264180", "pmid": "37817501", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1323, "title": "Cardiovascular safety of psychedelic medicine: current status and future directions.", "authors": "Wsół A", "journal": "Pharmacological reports: PR", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1007/s43440-023-00539-4", "pubmed_id": "37874530", "openalex_id": "https://openalex.org/W4387893679", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Microdosing,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37874530", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37874530", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37874530/", "doi": "10.1007/s43440-023-00539-4", "pmid": "37874530", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1321, "title": "Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.", "authors": "Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST", "journal": "Drug discovery today", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1016/j.drudis.2023.103818", "pubmed_id": "37925136", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:37925136", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37925136", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37925136/", "doi": "10.1016/j.drudis.2023.103818", "pmid": "37925136", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1315, "title": "Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.", "authors": "Mathai DS, Hilbert S, Sepeda ND, Strickland JC, Griffiths RR, Garcia-Romeu A", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0035", "pubmed_id": "38152462", "openalex_id": "https://openalex.org/W4386285211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38152462/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Wellbeing,Spirituality,Healthy Volunteers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38152462", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38152462/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38152462", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38152462/", "doi": "10.1089/psymed.2023.0035", "pmid": "38152462", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1309, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.", "authors": "Weintraub MJ, Jeffrey JK, Grob CS, Ichinose MC, Bergman RL, Cooper ZD, Miklowitz DJ", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0018", "pubmed_id": "40046861", "openalex_id": "https://openalex.org/W4386469528", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40046861", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046861", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046861/", "doi": "10.1089/psymed.2023.0018", "pmid": "40046861", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1308, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.", "authors": "Brennan W, Kelman AR, Belser AB", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0007", "pubmed_id": "40046864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046864/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40046864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046864/", "doi": "10.1089/psymed.2023.0007", "pmid": "40046864", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1307, "title": "Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings.", "authors": "Nicholas CR, Horton DM, Malicki J, Baltes A, Hutson PR, Brown RT", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-12-01", "publication_year": 2023, "doi": "10.1089/psymed.2023.0012", "pubmed_id": "40046866", "openalex_id": "https://openalex.org/W4389304198", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046866/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Adverse Events,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:40046866", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046866/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046866", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046866/", "doi": "10.1089/psymed.2023.0012", "pmid": "40046866", "publication_date": "2023-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3629, "title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).", "authors": "Apex Labs Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-29", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06141876", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06141876", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "source_url": "https://clinicaltrials.gov/study/NCT06141876", "doi": "", "pmid": "", "publication_date": "2023-11-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3781, "title": "Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach", "authors": "McAlpine R, Krajnović K, Khan M, Morometescu L, Simonsson O, Sacchet M, Kamboj S.", "journal": "PsyArXiv", "publication_date": "2023-11-22", "publication_year": 2023, "doi": "10.31234/osf.io/9ev27", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9ev27", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-08-09 08:15:21", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9ev27", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9ev27", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9ev27", "source_url": "https://doi.org/10.31234/osf.io/9ev27", "doi": "10.31234/osf.io/9ev27", "pmid": "", "publication_date": "2023-11-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3304, "title": "Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach", "authors": "Rosalind McAlpine, Katarina Krajnović, Maisha Khan, Larisa Morometescu, Otto Simonsson, Matthew Sacchet, Sunjeev Kamboj", "journal": "PsyArXiv", "publication_date": "2023-11-22", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9ev27_v1", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Qualitative Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9ev27_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9ev27_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9ev27_v1", "source_url": "https://osf.io/preprints/psyarxiv/9ev27_v1", "doi": "", "pmid": "", "publication_date": "2023-11-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4733, "title": "Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials", "authors": "Tahlia R. Harrison", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-20", "publication_year": 2023, "doi": "10.1556/2054.2023.00267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388822593", "source_url": "https://doi.org/10.1556/2054.2023.00267", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00267", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00267", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00267", "source_url": "https://doi.org/10.1556/2054.2023.00267", "doi": "10.1556/2054.2023.00267", "pmid": "", "publication_date": "2023-11-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4735, "title": "Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness", "authors": "Danelle Jones", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-16", "publication_year": 2023, "doi": "10.1556/2054.2023.00306", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388730617", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00306", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00306", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "doi": "10.1556/2054.2023.00306", "pmid": "", "publication_date": "2023-11-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3364, "title": "Aesthetic Chills Mitigate Maladaptive Cognition In Depression", "authors": "Schoeller F, Jain A, Adrien V, Maes P, Reggente N.", "journal": "Research Square", "publication_date": "2023-11-14", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3582420/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:27", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "doi": "10.21203/rs.3.rs-3582420/v1", "pmid": "", "publication_date": "2023-11-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3680, "title": "The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04739865", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04739865", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "source_url": "https://clinicaltrials.gov/study/NCT04739865", "doi": "", "pmid": "", "publication_date": "2023-11-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1336, "title": "Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.", "authors": "Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A", "journal": "The Journal of neuroscience: the official journal of the Society for Neuroscience", "publication_date": "2023-11-08", "publication_year": 2023, "doi": "10.1523/jneurosci.1384-23.2023", "pubmed_id": "37940583", "openalex_id": "https://openalex.org/W4388486766", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37940583/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37940583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37940583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37940583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37940583/", "doi": "10.1523/jneurosci.1384-23.2023", "pmid": "37940583", "publication_date": "2023-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5815, "title": "The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review", "authors": "7450 Summit Cir, Davison, MI48423, Sarah Naher", "journal": "Journal of Sociology Psychology & Religious Studies", "publication_date": "2023-11-06", "publication_year": 2023, "doi": "10.53819/81018102t4217", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388421437", "source_url": "http://dx.doi.org/10.53819/81018102t4217", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Wellbeing,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:33", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "DOI:10.53819/81018102t4217", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.53819/81018102t4217", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53819/81018102t4217", "source_url": "http://dx.doi.org/10.53819/81018102t4217", "doi": "10.53819/81018102t4217", "pmid": "", "publication_date": "2023-11-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1349, "title": "\"But the reality is it's happening\": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.", "authors": "Downey AE, Boyd M, Chaphekar AV, Woolley J, Raymond-Flesch M", "journal": "The International journal of eating disorders", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1002/eat.24041", "pubmed_id": "37551650", "openalex_id": "https://openalex.org/W4385664009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37551650/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37551650", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37551650/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37551650", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37551650/", "doi": "10.1002/eat.24041", "pmid": "37551650", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1348, "title": "Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.", "authors": "Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.07.011", "pubmed_id": "37557019", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37557019/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37557019", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37557019/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37557019", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37557019/", "doi": "10.1016/j.euroneuro.2023.07.011", "pmid": "37557019", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1340, "title": "[Determination of amanita peptide and tryptamine toxins in wild mushrooms by high performance liquid chromatography-tandem mass spectrometry].", "authors": "Liu LQ, Chen JZ, Fu WS, Tang CY", "journal": "Se pu = Chinese journal of chromatography", "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.3724/sp.j.1123.2023.07013", "pubmed_id": "37968816", "openalex_id": "https://openalex.org/W4388737296", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37968816/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37968816", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37968816/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37968816", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37968816/", "doi": "10.3724/sp.j.1123.2023.07013", "pmid": "37968816", "publication_date": "2023-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3798, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B.", "journal": "PsyArXiv", "publication_date": "2023-10-27", "publication_year": 2023, "doi": "10.31234/osf.io/4gfyd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/4gfyd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/4gfyd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/4gfyd", "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "doi": "10.31234/osf.io/4gfyd", "pmid": "", "publication_date": "2023-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3369, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "Sarah Kratina, Chris Lo, Robert Schwartz, Carol Strike, Sydney Jopling, Ayah Nayfeh, Brian Rush", "journal": "PsyArXiv", "publication_date": "2023-10-27", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "doi": "", "pmid": "", "publication_date": "2023-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4747, "title": "Extended difficulties following the use of psychedelic drugs: A mixed methods study", "authors": "Jules Evans, Oliver Robinson, Eirini K. Argyri, Shayam Suseelan, Ashleigh Murphy-Beiner, Rosalind McAlpine, David Luke, Katrina Michelle, Ed Prideaux", "journal": "PLoS ONE", "publication_date": "2023-10-23", "publication_year": 2023, "doi": "10.1371/journal.pone.0293349", "pubmed_id": "37874826", "openalex_id": "https://openalex.org/W4387902564", "source_url": "https://doi.org/10.1371/journal.pone.0293349", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37874826", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0293349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37874826", "source_url": "https://doi.org/10.1371/journal.pone.0293349", "doi": "10.1371/journal.pone.0293349", "pmid": "37874826", "publication_date": "2023-10-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3094, "title": "Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms", "authors": "Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Andrew Jones J, McMurray MS.", "journal": "bioRxiv", "publication_date": "2023-10-23", "publication_year": 2023, "doi": "10.1101/2023.10.19.563138", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.10.19.563138", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Receptor Pharmacology,Biomarkers,Animal Study,In Vitro Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-08-09 08:14:57", "bibtex": null, "source_record_id": "DOI:10.1101/2023.10.19.563138", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.10.19.563138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.10.19.563138", "source_url": "https://doi.org/10.1101/2023.10.19.563138", "doi": "10.1101/2023.10.19.563138", "pmid": "", "publication_date": "2023-10-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3619, "title": "Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2023-10-12", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03806985", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03806985", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03806985", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03806985", "source_url": "https://clinicaltrials.gov/study/NCT03806985", "doi": "", "pmid": "", "publication_date": "2023-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3569, "title": "Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2023-10-12", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03341689", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03341689", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03341689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03341689", "source_url": "https://clinicaltrials.gov/study/NCT03341689", "doi": "", "pmid": "", "publication_date": "2023-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3188, "title": "Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML.", "journal": "bioRxiv", "publication_date": "2023-10-07", "publication_year": 2023, "doi": "10.1101/2023.10.06.561183", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.10.06.561183", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:09", "bibtex": null, "source_record_id": "DOI:10.1101/2023.10.06.561183", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.10.06.561183", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.10.06.561183", "source_url": "https://doi.org/10.1101/2023.10.06.561183", "doi": "10.1101/2023.10.06.561183", "pmid": "", "publication_date": "2023-10-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4754, "title": "Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?", "authors": "Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2023-10-05", "publication_year": 2023, "doi": "10.1002/cpt.3050", "pubmed_id": "37795632", "openalex_id": "https://openalex.org/W4387357883", "source_url": "https://doi.org/10.1002/cpt.3050", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Microdosing,Wellbeing,Clinical Trial,Healthcare Workers,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:33", "bibtex": null, "source_record_id": "PMID:37795632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpt.3050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795632", "source_url": "https://doi.org/10.1002/cpt.3050", "doi": "10.1002/cpt.3050", "pmid": "37795632", "publication_date": "2023-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1360, "title": "An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).", "authors": "Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S", "journal": "Pilot and feasibility studies", "publication_date": "2023-10-05", "publication_year": 2023, "doi": "10.1186/s40814-023-01399-8", "pubmed_id": "37798662", "openalex_id": "https://openalex.org/W4387372869", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37798662", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37798662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37798662/", "doi": "10.1186/s40814-023-01399-8", "pmid": "37798662", "publication_date": "2023-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1368, "title": "Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.", "authors": "Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S", "journal": "Journal of palliative medicine", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1089/jpm.2022.0604", "pubmed_id": "37167080", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Mechanism of Action,Spirituality,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37167080", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37167080", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "doi": "10.1089/jpm.2022.0604", "pmid": "37167080", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1367, "title": "Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.", "authors": "Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, Coviello F, Dierbach S, Thomann J, Duthaler U, Luethi D, Varghese N, Eckert A, Liechti ME", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1038/s41386-023-01607-2", "pubmed_id": "37231080", "openalex_id": "https://openalex.org/W4378174725", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37231080/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Consciousness,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37231080", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37231080/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37231080", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37231080/", "doi": "10.1038/s41386-023-01607-2", "pmid": "37231080", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1365, "title": "Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.", "authors": "Calder A, Mock S, Friedli N, Pasi P, Hasler G", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.05.008", "pubmed_id": "37352816", "openalex_id": "https://openalex.org/W4381548553", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37352816/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Eating Disorders,Mechanism of Action,Review Article,Case Report,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37352816", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37352816/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37352816", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37352816/", "doi": "10.1016/j.euroneuro.2023.05.008", "pmid": "37352816", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1364, "title": "Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.", "authors": "Wolfgang AS, Hoge CW", "journal": "Current psychiatry reports", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1007/s11920-023-01446-4", "pubmed_id": "37682446", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Review Article,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37682446", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37682446", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37682446/", "doi": "10.1007/s11920-023-01446-4", "pmid": "37682446", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1363, "title": "The zebrafish for preclinical psilocybin research.", "authors": "Syed OA, Tsang B, Gerlai R", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2023-10-01", "publication_year": 2023, "doi": "10.1016/j.neubiorev.2023.105381", "pubmed_id": "37689090", "openalex_id": "https://openalex.org/W4386519754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37689090/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Mechanism of Action,Review Article,Animal Study,Safety,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37689090", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37689090/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37689090", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37689090/", "doi": "10.1016/j.neubiorev.2023.105381", "pmid": "37689090", "publication_date": "2023-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3667, "title": "Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT01534494", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT01534494", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "source_url": "https://clinicaltrials.gov/study/NCT01534494", "doi": "", "pmid": "", "publication_date": "2023-09-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3573, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-21", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04141501", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04141501", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "source_url": "https://clinicaltrials.gov/study/NCT04141501", "doi": "", "pmid": "", "publication_date": "2023-09-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4769, "title": "The psychedelic experience and treatment-resistant depression", "authors": "Guy M. Goodwin", "journal": "World Psychiatry", "publication_date": "2023-09-15", "publication_year": 2023, "doi": "10.1002/wps.21140", "pubmed_id": "37713542", "openalex_id": "https://openalex.org/W4386765441", "source_url": "http://dx.doi.org/10.1002/wps.21140", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "PMID:37713542", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/wps.21140", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37713542", "source_url": "http://dx.doi.org/10.1002/wps.21140", "doi": "10.1002/wps.21140", "pmid": "37713542", "publication_date": "2023-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3543, "title": "Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions", "authors": "Lobe Sciences Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-13", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06035900", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06035900", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "source_url": "https://clinicaltrials.gov/study/NCT06035900", "doi": "", "pmid": "", "publication_date": "2023-09-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1378, "title": "Psilocybin for anorexia nervosa: If it helps, let's learn how.", "authors": "Attia E, Steinglass JE", "journal": "Med (New York, N.Y.)", "publication_date": "2023-09-08", "publication_year": 2023, "doi": "10.1016/j.medj.2023.08.003", "pubmed_id": "37689054", "openalex_id": "https://openalex.org/W4386541001", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37689054/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37689054", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37689054/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37689054", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37689054/", "doi": "10.1016/j.medj.2023.08.003", "pmid": "37689054", "publication_date": "2023-09-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1379, "title": "Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.", "authors": "Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR", "journal": "JAMA", "publication_date": "2023-09-05", "publication_year": 2023, "doi": "10.1001/jama.2023.14530", "pubmed_id": "37651119", "openalex_id": "https://openalex.org/W4386305655", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37651119", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37651119", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37651119/", "doi": "10.1001/jama.2023.14530", "pmid": "37651119", "publication_date": "2023-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1397, "title": "HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.", "authors": "Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P", "journal": "Journal of pain and symptom management", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1016/j.jpainsymman.2023.06.006", "pubmed_id": "37302533", "openalex_id": "https://openalex.org/W4380151127", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37302533/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Review Article,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37302533", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37302533/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37302533", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37302533/", "doi": "10.1016/j.jpainsymman.2023.06.006", "pmid": "37302533", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1396, "title": "Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis.", "authors": "Nikolič M, Viktorin V, Zach P, Tylš F, Dudysová D, Janků K, Kopřivová J, Kuchař M, Brunovský M, Horáček J, Páleníček T", "journal": "European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.04.019", "pubmed_id": "37336163", "openalex_id": "https://openalex.org/W4381059735", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37336163/", "substance_tags": "psilocybin", "topic_tags": "Healthy Volunteers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37336163", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37336163/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37336163", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37336163/", "doi": "10.1016/j.euroneuro.2023.04.019", "pmid": "37336163", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1394, "title": "Clinical specificity profile for novel rapid acting antidepressant drugs.", "authors": "Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C", "journal": "International clinical psychopharmacology", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1097/yic.0000000000000488", "pubmed_id": "37381161", "openalex_id": "https://openalex.org/W4382502499", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37381161/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37381161", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37381161/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37381161", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37381161/", "doi": "10.1097/yic.0000000000000488", "pmid": "37381161", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1393, "title": "Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.", "authors": "Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1038/s41386-023-01648-7", "pubmed_id": "37443386", "openalex_id": "https://openalex.org/W4384130479", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37443386", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37443386", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37443386/", "doi": "10.1038/s41386-023-01648-7", "pmid": "37443386", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1390, "title": "Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.", "authors": "Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB", "journal": "Psychiatry research", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115349", "pubmed_id": "37523886", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37523886", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37523886", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37523886/", "doi": "10.1016/j.psychres.2023.115349", "pmid": "37523886", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1389, "title": "The Potential of Psychedelics for the Treatment of Episodic Migraine.", "authors": "Schindler EAD", "journal": "Current pain and headache reports", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1007/s11916-023-01145-y", "pubmed_id": "37540398", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37540398/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37540398", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37540398/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37540398", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37540398/", "doi": "10.1007/s11916-023-01145-y", "pmid": "37540398", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1388, "title": "The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.", "authors": "Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1177/02698811231190865", "pubmed_id": "37572027", "openalex_id": "https://openalex.org/W4385783116", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37572027/", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Microdosing,In Vitro Study,Safety", "study_type": "In Vitro Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37572027", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37572027/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37572027", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37572027/", "doi": "10.1177/02698811231190865", "pmid": "37572027", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1387, "title": "Psilocybin history, action and reaction: A narrative clinical review.", "authors": "Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.1177/02698811231190858", "pubmed_id": "37650489", "openalex_id": "https://openalex.org/W4386305913", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37650489", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37650489", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37650489/", "doi": "10.1177/02698811231190858", "pmid": "37650489", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1377, "title": "Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin.", "authors": "Bhuiya NMA, Jacobs RJ, Wang K, Sun Y, Nava B, Sampiere L, Yerubandi A, Caballero J", "journal": "Cureus", "publication_date": "2023-09-01", "publication_year": 2023, "doi": "10.7759/cureus.45169", "pubmed_id": "37842360", "openalex_id": "https://openalex.org/W4386702998", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37842360/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,End-of-Life Distress,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37842360", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37842360/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37842360", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37842360/", "doi": "10.7759/cureus.45169", "pmid": "37842360", "publication_date": "2023-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1407, "title": "Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.", "authors": "Zeifman RJ, Kettner H, Pagni BA, Mallard A, Roberts DE, Erritzoe D, Ross S, Carhart-Harris RL", "journal": "Scientific reports", "publication_date": "2023-08-22", "publication_year": 2023, "doi": "10.1038/s41598-023-40856-5", "pubmed_id": "37608057", "openalex_id": "https://openalex.org/W4386069067", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37608057/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37608057", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37608057/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37608057", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37608057/", "doi": "10.1038/s41598-023-40856-5", "pmid": "37608057", "publication_date": "2023-08-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4785, "title": "Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy", "authors": "Benjamin M. Ross, James T. Neill", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-08-21", "publication_year": 2023, "doi": "10.1556/2054.2023.00264", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386021261", "source_url": "https://doi.org/10.1556/2054.2023.00264", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Personality Change,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:34", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00264", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00264", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00264", "source_url": "https://doi.org/10.1556/2054.2023.00264", "doi": "10.1556/2054.2023.00264", "pmid": "", "publication_date": "2023-08-21", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4786, "title": "Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-08-15", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.09.9.20", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385829163", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "doi": "10.1176/appi.pn.2023.09.9.20", "pmid": "", "publication_date": "2023-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4788, "title": "Psilocybin's Emerging Role in Combating Depressive Disorder", "authors": "Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-08", "publication_year": 2023, "doi": "10.12775/jehs.2023.40.01.011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385658334", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Review Article,Animal Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "doi": "10.12775/jehs.2023.40.01.011", "pmid": "", "publication_date": "2023-08-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1413, "title": "[Not Available].", "authors": "Ibrahim IB, Videbech P, Straszek SPV", "journal": "Ugeskrift for laeger", "publication_date": "2023-08-07", "publication_year": 2023, "doi": null, "pubmed_id": "37615227", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37615227", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37615227", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37615227/", "doi": "", "pmid": "37615227", "publication_date": "2023-08-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1426, "title": "Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.", "authors": "Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M", "journal": "CNS spectrums", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1017/s1092852922000888", "pubmed_id": "35811423", "openalex_id": "https://openalex.org/W4285007883", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35811423/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:35811423", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35811423/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35811423", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35811423/", "doi": "10.1017/s1092852922000888", "pmid": "35811423", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1424, "title": "Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.", "authors": "Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A", "journal": "Neuropharmacology", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109528", "pubmed_id": "37015315", "openalex_id": "https://openalex.org/W4362508370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Spirituality,Clinical Trial,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37015315", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37015315", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37015315/", "doi": "10.1016/j.neuropharm.2023.109528", "pmid": "37015315", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1420, "title": "Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.", "authors": "Jing X, Hoeh NR, Menkes DB", "journal": "Palliative & supportive care", "publication_date": "2023-08-01", "publication_year": 2023, "doi": "10.1017/s147895152300069x", "pubmed_id": "37334486", "openalex_id": "https://openalex.org/W4381158131", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37334486", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37334486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37334486/", "doi": "10.1017/s147895152300069x", "pmid": "37334486", "publication_date": "2023-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4791, "title": "Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-07-27", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.08.8.3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385324763", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "doi": "10.1176/appi.pn.2023.08.8.3", "pmid": "", "publication_date": "2023-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3519, "title": "The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study", "authors": "Brain and Cognition Discovery Foundation", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-27", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05029466", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05029466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "source_url": "https://clinicaltrials.gov/study/NCT05029466", "doi": "", "pmid": "", "publication_date": "2023-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3279, "title": "“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance", "authors": "Finkelstein C, Soha O, Roy A, Phillipou A, Rossell S.", "journal": "Research Square", "publication_date": "2023-07-27", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3189970/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3189970/v1", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Aging,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3189970/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3189970/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3189970/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3189970/v1", "doi": "10.21203/rs.3.rs-3189970/v1", "pmid": "", "publication_date": "2023-07-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3470, "title": "An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.", "authors": "The Roots to Thrive Society for Psychedelic Therapy", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05958758", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Wellbeing,Resilience,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05958758", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05958758", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05958758", "source_url": "https://clinicaltrials.gov/study/NCT05958758", "doi": "", "pmid": "", "publication_date": "2023-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1427, "title": "Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.", "authors": "Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones BDM, Ortiz A, Kloiber S, Wang W, Rosenblat JD, Mulsant BH", "journal": "BJPsych open", "publication_date": "2023-07-25", "publication_year": 2023, "doi": "10.1192/bjo.2023.535", "pubmed_id": "37489299", "openalex_id": "https://openalex.org/W4385230722", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37489299/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Consciousness,Randomized Controlled Trial,Animal Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37489299", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37489299/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37489299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37489299/", "doi": "10.1192/bjo.2023.535", "pmid": "37489299", "publication_date": "2023-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1428, "title": "Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?", "authors": "Rudzki S", "journal": "Military medicine", "publication_date": "2023-07-22", "publication_year": 2023, "doi": "10.1093/milmed/usac095", "pubmed_id": "35446412", "openalex_id": "https://openalex.org/W4224232624", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35446412/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Epigenetics,Review Article,Safety,Genomics,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:35446412", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35446412/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35446412", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35446412/", "doi": "10.1093/milmed/usac095", "pmid": "35446412", "publication_date": "2023-07-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3143, "title": "Psilocybin as an antidepressant strategy - a review of safety aspects", "authors": "Zeiss R.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2023-07-19", "publication_year": 2023, "doi": "10.1192/j.eurpsy.2023.679", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385669209", "source_url": "https://europepmc.org/article/PMC/PMC10405689", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2023.679", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC10405689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.1192/j.eurpsy.2023.679", "source_url": "https://europepmc.org/article/PMC/PMC10405689", "doi": "10.1192/j.eurpsy.2023.679", "pmid": "", "publication_date": "2023-07-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4793, "title": "Pharmacognostic, Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Multidisciplinary Study with an Assessment of Peculiarities of Circulation (Use) of Smoking Mixtures of Spices and Entheogens of Amanita Muscaria Mushroom", "authors": "Вікторія Шаповалова, Alina Osyntseva, Валерій Шаповалов, Serhii Nehretskii", "journal": "SSP Modern Pharmacy and Medicine", "publication_date": "2023-07-18", "publication_year": 2023, "doi": "10.53933/sspmpm.v3i3.105", "pubmed_id": null, "openalex_id": "https://openalex.org/W4384694190", "source_url": "https://doi.org/10.53933/sspmpm.v3i3.105", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.53933/sspmpm.v3i3.105", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53933/sspmpm.v3i3.105", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53933/sspmpm.v3i3.105", "source_url": "https://doi.org/10.53933/sspmpm.v3i3.105", "doi": "10.53933/sspmpm.v3i3.105", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3422, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "William Brennan, Alex Kelman, Alexander B. Belser", "journal": "PsyArXiv", "publication_date": "2023-07-18", "publication_year": 2023, "doi": "10.1089/psymed.2023.00071", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "DOI:10.1089/psymed.2023.00071", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1089/psymed.2023.00071", "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "doi": "10.1089/psymed.2023.00071", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3380, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "Brennan B, Kelman A, Belser AB.", "journal": "PsyArXiv", "publication_date": "2023-07-18", "publication_year": 2023, "doi": "10.31234/osf.io/2ab59", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2ab59", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:30", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2ab59", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2ab59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2ab59", "source_url": "https://doi.org/10.31234/osf.io/2ab59", "doi": "10.31234/osf.io/2ab59", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3217, "title": "Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour", "authors": "Nkadimeng SM, Hay L, Steinmann CM, Eloff JN.", "journal": "Research Square", "publication_date": "2023-07-18", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3088850/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3088850/v1", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Animal Study,In Vitro Study,Safety", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3088850/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3088850/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3088850/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3088850/v1", "doi": "10.21203/rs.3.rs-3088850/v1", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4795, "title": "Leveraging psychedelic therapies for binge eating disorder", "authors": "Jim Gilligan", "journal": "Open Access Government", "publication_date": "2023-07-10", "publication_year": 2023, "doi": "10.56367/oag-039-10936", "pubmed_id": null, "openalex_id": "https://openalex.org/W4384523308", "source_url": "http://dx.doi.org/10.56367/oag-039-10936", "substance_tags": "psilocybin,psilocin", "topic_tags": "Eating Disorders,Pharmacology,Receptor Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.56367/oag-039-10936", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56367/oag-039-10936", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56367/oag-039-10936", "source_url": "http://dx.doi.org/10.56367/oag-039-10936", "doi": "10.56367/oag-039-10936", "pmid": "", "publication_date": "2023-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1432, "title": "[Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models].", "authors": "Chernoff T, Kliger B, Venturini DH", "journal": "Vertex (Buenos Aires, Argentina)", "publication_date": "2023-07-10", "publication_year": 2023, "doi": "10.53680/vertex.v34i160.463", "pubmed_id": "37562384", "openalex_id": "https://openalex.org/W4385197804", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37562384/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37562384", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37562384/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37562384", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37562384/", "doi": "10.53680/vertex.v34i160.463", "pmid": "37562384", "publication_date": "2023-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3755, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "Tetem J, Fischmann T, Möller TJ.", "journal": "PsyArXiv", "publication_date": "2023-07-06", "publication_year": 2023, "doi": "10.31234/osf.io/ztyxh", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ztyxh", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ztyxh", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ztyxh", "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "doi": "10.31234/osf.io/ztyxh", "pmid": "", "publication_date": "2023-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3161, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "Jenny Tetem, Tamara Fischmann, Tim Julian Möller", "journal": "PsyArXiv", "publication_date": "2023-07-06", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "doi": "", "pmid": "", "publication_date": "2023-07-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1451, "title": "The need for establishing best practices and gold standards in psychedelic medicine.", "authors": "Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM", "journal": "Journal of affective disorders", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.03.083", "pubmed_id": "37003433", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37003433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37003433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37003433/", "doi": "10.1016/j.jad.2023.03.083", "pmid": "37003433", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1439, "title": "Psilocybin's effects on cognition and creativity: A scoping review.", "authors": "Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231179801", "pubmed_id": "37395359", "openalex_id": "https://openalex.org/W4382918325", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37395359/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37395359", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37395359/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37395359", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37395359/", "doi": "10.1177/02698811231179801", "pmid": "37395359", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1438, "title": "Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.", "authors": "Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-07-01", "publication_year": 2023, "doi": "10.1177/02698811231180276", "pubmed_id": "37403379", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37403379", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37403379", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37403379/", "doi": "10.1177/02698811231180276", "pmid": "37403379", "publication_date": "2023-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4801, "title": "FDA issues first draft guidance on psychedelic research", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1002/mhw.33697", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382680172", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.33697", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/mhw.33697", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.33697", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "doi": "10.1002/mhw.33697", "pmid": "", "publication_date": "2023-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3538, "title": "Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder", "authors": "Halucenex Life Sciences Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-06-29", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05243329", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05243329", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "source_url": "https://clinicaltrials.gov/study/NCT05243329", "doi": "", "pmid": "", "publication_date": "2023-06-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4803, "title": "Experts Offer Tips on Talking With Patients About Psychedelics", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-06-28", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.51", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360061", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "doi": "10.1176/appi.pn.2023.07.7.51", "pmid": "", "publication_date": "2023-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4802, "title": "Psychedelic Therapy Requires Enhanced Consent Discussions", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-06-28", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.46", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360046", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.46", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Consciousness,Spirituality,Observational Study,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.46", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.46", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.46", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.46", "doi": "10.1176/appi.pn.2023.07.7.46", "pmid": "", "publication_date": "2023-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4806, "title": "A regulatory framework review of Schedule I psychedelics in the United States", "authors": "Kevin Herkenham", "journal": "JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY", "publication_date": "2023-06-12", "publication_year": 2023, "doi": "10.1002/jac5.1841", "pubmed_id": null, "openalex_id": "https://openalex.org/W4380357539", "source_url": "https://doi.org/10.1002/jac5.1841", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-08-09 08:25:35", "bibtex": null, "source_record_id": "DOI:10.1002/jac5.1841", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jac5.1841", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/jac5.1841", "source_url": "https://doi.org/10.1002/jac5.1841", "doi": "10.1002/jac5.1841", "pmid": "", "publication_date": "2023-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3190, "title": "Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes", "authors": "Nkadimeng SM, Steinmann CM, Eloff JN.", "journal": "Preprints.org", "publication_date": "2023-06-06", "publication_year": 2023, "doi": "10.20944/preprints202306.0362.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202306.0362.v1", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Mitochondrial Function,Oxidative Stress,Safety,Toxicity,Inflammation", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:09", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202306.0362.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202306.0362.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202306.0362.v1", "source_url": "https://doi.org/10.20944/preprints202306.0362.v1", "doi": "10.20944/preprints202306.0362.v1", "pmid": "", "publication_date": "2023-06-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4808, "title": "Psilocybin therapy: A novel approach to treating depression", "authors": "Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala", "journal": "International Journal of Surgery Global Health", "publication_date": "2023-06-02", "publication_year": 2023, "doi": "10.1097/gh9.0000000000000175", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379142909", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000175", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000175", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "doi": "10.1097/gh9.0000000000000175", "pmid": "", "publication_date": "2023-06-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1466, "title": "Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.", "authors": "Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1089/psymed.2022.0011", "pubmed_id": "40046728", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Clinical Trial,Review Article,Cancer Patients,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:40046728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "doi": "10.1089/psymed.2022.0011", "pmid": "40046728", "publication_date": "2023-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3475, "title": "Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans", "authors": "Combat Stress", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05876481", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05876481", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "source_url": "https://clinicaltrials.gov/study/NCT05876481", "doi": "", "pmid": "", "publication_date": "2023-05-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1481, "title": "Neurobiological Correlates of Psilocybin Response in Depression.", "authors": "Qasim S, Zaheer Z, Jawad MY, Shad MU", "journal": "The primary care companion for CNS disorders", "publication_date": "2023-05-23", "publication_year": 2023, "doi": "10.4088/pcc.22r03419", "pubmed_id": "37230065", "openalex_id": "https://openalex.org/W4377233162", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37230065/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37230065", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37230065/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37230065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37230065/", "doi": "10.4088/pcc.22r03419", "pmid": "37230065", "publication_date": "2023-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3683, "title": "Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04842045", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04842045", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "source_url": "https://clinicaltrials.gov/study/NCT04842045", "doi": "", "pmid": "", "publication_date": "2023-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5818, "title": "THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE", "authors": "Chirag Ambaliya, Dimple Gupta, Ashok Vala, Krupa Mukeshbhai Unadkat", "journal": "PARIPEX-INDIAN JOURNAL OF RESEARCH", "publication_date": "2023-05-15", "publication_year": 2023, "doi": "10.36106/paripex/6712845", "pubmed_id": null, "openalex_id": "https://openalex.org/W4381744623", "source_url": "https://doi.org/10.36106/paripex/6712845", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:36", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.36106/paripex/6712845", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36106/paripex/6712845", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36106/paripex/6712845", "source_url": "https://doi.org/10.36106/paripex/6712845", "doi": "10.36106/paripex/6712845", "pmid": "", "publication_date": "2023-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3634, "title": "A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-15", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05467761", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05467761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "source_url": "https://clinicaltrials.gov/study/NCT05467761", "doi": "", "pmid": "", "publication_date": "2023-05-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3463, "title": "Effects of Psilocybin in Anorexia Nervosa", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-06", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04052568", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04052568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "source_url": "https://clinicaltrials.gov/study/NCT04052568", "doi": "", "pmid": "", "publication_date": "2023-05-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1491, "title": "Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.", "authors": "Davis AK, Levin AW, Nagib PB, Armstrong SB, Lancelotta RL", "journal": "BMJ open", "publication_date": "2023-05-04", "publication_year": 2023, "doi": "10.1136/bmjopen-2022-068884", "pubmed_id": "37142308", "openalex_id": "https://openalex.org/W4372336620", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37142308/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Pharmacology,Clinical Trial,Review Article,Veterans,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37142308", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37142308/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37142308", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37142308/", "doi": "10.1136/bmjopen-2022-068884", "pmid": "37142308", "publication_date": "2023-05-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1493, "title": "Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.", "authors": "Schneier FR, Feusner J, Wheaton MG, Gomez GJ, Cornejo G, Naraindas AM, Hellerstein DJ", "journal": "Journal of psychiatric research", "publication_date": "2023-05-01", "publication_year": 2023, "doi": "10.1016/j.jpsychires.2023.03.031", "pubmed_id": "37004409", "openalex_id": "https://openalex.org/W4361279088", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37004409", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37004409", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37004409/", "doi": "10.1016/j.jpsychires.2023.03.031", "pmid": "37004409", "publication_date": "2023-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4819, "title": "A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history", "authors": "Eric N. Kramer, Kalyn Reddy, Bryan Shapiro", "journal": "Psychiatry Research Case Reports", "publication_date": "2023-04-26", "publication_year": 2023, "doi": "10.1016/j.psycr.2023.100118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367043450", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "doi": "10.1016/j.psycr.2023.100118", "pmid": "", "publication_date": "2023-04-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3563, "title": "The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-04-24", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03775200", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03775200", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "source_url": "https://clinicaltrials.gov/study/NCT03775200", "doi": "", "pmid": "", "publication_date": "2023-04-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3176, "title": "A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy", "authors": "Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R.", "journal": "medRxiv", "publication_date": "2023-04-19", "publication_year": 2023, "doi": "10.1101/2023.04.12.23288325", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-08-09 08:15:07", "bibtex": null, "source_record_id": "DOI:10.1101/2023.04.12.23288325", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.04.12.23288325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.04.12.23288325", "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "doi": "10.1101/2023.04.12.23288325", "pmid": "", "publication_date": "2023-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1521, "title": "To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.", "authors": "Christensen JA, Fipps DC, Bostwick JM", "journal": "Experimental and clinical psychopharmacology", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1037/pha0000597", "pubmed_id": "36048112", "openalex_id": "https://openalex.org/W4294127245", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36048112/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36048112", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36048112/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36048112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36048112/", "doi": "10.1037/pha0000597", "pmid": "36048112", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1517, "title": "Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.", "authors": "Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ", "journal": "Neurosurgery", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1227/neu.0000000000002275", "pubmed_id": "36512813", "openalex_id": "https://openalex.org/W4311273096", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36512813", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36512813", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36512813/", "doi": "10.1227/neu.0000000000002275", "pmid": "36512813", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1516, "title": "Are psychedelics the answer to chronic pain: A review of current literature.", "authors": "Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI", "journal": "Pain practice: the official journal of World Institute of Pain", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1111/papr.13203", "pubmed_id": "36597700", "openalex_id": "https://openalex.org/W4313488167", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36597700/", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Receptor Pharmacology,Review Article,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36597700", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36597700/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36597700", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36597700/", "doi": "10.1111/papr.13203", "pmid": "36597700", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1514, "title": "Psychedelics: Science sabotaged by Social Media.", "authors": "Sellers EM, Romach MK", "journal": "Neuropharmacology", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109426", "pubmed_id": "36693562", "openalex_id": "https://openalex.org/W4317677634", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36693562/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36693562", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36693562/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36693562", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36693562/", "doi": "10.1016/j.neuropharm.2023.109426", "pmid": "36693562", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1513, "title": "Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.", "authors": "Modlin NL, Miller TM, Rucker JJ, Kirlic N, Lennard-Jones M, Schlosser D, Aaronson ST", "journal": "Journal of affective disorders", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.077", "pubmed_id": "36707036", "openalex_id": "https://openalex.org/W4318393298", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36707036/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,End-of-Life Distress,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36707036", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36707036/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36707036", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36707036/", "doi": "10.1016/j.jad.2023.01.077", "pmid": "36707036", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1512, "title": "Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.", "authors": "Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB", "journal": "Journal of affective disorders", "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.073", "pubmed_id": "36720405", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36720405/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36720405", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36720405/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36720405", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36720405/", "doi": "10.1016/j.jad.2023.01.073", "pmid": "36720405", "publication_date": "2023-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1526, "title": "Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.", "authors": "Domanegg K, Sommer WH, Meinhardt MW", "journal": "Cells", "publication_date": "2023-03-22", "publication_year": 2023, "doi": "10.3390/cells12060963", "pubmed_id": "36980303", "openalex_id": "https://openalex.org/W4353070324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36980303/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Epigenetics,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36980303", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36980303/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36980303", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36980303/", "doi": "10.3390/cells12060963", "pmid": "36980303", "publication_date": "2023-03-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3433, "title": "Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects (\"MELO\"): A Blinded, Placebo-Controlled, Dose-Finding Study", "authors": "Optimi Health Corporation", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-20", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05252598", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05252598", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "source_url": "https://clinicaltrials.gov/study/NCT05252598", "doi": "", "pmid": "", "publication_date": "2023-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3763, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD", "authors": "Ching THW, Grazioplene R, Pittenger C, Kelmendi B.", "journal": "PsyArXiv", "publication_date": "2023-03-17", "publication_year": 2023, "doi": "10.31234/osf.io/ba42z", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ba42z", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:08", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ba42z", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ba42z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ba42z", "source_url": "https://doi.org/10.31234/osf.io/ba42z", "doi": "10.31234/osf.io/ba42z", "pmid": "", "publication_date": "2023-03-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3186, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD", "authors": "Terence Ching, Rachael Grazioplene, Christopher Pittenger, Benjamin Kelmendi", "journal": "PsyArXiv", "publication_date": "2023-03-17", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ba42z_v1", "substance_tags": "psilocybin", "topic_tags": "OCD,Pharmacology,Mechanism of Action,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ba42z_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ba42z_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ba42z_v1", "source_url": "https://osf.io/preprints/psyarxiv/ba42z_v1", "doi": "", "pmid": "", "publication_date": "2023-03-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3524, "title": "Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder", "authors": "New York State Psychiatric Institute", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-13", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04656301", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04656301", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "source_url": "https://clinicaltrials.gov/study/NCT04656301", "doi": "", "pmid": "", "publication_date": "2023-03-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3772, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": "10.31234/osf.io/wupvy", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/wupvy", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-08-09 08:15:13", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/wupvy", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/wupvy", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/wupvy", "source_url": "https://doi.org/10.31234/osf.io/wupvy", "doi": "10.31234/osf.io/wupvy", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3233, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "Mika Turkia", "journal": "PsyArXiv", "publication_date": "2023-03-10", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "doi": "", "pmid": "", "publication_date": "2023-03-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4833, "title": "Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?", "authors": "Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand", "journal": "Clinical Chemistry", "publication_date": "2023-03-07", "publication_year": 2023, "doi": "10.1093/clinchem/hvad016", "pubmed_id": "36881769", "openalex_id": "https://openalex.org/W4323351497", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "PMID:36881769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36881769", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "doi": "10.1093/clinchem/hvad016", "pmid": "36881769", "publication_date": "2023-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1536, "title": "Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.", "authors": "Kalkman HO", "journal": "Biomedicines", "publication_date": "2023-03-07", "publication_year": 2023, "doi": "10.3390/biomedicines11030806", "pubmed_id": "36979785", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,In Vitro Study,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:36979785", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36979785", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "doi": "10.3390/biomedicines11030806", "pmid": "36979785", "publication_date": "2023-03-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1552, "title": "A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.", "authors": "Kisely S, Connor M, Somogyi AA, Siskind D", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1177/00048674221083868", "pubmed_id": "35285280", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285280/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:35285280", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35285280/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35285280", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285280/", "doi": "10.1177/00048674221083868", "pmid": "35285280", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1549, "title": "Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.", "authors": "Heal DJ, Gosden J, Smith SL, Atterwill CK", "journal": "Neuropharmacology", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2022.109375", "pubmed_id": "36529260", "openalex_id": "https://openalex.org/W4311766514", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36529260/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Animal Study,Safety,Toxicity,Drug Interactions,Inflammation", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36529260", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36529260/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36529260", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36529260/", "doi": "10.1016/j.neuropharm.2022.109375", "pmid": "36529260", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1548, "title": "Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.", "authors": "Otterman LS", "journal": "Journal of bioethical inquiry", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1007/s11673-022-10220-9", "pubmed_id": "36534233", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36534233/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36534233", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36534233/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36534233", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36534233/", "doi": "10.1007/s11673-022-10220-9", "pmid": "36534233", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1542, "title": "Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.", "authors": "Jha MK, Mathew SJ", "journal": "The American journal of psychiatry", "publication_date": "2023-03-01", "publication_year": 2023, "doi": "10.1176/appi.ajp.20230025", "pubmed_id": "36855876", "openalex_id": "https://openalex.org/W4322719045", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36855876", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36855876", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36855876/", "doi": "10.1176/appi.ajp.20230025", "pmid": "36855876", "publication_date": "2023-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1553, "title": "Effect of psilocybin on decision-making and motivation in the healthy rat.", "authors": "Roberts BF, Zylko AL, Waters CE, Crowder JD, Gibbons WJ, Sen AK, Jones JA, McMurray MS", "journal": "Behavioural brain research", "publication_date": "2023-02-25", "publication_year": 2023, "doi": "10.1016/j.bbr.2022.114262", "pubmed_id": "36529299", "openalex_id": "https://openalex.org/W36529299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36529299/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36529299", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36529299/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36529299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36529299/", "doi": "10.1016/j.bbr.2022.114262", "pmid": "36529299", "publication_date": "2023-02-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4846, "title": "Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First", "authors": "Jacques Ambrose, J.S. Zabinski", "journal": "Psychiatric News", "publication_date": "2023-02-16", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.03.3.43", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321033113", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "doi": "10.1176/appi.pn.2023.03.3.43", "pmid": "", "publication_date": "2023-02-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4845, "title": "Psychedelics Legislation Gains Momentum", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-02-16", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.03.3.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321017755", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.4", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.4", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.4", "doi": "10.1176/appi.pn.2023.03.3.4", "pmid": "", "publication_date": "2023-02-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1557, "title": "Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.", "authors": "Meir P, Taylor L, Soares JC, Meyer TD", "journal": "Journal of affective disorders", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1016/j.jad.2022.12.050", "pubmed_id": "36535547", "openalex_id": "https://openalex.org/W4312084004", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36535547/", "substance_tags": "psilocybin", "topic_tags": "Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36535547", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36535547/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36535547", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36535547/", "doi": "10.1016/j.jad.2022.12.050", "pmid": "36535547", "publication_date": "2023-02-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1564, "title": "Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.", "authors": "Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF", "journal": "Toxics", "publication_date": "2023-02-03", "publication_year": 2023, "doi": "10.3390/toxics11020148", "pubmed_id": "36851023", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36851023/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36851023", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36851023/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36851023", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36851023/", "doi": "10.3390/toxics11020148", "pmid": "36851023", "publication_date": "2023-02-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1573, "title": "Novel antidepressant drugs: Beyond monoamine targets.", "authors": "Gonda X, Dome P, Neill JC, Tarazi FI", "journal": "CNS spectrums", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1017/s1092852921000791", "pubmed_id": "34588093", "openalex_id": "https://openalex.org/W3204478846", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:34588093", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34588093", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34588093/", "doi": "10.1017/s1092852921000791", "pmid": "34588093", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1569, "title": "5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.", "authors": "Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, Chow WL, Gray JA, Olson DE", "journal": "ACS chemical neuroscience", "publication_date": "2023-02-01", "publication_year": 2023, "doi": "10.1021/acschemneuro.2c00718", "pubmed_id": "36630260", "openalex_id": "https://openalex.org/W4315620747", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36630260/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Pharmacology,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36630260", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36630260/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36630260", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36630260/", "doi": "10.1021/acschemneuro.2c00718", "pmid": "36630260", "publication_date": "2023-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4855, "title": "Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial", "authors": "Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-18", "publication_year": 2023, "doi": "10.1556/2054.2022.00222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317355030", "source_url": "https://doi.org/10.1556/2054.2022.00222", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00222", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00222", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00222", "source_url": "https://doi.org/10.1556/2054.2022.00222", "doi": "10.1556/2054.2022.00222", "pmid": "", "publication_date": "2023-01-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4856, "title": "Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder", "authors": "Dragana Marković, Eleonora Čapelja", "journal": "AIDASCO Reviews", "publication_date": "2023-01-17", "publication_year": 2023, "doi": "10.59783/aire.2023.15", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406142619", "source_url": "https://doi.org/10.59783/aire.2023.15", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.59783/aire.2023.15", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59783/aire.2023.15", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59783/aire.2023.15", "source_url": "https://doi.org/10.59783/aire.2023.15", "doi": "10.59783/aire.2023.15", "pmid": "", "publication_date": "2023-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3568, "title": "Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "Keith Heinzerling", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-17", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04410913", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Mystical Experience,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04410913", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "source_url": "https://clinicaltrials.gov/study/NCT04410913", "doi": "", "pmid": "", "publication_date": "2023-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1576, "title": "Is psilocybin an effective antidepressant and what is its Mechanism of action?", "authors": "Mann JJ", "journal": "Cell reports. Medicine", "publication_date": "2023-01-17", "publication_year": 2023, "doi": "10.1016/j.xcrm.2022.100906", "pubmed_id": "36652915", "openalex_id": "https://openalex.org/W4316876990", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36652915/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36652915", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36652915/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36652915", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36652915/", "doi": "10.1016/j.xcrm.2022.100906", "pmid": "36652915", "publication_date": "2023-01-17", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4858, "title": "Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeism", "authors": "Benjamin A. Korman", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-16", "publication_year": 2023, "doi": "10.1556/2054.2022.00240", "pubmed_id": null, "openalex_id": "https://openalex.org/W4316511320", "source_url": "https://doi.org/10.1556/2054.2022.00240", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00240", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00240", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00240", "source_url": "https://doi.org/10.1556/2054.2022.00240", "doi": "10.1556/2054.2022.00240", "pmid": "", "publication_date": "2023-01-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1577, "title": "On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression.", "authors": "Gukasyan N", "journal": "Med (New York, N.Y.)", "publication_date": "2023-01-13", "publication_year": 2023, "doi": "10.1016/j.medj.2022.12.003", "pubmed_id": "36640755", "openalex_id": "https://openalex.org/W4315874306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36640755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36640755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36640755/", "doi": "10.1016/j.medj.2022.12.003", "pmid": "36640755", "publication_date": "2023-01-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4862, "title": "Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa", "authors": "Sebastian William Foster", "journal": "South African Journal on Human Rights", "publication_date": "2023-01-02", "publication_year": 2023, "doi": "10.1080/02587203.2023.2202875", "pubmed_id": null, "openalex_id": "https://openalex.org/W4376279288", "source_url": "http://dx.doi.org/10.1080/02587203.2023.2202875", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1080/02587203.2023.2202875", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1080/02587203.2023.2202875", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/02587203.2023.2202875", "source_url": "http://dx.doi.org/10.1080/02587203.2023.2202875", "doi": "10.1080/02587203.2023.2202875", "pmid": "", "publication_date": "2023-01-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5820, "title": "Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review", "authors": "Fabiano F. da Silva, Thaysa Adriane Costa Bernardo, Johny Ricarte das Silva Rodrigues, Pierre Teodósio Félix", "journal": "IJS - International Journal of Sciences", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.29327/229003.5.3-1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4395102419", "source_url": "https://doi.org/10.29327/229003.5.3-1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Chronic Pain,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:38", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.29327/229003.5.3-1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29327/229003.5.3-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29327/229003.5.3-1", "source_url": "https://doi.org/10.29327/229003.5.3-1", "doi": "10.29327/229003.5.3-1", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4887, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study", "authors": "Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.102906", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223380", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "doi": "10.1016/j.nsa.2023.102906", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4868, "title": "The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa", "authors": "Sebastian William Foster", "journal": "Law Democracy & Development", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.17159/2077-4907/2023/ldd.v27.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4366774867", "source_url": "https://doi.org/10.17159/2077-4907/2023/ldd.v27.1", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-08-09 08:25:38", "bibtex": null, "source_record_id": "DOI:10.17159/2077-4907/2023/ldd.v27.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17159/2077-4907/2023/ldd.v27.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17159/2077-4907/2023/ldd.v27.1", "source_url": "https://doi.org/10.17159/2077-4907/2023/ldd.v27.1", "doi": "10.17159/2077-4907/2023/ldd.v27.1", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1614, "title": "Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.", "authors": "Simonsson O, Goldberg SB", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2021.2022816", "pubmed_id": "35000559", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35000559/", "substance_tags": "psilocybin", "topic_tags": "Randomized Controlled Trial,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35000559", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35000559/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35000559", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35000559/", "doi": "10.1080/02791072.2021.2022816", "pmid": "35000559", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1611, "title": "The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.", "authors": "Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2044096", "pubmed_id": "35225726", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Microdosing,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35225726", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35225726", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225726/", "doi": "10.1080/02791072.2022.2044096", "pmid": "35225726", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1608, "title": "The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.", "authors": "Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V", "journal": "Canadian journal of psychiatry. Revue canadienne de psychiatrie", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/07067437221111371", "pubmed_id": "35975555", "openalex_id": "https://openalex.org/W4292262959", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35975555", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35975555", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35975555/", "doi": "10.1177/07067437221111371", "pmid": "35975555", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1606, "title": "The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.", "authors": "Johnston CB, Mangini M, Grob C, Anderson B", "journal": "The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1016/j.jagp.2022.08.007", "pubmed_id": "36184377", "openalex_id": "https://openalex.org/W4294723946", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36184377/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36184377", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36184377/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36184377", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36184377/", "doi": "10.1016/j.jagp.2022.08.007", "pmid": "36184377", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1597, "title": "Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.", "authors": "Morton E, Sakai K, Ashtari A, Pleet M, Michalak EE, Woolley J", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221131997", "pubmed_id": "36515370", "openalex_id": "https://openalex.org/W4311477082", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36515370", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36515370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36515370/", "doi": "10.1177/02698811221131997", "pmid": "36515370", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1595, "title": "Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.", "authors": "Henningfield JE, Ashworth J, Heal DJ, Smith SL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1177/02698811221140004", "pubmed_id": "36588452", "openalex_id": "https://openalex.org/W4313424238", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36588452/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36588452", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36588452/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36588452", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36588452/", "doi": "10.1177/02698811221140004", "pmid": "36588452", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1593, "title": "Psilocybin in Palliative Care: An Update.", "authors": "Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S", "journal": "Current geriatrics reports", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1007/s13670-023-00383-7", "pubmed_id": "37305379", "openalex_id": "https://openalex.org/W4366089680", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37305379/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Aging,Emotional Processing,Spirituality,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:37305379", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37305379/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37305379", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37305379/", "doi": "10.1007/s13670-023-00383-7", "pmid": "37305379", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1587, "title": "Biological embedding of early trauma: the role of higher prefrontal synaptic strength.", "authors": "Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG", "journal": "European journal of psychotraumatology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/20008066.2023.2246338", "pubmed_id": "37642398", "openalex_id": "https://openalex.org/W4386255018", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37642398/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:37642398", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37642398/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37642398", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37642398/", "doi": "10.1080/20008066.2023.2246338", "pmid": "37642398", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1585, "title": "Efficacy and Safety of Psychedelics in Treating Anxiety Disorders.", "authors": "Feulner L, Sermchaiwong T, Rodland N, Galarneau D", "journal": "Ochsner journal", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.31486/toj.23.0076", "pubmed_id": "38143548", "openalex_id": "https://openalex.org/W4389868195", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38143548/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:38143548", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38143548/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38143548", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38143548/", "doi": "10.31486/toj.23.0076", "pmid": "38143548", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1584, "title": "Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment.", "authors": "Edelsohn GA, Sisti D", "journal": "Perspectives in biology and medicine", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1353/pbm.2023.0007", "pubmed_id": "38662012", "openalex_id": "https://openalex.org/W4324007078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Personality Change,Clinical Trial,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:38662012", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38662012", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38662012/", "doi": "10.1353/pbm.2023.0007", "pmid": "38662012", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1574, "title": "Classic psychedelics do not affect T cell and monocyte immune responses.", "authors": "Rudin D, Areesanan A, Liechti ME, Gründemann C", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1042440", "pubmed_id": "36741125", "openalex_id": "https://openalex.org/W4317631458", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36741125/", "substance_tags": "psilocin", "topic_tags": "End-of-Life Distress,Safety,Immune Function", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:17", "bibtex": null, "source_record_id": "PMID:36741125", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36741125/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36741125", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36741125/", "doi": "10.3389/fpsyt.2023.1042440", "pmid": "36741125", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1523, "title": "Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.", "authors": "Shaw L, Rea K, Lachowsky NJ, Roth EA", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2022.2054746", "pubmed_id": "35315749", "openalex_id": "https://openalex.org/W4220816548", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35315749/", "substance_tags": "psilocybin", "topic_tags": "Aging,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:35315749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35315749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35315749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35315749/", "doi": "10.1080/02791072.2022.2054746", "pmid": "35315749", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1509, "title": "The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.", "authors": "IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I", "journal": "Innovations in clinical neuroscience", "publication_date": "2023-01-01", "publication_year": 2023, "doi": null, "pubmed_id": "37387703", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37387703", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37387703", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37387703/", "doi": "", "pmid": "37387703", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1506, "title": "Use of Selective Alternative Therapies for Treatment of OCD.", "authors": "Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A", "journal": "Neuropsychiatric disease and treatment", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.2147/ndt.s403997", "pubmed_id": "37041856", "openalex_id": "https://openalex.org/W4362614112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37041856/", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37041856", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37041856/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37041856", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37041856/", "doi": "10.2147/ndt.s403997", "pmid": "37041856", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1499, "title": "Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.", "authors": "Ching THW, Grazioplene R, Bohner C, Kichuk SA, DePalmer G, D'Amico E, Eilbott J, Jankovsky A, Burke M, Hokanson J, Martins B, Witherow C, Patel P, Amoroso L, Schaer H, Pittenger C, Kelmendi B", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1178529", "pubmed_id": "37181888", "openalex_id": "https://openalex.org/W4366989647", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37181888/", "substance_tags": "psilocybin", "topic_tags": "OCD,Brain Imaging,Mechanism of Action,Aging,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37181888", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37181888/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37181888", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37181888/", "doi": "10.3389/fpsyt.2023.1178529", "pmid": "37181888", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1485, "title": "Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders.", "authors": "Blest-Hopley G, Amit BH, O'Neill A, Ruffell SGD", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1191970", "pubmed_id": "37252138", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37252138/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:16", "bibtex": null, "source_record_id": "PMID:37252138", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37252138", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37252138/", "doi": "10.3389/fpsyt.2023.1191970", "pmid": "37252138", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1461, "title": "Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.", "authors": "Phan AN, Terry GE", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1144276", "pubmed_id": "37435402", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37435402/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37435402", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37435402/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37435402", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37435402/", "doi": "10.3389/fpsyt.2023.1144276", "pmid": "37435402", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1458, "title": "Medical student attitudes and perceptions of psychedelic-assisted therapies.", "authors": "Li I, Fong R, Hagen M, Tabaac B", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1190507", "pubmed_id": "37441143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37441143/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37441143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37441143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37441143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37441143/", "doi": "10.3389/fpsyt.2023.1190507", "pmid": "37441143", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1457, "title": "Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.", "authors": "Blond BN, Schindler EAD", "journal": "Frontiers in neurology", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fneur.2023.1214969", "pubmed_id": "37456653", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37456653/", "substance_tags": "psilocybin", "topic_tags": "Case Report,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:15", "bibtex": null, "source_record_id": "PMID:37456653", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37456653/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37456653", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37456653/", "doi": "10.3389/fneur.2023.1214969", "pmid": "37456653", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1435, "title": "Adapting psychedelic medicine for headache and chronic pain disorders.", "authors": "Schindler EAD, Hendricks PS", "journal": "Expert review of neurotherapeutics", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/14737175.2023.2246655", "pubmed_id": "37652000", "openalex_id": "https://openalex.org/W4386317658", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Review Article,Case Report,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37652000", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37652000", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37652000/", "doi": "10.1080/14737175.2023.2246655", "pmid": "37652000", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1434, "title": "Assessing potential of psilocybin for depressive disorders.", "authors": "Kozak Z, Johnson MW, Aaronson ST", "journal": "Expert opinion on investigational drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/13543784.2023.2273493", "pubmed_id": "37869790", "openalex_id": "https://openalex.org/W4387866078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:14", "bibtex": null, "source_record_id": "PMID:37869790", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37869790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37869790/", "doi": "10.1080/13543784.2023.2273493", "pmid": "37869790", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1416, "title": "Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.", "authors": "Boehnke KF, Cox K, Weston C, Herberholz M, Glynos N, Kolbman N, Fields CW, Barron J, Kruger DJ", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1224551", "pubmed_id": "37599880", "openalex_id": "https://openalex.org/W4385581517", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37599880/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety,Adverse Events,Drug Interactions", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37599880", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37599880/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37599880", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37599880/", "doi": "10.3389/fpsyt.2023.1224551", "pmid": "37599880", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1381, "title": "Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.", "authors": "Lawrence DW", "journal": "Innovations in clinical neuroscience", "publication_date": "2023-01-01", "publication_year": 2023, "doi": null, "pubmed_id": "37817818", "openalex_id": "https://openalex.org/W4387516129", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817818/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Pharmacology,Receptor Pharmacology,Case Report,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:34:28", "bibtex": null, "source_record_id": "PMID:37817818", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37817818/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37817818", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817818/", "doi": "", "pmid": "37817818", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1380, "title": "Psychedelics for treatment resistant depression: are they game changers?", "authors": "Kalfas M, Taylor RH, Tsapekos D, Young AH", "journal": "Expert opinion on pharmacotherapy", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/14656566.2023.2281582", "pubmed_id": "37947195", "openalex_id": "https://openalex.org/W4388574768", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37947195/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:13", "bibtex": null, "source_record_id": "PMID:37947195", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37947195/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37947195", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37947195/", "doi": "10.1080/14656566.2023.2281582", "pmid": "37947195", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1373, "title": "Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.", "authors": "Heinzerling KG, Sergi K, Linton M, Rich R, Youssef B, Bentancourt I, Bramen J, Siddarth P, Schwartzberg L, Kelly DF", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1215972", "pubmed_id": "37795513", "openalex_id": "https://openalex.org/W4386849390", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795513/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37795513", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37795513/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37795513", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37795513/", "doi": "10.3389/fpsyt.2023.1215972", "pmid": "37795513", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1371, "title": "Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the \"high-risk\" addiction patient.", "authors": "Black T", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1159843", "pubmed_id": "37799400", "openalex_id": "https://openalex.org/W4386931181", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37799400/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Wellbeing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37799400", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37799400/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37799400", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37799400/", "doi": "10.3389/fpsyt.2023.1159843", "pmid": "37799400", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1370, "title": "Manic episode following psilocybin use in a man with bipolar II disorder: a case report.", "authors": "Halim HJ, Burk BG, Fargason RE, Birur B", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1221131", "pubmed_id": "37810598", "openalex_id": "https://openalex.org/W4386961159", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37810598/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Case Report,Treatment-Resistant Depression,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37810598", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37810598/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37810598", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37810598/", "doi": "10.3389/fpsyt.2023.1221131", "pmid": "37810598", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1355, "title": "Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.", "authors": "Barnett BS, Bassir Nia A, Sackett NB, Weleff J", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1305478", "pubmed_id": "37928914", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37928914/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37928914", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37928914", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37928914/", "doi": "10.3389/fpsyt.2023.1305478", "pmid": "37928914", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1351, "title": "\"How Do I Learn More About this?\": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.", "authors": "Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2023.2201263", "pubmed_id": "37078418", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37078418/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37078418", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37078418/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37078418", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37078418/", "doi": "10.1080/02791072.2023.2201263", "pmid": "37078418", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1347, "title": "A Proposal to Study the Safety and Efficacy of in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder.", "authors": "Escamilla R, González-Trujano ME, González Mariscal JM, Torres-Valencia JM, Guzmán-González H, Vega JL, Loizaga-Velder A", "journal": "Journal of psychoactive drugs", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02791072.2023.2246459", "pubmed_id": "37594163", "openalex_id": "https://openalex.org/W4385969211", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37594163/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:37594163", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37594163/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37594163", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37594163/", "doi": "10.1080/02791072.2023.2246459", "pmid": "37594163", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1335, "title": "Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.", "authors": "Kvam TM, Uthaug MV, Andersen KAA, Refsum BB, Tunstad PA, Stewart LH, Jacobsen HB, Grønnerød C", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1287196", "pubmed_id": "38025484", "openalex_id": "https://openalex.org/W4388646562", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38025484/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:12", "bibtex": null, "source_record_id": "PMID:38025484", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38025484/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38025484", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38025484/", "doi": "10.3389/fpsyt.2023.1287196", "pmid": "38025484", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1261, "title": "Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.", "authors": "Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B", "journal": "Frontiers in psychiatry", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1278823", "pubmed_id": "38264632", "openalex_id": "https://openalex.org/W4390753253", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38264632/", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:11", "bibtex": null, "source_record_id": "PMID:38264632", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38264632/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38264632", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38264632/", "doi": "10.3389/fpsyt.2023.1278823", "pmid": "38264632", "publication_date": "2023-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1630, "title": "Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.", "authors": "O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP", "journal": "Contemporary clinical trials", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1016/j.cct.2022.106976", "pubmed_id": "36332827", "openalex_id": "https://openalex.org/W4308040950", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36332827/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36332827", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36332827/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36332827", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36332827/", "doi": "10.1016/j.cct.2022.106976", "pmid": "36332827", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1627, "title": "Psychedelic-Assisted Therapy for People with Eating Disorders.", "authors": "Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS", "journal": "Current psychiatry reports", "publication_date": "2022-12-01", "publication_year": 2022, "doi": "10.1007/s11920-022-01394-5", "pubmed_id": "36374357", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36374357", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36374357", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "doi": "10.1007/s11920-022-01394-5", "pmid": "36374357", "publication_date": "2022-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1638, "title": "Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.", "authors": "Gotvaldová K, Borovička J, Hájková K, Cihlářová P, Rockefeller A, Kuchař M", "journal": "International journal of molecular sciences", "publication_date": "2022-11-15", "publication_year": 2022, "doi": "10.3390/ijms232214068", "pubmed_id": "36430546", "openalex_id": "https://openalex.org/W4309210963", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36430546/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Microdosing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36430546", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36430546/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36430546", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36430546/", "doi": "10.3390/ijms232214068", "pmid": "36430546", "publication_date": "2022-11-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3442, "title": "A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2022-11-08", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02061293", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02061293", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "source_url": "https://clinicaltrials.gov/study/NCT02061293", "doi": "", "pmid": "", "publication_date": "2022-11-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1642, "title": "Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.", "authors": "Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E", "journal": "The New England journal of medicine", "publication_date": "2022-11-03", "publication_year": 2022, "doi": "10.1056/nejmoa2206443", "pubmed_id": "36322843", "openalex_id": "https://openalex.org/W4308146982", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36322843", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36322843", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36322843/", "doi": "10.1056/nejmoa2206443", "pmid": "36322843", "publication_date": "2022-11-03", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4910, "title": "The psychedelic renaissance: can psilocybin possibly combat depression?", "authors": "Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh", "journal": "International Journal of Surgery Global Health", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1097/gh9.0000000000000089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318965036", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Wellbeing,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-08-09 08:25:39", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000089", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "doi": "10.1097/gh9.0000000000000089", "pmid": "", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1650, "title": "Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.", "authors": "Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ", "journal": "Neuropharmacology", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1016/j.neuropharm.2022.109220", "pubmed_id": "35987353", "openalex_id": "https://openalex.org/W4292136326", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35987353/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Spirituality,Safety,Abuse Liability", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:35987353", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35987353/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35987353", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35987353/", "doi": "10.1016/j.neuropharm.2022.109220", "pmid": "35987353", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1635, "title": "Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.", "authors": "Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J", "journal": "Cureus", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.7759/cureus.31796", "pubmed_id": "36569662", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36569662", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36569662", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36569662/", "doi": "10.7759/cureus.31796", "pmid": "36569662", "publication_date": "2022-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3461, "title": "The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-25", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433845", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433845", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "source_url": "https://clinicaltrials.gov/study/NCT04433845", "doi": "", "pmid": "", "publication_date": "2022-10-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3685, "title": "An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)", "authors": "Beckley Psytech Limited", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-12", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04905121", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04905121", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "source_url": "https://clinicaltrials.gov/study/NCT04905121", "doi": "", "pmid": "", "publication_date": "2022-10-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3765, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355", "authors": "Ching THW, Kichuk S, DePalmer G, Pittenger C, Kelmendi B.", "journal": "PsyArXiv", "publication_date": "2022-10-05", "publication_year": 2022, "doi": "10.31234/osf.io/85s9p", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/85s9p", "substance_tags": "psilocybin", "topic_tags": "OCD,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-08-09 08:15:10", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/85s9p", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/85s9p", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/85s9p", "source_url": "https://doi.org/10.31234/osf.io/85s9p", "doi": "10.31234/osf.io/85s9p", "pmid": "", "publication_date": "2022-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3204, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355", "authors": "Terence Ching, Stephen Kichuk, Giuliana DePalmer, Christopher Pittenger, Benjamin Kelmendi", "journal": "PsyArXiv", "publication_date": "2022-10-05", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/85s9p_v1", "substance_tags": "psilocybin", "topic_tags": "OCD,Pharmacology,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/85s9p_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/85s9p_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/85s9p_v1", "source_url": "https://osf.io/preprints/psyarxiv/85s9p_v1", "doi": "", "pmid": "", "publication_date": "2022-10-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1690, "title": "Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.", "authors": "Timmermann C, Watts R, Dupuis D", "journal": "Transcultural psychiatry", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1177/13634615221082796", "pubmed_id": "35313754", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35313754/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35313754", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35313754/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35313754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35313754/", "doi": "10.1177/13634615221082796", "pmid": "35313754", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1689, "title": "If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.", "authors": "Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC", "journal": "The journal of pain", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1016/j.jpain.2022.05.003", "pubmed_id": "35643270", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Consciousness,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35643270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35643270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "doi": "10.1016/j.jpain.2022.05.003", "pmid": "35643270", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1685, "title": "Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.", "authors": "Levin A, Nagib PB, Deiparine S, Gao T, Mitchell J, Davis AK", "journal": "The International journal on drug policy", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1016/j.drugpo.2022.103816", "pubmed_id": "35964449", "openalex_id": "https://openalex.org/W4290990311", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35964449/", "substance_tags": "psilocybin", "topic_tags": "Aging,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35964449", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35964449/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35964449", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35964449/", "doi": "10.1016/j.drugpo.2022.103816", "pmid": "35964449", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1682, "title": "Prevalence and associations of classic psychedelic-related seizures in a population-based sample.", "authors": "Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS", "journal": "Drug and alcohol dependence", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1016/j.drugalcdep.2022.109586", "pubmed_id": "35981469", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35981469/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35981469", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35981469/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35981469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35981469/", "doi": "10.1016/j.drugalcdep.2022.109586", "pmid": "35981469", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1679, "title": "Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.", "authors": "Kaypak AC, Raz A", "journal": "Transcultural psychiatry", "publication_date": "2022-10-01", "publication_year": 2022, "doi": "10.1177/13634615221119386", "pubmed_id": "36031848", "openalex_id": "https://openalex.org/W4293426683", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36031848/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36031848", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36031848/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36031848", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36031848/", "doi": "10.1177/13634615221119386", "pmid": "36031848", "publication_date": "2022-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3244, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA.", "journal": "PsyArXiv", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.31234/osf.io/kh3cx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:14", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kh3cx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kh3cx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kh3cx", "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "doi": "10.31234/osf.io/kh3cx", "pmid": "", "publication_date": "2022-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 643, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Robert F. Dougherty, Patrick Clarke, Merve Alti, Joanna Kuc, Danielle Schlosser, Boadie W. Dunlop, David J. Hellerstein, Scott T. Aaronson, Sidney Zisook, Allan H Young", "journal": "PsyArXiv", "publication_date": "2022-09-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-08-09 08:20:21", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "doi": "", "pmid": "", "publication_date": "2022-09-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3477, "title": "Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2022-09-22", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04519957", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04519957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "source_url": "https://clinicaltrials.gov/study/NCT04519957", "doi": "", "pmid": "", "publication_date": "2022-09-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1693, "title": "Psychedelic drugs for psychiatric disorders.", "authors": "da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M", "journal": "Journal of the neurological sciences", "publication_date": "2022-09-15", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120332", "pubmed_id": "35841696", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Consciousness,Aging,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35841696", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35841696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35841696/", "doi": "10.1016/j.jns.2022.120332", "pmid": "35841696", "publication_date": "2022-09-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1695, "title": "Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.", "authors": "Mellner C, Dahlen M, Simonsson O", "journal": "International journal of environmental research and public health", "publication_date": "2022-09-09", "publication_year": 2022, "doi": "10.3390/ijerph191811353", "pubmed_id": "36141631", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36141631/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36141631", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36141631/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36141631", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36141631/", "doi": "10.3390/ijerph191811353", "pmid": "36141631", "publication_date": "2022-09-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3383, "title": "Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder", "authors": "Rodrigues J, Nombora O, Ribeiro L.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2022-09-01", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9567436", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:31", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9567436", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9567436", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9567436", "source_url": "https://europepmc.org/article/PMC/PMC9567436", "doi": "", "pmid": "", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3376, "title": "Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop", "authors": "National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders.", "journal": "National Academies Press (US), Washington (DC)", "publication_date": "2022-09-01", "publication_year": 2022, "doi": null, "pubmed_id": "36049038", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36049038", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:29", "bibtex": null, "source_record_id": "PMID:36049038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36049038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36049038", "source_url": "https://europepmc.org/article/MED/36049038", "doi": "", "pmid": "36049038", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1703, "title": "Psychedelics as preventive treatment in headache and chronic pain disorders.", "authors": "Schindler EAD", "journal": "Neuropharmacology", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1016/j.neuropharm.2022.109166", "pubmed_id": "35718005", "openalex_id": "https://openalex.org/W4282962482", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35718005/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35718005", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35718005/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35718005", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35718005/", "doi": "10.1016/j.neuropharm.2022.109166", "pmid": "35718005", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1700, "title": "Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.", "authors": "Clifton JM, Belcher AM, Greenblatt AD, Welsh CM, Cole TO, Davis AK", "journal": "Journal of psychedelic studies", "publication_date": "2022-09-01", "publication_year": 2022, "doi": "10.1556/2054.2022.00214", "pubmed_id": "36686617", "openalex_id": "https://openalex.org/W4291721232", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36686617/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:36686617", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36686617/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36686617", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36686617/", "doi": "10.1556/2054.2022.00214", "pmid": "36686617", "publication_date": "2022-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4941, "title": "A-118 Psychedelic Interventions for Neuropsychological Conditions", "authors": "Brian Peacock", "journal": "Archives of Clinical Neuropsychology", "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1093/arclin/acac060.118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292089187", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1093/arclin/acac060.118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/arclin/acac060.118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/arclin/acac060.118", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "doi": "10.1093/arclin/acac060.118", "pmid": "", "publication_date": "2022-08-16", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1713, "title": "Review of potential psychedelic treatments for PTSD.", "authors": "Henner RL, Keshavan MS, Hill KP", "journal": "Journal of the neurological sciences", "publication_date": "2022-08-15", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120302", "pubmed_id": "35700643", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35700643/", "substance_tags": "psilocybin,psilocin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35700643", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35700643/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35700643", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35700643/", "doi": "10.1016/j.jns.2022.120302", "pmid": "35700643", "publication_date": "2022-08-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4946, "title": "Med Check: Psilocybin for OCD, Nuplazid Vote, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.08.8.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4289781881", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "doi": "10.1176/appi.pn.2022.08.8.2", "pmid": "", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1729, "title": "Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.", "authors": "Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y", "journal": "Journal of palliative medicine", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1089/jpm.2022.0036", "pubmed_id": "35285721", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35285721", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35285721", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "doi": "10.1089/jpm.2022.0036", "pmid": "35285721", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1728, "title": "Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.", "authors": "Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1177/02698811221084063", "pubmed_id": "35388724", "openalex_id": "https://openalex.org/W4226060882", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35388724/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Spirituality,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35388724", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35388724/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35388724", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35388724/", "doi": "10.1177/02698811221084063", "pmid": "35388724", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1725, "title": "The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.", "authors": "Polito V, Liknaitzky P", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1016/j.neubiorev.2022.104706", "pubmed_id": "35609684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35609684/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Consciousness,Microdosing,Wellbeing,Personality Change,Creativity,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35609684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35609684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35609684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35609684/", "doi": "10.1016/j.neubiorev.2022.104706", "pmid": "35609684", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1724, "title": "Postpartum depression: A role for psychedelics?", "authors": "Jairaj C, Rucker JJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-08-01", "publication_year": 2022, "doi": "10.1177/02698811221093793", "pubmed_id": "35638179", "openalex_id": "https://openalex.org/W4281640359", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35638179/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35638179", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35638179/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35638179", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35638179/", "doi": "10.1177/02698811221093793", "pmid": "35638179", "publication_date": "2022-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3594, "title": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2022-07-25", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04661514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04661514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "source_url": "https://clinicaltrials.gov/study/NCT04661514", "doi": "", "pmid": "", "publication_date": "2022-07-25", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1735, "title": "A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.", "authors": "Farley M, Tran H, Towler S, Gevorkyan J, Pearring S, Rodda LN", "journal": "Journal of analytical toxicology", "publication_date": "2022-07-14", "publication_year": 2022, "doi": "10.1093/jat/bkab075", "pubmed_id": "34159389", "openalex_id": "https://openalex.org/W3177184994", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34159389/", "substance_tags": "psilocin", "topic_tags": "Addiction,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:34159389", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34159389/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34159389", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34159389/", "doi": "10.1093/jat/bkab075", "pmid": "34159389", "publication_date": "2022-07-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3220, "title": "Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity", "authors": "Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM.", "journal": "medRxiv", "publication_date": "2022-07-10", "publication_year": 2022, "doi": "10.1101/2022.07.10.22277414", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:12", "bibtex": null, "source_record_id": "DOI:10.1101/2022.07.10.22277414", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.07.10.22277414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.07.10.22277414", "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "doi": "10.1101/2022.07.10.22277414", "pmid": "", "publication_date": "2022-07-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3379, "title": "Pharmacotherapy for the Secondary Prevention of Suicide: Leads from the Social Pain Hypothesis", "authors": "Rajkumar RP.", "journal": "Preprints.org", "publication_date": "2022-07-05", "publication_year": 2022, "doi": "10.20944/preprints202207.0064.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202207.0064.v1", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:29", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202207.0064.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202207.0064.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202207.0064.v1", "source_url": "https://doi.org/10.20944/preprints202207.0064.v1", "doi": "10.20944/preprints202207.0064.v1", "pmid": "", "publication_date": "2022-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1738, "title": "Psychedelics in the treatment of unipolar and bipolar depression.", "authors": "Bosch OG, Halm S, Seifritz E", "journal": "International journal of bipolar disorders", "publication_date": "2022-07-05", "publication_year": 2022, "doi": "10.1186/s40345-022-00265-5", "pubmed_id": "35788817", "openalex_id": "https://openalex.org/W4283813871", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35788817", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35788817", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35788817/", "doi": "10.1186/s40345-022-00265-5", "pmid": "35788817", "publication_date": "2022-07-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1751, "title": "Psilocybin: A brief overview for psychiatric mental health nurse practitioners.", "authors": "Fradkin D", "journal": "Perspectives in psychiatric care", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1111/ppc.12888", "pubmed_id": "34101846", "openalex_id": "https://openalex.org/W3169192423", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34101846/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34101846", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34101846/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34101846", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34101846/", "doi": "10.1111/ppc.12888", "pmid": "34101846", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1744, "title": "The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.", "authors": "Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS", "journal": "Psychiatry research", "publication_date": "2022-07-01", "publication_year": 2022, "doi": "10.1016/j.psychres.2022.114577", "pubmed_id": "35580433", "openalex_id": "https://openalex.org/W4224751771", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35580433/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:35580433", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35580433/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35580433", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35580433/", "doi": "10.1016/j.psychres.2022.114577", "pmid": "35580433", "publication_date": "2022-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3653, "title": "Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults", "authors": "Wake Network, Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2022-06-30", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04989972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04989972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "source_url": "https://clinicaltrials.gov/study/NCT04989972", "doi": "", "pmid": "", "publication_date": "2022-06-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4956, "title": "Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions", "authors": "Annie M. McCartney, H. T. McGovern, Alexander De Foe", "journal": "Journal of Psychedelic Studies", "publication_date": "2022-06-09", "publication_year": 2022, "doi": "10.1556/2054.2022.00211", "pubmed_id": null, "openalex_id": "https://openalex.org/W4282040347", "source_url": "https://doi.org/10.1556/2054.2022.00211", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00211", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00211", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00211", "source_url": "https://doi.org/10.1556/2054.2022.00211", "doi": "10.1556/2054.2022.00211", "pmid": "", "publication_date": "2022-06-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1776, "title": "Serotonin toxicity of serotonergic psychedelics.", "authors": "Malcolm B, Thomas K", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-021-05876-x", "pubmed_id": "34251464", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34251464/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34251464", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34251464/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34251464", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34251464/", "doi": "10.1007/s00213-021-05876-x", "pmid": "34251464", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1773, "title": "Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.", "authors": "Bender D, Hellerstein DJ", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-021-06049-6", "pubmed_id": "35022823", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35022823", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35022823", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35022823/", "doi": "10.1007/s00213-021-06049-6", "pmid": "35022823", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1770, "title": "The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.", "authors": "Maia LO, Beaussant Y, Garcia ACM", "journal": "Journal of pain and symptom management", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1016/j.jpainsymman.2022.01.024", "pubmed_id": "35157985", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35157985/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35157985", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35157985/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35157985", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35157985/", "doi": "10.1016/j.jpainsymman.2022.01.024", "pmid": "35157985", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1769, "title": "The therapeutic potential of psilocybin: a systematic review.", "authors": "van Amsterdam J, van den Brink W", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2047929", "pubmed_id": "35225143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35225143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35225143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35225143/", "doi": "10.1080/14740338.2022.2047929", "pmid": "35225143", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1768, "title": "Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.", "authors": "Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J", "journal": "Psychopharmacology", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06092-x", "pubmed_id": "35233648", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35233648/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35233648", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35233648/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35233648", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35233648/", "doi": "10.1007/s00213-022-06092-x", "pmid": "35233648", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1764, "title": "Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.", "authors": "Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA", "journal": "Metabolic engineering communications", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1016/j.mec.2022.e00196", "pubmed_id": "35310468", "openalex_id": "https://openalex.org/W4220669239", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35310468/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35310468", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35310468/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35310468", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35310468/", "doi": "10.1016/j.mec.2022.e00196", "pmid": "35310468", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1762, "title": "Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?", "authors": "Husain MI, Umer M, Mulsant BH", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2063274", "pubmed_id": "35387542", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35387542", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35387542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "doi": "10.1080/14740338.2022.2063274", "pmid": "35387542", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1761, "title": "Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.", "authors": "Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG", "journal": "Expert opinion on drug safety", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2066650", "pubmed_id": "35426754", "openalex_id": "https://openalex.org/W4223893856", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35426754", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35426754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35426754/", "doi": "10.1080/14740338.2022.2066650", "pmid": "35426754", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1753, "title": "3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.", "authors": "Inouye A, Wolfgang A", "journal": "Cureus", "publication_date": "2022-06-01", "publication_year": 2022, "doi": "10.7759/cureus.26402", "pubmed_id": "35915689", "openalex_id": "https://openalex.org/W4283698346", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35915689", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35915689", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35915689/", "doi": "10.7759/cureus.26402", "pmid": "35915689", "publication_date": "2022-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4962, "title": "SP56 Psychedelic drugs and pain", "authors": "M Rekatsina, E Moka, A Vadalouca, G Varrassi", "journal": "Invited speakers", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1136/rapm-2022-esra.62", "pubmed_id": null, "openalex_id": "https://openalex.org/W4291018630", "source_url": "https://doi.org/10.1136/rapm-2022-esra.62", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:37:59", "bibtex": null, "source_record_id": "DOI:10.1136/rapm-2022-esra.62", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/rapm-2022-esra.62", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/rapm-2022-esra.62", "source_url": "https://doi.org/10.1136/rapm-2022-esra.62", "doi": "10.1136/rapm-2022-esra.62", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4959, "title": "The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.", "authors": "Manish Agrawal, Paul Thambi, Sarah Shnayder", "journal": "Journal of Clinical Oncology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1200/jco.2022.40.16_suppl.12097", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281784879", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "doi": "10.1200/jco.2022.40.16_suppl.12097", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4967, "title": "Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits", "authors": "Richard Karel", "journal": "Psychiatric News", "publication_date": "2022-05-23", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.06.6.30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281400661", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Consciousness,Wellbeing,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "doi": "10.1176/appi.pn.2022.06.6.30", "pmid": "", "publication_date": "2022-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4966, "title": "An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus", "authors": "Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout", "journal": "Frontiers in Forests and Global Change", "publication_date": "2022-05-23", "publication_year": 2022, "doi": "10.3389/ffgc.2022.813998", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281296724", "source_url": "https://doi.org/10.3389/ffgc.2022.813998", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:41", "bibtex": null, "source_record_id": "DOI:10.3389/ffgc.2022.813998", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/ffgc.2022.813998", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/ffgc.2022.813998", "source_url": "https://doi.org/10.3389/ffgc.2022.813998", "doi": "10.3389/ffgc.2022.813998", "pmid": "", "publication_date": "2022-05-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3676, "title": "Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression", "authors": "National Institute of Mental Health, Czech Republic", "journal": "ClinicalTrials.gov", "publication_date": "2022-05-20", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05383313", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-08-09 10:12:42", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05383313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "source_url": "https://clinicaltrials.gov/study/NCT05383313", "doi": "", "pmid": "", "publication_date": "2022-05-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1788, "title": "Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.", "authors": "Mocanu V, Mackay L, Christie D, Argento E", "journal": "Substance abuse treatment, prevention, and policy", "publication_date": "2022-05-14", "publication_year": 2022, "doi": "10.1186/s13011-022-00468-0", "pubmed_id": "35568884", "openalex_id": "https://openalex.org/W4280525486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35568884/", "substance_tags": "psilocybin", "topic_tags": "Aging,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35568884", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35568884/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35568884", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35568884/", "doi": "10.1186/s13011-022-00468-0", "pmid": "35568884", "publication_date": "2022-05-14", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4973, "title": "P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy", "authors": "Stéphanie Knatz Peck, Samatha Shao, Susan Murray, Walter H. Kaye", "journal": "Biological Psychiatry", "publication_date": "2022-04-27", "publication_year": 2022, "doi": "10.1016/j.biopsych.2022.02.686", "pubmed_id": null, "openalex_id": "https://openalex.org/W4293242421", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.686", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2022.02.686", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2022.02.686", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.686", "doi": "10.1016/j.biopsych.2022.02.686", "pmid": "", "publication_date": "2022-04-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1793, "title": "Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.", "authors": "Hackl B, Todt H, Kubista H, Hilber K, Koenig X", "journal": "The international journal of neuropsychopharmacology", "publication_date": "2022-04-19", "publication_year": 2022, "doi": "10.1093/ijnp/pyab085", "pubmed_id": "34871422", "openalex_id": "https://openalex.org/W4200455094", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34871422/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34871422", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34871422/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34871422", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34871422/", "doi": "10.1093/ijnp/pyab085", "pmid": "34871422", "publication_date": "2022-04-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4976, "title": "Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discrimination", "authors": "Cátia Esteves, Elena M. M. de Redrojo, José Luis Manjón, Gabriel Moreno, Filipe E. Antunes, Gemma Montalvo, Fernando E. Ortega-Ojeda", "journal": "Forensic Chemistry", "publication_date": "2022-04-08", "publication_year": 2022, "doi": "10.1016/j.forc.2022.100421", "pubmed_id": null, "openalex_id": "https://openalex.org/W4224903330", "source_url": "https://doi.org/10.1016/j.forc.2022.100421", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1016/j.forc.2022.100421", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.forc.2022.100421", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.forc.2022.100421", "source_url": "https://doi.org/10.1016/j.forc.2022.100421", "doi": "10.1016/j.forc.2022.100421", "pmid": "", "publication_date": "2022-04-08", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1799, "title": "Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.", "authors": "Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK", "journal": "Fungal biology", "publication_date": "2022-04-01", "publication_year": 2022, "doi": "10.1016/j.funbio.2022.01.003", "pubmed_id": "35314062", "openalex_id": "https://openalex.org/W4211114943", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35314062/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35314062", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35314062/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35314062", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35314062/", "doi": "10.1016/j.funbio.2022.01.003", "pmid": "35314062", "publication_date": "2022-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4980, "title": "Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?", "authors": "Michael Avissar, Adrian Jacques H. Ambrose", "journal": "Psychiatric News", "publication_date": "2022-03-24", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.04.4.35", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220982704", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-08-09 08:25:42", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "doi": "10.1176/appi.pn.2022.04.4.35", "pmid": "", "publication_date": "2022-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1808, "title": "Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.", "authors": "Pearson C, Siegel J, Gold JA", "journal": "Journal of the neurological sciences", "publication_date": "2022-03-15", "publication_year": 2022, "doi": "10.1016/j.jns.2021.120096", "pubmed_id": "34942586", "openalex_id": "https://openalex.org/W4200117112", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34942586", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34942586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34942586/", "doi": "10.1016/j.jns.2021.120096", "pmid": "34942586", "publication_date": "2022-03-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1809, "title": "Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.", "authors": "Meade E, Hehir S, Rowan N, Garvey M", "journal": "Journal of fungi (Basel, Switzerland)", "publication_date": "2022-03-11", "publication_year": 2022, "doi": "10.3390/jof8030290", "pubmed_id": "35330292", "openalex_id": "https://openalex.org/W4220724929", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35330292/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Review Article,Safety,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35330292", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35330292/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35330292", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35330292/", "doi": "10.3390/jof8030290", "pmid": "35330292", "publication_date": "2022-03-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1817, "title": "Beating pain with psychedelics: Matter over mind?", "authors": "Elman I, Pustilnik A, Borsook D", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1016/j.neubiorev.2021.12.005", "pubmed_id": "34922987", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34922987/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:34922987", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34922987/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34922987", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34922987/", "doi": "10.1016/j.neubiorev.2021.12.005", "pmid": "34922987", "publication_date": "2022-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1815, "title": "Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.", "authors": "Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1177/02698811211069100", "pubmed_id": "35107059", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35107059/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Healthcare Workers,Safety,Toxicity,Abuse Liability", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35107059", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35107059/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35107059", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35107059/", "doi": "10.1177/02698811211069100", "pmid": "35107059", "publication_date": "2022-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1813, "title": "Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.", "authors": "Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF", "journal": "Current treatment options in oncology", "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1007/s11864-022-00954-4", "pubmed_id": "35254595", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35254595/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Aging,Cancer Patients,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35254595", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35254595/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35254595", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35254595/", "doi": "10.1007/s11864-022-00954-4", "pmid": "35254595", "publication_date": "2022-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1822, "title": "Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.", "authors": "Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP", "journal": "Journal of clinical medicine", "publication_date": "2022-02-11", "publication_year": 2022, "doi": "10.3390/jcm11040938", "pubmed_id": "35207210", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35207210/", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35207210", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35207210/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35207210", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35207210/", "doi": "10.3390/jcm11040938", "pmid": "35207210", "publication_date": "2022-02-11", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1827, "title": "Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.", "authors": "Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-02-01", "publication_year": 2022, "doi": "10.1177/02698811211073759", "pubmed_id": "35166158", "openalex_id": "https://openalex.org/W4212903385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Spirituality,Mystical Experience,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35166158", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35166158", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35166158/", "doi": "10.1177/02698811211073759", "pmid": "35166158", "publication_date": "2022-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1825, "title": "Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.", "authors": "Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR", "journal": "Cureus", "publication_date": "2022-02-01", "publication_year": 2022, "doi": "10.7759/cureus.21944", "pubmed_id": "35273885", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35273885", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35273885", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35273885/", "doi": "10.7759/cureus.21944", "pmid": "35273885", "publication_date": "2022-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5007, "title": "Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects", "authors": "Friederike Holze, Laura Ley, F. Müller, V. Nimmy, Anne Eckert, Matthias E. Liechti", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100075", "pubmed_id": null, "openalex_id": "https://openalex.org/W4221097544", "source_url": "https://doi.org/10.1016/j.nsa.2022.100075", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Biomarkers,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100075", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100075", "source_url": "https://doi.org/10.1016/j.nsa.2022.100075", "doi": "10.1016/j.nsa.2022.100075", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5005, "title": "The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial", "authors": "G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100213", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313200620", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100213", "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "doi": "10.1016/j.nsa.2022.100213", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5004, "title": "Psychedelic Agents as Potential Therapeutics for Obsessive Compulsive Disorder", "authors": "Josh Nagra", "journal": "DOAJ (DOAJ: Directory of Open Access Journals)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W4390649922", "source_url": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Receptor Pharmacology,Safety,Inflammation", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "source_url": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "doi": "", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5002, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial", "authors": "G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199626", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "doi": "10.1016/j.nsa.2022.100511", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4998, "title": "An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma", "authors": "F. N. Smith, Joanna C. Neill, Verity Wainwright", "journal": "Drug Science Policy and Law", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/20503245221124117", "pubmed_id": null, "openalex_id": "https://openalex.org/W4295169116", "source_url": "https://doi.org/10.1177/20503245221124117", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.1177/20503245221124117", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245221124117", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245221124117", "source_url": "https://doi.org/10.1177/20503245221124117", "doi": "10.1177/20503245221124117", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 4996, "title": "Should Adolescents be Included in Emerging Psychedelic Research?", "authors": "Khaleel Rajwani", "journal": "Canadian Journal of Bioethics", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.7202/1089784ar", "pubmed_id": null, "openalex_id": "https://openalex.org/W4285297088", "source_url": "https://doi.org/10.7202/1089784ar", "substance_tags": "psilocybin", "topic_tags": "Adolescents,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.7202/1089784ar", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7202/1089784ar", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.7202/1089784ar", "source_url": "https://doi.org/10.7202/1089784ar", "doi": "10.7202/1089784ar", "pmid": "", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1867, "title": "Psychedelics and health behaviour change.", "authors": "Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211008554", "pubmed_id": "34053342", "openalex_id": "https://openalex.org/W3164067847", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34053342/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Mechanism of Action,Receptor Pharmacology,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34053342", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34053342/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34053342", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34053342/", "doi": "10.1177/02698811211008554", "pmid": "34053342", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1865, "title": "Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.", "authors": "Mayer CE, LeBaron VT, Acquaviva KD", "journal": "Journal of psychoactive drugs", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1080/02791072.2021.1916659", "pubmed_id": "34266372", "openalex_id": "https://openalex.org/W3178288974", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34266372/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34266372", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34266372/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34266372", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34266372/", "doi": "10.1080/02791072.2021.1916659", "pmid": "34266372", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1862, "title": "United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.", "authors": "Barnett BS, Parker SE, Weleff J", "journal": "The International journal on drug policy", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.drugpo.2021.103473", "pubmed_id": "34624734", "openalex_id": "https://openalex.org/W3203419443", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34624734/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34624734", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34624734/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34624734", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34624734/", "doi": "10.1016/j.drugpo.2021.103473", "pmid": "34624734", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1856, "title": "Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.", "authors": "Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA", "journal": "Psychopharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/s00213-021-06027-y", "pubmed_id": "34812901", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34812901/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34812901", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34812901/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34812901", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34812901/", "doi": "10.1007/s00213-021-06027-y", "pmid": "34812901", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1849, "title": "MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.", "authors": "Jones GM, Nock MK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211058923", "pubmed_id": "34983249", "openalex_id": "https://openalex.org/W4206486089", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34983249/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34983249", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34983249/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34983249", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34983249/", "doi": "10.1177/02698811211058923", "pmid": "34983249", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1848, "title": "Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.", "authors": "Jones GM, Nock MK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211066714", "pubmed_id": "34983261", "openalex_id": "https://openalex.org/W4205618858", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34983261/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34983261", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34983261/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34983261", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34983261/", "doi": "10.1177/02698811211066714", "pmid": "34983261", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1847, "title": "The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.", "authors": "Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1177/02698811211064720", "pubmed_id": "35090363", "openalex_id": "https://openalex.org/W4205906672", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35090363", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35090363", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35090363/", "doi": "10.1177/02698811211064720", "pmid": "35090363", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1843, "title": "Psychedelics in the Treatment of Headache and Chronic Pain Disorders.", "authors": "Schindler EAD", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2022_365", "pubmed_id": "35546382", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35546382/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35546382", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35546382/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35546382", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35546382/", "doi": "10.1007/7854_2022_365", "pmid": "35546382", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1841, "title": "Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.", "authors": "Johnson MW", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2022_327", "pubmed_id": "35704271", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35704271/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35704271", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35704271/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35704271", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35704271/", "doi": "10.1007/7854_2022_327", "pmid": "35704271", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1840, "title": "Psilocybin for Trauma-Related Disorders.", "authors": "Khan AJ, Bradley E, O'Donovan A, Woolley J", "journal": "Current topics in behavioral neurosciences", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1007/7854_2022_366", "pubmed_id": "35711024", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35711024/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Emotional Processing,Veterans,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35711024", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35711024/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35711024", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35711024/", "doi": "10.1007/7854_2022_366", "pmid": "35711024", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1811, "title": "Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.", "authors": "Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G", "journal": "Neuroscience applied", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100104", "pubmed_id": "40656230", "openalex_id": "https://openalex.org/W4220708535", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:40656230", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40656230", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40656230/", "doi": "10.1016/j.nsa.2022.100104", "pmid": "40656230", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1807, "title": "Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Raison CL, Jain R, Penn AD, Cole SP, Jain S", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.831092", "pubmed_id": "35370864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35370864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35370864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "doi": "10.3389/fpsyt.2022.831092", "pmid": "35370864", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1804, "title": "Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.", "authors": "Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT", "journal": "Frontiers in epidemiology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fepid.2022.876706", "pubmed_id": "38455323", "openalex_id": "https://openalex.org/W4220885585", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38455323/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:38455323", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38455323/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38455323", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38455323/", "doi": "10.3389/fepid.2022.876706", "pmid": "38455323", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1783, "title": "Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.", "authors": "Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW", "journal": "Frontiers in psychology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyg.2022.873279", "pubmed_id": "35677124", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35677124/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:20", "bibtex": null, "source_record_id": "PMID:35677124", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35677124/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35677124", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35677124/", "doi": "10.3389/fpsyg.2022.873279", "pmid": "35677124", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1708, "title": "Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.", "authors": "Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J", "journal": "Journal of psychoactive drugs", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1080/02791072.2021.1971343", "pubmed_id": "34468293", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34468293/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:19", "bibtex": null, "source_record_id": "PMID:34468293", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34468293/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34468293", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34468293/", "doi": "10.1080/02791072.2021.1971343", "pmid": "34468293", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1661, "title": "A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.", "authors": "Sottile RJ, Vida T", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.991753", "pubmed_id": "36311515", "openalex_id": "https://openalex.org/W4304784508", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36311515/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36311515", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36311515/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36311515", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36311515/", "doi": "10.3389/fpsyt.2022.991753", "pmid": "36311515", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1649, "title": "A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.", "authors": "Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI", "journal": "Journal of clinical psychopharmacology", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001608", "pubmed_id": "36193898", "openalex_id": "https://openalex.org/W4301392523", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36193898", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36193898", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36193898/", "doi": "10.1097/jcp.0000000000001608", "pmid": "36193898", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1644, "title": "[Treatment-resistant depression. From classification to new therapies.].", "authors": "Paganin W, Signorini S, Leccese V, Sciarretta A", "journal": "Rivista di psichiatria", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1708/3922.39072", "pubmed_id": "36503940", "openalex_id": "https://openalex.org/W4311667760", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36503940/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36503940", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36503940/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36503940", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36503940/", "doi": "10.1708/3922.39072", "pmid": "36503940", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1625, "title": "Therapeutic use of psilocybin: Practical considerations for dosing and administration.", "authors": "MacCallum CA, Lo LA, Pistawka CA, Deol JK", "journal": "Frontiers in psychiatry", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.1040217", "pubmed_id": "36532184", "openalex_id": "https://openalex.org/W4311043198", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36532184/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Review Article,Safety,Adverse Events,Drug Interactions,Contraindications", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36532184", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36532184/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36532184", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36532184/", "doi": "10.3389/fpsyt.2022.1040217", "pmid": "36532184", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1620, "title": "\"A sense of the bigger picture:\" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.", "authors": "DellaCrosse M, Pleet M, Morton E, Ashtari A, Sakai K, Woolley J, Michalak E", "journal": "PloS one", "publication_date": "2022-01-01", "publication_year": 2022, "doi": "10.1371/journal.pone.0279073", "pubmed_id": "36516137", "openalex_id": "https://openalex.org/W4311439362", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:18", "bibtex": null, "source_record_id": "PMID:36516137", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36516137", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36516137/", "doi": "10.1371/journal.pone.0279073", "pmid": "36516137", "publication_date": "2022-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5025, "title": "Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020", "authors": "Victor Chiruta, Paulina K Zemla, Pixie Miller, Nicola Santarossa, John A Hannan", "journal": "Journal of Medical and Health Studies", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.32996/jmhs.2021.2.2.18", "pubmed_id": null, "openalex_id": "https://openalex.org/W3129289556", "source_url": "https://doi.org/10.32996/jmhs.2021.2.2.18", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:43", "bibtex": null, "source_record_id": "DOI:10.32996/jmhs.2021.2.2.18", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.32996/jmhs.2021.2.2.18", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.32996/jmhs.2021.2.2.18", "source_url": "https://doi.org/10.32996/jmhs.2021.2.2.18", "doi": "10.32996/jmhs.2021.2.2.18", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1871, "title": "Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.", "authors": "Niles H, Fogg C, Kelmendi B, Lazenby M", "journal": "BMC palliative care", "publication_date": "2021-12-20", "publication_year": 2021, "doi": "10.1186/s12904-021-00889-x", "pubmed_id": "34930220", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34930220", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34930220", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "doi": "10.1186/s12904-021-00889-x", "pmid": "34930220", "publication_date": "2021-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5037, "title": "P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status", "authors": "Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer", "journal": "European Neuropsychopharmacology", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.394", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200326768", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "doi": "10.1016/j.euroneuro.2021.10.394", "pmid": "", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5034, "title": "P.0623 The clinical relevance of the pharmacokinetics of psilocybin", "authors": "A. Andreiev, E. Bucuci, James Chue, Charl Els, Pierre Chue", "journal": "European Neuropsychopharmacology", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.588", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200545220", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.588", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.588", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.588", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.588", "doi": "10.1016/j.euroneuro.2021.10.588", "pmid": "", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1880, "title": "Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.", "authors": "Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D", "journal": "The Australian and New Zealand journal of psychiatry", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1177/0004867421998785", "pubmed_id": "33745287", "openalex_id": "https://openalex.org/W3134642859", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33745287/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:33745287", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33745287/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33745287", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33745287/", "doi": "10.1177/0004867421998785", "pmid": "33745287", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1877, "title": "Use of hallucinogens in Slovakia: Does it differ from global trends?", "authors": "Lukačovič M, Masaryk R", "journal": "The International journal on drug policy", "publication_date": "2021-12-01", "publication_year": 2021, "doi": "10.1016/j.drugpo.2021.103385", "pubmed_id": "34364200", "openalex_id": "https://openalex.org/W3193012633", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34364200/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34364200", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34364200/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34364200", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34364200/", "doi": "10.1016/j.drugpo.2021.103385", "pmid": "34364200", "publication_date": "2021-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5041, "title": "Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.11.29", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216860842", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "doi": "10.1176/appi.pn.2021.11.29", "pmid": "", "publication_date": "2021-11-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5045, "title": "Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea", "authors": "David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman", "journal": "Psychiatric News", "publication_date": "2021-11-29", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.12.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216344082", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-08-09 08:25:44", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "doi": "10.1176/appi.pn.2021.12.14", "pmid": "", "publication_date": "2021-11-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3335, "title": "Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies", "authors": "Weleff J, Akiki TJ, Barnett BS.", "journal": "medRxiv", "publication_date": "2021-11-24", "publication_year": 2021, "doi": "10.1101/2021.11.22.21266718", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.11.22.21266718", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:25", "bibtex": null, "source_record_id": "DOI:10.1101/2021.11.22.21266718", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.11.22.21266718", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.11.22.21266718", "source_url": "https://doi.org/10.1101/2021.11.22.21266718", "doi": "10.1101/2021.11.22.21266718", "pmid": "", "publication_date": "2021-11-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1882, "title": "Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.", "authors": "Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2021-11-24", "publication_year": 2021, "doi": "10.3390/ph14121213", "pubmed_id": "34959614", "openalex_id": "https://openalex.org/W3215766429", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34959614/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Spirituality,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34959614", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34959614/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34959614", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34959614/", "doi": "10.3390/ph14121213", "pmid": "34959614", "publication_date": "2021-11-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3459, "title": "The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder", "authors": "Maryland Oncology Hematology, PA", "journal": "ClinicalTrials.gov", "publication_date": "2021-10-15", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04593563", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:43", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04593563", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "source_url": "https://clinicaltrials.gov/study/NCT04593563", "doi": "", "pmid": "", "publication_date": "2021-10-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1901, "title": "Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.", "authors": "Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT", "journal": "Experimental and clinical psychopharmacology", "publication_date": "2021-10-01", "publication_year": 2021, "doi": "10.1037/pha0000490", "pubmed_id": "34096755", "openalex_id": "https://openalex.org/W3171546624", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34096755", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34096755", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34096755/", "doi": "10.1037/pha0000490", "pmid": "34096755", "publication_date": "2021-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1899, "title": "Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.", "authors": "Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS", "journal": "Psychiatry investigation", "publication_date": "2021-10-01", "publication_year": 2021, "doi": "10.30773/pi.2021.0209", "pubmed_id": "34619818", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34619818/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34619818", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34619818/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34619818", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34619818/", "doi": "10.30773/pi.2021.0209", "pmid": "34619818", "publication_date": "2021-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1904, "title": "Rediscovering Psilocybin as an Antidepressive Treatment Strategy.", "authors": "Zeiss R, Gahr M, Graf H", "journal": "Pharmaceuticals (Basel, Switzerland)", "publication_date": "2021-09-28", "publication_year": 2021, "doi": "10.3390/ph14100985", "pubmed_id": "34681209", "openalex_id": "https://openalex.org/W3204600425", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34681209/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34681209", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34681209/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34681209", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34681209/", "doi": "10.3390/ph14100985", "pmid": "34681209", "publication_date": "2021-09-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1911, "title": "Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.", "authors": "Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR", "journal": "Pharmacopsychiatry", "publication_date": "2021-09-01", "publication_year": 2021, "doi": "10.1055/a-1524-2794", "pubmed_id": "34348413", "openalex_id": "https://openalex.org/W3160183306", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34348413", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34348413", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34348413/", "doi": "10.1055/a-1524-2794", "pmid": "34348413", "publication_date": "2021-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1910, "title": "Treatment-Resistant Depression: Approaches to Treatment.", "authors": "Kverno KS, Mangano E", "journal": "Journal of psychosocial nursing and mental health services", "publication_date": "2021-09-01", "publication_year": 2021, "doi": "10.3928/02793695-20210816-01", "pubmed_id": "34459676", "openalex_id": "https://openalex.org/W3196802696", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34459676/", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34459676", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34459676/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34459676", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34459676/", "doi": "10.3928/02793695-20210816-01", "pmid": "34459676", "publication_date": "2021-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3395, "title": "Therapeutic interventions for PTSD - current evidence on the the role of psychedelics", "authors": "Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9475922", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:32", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9475922", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9475922", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9475922", "source_url": "https://europepmc.org/article/PMC/PMC9475922", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3346, "title": "Treating addiction with psychedelics - are we waking up?", "authors": "Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A.", "journal": "European psychiatry: the journal of the Association of European Psychiatrists", "publication_date": "2021-08-13", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9480123", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Mystical Experience,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:26", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9480123", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9480123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9480123", "source_url": "https://europepmc.org/article/PMC/PMC9480123", "doi": "", "pmid": "", "publication_date": "2021-08-13", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5071, "title": "What can we learn from the history of research on psychedelic drugs in the addictions?", "authors": "Wayne Hall, Michael Farrell", "journal": "Addiction", "publication_date": "2021-08-12", "publication_year": 2021, "doi": "10.1111/add.15560", "pubmed_id": "34382252", "openalex_id": "https://openalex.org/W3187445852", "source_url": "https://doi.org/10.1111/add.15560", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34382252", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.15560", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34382252", "source_url": "https://doi.org/10.1111/add.15560", "doi": "10.1111/add.15560", "pmid": "34382252", "publication_date": "2021-08-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2137, "title": "Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.", "authors": "van Dongen RM, Alderliefste GJ, Onderwater GLJ, Ferrari MD, Terwindt GM", "journal": "European journal of neurology", "publication_date": "2021-07-31", "publication_year": 2021, "doi": "10.1111/ene.14914", "pubmed_id": "33979006", "openalex_id": "https://openalex.org/W3160485194", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33979006/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "PMID:33979006", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33979006/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33979006", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33979006/", "doi": "10.1111/ene.14914", "pmid": "33979006", "publication_date": "2021-07-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2139, "title": "The Potential Role of Serotonergic Hallucinogens in Depression Treatment.", "authors": "Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M", "journal": "Life (Basel, Switzerland)", "publication_date": "2021-07-29", "publication_year": 2021, "doi": "10.3390/life11080765", "pubmed_id": "34440508", "openalex_id": "https://openalex.org/W3193251618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34440508", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34440508", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34440508/", "doi": "10.3390/life11080765", "pmid": "34440508", "publication_date": "2021-07-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5074, "title": "Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis", "authors": "Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić", "journal": "Current Addiction Reports", "publication_date": "2021-07-26", "publication_year": 2021, "doi": "10.1007/s40429-021-00385-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W3186726344", "source_url": "https://doi.org/10.1007/s40429-021-00385-5", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Receptor Pharmacology,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1007/s40429-021-00385-5", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40429-021-00385-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40429-021-00385-5", "source_url": "https://doi.org/10.1007/s40429-021-00385-5", "doi": "10.1007/s40429-021-00385-5", "pmid": "", "publication_date": "2021-07-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5075, "title": "Psychedelic Therapy Hits Another Milestone, But Caution Urged", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-07-22", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.7.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3193219878", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "doi": "10.1176/appi.pn.2021.7.14", "pmid": "", "publication_date": "2021-07-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3481, "title": "A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2021-07-22", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04959253", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:45", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04959253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "source_url": "https://clinicaltrials.gov/study/NCT04959253", "doi": "", "pmid": "", "publication_date": "2021-07-22", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2148, "title": "Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.", "authors": "Mertens LJ, Preller KH", "journal": "Pharmacopsychiatry", "publication_date": "2021-07-01", "publication_year": 2021, "doi": "10.1055/a-1341-1907", "pubmed_id": "33472250", "openalex_id": "https://openalex.org/W3124059976", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33472250", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33472250", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33472250/", "doi": "10.1055/a-1341-1907", "pmid": "33472250", "publication_date": "2021-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2146, "title": "The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.", "authors": "Gründer G, Jungaberle H", "journal": "Pharmacopsychiatry", "publication_date": "2021-07-01", "publication_year": 2021, "doi": "10.1055/a-1486-7386", "pubmed_id": "33979868", "openalex_id": "https://openalex.org/W3162909048", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33979868/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33979868", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33979868/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33979868", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33979868/", "doi": "10.1055/a-1486-7386", "pmid": "33979868", "publication_date": "2021-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3786, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "McCartney A, McGovern H, De Foe A.", "journal": "PsyArXiv", "publication_date": "2021-06-27", "publication_year": 2021, "doi": "10.31234/osf.io/9kuhs", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-08-09 08:15:25", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9kuhs", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9kuhs", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9kuhs", "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "doi": "10.31234/osf.io/9kuhs", "pmid": "", "publication_date": "2021-06-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3336, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "Annie McCartney, Hugh McGovern, Alexander De Foe", "journal": "PsyArXiv", "publication_date": "2021-06-27", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "doi": "", "pmid": "", "publication_date": "2021-06-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5080, "title": "Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa", "authors": "Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire", "journal": "OBM Neurobiology", "publication_date": "2021-06-24", "publication_year": 2021, "doi": "10.21926/obm.neurobiol.2102102", "pubmed_id": null, "openalex_id": "https://openalex.org/W3174884462", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "doi": "10.21926/obm.neurobiol.2102102", "pmid": "", "publication_date": "2021-06-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3208, "title": "Psilocybin: the magic medicine for depression?", "authors": "Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L.", "journal": "BJPsych open", "publication_date": "2021-06-18", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC8770735", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-08-09 08:15:11", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC8770735", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "source_url": "https://europepmc.org/article/PMC/PMC8770735", "doi": "", "pmid": "", "publication_date": "2021-06-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5085, "title": "Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis", "authors": "Gabrielle Agin-Liebes, Eve Ekman, B. Anderson, Maxx Malloy, Alexandra Haas, Josh Woolley", "journal": "Journal of Humanistic Psychology", "publication_date": "2021-06-12", "publication_year": 2021, "doi": "10.1177/00221678211022949", "pubmed_id": null, "openalex_id": "https://openalex.org/W3166459008", "source_url": "https://doi.org/10.1177/00221678211022949", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Spirituality,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1177/00221678211022949", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678211022949", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678211022949", "source_url": "https://doi.org/10.1177/00221678211022949", "doi": "10.1177/00221678211022949", "pmid": "", "publication_date": "2021-06-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5087, "title": "Psilocybin: the magic medicine for depression?", "authors": "Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft", "journal": "BJPsych Open", "publication_date": "2021-06-01", "publication_year": 2021, "doi": "10.1192/bjo.2021.456", "pubmed_id": null, "openalex_id": "https://openalex.org/W3173209673", "source_url": "https://doi.org/10.1192/bjo.2021.456", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1192/bjo.2021.456", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2021.456", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/bjo.2021.456", "source_url": "https://doi.org/10.1192/bjo.2021.456", "doi": "10.1192/bjo.2021.456", "pmid": "", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3385, "title": "Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders", "authors": "Chao YS, Horton J.", "journal": "Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)", "publication_date": "2021-06-01", "publication_year": 2021, "doi": null, "pubmed_id": "36170470", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36170470", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:31", "bibtex": null, "source_record_id": "PMID:36170470", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36170470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36170470", "source_url": "https://europepmc.org/article/MED/36170470", "doi": "", "pmid": "36170470", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2151, "title": "Psychedelic science in post-COVID-19 psychiatry.", "authors": "Kelly JR, Crockett MT, Alexander L, Haran M, Baker A, Burke L, Brennan C, O'Keane V", "journal": "Irish journal of psychological medicine", "publication_date": "2021-06-01", "publication_year": 2021, "doi": "10.1017/ipm.2020.94", "pubmed_id": "32811575", "openalex_id": "https://openalex.org/W3054886531", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:32811575", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32811575", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32811575/", "doi": "10.1017/ipm.2020.94", "pmid": "32811575", "publication_date": "2021-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5091, "title": "The need for publicly funded research on therapeutic use of psychedelic drugs", "authors": "Wayne Hall", "journal": "World Psychiatry", "publication_date": "2021-05-18", "publication_year": 2021, "doi": "10.1002/wps.20847", "pubmed_id": "34002493", "openalex_id": "https://openalex.org/W3162774823", "source_url": "https://doi.org/10.1002/wps.20847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "PMID:34002493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34002493", "source_url": "https://doi.org/10.1002/wps.20847", "doi": "10.1002/wps.20847", "pmid": "34002493", "publication_date": "2021-05-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5094, "title": "Addressing the Implicit Impacts of Sexual Trauma: An Exploration of Somatic Experiencing as an Adjunct to Psilocybin-Assisted Therapy", "authors": "Despina Stratidakis", "journal": "National University System Repository (National University System)", "publication_date": "2021-04-30", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3168063229", "source_url": "http://hdl.handle.net/20.500.11803/1295", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "http://hdl.handle.net/20.500.11803/1295", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/20.500.11803/1295", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/20.500.11803/1295", "source_url": "http://hdl.handle.net/20.500.11803/1295", "doi": "", "pmid": "", "publication_date": "2021-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2173, "title": "On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.", "authors": "Zeifman RJ, Singhal N, Breslow L, Weissman CR", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00024", "pubmed_id": "33860173", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860173/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860173", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860173/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860173", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860173/", "doi": "10.1021/acsptsci.1c00024", "pmid": "33860173", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2170, "title": "Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.", "authors": "Stauffer CS, Anderson BT, Ortigo KM, Woolley J", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.0c00169", "pubmed_id": "33860182", "openalex_id": "https://openalex.org/W3112557491", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860182/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860182", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860182/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860182", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860182/", "doi": "10.1021/acsptsci.0c00169", "pmid": "33860182", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2168, "title": "Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.", "authors": "Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE", "journal": "ACS pharmacology & translational science", "publication_date": "2021-04-09", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00020", "pubmed_id": "33860185", "openalex_id": "https://openalex.org/W3138429576", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33860185", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33860185", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33860185/", "doi": "10.1021/acsptsci.1c00020", "pmid": "33860185", "publication_date": "2021-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3255, "title": "Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies", "authors": "Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD.", "journal": "medRxiv", "publication_date": "2021-04-07", "publication_year": 2021, "doi": "10.1101/2021.04.02.21254838", "pubmed_id": null, "openalex_id": "https://openalex.org/W3201512146", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:25:45", "bibtex": null, "source_record_id": "DOI:10.1101/2021.04.02.21254838", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.04.02.21254838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.04.02.21254838", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "doi": "10.1101/2021.04.02.21254838", "pmid": "", "publication_date": "2021-04-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2180, "title": "Use and abuse of dissociative and psychedelic drugs in adolescence.", "authors": "Bates MLS, Trujillo KA", "journal": "Pharmacology, biochemistry, and behavior", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1016/j.pbb.2021.173129", "pubmed_id": "33515586", "openalex_id": "https://openalex.org/W3123680632", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33515586/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Review Article,Animal Study,Adolescents,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33515586", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33515586/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33515586", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33515586/", "doi": "10.1016/j.pbb.2021.173129", "pmid": "33515586", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2175, "title": "Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.", "authors": "Dos Santos RG, Hallak JE, Baker G, Dursun S", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2021-04-01", "publication_year": 2021, "doi": "10.1177/0269881120986422", "pubmed_id": "33740877", "openalex_id": "https://openalex.org/W3137933781", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33740877/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33740877", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33740877/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33740877", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33740877/", "doi": "10.1177/0269881120986422", "pmid": "33740877", "publication_date": "2021-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5115, "title": "The Return of Psychedelics: Still Time to Prevent Tragedy", "authors": "Stanley N. Caroff", "journal": "Psychiatric News", "publication_date": "2021-03-31", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.4.8", "pubmed_id": null, "openalex_id": "https://openalex.org/W3147930394", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Case Report,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "doi": "10.1176/appi.pn.2021.4.8", "pmid": "", "publication_date": "2021-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3799, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R.", "journal": "PsyArXiv", "publication_date": "2021-03-24", "publication_year": 2021, "doi": "10.31234/osf.io/8vks6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/8vks6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-08-09 08:15:29", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/8vks6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/8vks6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/8vks6", "source_url": "https://doi.org/10.31234/osf.io/8vks6", "doi": "10.31234/osf.io/8vks6", "pmid": "", "publication_date": "2021-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3374, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "Pedro Teixeira, Matthew Johnson, Christopher Timmermann, Rosalind Watts, David Erritzoe, Hannah Douglass, Hannes Kettner, Robin Carhart-Harris", "journal": "PsyArXiv", "publication_date": "2021-03-24", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "doi": "", "pmid": "", "publication_date": "2021-03-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5119, "title": "Session on Psychedelics Sure to Be Enlightening", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-03-01", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.3.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3133604748", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Wellbeing,Emotional Processing,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:25:46", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "doi": "10.1176/appi.pn.2021.3.14", "pmid": "", "publication_date": "2021-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3370, "title": "Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports", "authors": "Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.", "journal": "PsyArXiv", "publication_date": "2021-02-24", "publication_year": 2021, "doi": "10.31234/osf.io/r726d", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/r726d", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-08-09 08:15:28", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/r726d", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/r726d", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/r726d", "source_url": "https://doi.org/10.31234/osf.io/r726d", "doi": "10.31234/osf.io/r726d", "pmid": "", "publication_date": "2021-02-24", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2201, "title": "Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.", "authors": "Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D", "journal": "Acta psychiatrica Scandinavica", "publication_date": "2021-02-01", "publication_year": 2021, "doi": "10.1111/acps.13249", "pubmed_id": "33125716", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33125716/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33125716", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33125716/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33125716", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33125716/", "doi": "10.1111/acps.13249", "pmid": "33125716", "publication_date": "2021-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5141, "title": "Unmet need in depression: Psilocybin, a breakthrough treatment option", "authors": "Yogesh Kumar Chahar", "journal": "International Journal of Advanced Research in Medicine", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.22271/27069567.2021.v3.i1f.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164081616", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "doi": "10.22271/27069567.2021.v3.i1f.159", "pmid": "", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2217, "title": "Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.", "authors": "Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC", "journal": "Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1007/s13311-020-00962-y", "pubmed_id": "33184743", "openalex_id": "https://openalex.org/W3105240299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33184743/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33184743", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33184743/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33184743", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33184743/", "doi": "10.1007/s13311-020-00962-y", "pmid": "33184743", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2214, "title": "Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.", "authors": "Inserra A, De Gregorio D, Gobbi G", "journal": "Pharmacological reviews", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1124/pharmrev.120.000056", "pubmed_id": "33328244", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33328244/", "substance_tags": "psilocybin", "topic_tags": "PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33328244", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33328244/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33328244", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33328244/", "doi": "10.1124/pharmrev.120.000056", "pmid": "33328244", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2211, "title": "Psychedelic Medicines in Major Depression: Progress and Future Challenges.", "authors": "Bouso JC, Ona G, Dos Santos RG, Hallak JEC", "journal": "Advances in experimental medicine and biology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1007/978-981-33-6044-0_26", "pubmed_id": "33834416", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33834416", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33834416", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33834416/", "doi": "10.1007/978-981-33-6044-0_26", "pmid": "33834416", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2198, "title": "Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.", "authors": "Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.586682", "pubmed_id": "33643087", "openalex_id": "https://openalex.org/W3127909847", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33643087", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33643087", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33643087/", "doi": "10.3389/fpsyt.2021.586682", "pmid": "33643087", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2164, "title": "Psilocybin: From Serendipity to Credibility?", "authors": "Rucker JJ, Young AH", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.659044", "pubmed_id": "33967860", "openalex_id": "https://openalex.org/W3154999065", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33967860", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33967860", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33967860/", "doi": "10.3389/fpsyt.2021.659044", "pmid": "33967860", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2156, "title": "Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.", "authors": "Rocha JM, Rossi GN, de Lima Osório F, Bouso JC, de Oliveira Silveira G, Yonamine M, Campos AC, Bertozi G, Cecílio Hallak JE, Dos Santos RG", "journal": "Journal of clinical psychopharmacology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1097/jcp.0000000000001396", "pubmed_id": "33843820", "openalex_id": "https://openalex.org/W3154361912", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33843820/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Wellbeing,Emotional Processing,Randomized Controlled Trial,Healthy Volunteers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:33843820", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33843820/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33843820", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33843820/", "doi": "10.1097/jcp.0000000000001396", "pmid": "33843820", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2144, "title": "Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.", "authors": "Barnett BS, Greer GR", "journal": "Journal of the Academy of Consultation-Liaison Psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.1016/j.jaclp.2020.12.011", "pubmed_id": "34210406", "openalex_id": "https://openalex.org/W3123670341", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34210406/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:22", "bibtex": null, "source_record_id": "PMID:34210406", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34210406/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34210406", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34210406/", "doi": "10.1016/j.jaclp.2020.12.011", "pmid": "34210406", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1889, "title": "Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.", "authors": "Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J", "journal": "Frontiers in psychiatry", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.737738", "pubmed_id": "34803761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Creativity,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:34803761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34803761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "doi": "10.3389/fpsyt.2021.737738", "pmid": "34803761", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 1832, "title": "Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.", "authors": "Markopoulos A, Inserra A, De Gregorio D, Gobbi G", "journal": "Frontiers in pharmacology", "publication_date": "2021-01-01", "publication_year": 2021, "doi": "10.3389/fphar.2021.749068", "pubmed_id": "35177979", "openalex_id": "https://openalex.org/W4210379385", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35177979/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-08-09 08:28:21", "bibtex": null, "source_record_id": "PMID:35177979", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35177979/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35177979", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35177979/", "doi": "10.3389/fphar.2021.749068", "pmid": "35177979", "publication_date": "2021-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5143, "title": "The Effect of Psilocybin on Personality", "authors": "Ravital LaBua", "journal": "CUNY Academic Works (City University of New York)", "publication_date": "2020-12-31", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3194396335", "source_url": "https://academicworks.cuny.edu/gc_etds/4460", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Personality Change,Mystical Experience,Safety,Drug Interactions,Contraindications", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://academicworks.cuny.edu/gc_etds/4460", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://academicworks.cuny.edu/gc_etds/4460", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://academicworks.cuny.edu/gc_etds/4460", "source_url": "https://academicworks.cuny.edu/gc_etds/4460", "doi": "", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2221, "title": "Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.", "authors": "Nkadimeng SM, Steinmann CML, Eloff JN", "journal": "Scientific reports", "publication_date": "2020-12-18", "publication_year": 2020, "doi": "10.1038/s41598-020-79328-5", "pubmed_id": "33339902", "openalex_id": "https://openalex.org/W3115524456", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33339902/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33339902", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33339902/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33339902", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33339902/", "doi": "10.1038/s41598-020-79328-5", "pmid": "33339902", "publication_date": "2020-12-18", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2224, "title": "DARK Classics in Chemical Neuroscience: NBOMes.", "authors": "Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL", "journal": "ACS chemical neuroscience", "publication_date": "2020-12-02", "publication_year": 2020, "doi": "10.1021/acschemneuro.9b00528", "pubmed_id": "31657895", "openalex_id": "https://openalex.org/W2981860490", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31657895/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:31657895", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31657895/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31657895", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31657895/", "doi": "10.1021/acschemneuro.9b00528", "pmid": "31657895", "publication_date": "2020-12-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3491, "title": "Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2020-12-01", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03912974", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Consciousness,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03912974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "source_url": "https://clinicaltrials.gov/study/NCT03912974", "doi": "", "pmid": "", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2228, "title": "The emerging role of psilocybin and MDMA in the treatment of mental illness.", "authors": "Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS", "journal": "Expert review of neurotherapeutics", "publication_date": "2020-12-01", "publication_year": 2020, "doi": "10.1080/14737175.2020.1826931", "pubmed_id": "32954860", "openalex_id": "https://openalex.org/W3087462486", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32954860", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32954860", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32954860/", "doi": "10.1080/14737175.2020.1826931", "pmid": "32954860", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2227, "title": "Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.", "authors": "Ona G, Bouso JC", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2020-12-01", "publication_year": 2020, "doi": "10.1016/j.neubiorev.2020.09.035", "pubmed_id": "33031815", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33031815/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33031815", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33031815/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33031815", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33031815/", "doi": "10.1016/j.neubiorev.2020.09.035", "pmid": "33031815", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2226, "title": "Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.", "authors": "Holoyda B", "journal": "Psychiatric services (Washington, D.C.)", "publication_date": "2020-12-01", "publication_year": 2020, "doi": "10.1176/appi.ps.202000213", "pubmed_id": "33050796", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33050796/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Aging,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33050796", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33050796/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33050796", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33050796/", "doi": "10.1176/appi.ps.202000213", "pmid": "33050796", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2225, "title": "Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.", "authors": "Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL", "journal": "Psychological medicine", "publication_date": "2020-12-01", "publication_year": 2020, "doi": "10.1017/s003329172000389x", "pubmed_id": "33143790", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33143790/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33143790", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33143790/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33143790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33143790/", "doi": "10.1017/s003329172000389x", "pmid": "33143790", "publication_date": "2020-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3822, "title": "Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy", "authors": "Courtney C. Walton, Paul Liknaitzky", "journal": "Journal of Applied Sport Psychology", "publication_date": "2020-11-10", "publication_year": 2020, "doi": "10.1080/10413200.2020.1848941", "pubmed_id": null, "openalex_id": "https://openalex.org/W3100320203", "source_url": "https://doi.org/10.1080/10413200.2020.1848941", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Aging,Wellbeing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.1080/10413200.2020.1848941", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/10413200.2020.1848941", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/10413200.2020.1848941", "source_url": "https://doi.org/10.1080/10413200.2020.1848941", "doi": "10.1080/10413200.2020.1848941", "pmid": "", "publication_date": "2020-11-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3429, "title": "Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2020-10-20", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00957359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-08-09 10:12:44", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00957359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "source_url": "https://clinicaltrials.gov/study/NCT00957359", "doi": "", "pmid": "", "publication_date": "2020-10-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2241, "title": "Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.", "authors": "Cozzi NV, Daley PF", "journal": "Drug testing and analysis", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.1002/dta.2889", "pubmed_id": "32608093", "openalex_id": "https://openalex.org/W3038172304", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32608093", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32608093", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32608093/", "doi": "10.1002/dta.2889", "pmid": "32608093", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2238, "title": "Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.", "authors": "Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J", "journal": "EClinicalMedicine", "publication_date": "2020-10-01", "publication_year": 2020, "doi": "10.1016/j.eclinm.2020.100538", "pubmed_id": "33150319", "openalex_id": "https://openalex.org/W3087859780", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33150319/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Veterans,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:33150319", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33150319/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33150319", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33150319/", "doi": "10.1016/j.eclinm.2020.100538", "pmid": "33150319", "publication_date": "2020-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3834, "title": "Wait for the Science Before Widespread Use of Psilocybin", "authors": "Nicole Harrington Cirino", "journal": "Psychiatric News", "publication_date": "2020-09-29", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.10a32", "pubmed_id": null, "openalex_id": "https://openalex.org/W3091539953", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:47", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "doi": "10.1176/appi.pn.2020.10a32", "pmid": "", "publication_date": "2020-09-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2247, "title": "Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.", "authors": "Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L", "journal": "Biomedicines", "publication_date": "2020-09-05", "publication_year": 2020, "doi": "10.3390/biomedicines8090331", "pubmed_id": "32899469", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32899469", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32899469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32899469/", "doi": "10.3390/biomedicines8090331", "pmid": "32899469", "publication_date": "2020-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2254, "title": "Compassionate use of psychedelics.", "authors": "Greif A, Šurkala M", "journal": "Medicine, health care, and philosophy", "publication_date": "2020-09-01", "publication_year": 2020, "doi": "10.1007/s11019-020-09958-z", "pubmed_id": "32468195", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32468195/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32468195", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32468195/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32468195", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32468195/", "doi": "10.1007/s11019-020-09958-z", "pmid": "32468195", "publication_date": "2020-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2266, "title": "Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.", "authors": "Meinhardt MW, Güngör C, Skorodumov I, Mertens LJ, Spanagel R", "journal": "Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology", "publication_date": "2020-07-01", "publication_year": 2020, "doi": "10.1038/s41386-020-0694-z", "pubmed_id": "32369828", "openalex_id": "https://openalex.org/W3020950088", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32369828/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Microdosing,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32369828", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32369828/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32369828", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32369828/", "doi": "10.1038/s41386-020-0694-z", "pmid": "32369828", "publication_date": "2020-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3846, "title": "A potential role for psilocybin in the treatment of obsessive-compulsive disorder", "authors": "Edward Jacobs", "journal": "Journal of Psychedelic Studies", "publication_date": "2020-06-01", "publication_year": 2020, "doi": "10.1556/2054.2020.00128", "pubmed_id": null, "openalex_id": "https://openalex.org/W3048223422", "source_url": "https://doi.org/10.1556/2054.2020.00128", "substance_tags": "psilocybin", "topic_tags": "Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2020.00128", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2020.00128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2020.00128", "source_url": "https://doi.org/10.1556/2054.2020.00128", "doi": "10.1556/2054.2020.00128", "pmid": "", "publication_date": "2020-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2272, "title": "Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.", "authors": "Rosenbaum D, Weissman C, Anderson T, Petranker R, Dinh-Williams LA, Hui K, Hapke E", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2020-06-01", "publication_year": 2020, "doi": "10.1177/0269881120908004", "pubmed_id": "32108529", "openalex_id": "https://openalex.org/W3007315114", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32108529/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Microdosing,Randomized Controlled Trial,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32108529", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32108529/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32108529", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32108529/", "doi": "10.1177/0269881120908004", "pmid": "32108529", "publication_date": "2020-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3848, "title": "Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-05-28", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.6a34", "pubmed_id": null, "openalex_id": "https://openalex.org/W3033314635", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Consciousness,Aging,Creativity,Case Report,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "doi": "10.1176/appi.pn.2020.6a34", "pmid": "", "publication_date": "2020-05-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2274, "title": "Ethics and ego dissolution: the case of psilocybin.", "authors": "Smith WR, Sisti D", "journal": "Journal of medical ethics", "publication_date": "2020-05-27", "publication_year": 2020, "doi": "10.1136/medethics-2020-106070", "pubmed_id": "32461241", "openalex_id": "https://openalex.org/W3029961383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32461241/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Personality Change,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32461241", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32461241/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32461241", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32461241/", "doi": "10.1136/medethics-2020-106070", "pmid": "32461241", "publication_date": "2020-05-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3850, "title": "Psychedelics, Safety and Clinical Trial Design", "authors": "Ron Shore", "journal": "QSpace (Queen's University Library)", "publication_date": "2020-05-19", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3043468905", "source_url": "http://hdl.handle.net/1974/27835", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://hdl.handle.net/1974/27835", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/1974/27835", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/1974/27835", "source_url": "http://hdl.handle.net/1974/27835", "doi": "", "pmid": "", "publication_date": "2020-05-19", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2282, "title": "A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.", "authors": "Chi T, Gold JA", "journal": "Journal of the neurological sciences", "publication_date": "2020-04-15", "publication_year": 2020, "doi": "10.1016/j.jns.2020.116715", "pubmed_id": "32044687", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/32044687/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32044687", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32044687/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32044687", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32044687/", "doi": "10.1016/j.jns.2020.116715", "pmid": "32044687", "publication_date": "2020-04-15", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2283, "title": "Psilocybin Therapeutic Research: The Present and Future Paradigm.", "authors": "Kargbo RB", "journal": "ACS medicinal chemistry letters", "publication_date": "2020-04-09", "publication_year": 2020, "doi": "10.1021/acsmedchemlett.0c00048", "pubmed_id": "32292538", "openalex_id": "https://openalex.org/W3009264042", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32292538/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32292538", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32292538/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32292538", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32292538/", "doi": "10.1021/acsmedchemlett.0c00048", "pmid": "32292538", "publication_date": "2020-04-09", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3863, "title": "Can Psychedelics Radically Change SUD Treatment?", "authors": "Katie O’Connor", "journal": "Psychiatric News", "publication_date": "2020-03-20", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.2a12", "pubmed_id": null, "openalex_id": "https://openalex.org/W3012401750", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Addiction,Chronic Pain,Pharmacology,Consciousness,Clinical Trial,Observational Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "doi": "10.1176/appi.pn.2020.2a12", "pmid": "", "publication_date": "2020-03-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3866, "title": "Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s", "authors": "Wendy Kline", "journal": "Gender & History", "publication_date": "2020-03-01", "publication_year": 2020, "doi": "10.1111/1468-0424.12471", "pubmed_id": null, "openalex_id": "https://openalex.org/W3016699155", "source_url": "https://doi.org/10.1111/1468-0424.12471", "substance_tags": "psilocybin", "topic_tags": "PTSD,Chronic Pain,Mechanism of Action,Consciousness,Personality Change,Emotional Processing,Creativity,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:48", "bibtex": null, "source_record_id": "DOI:10.1111/1468-0424.12471", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/1468-0424.12471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/1468-0424.12471", "source_url": "https://doi.org/10.1111/1468-0424.12471", "doi": "10.1111/1468-0424.12471", "pmid": "", "publication_date": "2020-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2301, "title": "The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.", "authors": "Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR", "journal": "Psychiatry research", "publication_date": "2020-02-01", "publication_year": 2020, "doi": "10.1016/j.psychres.2020.112749", "pubmed_id": "31931272", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31931272/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Meta-Analysis,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31931272", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31931272/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31931272", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31931272/", "doi": "10.1016/j.psychres.2020.112749", "pmid": "31931272", "publication_date": "2020-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3882, "title": "Medicinal use of psilocybin: Reducing restrictions on research and treatment.", "authors": "James Rucker, Jessie Schnall, Daniel D’Hotman, David King, Timmy Davis, Joanna C. Neill", "journal": "Conservative Drug Policy Reform Group", "publication_date": "2020-01-01", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3047998072", "source_url": "https://www.drugsandalcohol.ie/32599/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:57:51", "bibtex": null, "source_record_id": "https://www.drugsandalcohol.ie/32599/", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.drugsandalcohol.ie/32599/", "source_url": "https://www.drugsandalcohol.ie/32599/", "doi": "", "pmid": "", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2295, "title": "Self-reported negative outcomes of psilocybin users: A quantitative textual analysis.", "authors": "Bienemann B, Ruschel NS, Campos ML, Negreiros MA, Mograbi DC", "journal": "PloS one", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1371/journal.pone.0229067", "pubmed_id": "32084160", "openalex_id": "https://openalex.org/W3007379062", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32084160/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32084160", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32084160/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32084160", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32084160/", "doi": "10.1371/journal.pone.0229067", "pmid": "32084160", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2287, "title": "Psychedelic Microdosing: A Subreddit Analysis.", "authors": "Lea T, Amada N, Jungaberle H", "journal": "Journal of psychoactive drugs", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1080/02791072.2019.1683260", "pubmed_id": "31648596", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Creativity,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31648596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31648596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "doi": "10.1080/02791072.2019.1683260", "pmid": "31648596", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2240, "title": "Hallucinogenic mushroom misuse reported to Texas poison centers.", "authors": "Forrester MB", "journal": "Journal of addictive diseases", "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1080/10550887.2020.1785817", "pubmed_id": "32627708", "openalex_id": "https://openalex.org/W3040125782", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32627708/", "substance_tags": "psilocybin", "topic_tags": "Adolescents,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:23", "bibtex": null, "source_record_id": "PMID:32627708", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32627708/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32627708", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32627708/", "doi": "10.1080/10550887.2020.1785817", "pmid": "32627708", "publication_date": "2020-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3895, "title": "Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019", "authors": "Dax Oliver", "journal": "CUNY Academic Works (City University of New York)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3121348693", "source_url": "https://academicworks.cuny.edu/gc_etds/4074", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://academicworks.cuny.edu/gc_etds/4074", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://academicworks.cuny.edu/gc_etds/4074", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://academicworks.cuny.edu/gc_etds/4074", "source_url": "https://academicworks.cuny.edu/gc_etds/4074", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3891, "title": "The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder", "authors": "Sofia Gyllvik", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3083741926", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3285, "title": "Mapping Psilocybin-Assisted Therapies: A Scoping Review", "authors": "Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On.", "journal": "medRxiv", "publication_date": "2019-12-12", "publication_year": 2019, "doi": "10.1101/2019.12.04.19013896", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-08-09 08:15:18", "bibtex": null, "source_record_id": "DOI:10.1101/2019.12.04.19013896", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2019.12.04.19013896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2019.12.04.19013896", "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "doi": "10.1101/2019.12.04.19013896", "pmid": "", "publication_date": "2019-12-12", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2318, "title": "Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.", "authors": "Andersson M, Kjellgren A", "journal": "Harm reduction journal", "publication_date": "2019-11-28", "publication_year": 2019, "doi": "10.1186/s12954-019-0333-3", "pubmed_id": "31779667", "openalex_id": "https://openalex.org/W2991503240", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31779667/", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Emotional Processing,Safety,Drug Interactions", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:31779667", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31779667/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31779667", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31779667/", "doi": "10.1186/s12954-019-0333-3", "pmid": "31779667", "publication_date": "2019-11-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2320, "title": "Classical psychedelics for the treatment of depression and anxiety: A systematic review.", "authors": "Muttoni S, Ardissino M, John C", "journal": "Journal of affective disorders", "publication_date": "2019-11-01", "publication_year": 2019, "doi": "10.1016/j.jad.2019.07.076", "pubmed_id": "31382100", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31382100", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31382100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31382100/", "doi": "10.1016/j.jad.2019.07.076", "pmid": "31382100", "publication_date": "2019-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3915, "title": "Johns Hopkins Opens Research Center on Psychedelics", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.10a16", "pubmed_id": null, "openalex_id": "https://openalex.org/W2982427347", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Consciousness,Biomarkers,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "doi": "10.1176/appi.pn.2019.10a16", "pmid": "", "publication_date": "2019-10-27", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3920, "title": "Psilocybin for depression: Considerations for clinical trial design", "authors": "Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1556/2054.2019.026", "pubmed_id": null, "openalex_id": "https://openalex.org/W2974814938", "source_url": "https://doi.org/10.1556/2054.2019.026", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.026", "source_url": "https://doi.org/10.1556/2054.2019.026", "doi": "10.1556/2054.2019.026", "pmid": "", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2331, "title": "Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.", "authors": "Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1177/0269881119857204", "pubmed_id": "31303095", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31303095/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Microdosing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31303095", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31303095/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31303095", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31303095/", "doi": "10.1177/0269881119857204", "pmid": "31303095", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2330, "title": "Hallucinogens and Their Therapeutic Use: A Literature Review.", "authors": "Begola MJ, Schillerstrom JE", "journal": "Journal of psychiatric practice", "publication_date": "2019-09-01", "publication_year": 2019, "doi": "10.1097/pra.0000000000000409", "pubmed_id": "31505518", "openalex_id": "https://openalex.org/W2986818733", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31505518/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31505518", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31505518/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31505518", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31505518/", "doi": "10.1097/pra.0000000000000409", "pmid": "31505518", "publication_date": "2019-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2333, "title": "Psychedelic-assisted therapies: The past, and the need to move forward responsibly.", "authors": "Gardner J, Carter A, O'Brien K, Seear K", "journal": "The International journal on drug policy", "publication_date": "2019-08-01", "publication_year": 2019, "doi": "10.1016/j.drugpo.2019.05.019", "pubmed_id": "31136924", "openalex_id": "https://openalex.org/W2945745191", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31136924/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31136924", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31136924/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31136924", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31136924/", "doi": "10.1016/j.drugpo.2019.05.019", "pmid": "31136924", "publication_date": "2019-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3926, "title": "The Potential of Psilocybin Administration in Terminal Cancer Patients", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2019-06-28", "publication_year": 2019, "doi": "10.1097/01.cot.0000574916.46844.cf", "pubmed_id": null, "openalex_id": "https://openalex.org/W2956046898", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:49", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "doi": "10.1097/01.cot.0000574916.46844.cf", "pmid": "", "publication_date": "2019-06-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3936, "title": "Psychedelic Medicine: Careful Studies, Regulations Are the Answer", "authors": "Paul Summergrad", "journal": "Psychiatric News", "publication_date": "2019-04-30", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.5a25", "pubmed_id": null, "openalex_id": "https://openalex.org/W2943550935", "source_url": "https://doi.org/10.1176/appi.pn.2019.5a25", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Mechanism of Action,Aging,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.5a25", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.5a25", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.5a25", "source_url": "https://doi.org/10.1176/appi.pn.2019.5a25", "doi": "10.1176/appi.pn.2019.5a25", "pmid": "", "publication_date": "2019-04-30", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3943, "title": "Is Psychedelic Medicine on the Horizon?", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-02-28", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.1b1", "pubmed_id": null, "openalex_id": "https://openalex.org/W2918650357", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Consciousness,Review Article,Case Report,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "doi": "10.1176/appi.pn.2019.1b1", "pmid": "", "publication_date": "2019-02-28", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3732, "title": "Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS", "journal": "Psychopharmacology", "publication_date": "2019-02-01", "publication_year": 2019, "doi": "10.1007/s00213-018-5106-2", "pubmed_id": "30604183", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30604183/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 11:08:44", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30604183", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30604183/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30604183", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30604183/", "doi": "10.1007/s00213-018-5106-2", "pmid": "30604183", "publication_date": "2019-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2364, "title": "Ceremonial \"plant medicine\" use and its relationship to recreational drug use: an exploratory study.", "authors": "Dorsen C, Palamar J, Shedlin MG", "journal": "Addiction research & theory", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1080/16066359.2018.1455187", "pubmed_id": "31534445", "openalex_id": "https://openalex.org/W2794634193", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31534445/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31534445", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31534445/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31534445", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31534445/", "doi": "10.1080/16066359.2018.1455187", "pmid": "31534445", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2351, "title": "The Past and Future of Psychedelic Science: An Introduction to This Issue.", "authors": "Doblin RE, Christiansen M, Jerome L, Burge B", "journal": "Journal of psychoactive drugs", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1080/02791072.2019.1606472", "pubmed_id": "31132970", "openalex_id": "https://openalex.org/W2947995541", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Creativity,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:31132970", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31132970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31132970/", "doi": "10.1080/02791072.2019.1606472", "pmid": "31132970", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2297, "title": "Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.", "authors": "Sexton JD, Nichols CD, Hendricks PS", "journal": "Frontiers in psychiatry", "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.3389/fpsyt.2019.00896", "pubmed_id": "32116806", "openalex_id": "https://openalex.org/W3006069447", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32116806/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:24", "bibtex": null, "source_record_id": "PMID:32116806", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/32116806/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:32116806", "source_url": "https://pubmed.ncbi.nlm.nih.gov/32116806/", "doi": "10.3389/fpsyt.2019.00896", "pmid": "32116806", "publication_date": "2019-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2370, "title": "Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.", "authors": "Leonard JB, Anderson B, Klein-Schwartz W", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2018-12-01", "publication_year": 2018, "doi": "10.1177/0269881118793086", "pubmed_id": "30182795", "openalex_id": "https://openalex.org/W2889566085", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30182795/", "substance_tags": "psilocybin", "topic_tags": "Adolescents,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30182795", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30182795/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30182795", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30182795/", "doi": "10.1177/0269881118793086", "pmid": "30182795", "publication_date": "2018-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 3405, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS.", "journal": "PsyArXiv", "publication_date": "2018-11-02", "publication_year": 2018, "doi": "10.31234/osf.io/gk4jd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-08-09 08:15:33", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/gk4jd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/gk4jd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/gk4jd", "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "doi": "10.31234/osf.io/gk4jd", "pmid": "", "publication_date": "2018-11-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2360, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "Thomas Anderson, Rotem Petranker, Daniel Rosenbaum, Cory Weissman, Le-Anh Dinh-Williams, Katrina Hui, Emma Hapke, Norman Farb", "journal": "PsyArXiv", "publication_date": "2018-11-02", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:20:22", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "doi": "", "pmid": "", "publication_date": "2018-11-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2377, "title": "Psychiatry & the psychedelic drugs. Past, present & future.", "authors": "Rucker JJH, Iliff J, Nutt DJ", "journal": "Neuropharmacology", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.1016/j.neuropharm.2017.12.040", "pubmed_id": "29284138", "openalex_id": "https://openalex.org/W2781316183", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29284138/", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29284138", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29284138/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29284138", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29284138/", "doi": "10.1016/j.neuropharm.2017.12.040", "pmid": "29284138", "publication_date": "2018-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2375, "title": "The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.", "authors": "Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE", "journal": "Neuropharmacology", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.1016/j.neuropharm.2018.05.012", "pubmed_id": "29753748", "openalex_id": "https://openalex.org/W2806419184", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:29753748", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29753748", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29753748/", "doi": "10.1016/j.neuropharm.2018.05.012", "pmid": "29753748", "publication_date": "2018-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5157, "title": "Serotonin, psychedelics and psychiatry", "authors": "Robin Carhart-Harris", "journal": "World Psychiatry", "publication_date": "2018-09-07", "publication_year": 2018, "doi": "10.1002/wps.20555", "pubmed_id": "30192100", "openalex_id": "https://openalex.org/W2891343109", "source_url": "https://doi.org/10.1002/wps.20555", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:01", "last_checked": "2026-08-09 08:25:50", "bibtex": null, "source_record_id": "PMID:30192100", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20555", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:30192100", "source_url": "https://doi.org/10.1002/wps.20555", "doi": "10.1002/wps.20555", "pmid": "30192100", "publication_date": "2018-09-07", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2389, "title": "Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.", "authors": "Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC", "journal": "Expert review of clinical pharmacology", "publication_date": "2018-09-01", "publication_year": 2018, "doi": "10.1080/17512433.2018.1511424", "pubmed_id": "30102078", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102078/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30102078", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30102078/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30102078", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30102078/", "doi": "10.1080/17512433.2018.1511424", "pmid": "30102078", "publication_date": "2018-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2391, "title": "Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.", "authors": "Garcia-Romeu A, Richards WA", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2018-08-01", "publication_year": 2018, "doi": "10.1080/09540261.2018.1486289", "pubmed_id": "30422079", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30422079/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30422079", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30422079/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30422079", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30422079/", "doi": "10.1080/09540261.2018.1486289", "pmid": "30422079", "publication_date": "2018-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2417, "title": "Taking Psychedelics Seriously.", "authors": "Byock I", "journal": "Journal of palliative medicine", "publication_date": "2018-04-01", "publication_year": 2018, "doi": "10.1089/jpm.2017.0684", "pubmed_id": "29356590", "openalex_id": "https://openalex.org/W2784340661", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29356590/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Emotional Processing,Spirituality,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29356590", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29356590/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29356590", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29356590/", "doi": "10.1089/jpm.2017.0684", "pmid": "29356590", "publication_date": "2018-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2424, "title": "Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.", "authors": "Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2018-02-02", "publication_year": 2018, "doi": "10.1016/j.pnpbp.2017.09.012", "pubmed_id": "28947181", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28947181", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28947181", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947181/", "doi": "10.1016/j.pnpbp.2017.09.012", "pmid": "28947181", "publication_date": "2018-02-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2430, "title": "The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.", "authors": "Sessa B", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4713-7", "pubmed_id": "28831571", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28831571/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28831571", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28831571/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28831571", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28831571/", "doi": "10.1007/s00213-017-4713-7", "pmid": "28831571", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2427, "title": "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.", "authors": "Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4771-x", "pubmed_id": "29119217", "openalex_id": "https://openalex.org/W2767530231", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29119217", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29119217", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29119217/", "doi": "10.1007/s00213-017-4771-x", "pmid": "29119217", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2425, "title": "The hidden therapist: evidence for a central role of music in psychedelic therapy.", "authors": "Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4820-5", "pubmed_id": "29396616", "openalex_id": "https://openalex.org/W2784069100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29396616/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29396616", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29396616/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29396616", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29396616/", "doi": "10.1007/s00213-017-4820-5", "pmid": "29396616", "publication_date": "2018-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5173, "title": "Psychedelics, the Spiritual and Consciousness-an Evolving Confluence in the Cultural Stream", "authors": "Phil Wolfson", "journal": "Tikkun", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1215/08879982-4354390", "pubmed_id": null, "openalex_id": "https://openalex.org/W2800678235", "source_url": "https://doi.org/10.1215/08879982-4354390", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Consciousness,Aging,Emotional Processing,Creativity,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "DOI:10.1215/08879982-4354390", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1215/08879982-4354390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1215/08879982-4354390", "source_url": "https://doi.org/10.1215/08879982-4354390", "doi": "10.1215/08879982-4354390", "pmid": "", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2441, "title": "Therapeutic Applications of Classic Hallucinogens.", "authors": "Bogenschutz MP, Ross S", "journal": "Current topics in behavioral neurosciences", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.1007/7854_2016_464", "pubmed_id": "28512684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Observational Study,In Vitro Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28512684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28512684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28512684/", "doi": "10.1007/7854_2016_464", "pmid": "28512684", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2397, "title": "Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.", "authors": "Schenberg EE", "journal": "Frontiers in pharmacology", "publication_date": "2018-01-01", "publication_year": 2018, "doi": "10.3389/fphar.2018.00733", "pubmed_id": "30026698", "openalex_id": "https://openalex.org/W2831064708", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30026698/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:25", "bibtex": null, "source_record_id": "PMID:30026698", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30026698/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30026698", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30026698/", "doi": "10.3389/fphar.2018.00733", "pmid": "30026698", "publication_date": "2018-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5181, "title": "„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku", "authors": "Joanna Stefaniuk", "journal": "CeON Repository (Centre for Evaluation in Education and Science)", "publication_date": "2017-12-01", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2771603125", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-08-09 08:25:51", "bibtex": null, "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://depot.ceon.pl/handle/123456789/13483", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "doi": "", "pmid": "", "publication_date": "2017-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2446, "title": "Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.", "authors": "Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR", "journal": "Clinical pharmacokinetics", "publication_date": "2017-12-01", "publication_year": 2017, "doi": "10.1007/s40262-017-0540-6", "pubmed_id": "28353056", "openalex_id": "https://openalex.org/W2600624779", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28353056", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28353056", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28353056/", "doi": "10.1007/s40262-017-0540-6", "pmid": "28353056", "publication_date": "2017-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2449, "title": "Psychedelic Drugs in Biomedicine.", "authors": "Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV", "journal": "Trends in pharmacological sciences", "publication_date": "2017-11-01", "publication_year": 2017, "doi": "10.1016/j.tips.2017.08.003", "pubmed_id": "28947075", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28947075", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28947075", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28947075/", "doi": "10.1016/j.tips.2017.08.003", "pmid": "28947075", "publication_date": "2017-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2454, "title": "LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.", "authors": "Larsen JK", "journal": "Nordic journal of psychiatry", "publication_date": "2017-10-01", "publication_year": 2017, "doi": "10.1080/08039488.2017.1336251", "pubmed_id": "28678583", "openalex_id": "https://openalex.org/W2727276162", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28678583/", "substance_tags": "psilocybin", "topic_tags": "OCD,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28678583", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28678583/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28678583", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28678583/", "doi": "10.1080/08039488.2017.1336251", "pmid": "28678583", "publication_date": "2017-10-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2459, "title": "Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.", "authors": "Andersson M, Persson M, Kjellgren A", "journal": "Harm reduction journal", "publication_date": "2017-09-05", "publication_year": 2017, "doi": "10.1186/s12954-017-0186-6", "pubmed_id": "28870224", "openalex_id": "https://openalex.org/W2751240458", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28870224/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety,Adverse Events", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28870224", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28870224/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28870224", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28870224/", "doi": "10.1186/s12954-017-0186-6", "pmid": "28870224", "publication_date": "2017-09-05", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2462, "title": "[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].", "authors": "Jeanne G, Purper-Ouakil D, Rigole H, Franc N", "journal": "L'Encephale", "publication_date": "2017-08-01", "publication_year": 2017, "doi": "10.1016/j.encep.2016.05.012", "pubmed_id": "27720453", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27720453/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Review Article,Adolescents,Healthcare Workers,Safety,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:27720453", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27720453/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27720453", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27720453/", "doi": "10.1016/j.encep.2016.05.012", "pmid": "27720453", "publication_date": "2017-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2467, "title": "Potential Therapeutic Effects of Psilocybin.", "authors": "Johnson MW, Griffiths RR", "journal": "Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics", "publication_date": "2017-07-01", "publication_year": 2017, "doi": "10.1007/s13311-017-0542-y", "pubmed_id": "28585222", "openalex_id": "https://openalex.org/W2622982732", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28585222", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28585222", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28585222/", "doi": "10.1007/s13311-017-0542-y", "pmid": "28585222", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2466, "title": "[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].", "authors": "Majić T, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J", "journal": "Fortschritte der Neurologie-Psychiatrie", "publication_date": "2017-07-01", "publication_year": 2017, "doi": "10.1055/s-0043-103085", "pubmed_id": "28768346", "openalex_id": "https://openalex.org/W2739569800", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28768346/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28768346", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28768346/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28768346", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28768346/", "doi": "10.1055/s-0043-103085", "pmid": "28768346", "publication_date": "2017-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5832, "title": "Should addiction researchers be interested in psychedelic science?", "authors": "Stephen Bright, M.L. Williams, David Caldicott", "journal": "Drug and Alcohol Review", "publication_date": "2017-04-10", "publication_year": 2017, "doi": "10.1111/dar.12544", "pubmed_id": "28397321", "openalex_id": "https://openalex.org/W2606394595", "source_url": "https://doi.org/10.1111/dar.12544", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Observational Study,Veterans,Safety,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:52", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "PMID:28397321", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/dar.12544", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:28397321", "source_url": "https://doi.org/10.1111/dar.12544", "doi": "10.1111/dar.12544", "pmid": "28397321", "publication_date": "2017-04-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2478, "title": "Psilocybin for treating substance use disorders?", "authors": "de Veen BT, Schellekens AF, Verheij MM, Homberg JR", "journal": "Expert review of neurotherapeutics", "publication_date": "2017-02-01", "publication_year": 2017, "doi": "10.1080/14737175.2016.1220834", "pubmed_id": "27684102", "openalex_id": "https://openalex.org/W2499216663", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27684102/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:27684102", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27684102/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27684102", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27684102/", "doi": "10.1080/14737175.2016.1220834", "pmid": "27684102", "publication_date": "2017-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2450, "title": "Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.", "authors": "Thomas K, Malcolm B, Lastra D", "journal": "Journal of psychoactive drugs", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.1080/02791072.2017.1320734", "pubmed_id": "28481178", "openalex_id": "https://openalex.org/W2612228298", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:28481178", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:28481178", "source_url": "https://pubmed.ncbi.nlm.nih.gov/28481178/", "doi": "10.1080/02791072.2017.1320734", "pmid": "28481178", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2447, "title": "The \"Endless Trip\" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.", "authors": "Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F", "journal": "Frontiers in psychiatry", "publication_date": "2017-01-01", "publication_year": 2017, "doi": "10.3389/fpsyt.2017.00240", "pubmed_id": "29209235", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/29209235/", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:26", "bibtex": null, "source_record_id": "PMID:29209235", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/29209235/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:29209235", "source_url": "https://pubmed.ncbi.nlm.nih.gov/29209235/", "doi": "10.3389/fpsyt.2017.00240", "pmid": "29209235", "publication_date": "2017-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2500, "title": "Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.", "authors": "Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116662634", "pubmed_id": "27578767", "openalex_id": "https://openalex.org/W2513336695", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27578767/", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27578767", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27578767/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27578767", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27578767/", "doi": "10.1177/0269881116662634", "pmid": "27578767", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2498, "title": "The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.", "authors": "Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116678781", "pubmed_id": "27856683", "openalex_id": "https://openalex.org/W2549202270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Wellbeing,Spirituality,Case Report,Observational Study,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27856683", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27856683", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856683/", "doi": "10.1177/0269881116678781", "pmid": "27856683", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2497, "title": "Psychedelics in the treatment of unipolar mood disorders: a systematic review.", "authors": "Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1177/0269881116679368", "pubmed_id": "27856684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27856684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27856684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27856684/", "doi": "10.1177/0269881116679368", "pmid": "27856684", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2486, "title": "Return of the psychedelics: Psilocybin for treatment resistant depression.", "authors": "Patra S", "journal": "Asian journal of psychiatry", "publication_date": "2016-12-01", "publication_year": 2016, "doi": "10.1016/j.ajp.2016.08.010", "pubmed_id": "27931907", "openalex_id": "https://openalex.org/W2512668841", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27931907", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27931907", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27931907/", "doi": "10.1016/j.ajp.2016.08.010", "pmid": "27931907", "publication_date": "2016-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5833, "title": "Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case", "authors": "Cornel N. Stanciu, Thomas M. Penders", "journal": "Current Psychiatry Reviews", "publication_date": "2016-08-10", "publication_year": 2016, "doi": "10.2174/1573400512999160803102947", "pubmed_id": null, "openalex_id": "https://openalex.org/W4242698627", "source_url": "https://doi.org/10.2174/1573400512999160803102947", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:52", "last_checked": "2026-08-09 08:25:52", "bibtex": null, "source_record_id": "DOI:10.2174/1573400512999160803102947", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/1573400512999160803102947", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/1573400512999160803102947", "source_url": "https://doi.org/10.2174/1573400512999160803102947", "doi": "10.2174/1573400512999160803102947", "pmid": "", "publication_date": "2016-08-10", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2511, "title": "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.", "authors": "Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ", "journal": "The lancet. Psychiatry", "publication_date": "2016-07-01", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30065-7", "pubmed_id": "27210031", "openalex_id": "https://openalex.org/W2396675581", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27210031/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:27210031", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/27210031/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:27210031", "source_url": "https://pubmed.ncbi.nlm.nih.gov/27210031/", "doi": "10.1016/s2215-0366(16)30065-7", "pmid": "27210031", "publication_date": "2016-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5248, "title": "The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)", "authors": "Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis", "journal": "European Psychiatry", "publication_date": "2016-02-29", "publication_year": 2016, "doi": "10.1016/j.eurpsy.2016.01.1060", "pubmed_id": null, "openalex_id": "https://openalex.org/W2376514477", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "doi": "10.1016/j.eurpsy.2016.01.1060", "pmid": "", "publication_date": "2016-02-29", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2522, "title": "The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.", "authors": "Di Lorenzo C, Coppola G, Di Lorenzo G, Bracaglia M, Rossi P, Pierelli F", "journal": "Cephalalgia: an international journal of headache", "publication_date": "2016-02-01", "publication_year": 2016, "doi": "10.1177/0333102415583145", "pubmed_id": "25903763", "openalex_id": "https://openalex.org/W1999427970", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25903763/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Headache / Migraine,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25903763", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25903763/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25903763", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25903763/", "doi": "10.1177/0333102415583145", "pmid": "25903763", "publication_date": "2016-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2523, "title": "Classic hallucinogens in the treatment of addictions.", "authors": "Bogenschutz MP, Johnson MW", "journal": "Progress in neuro-psychopharmacology & biological psychiatry", "publication_date": "2016-01-04", "publication_year": 2016, "doi": "10.1016/j.pnpbp.2015.03.002", "pubmed_id": "25784600", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25784600/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Mystical Experience,Clinical Trial,Meta-Analysis,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25784600", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25784600/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25784600", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25784600/", "doi": "10.1016/j.pnpbp.2015.03.002", "pmid": "25784600", "publication_date": "2016-01-04", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2540, "title": "Legal highs: staying on top of the flood of novel psychoactive substances.", "authors": "Baumeister D, Tojo LM, Tracy DK", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2015-04-01", "publication_year": 2015, "doi": "10.1177/2045125314559539", "pubmed_id": "26240749", "openalex_id": "https://openalex.org/W2098915861", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26240749/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Review Article,Animal Study,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:26240749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/26240749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:26240749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/26240749/", "doi": "10.1177/2045125314559539", "pmid": "26240749", "publication_date": "2015-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2545, "title": "Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.", "authors": "Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2015-03-01", "publication_year": 2015, "doi": "10.1177/0269881114565144", "pubmed_id": "25586396", "openalex_id": "https://openalex.org/W2075238613", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25586396/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25586396", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25586396/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25586396", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25586396/", "doi": "10.1177/0269881114565144", "pmid": "25586396", "publication_date": "2015-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2542, "title": "Psychedelics not linked to mental health problems or suicidal behavior: a population study.", "authors": "Johansen PØ, Krebs TS", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2015-03-01", "publication_year": 2015, "doi": "10.1177/0269881114568039", "pubmed_id": "25744618", "openalex_id": "https://openalex.org/W2097999899", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25744618/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25744618", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25744618/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25744618", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25744618/", "doi": "10.1177/0269881114568039", "pmid": "25744618", "publication_date": "2015-03-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2555, "title": "Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.", "authors": "Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2014-11-01", "publication_year": 2014, "doi": "10.1177/0269881114548296", "pubmed_id": "25213996", "openalex_id": "https://openalex.org/W2122459973", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25213996/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Biomarkers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25213996", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25213996/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25213996", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25213996/", "doi": "10.1177/0269881114548296", "pmid": "25213996", "publication_date": "2014-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2558, "title": "Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.", "authors": "Baumeister D, Barnes G, Giaroli G, Tracy D", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2014-08-01", "publication_year": 2014, "doi": "10.1177/2045125314527985", "pubmed_id": "25083275", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Spirituality,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:27", "bibtex": null, "source_record_id": "PMID:25083275", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25083275", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "doi": "10.1177/2045125314527985", "pmid": "25083275", "publication_date": "2014-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5300, "title": "PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A 2014 REPORT", "authors": "Robert L. Jesse, Roland R. Griffiths", "journal": "Council on Spiritual Practices", "publication_date": "2014-01-01", "publication_year": 2014, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2551216332", "source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "substance_tags": "psilocybin", "topic_tags": "Addiction,Wellbeing,Spirituality,Mystical Experience,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 09:00:16", "bibtex": null, "source_record_id": "http://csp.org/HopkinsPsilocybin2014.pdf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://csp.org/HopkinsPsilocybin2014.pdf", "source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "doi": "", "pmid": "", "publication_date": "2014-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5306, "title": "Literature review: Considerations for Psychedelic Research", "authors": "Charlesice Hawkins", "journal": "UC Merced Undergraduate Research Journal", "publication_date": "2013-12-20", "publication_year": 2013, "doi": "10.5070/m451020759", "pubmed_id": null, "openalex_id": "https://openalex.org/W2767418535", "source_url": "https://doi.org/10.5070/m451020759", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:53", "bibtex": null, "source_record_id": "DOI:10.5070/m451020759", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5070/m451020759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5070/m451020759", "source_url": "https://doi.org/10.5070/m451020759", "doi": "10.5070/m451020759", "pmid": "", "publication_date": "2013-12-20", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2573, "title": "Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.", "authors": "Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ", "journal": "Schizophrenia bulletin", "publication_date": "2013-11-01", "publication_year": 2013, "doi": "10.1093/schbul/sbs117", "pubmed_id": "23044373", "openalex_id": "https://openalex.org/W2122335802", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23044373/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Healthy Volunteers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23044373", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23044373/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23044373", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23044373/", "doi": "10.1093/schbul/sbs117", "pmid": "23044373", "publication_date": "2013-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5835, "title": "Exposure to Potent Hallucinogens in an Adolescent", "authors": "Deepak Prabhakar", "journal": "The Primary Care Companion For CNS Disorders", "publication_date": "2013-10-23", "publication_year": 2013, "doi": "10.4088/pcc.13l01552", "pubmed_id": "24511446", "openalex_id": "https://openalex.org/W1965375227", "source_url": "http://doi.org/10.4088/pcc.13l01552", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Receptor Pharmacology,Case Report,Adolescents,Safety,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-08-09 08:25:54", "last_checked": "2026-08-09 08:25:54", "bibtex": null, "source_record_id": "PMID:24511446", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://doi.org/10.4088/pcc.13l01552", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:24511446", "source_url": "http://doi.org/10.4088/pcc.13l01552", "doi": "10.4088/pcc.13l01552", "pmid": "24511446", "publication_date": "2013-10-23", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2577, "title": "A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.", "authors": "Burdick BV, Adinoff B", "journal": "The American journal of drug and alcohol abuse", "publication_date": "2013-09-01", "publication_year": 2013, "doi": "10.3109/00952990.2013.811513", "pubmed_id": "23968172", "openalex_id": "https://openalex.org/W2043530175", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23968172/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mystical Experience,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23968172", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23968172/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23968172", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23968172/", "doi": "10.3109/00952990.2013.811513", "pmid": "23968172", "publication_date": "2013-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5309, "title": "PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS", "authors": "Robin Carhart-Harris", "journal": "Journal of Neurology Neurosurgery & Psychiatry", "publication_date": "2013-08-06", "publication_year": 2013, "doi": "10.1136/jnnp-2013-306103.17", "pubmed_id": null, "openalex_id": "https://openalex.org/W2003006205", "source_url": "https://doi.org/10.1136/jnnp-2013-306103.17", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Personality Change,Spirituality,Mystical Experience,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-08-09 08:25:54", "bibtex": null, "source_record_id": "DOI:10.1136/jnnp-2013-306103.17", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/jnnp-2013-306103.17", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/jnnp-2013-306103.17", "source_url": "https://doi.org/10.1136/jnnp-2013-306103.17", "doi": "10.1136/jnnp-2013-306103.17", "pmid": "", "publication_date": "2013-08-06", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2581, "title": "Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.", "authors": "Helander A, Beck O, Hägerkvist R, Hultén P", "journal": "Scandinavian journal of clinical and laboratory investigation", "publication_date": "2013-08-01", "publication_year": 2013, "doi": "10.3109/00365513.2013.793817", "pubmed_id": "23692208", "openalex_id": "https://openalex.org/W2028152704", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23692208/", "substance_tags": "psilocin", "topic_tags": "Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23692208", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23692208/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23692208", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23692208/", "doi": "10.3109/00365513.2013.793817", "pmid": "23692208", "publication_date": "2013-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2595, "title": "Substance use initiation: the role of simultaneous polysubstance use.", "authors": "Olthuis JV, Darredeau C, Barrett SP", "journal": "Drug and alcohol review", "publication_date": "2013-01-01", "publication_year": 2013, "doi": "10.1111/j.1465-3362.2012.00470.x", "pubmed_id": "22612987", "openalex_id": "https://openalex.org/W1892791858", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22612987/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:22612987", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/22612987/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:22612987", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22612987/", "doi": "10.1111/j.1465-3362.2012.00470.x", "pmid": "22612987", "publication_date": "2013-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2582, "title": "Methoxetamine (MXE)--a phenomenological study of experiences induced by a \"legal high\" from the internet.", "authors": "Kjellgren A, Jonsson K", "journal": "Journal of psychoactive drugs", "publication_date": "2013-01-01", "publication_year": 2013, "doi": "10.1080/02791072.2013.803647", "pubmed_id": "24175493", "openalex_id": "https://openalex.org/W2060192760", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24175493/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Consciousness,Emotional Processing,Spirituality,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:24175493", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/24175493/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:24175493", "source_url": "https://pubmed.ncbi.nlm.nih.gov/24175493/", "doi": "10.1080/02791072.2013.803647", "pmid": "24175493", "publication_date": "2013-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2579, "title": "Psychedelics and mental health: a population study.", "authors": "Krebs TS, Johansen PØ", "journal": "PloS one", "publication_date": "2013-01-01", "publication_year": 2013, "doi": "10.1371/journal.pone.0063972", "pubmed_id": "23976938", "openalex_id": "https://openalex.org/W2014761647", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23976938/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:23976938", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/23976938/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:23976938", "source_url": "https://pubmed.ncbi.nlm.nih.gov/23976938/", "doi": "10.1371/journal.pone.0063972", "pmid": "23976938", "publication_date": "2013-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2602, "title": "Moral transhumanism: the next step.", "authors": "Tennison MN", "journal": "The Journal of medicine and philosophy", "publication_date": "2012-08-01", "publication_year": 2012, "doi": "10.1093/jmp/jhs024", "pubmed_id": "22855738", "openalex_id": "https://openalex.org/W2123238370", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22855738/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:22855738", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/22855738/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:22855738", "source_url": "https://pubmed.ncbi.nlm.nih.gov/22855738/", "doi": "10.1093/jmp/jhs024", "pmid": "22855738", "publication_date": "2012-08-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2616, "title": "The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.", "authors": "Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2011-11-01", "publication_year": 2011, "doi": "10.1177/0269881110367445", "pubmed_id": "20395317", "openalex_id": "https://openalex.org/W2051426845", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20395317/", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:20395317", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/20395317/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:20395317", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20395317/", "doi": "10.1177/0269881110367445", "pmid": "20395317", "publication_date": "2011-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2615, "title": "Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.", "authors": "Studerus E, Kometer M, Hasler F, Vollenweider FX", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2011-11-01", "publication_year": 2011, "doi": "10.1177/0269881110382466", "pubmed_id": "20855349", "openalex_id": "https://openalex.org/W1981740630", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20855349/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:20855349", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/20855349/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:20855349", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20855349/", "doi": "10.1177/0269881110382466", "pmid": "20855349", "publication_date": "2011-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2622, "title": "Harm potential of magic mushroom use: a review.", "authors": "van Amsterdam J, Opperhuizen A, van den Brink W", "journal": "Regulatory toxicology and pharmacology: RTP", "publication_date": "2011-03-31", "publication_year": 2011, "doi": "10.1016/j.yrtph.2011.01.006", "pubmed_id": "21256914", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/21256914/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 06:54:14", "bibtex": null, "source_record_id": "PMID:21256914", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/21256914/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:21256914", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21256914/", "doi": "10.1016/j.yrtph.2011.01.006", "pmid": "21256914", "publication_date": "2011-03-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2625, "title": "Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.", "authors": "Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J", "journal": "The Journal of neuroscience: the official journal of the Society for Neuroscience", "publication_date": "2011-02-02", "publication_year": 2011, "doi": "10.1523/jneurosci.4230-10.2011", "pubmed_id": "21289196", "openalex_id": "https://openalex.org/W2072898255", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21289196/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:21289196", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/21289196/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:21289196", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21289196/", "doi": "10.1523/jneurosci.4230-10.2011", "pmid": "21289196", "publication_date": "2011-02-02", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2626, "title": "Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.", "authors": "Meyer MR, Maurer HH", "journal": "Pharmacogenomics", "publication_date": "2011-02-01", "publication_year": 2011, "doi": "10.2217/pgs.10.171", "pubmed_id": "21332315", "openalex_id": "https://openalex.org/W2111087316", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21332315/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Safety,Drug Interactions,Genomics", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:21332315", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/21332315/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:21332315", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21332315/", "doi": "10.2217/pgs.10.171", "pmid": "21332315", "publication_date": "2011-02-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2627, "title": "Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.", "authors": "Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR", "journal": "Archives of general psychiatry", "publication_date": "2011-01-01", "publication_year": 2011, "doi": "10.1001/archgenpsychiatry.2010.116", "pubmed_id": "20819978", "openalex_id": "https://openalex.org/W2161555895", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20819978/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:20819978", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/20819978/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:20819978", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20819978/", "doi": "10.1001/archgenpsychiatry.2010.116", "pmid": "20819978", "publication_date": "2011-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2628, "title": "Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.", "authors": "Riley S, Thompson J, Griffin C", "journal": "The International journal on drug policy", "publication_date": "2010-11-01", "publication_year": 2010, "doi": "10.1016/j.drugpo.2010.07.001", "pubmed_id": "20810266", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/20810266/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Spirituality,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:28", "bibtex": null, "source_record_id": "PMID:20810266", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/20810266/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:20810266", "source_url": "https://pubmed.ncbi.nlm.nih.gov/20810266/", "doi": "10.1016/j.drugpo.2010.07.001", "pmid": "20810266", "publication_date": "2010-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5343, "title": "The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series", "authors": "Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie", "journal": "Cephalalgia", "publication_date": "2010-03-26", "publication_year": 2010, "doi": "10.1177/0333102410363490", "pubmed_id": "20713566", "openalex_id": "https://openalex.org/W2151828427", "source_url": "https://doi.org/10.1177/0333102410363490", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Case Report,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:05", "last_checked": "2026-08-09 08:25:55", "bibtex": null, "source_record_id": "PMID:20713566", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0333102410363490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:20713566", "source_url": "https://doi.org/10.1177/0333102410363490", "doi": "10.1177/0333102410363490", "pmid": "20713566", "publication_date": "2010-03-26", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5380, "title": "Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder", "authors": "J.C. Ballenger", "journal": "Yearbook of Psychiatry and Applied Mental Health", "publication_date": "2008-01-01", "publication_year": 2008, "doi": "10.1016/s0084-3970(08)70820-x", "pubmed_id": null, "openalex_id": "https://openalex.org/W2323886621", "source_url": "https://doi.org/10.1016/s0084-3970(08)70820-x", "substance_tags": "psilocybin", "topic_tags": "OCD,Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-08-09 08:25:55", "bibtex": null, "source_record_id": "DOI:10.1016/s0084-3970(08)70820-x", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0084-3970(08)70820-x", "source_url": "https://doi.org/10.1016/s0084-3970(08)70820-x", "doi": "10.1016/s0084-3970(08)70820-x", "pmid": "", "publication_date": "2008-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5387, "title": "Mad Thoughts on Mushrooms: Discourse and Power in the Study of Psychedelic Consciousness", "authors": "Andy Letcher", "journal": "Anthropology of Consciousness", "publication_date": "2007-09-01", "publication_year": 2007, "doi": "10.1525/ac.2007.18.2.74", "pubmed_id": null, "openalex_id": "https://openalex.org/W2131711520", "source_url": "https://doi.org/10.1525/ac.2007.18.2.74", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-08-09 08:25:55", "bibtex": null, "source_record_id": "DOI:10.1525/ac.2007.18.2.74", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1525/ac.2007.18.2.74", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1525/ac.2007.18.2.74", "source_url": "https://doi.org/10.1525/ac.2007.18.2.74", "doi": "10.1525/ac.2007.18.2.74", "pmid": "", "publication_date": "2007-09-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2675, "title": "The adverse effects of hallucinogens from intramural perspective.", "authors": "Frecska E, Luna LE", "journal": "Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology", "publication_date": "2006-12-01", "publication_year": 2006, "doi": null, "pubmed_id": "17211054", "openalex_id": "https://openalex.org/W110752286", "source_url": "https://pubmed.ncbi.nlm.nih.gov/17211054/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:34:29", "bibtex": null, "source_record_id": "PMID:17211054", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/17211054/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:17211054", "source_url": "https://pubmed.ncbi.nlm.nih.gov/17211054/", "doi": "", "pmid": "17211054", "publication_date": "2006-12-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2678, "title": "Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.", "authors": "Moreno FA, Wiegand CB, Taitano EK, Delgado PL", "journal": "The Journal of clinical psychiatry", "publication_date": "2006-11-01", "publication_year": 2006, "doi": "10.4088/jcp.v67n1110", "pubmed_id": "17196053", "openalex_id": "https://openalex.org/W2043197532", "source_url": "https://pubmed.ncbi.nlm.nih.gov/17196053/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:29", "bibtex": null, "source_record_id": "PMID:17196053", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/17196053/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:17196053", "source_url": "https://pubmed.ncbi.nlm.nih.gov/17196053/", "doi": "10.4088/jcp.v67n1110", "pmid": "17196053", "publication_date": "2006-11-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2700, "title": "Hallucinogens and dissociative agents naturally growing in the United States.", "authors": "Halpern JH", "journal": "Pharmacology & therapeutics", "publication_date": "2004-05-01", "publication_year": 2004, "doi": "10.1016/j.pharmthera.2004.03.003", "pubmed_id": "15163594", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/15163594/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:29", "bibtex": null, "source_record_id": "PMID:15163594", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/15163594/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:15163594", "source_url": "https://pubmed.ncbi.nlm.nih.gov/15163594/", "doi": "10.1016/j.pharmthera.2004.03.003", "pmid": "15163594", "publication_date": "2004-05-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2709, "title": "[Hallucinogens, amphetamines and entactogens].", "authors": "Vollenweider FX, Vollenweider-Scherpenhuyzen MF", "journal": "Therapeutische Umschau. Revue therapeutique", "publication_date": "2003-06-01", "publication_year": 2003, "doi": "10.1024/0040-5930.60.6.323", "pubmed_id": "12848067", "openalex_id": "https://openalex.org/W2145879190", "source_url": "https://pubmed.ncbi.nlm.nih.gov/12848067/", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:29", "bibtex": null, "source_record_id": "PMID:12848067", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/12848067/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:12848067", "source_url": "https://pubmed.ncbi.nlm.nih.gov/12848067/", "doi": "10.1024/0040-5930.60.6.323", "pmid": "12848067", "publication_date": "2003-06-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 5645, "title": "Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms", "authors": "Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Leszek Domański, Sławomir Majdanik, Edward Dutkiewicz, K Safranow, Tomasz Janus, V Mikolajek", "journal": "Acta Toxicologica", "publication_date": "2003-01-01", "publication_year": 2003, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W1435711203", "source_url": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:11", "last_checked": "2026-08-09 08:26:00", "bibtex": null, "source_record_id": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "source_url": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "doi": "", "pmid": "", "publication_date": "2003-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2721, "title": "Drugs of abuse monitoring in blood for control of driving under the influence of drugs.", "authors": "Moeller MR, Kraemer T", "journal": "Therapeutic drug monitoring", "publication_date": "2002-04-01", "publication_year": 2002, "doi": "10.1097/00007691-200204000-00003", "pubmed_id": "11897967", "openalex_id": "https://openalex.org/W2087988991", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11897967/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:30", "bibtex": null, "source_record_id": "PMID:11897967", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/11897967/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:11897967", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11897967/", "doi": "10.1097/00007691-200204000-00003", "pmid": "11897967", "publication_date": "2002-04-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2729, "title": "Patterns of recreational drug use at dance events in Edinburgh, Scotland.", "authors": "Riley SC, James C, Gregory D, Dingle H, Cadger M", "journal": "Addiction (Abingdon, England)", "publication_date": "2001-07-01", "publication_year": 2001, "doi": "10.1046/j.1360-0443.2001.967103513.x", "pubmed_id": "11440614", "openalex_id": "https://openalex.org/W2151598790", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11440614/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:30", "bibtex": null, "source_record_id": "PMID:11440614", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/11440614/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:11440614", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11440614/", "doi": "10.1046/j.1360-0443.2001.967103513.x", "pmid": "11440614", "publication_date": "2001-07-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2728, "title": "Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).", "authors": "Ho E, Karimi-Tabesh L, Koren G", "journal": "Neurotoxicology and teratology", "publication_date": "2000-12-31", "publication_year": 2000, "doi": "10.1016/s0892-0362(01)00178-7", "pubmed_id": "11792525", "openalex_id": "https://openalex.org/W2092775753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11792525/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 06:54:14", "bibtex": null, "source_record_id": "PMID:11792525", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/11792525/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:11792525", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11792525/", "doi": "10.1016/s0892-0362(01)00178-7", "pmid": "11792525", "publication_date": "2000-12-31", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2760, "title": "Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.", "authors": "Borowiak KS, Ciechanowski K, Waloszczyk P", "journal": "Journal of toxicology. Clinical toxicology", "publication_date": "1998-01-01", "publication_year": 1998, "doi": "10.3109/15563659809162584", "pubmed_id": "9541042", "openalex_id": "https://openalex.org/W2139748231", "source_url": "https://pubmed.ncbi.nlm.nih.gov/9541042/", "substance_tags": "psilocybin", "topic_tags": "Randomized Controlled Trial,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:30", "bibtex": null, "source_record_id": "PMID:9541042", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/9541042/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:9541042", "source_url": "https://pubmed.ncbi.nlm.nih.gov/9541042/", "doi": "10.3109/15563659809162584", "pmid": "9541042", "publication_date": "1998-01-01", "importer_version": "2.1.3", "text_redistributed": false } }, { "id": 2778, "title": "Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.", "authors": "Gable RS", "journal": "The American journal of drug and alcohol abuse", "publication_date": "1993-01-01", "publication_year": 1993, "doi": "10.3109/00952999309001618", "pubmed_id": "8213692", "openalex_id": "https://openalex.org/W2038786381", "source_url": "https://pubmed.ncbi.nlm.nih.gov/8213692/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-08-09 08:28:30", "bibtex": null, "source_record_id": "PMID:8213692", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/8213692/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:8213692", "source_url": "https://pubmed.ncbi.nlm.nih.gov/8213692/", "doi": "10.3109/00952999309001618", "pmid": "8213692", "publication_date": "1993-01-01", "importer_version": "2.1.3", "text_redistributed": false } } ] }